CV Prof Carlos Simon (1) · 2017-12-29 · 2011 Serono Symposia International Foundation (SSIF)...

CURRICULUM VITAE

Professor Carlos Simón MD, PhD.

1

Contents

Contact Details........................................................................................................................................3

Qualifications...........................................................................................................................................3

Current Appointments............................................................................................................................3

Fellowships..............................................................................................................................................3

Registration.............................................................................................................................................3

Visiting Professorships..........................................................................................................................3

Affiliations, Member of Societies...........................................................................................................4

Board Membership..................................................................................................................................4

National Research Committees..............................................................................................................4

Scholarships and Awards.......................................................................................................................4

Previous Appointments..........................................................................................................................6

Current Institutional Affiliation...............................................................................................................6

Committees and Leadership..................................................................................................................6

Peer Review Granting Bodies................................................................................................................7

Involvement in Scientific Disciplines....................................................................................................8

Panel of Referees for Granting Bodies..................................................................................................8

Panel of Referees for Professional Journals........................................................................................8

Previous, and Current Research Experience......................................................................................10

Research Interest..................................................................................................................................10

Patents....................................................................................................................................................11

Commercial Translation of Research..................................................................................................11

Governmental Grants Held as PI..........................................................................................................11

Grants from Scientific Societies and Pharma Companies Held as PI..............................................15

Publications...........................................................................................................................................18

Summary of Educational Accomplishments (CME)...........................................................................57

Invited Seminars / Symposium Presentations International Invitations..........................................62

Invited Seminars / Symposium Presentations National Invitations..................................................77

Undergraduate & Postgraduate Teaching, Past & Present Students...............................................82

Conference Organization......................................................................................................................85

Conference Presentations & Abstracts...............................................................................................87

2

Curriculum VitaeProfessor Carlos Simón MD, PhD.

Contact Details Igenomix SL

Calle Narcís Monturiol Estarriol nº11 Parcela B, Edificio Europark

Parque Tecnológico de Paterna

46980 - Paterna

Valencia, Spain

Tel: +34 963905095 (EA Susana Chorro)

Movil: +34 639 125 447

Fax: +34 96 390 2522

Email: [email protected]

Webs: www.carlos-simon.com; Igenomix

Qualifications 1985 MD Medicine and Surgery

School of Medicine; University of Valencia, Spain

1986 MD Excellence Award


1987 PhD Medicine and Surgery


1991 Board Certified in Ob/Gyn

University Clinic Hospital; University of Valencia, Spain

2005 – Present Académico Correspondiente Royal Academy of Medicine; Valencia

Current Appointments

Professor of Obstetrics and Gynecology, University of Valencia. Spain (since 2007) Department Obs/Gyn

Adjunct Clinical Professor of Obstetrics and Gynecology, Stanford University. USA (since 2013). Department Obs/Gyn - REI

Adjunct Professor of Obstetrics and Gynecology, Baylor College of Medicine. USA (since 2014)

Scientific Director, Instituto Valenciano de Infertilidad (IVI), Valencia. Spain (1994 - 2016) IVI

Scientific Director, Fundación IVI, Valencia. Spain (1994 - 2016) Fundacion IVI

Founder & Scientific Director, Igenomix SL. Biotec company located in Valencia (Spain) Miami,New York & Los Angeles (USA), Mexico City (Mexico), New Delhi (India), Sao Paulo (Brasil),Dubai (UAE), Montreal (Canada), Istanbul (Turkey) (since 2009), London (UK), Tokio (Japan)Igenomix

Fellowships 1983 Fellow in Obstetrics and Gynecology. Universität-Klinik of Mainz. Germany.

1991–1994 Research Fellowship in Reproductive Endocrinology. Stanford University.

USA. Post-doctoral Grant from the Spanish Government.

1997 Fellow in Reproductive Endocrinology. Stanford University. USA

Registration 1993 – Present College of Physicians of Valencia. Spain (#464612993) COMV

2005 – Present Royal Academy of Medicine; Valencia, Spain. RAMCV

Visiting Professorships

1997 University of Adelaide (Australia)

2006 The University of Hong Kong (Hong Kong)

2007 Yale University (USA)

3

Affiliations, Member Societies

• American Society for Reproductive Medicine (ASRM)

• European Society of Human Reproduction and Embryology (ESHRE)

• Society for Gynecologic Investigation (SGI)

• European Federation of Immunology and Reproduction (EFIR).

• Preimplantation Genetic Diagnosis International Society (PGDIS)

• International Society for Immunology of Reproduction (ISIR)

• American Association for the Advancement of Science (AAAS)

• American Society for Reproductive Immunology (ASRI)

• New York Academy of Sciences (NYAS)

• American Society for Cell Biology (ASCB)

• International Federation of Fertility Societies (IFFS)

• International Society for Stem Cell Research (ISSCR)

• Spanish Fertility Society (SEF)

• Spanish Obstetrics and Ginecology Society (SEGO)

• International Federation of Cervical Patology and Colposcopy (IFCPC)

• Colombian Asociation of Fertility and Sterility (ACFE)

• Member of the Evaluation Board for the Diabetes & Endocrinology Faculty of Faculty of 1000 Medicine

• Argentinean Society of Sterility and Fertility (SAEF)

Board Membership

2012 – 2016 Member of the Strategic Advisory Board of the Department of Development

and Regeneration, Katholieke Universiteit Leuven (Belgium)

2007 – 2011 Member of the Steering Committee and Scientific Advisory Board, European

Human Embryonic Stem Cells Registry (Germany)

2009 – 2016 Board of Equipo IVI

2012 – present Board of Igenomix

National Research Committees

2006 – 2011 Member of the National Stem Cell Bank Committee, Ministry of Health, Spanish

Government (Spain)

2004 – 2005 Member of the Working Group for the Spanish Biomedicine Research Law,

Ministry of Health, Spanish Government (Spain)

2006 Secretary of the National Faculty Selection Committee, Ministry of Education and

Science, Spanish Government. Call 2/645/2006V. Spain

4

Scholarships and Awards

2016 American Society for Reproductive Medicine (ASRM). Distinguished Research Award.

2016 Society for Reproductive Endocrinology and Infertility (SREI). Prize Paper.

2016 Society for Reproductive Investigation (SRI). Pfizer-SRI President's Presenter's Award. 63rd Annual Meeting, Montreal (Canada) (2 awards). Trainees Director

2015 Salud 2000 Foundation Award. Madrid (Spain)

2015 Society for Reproductive Investigation (SRI). New Investigator Plenary Session

Award. 62nd Annual Meeting, San Francisco (USA)

2015 Society for Reproductive Investigation (SRI), Best New Investigator Poster Award.

62nd Annual Meeting, San Francisco (USA)

2014 American Society for Reproductive Medicine (ASRM). KY Cha Award in Stem Cell

Technology. Honolulu (USA)

2014 Society for Reproductive Investigation (SRI), President’s Presenter Award. 61st Annual Meeting, Florence (Italy)

2012 European Society of Human Reproduction and Embryology (ESHRE). Basic Science Oral Presentation Award. 28th Annual Meeting, Istanbul (Turkey)

2011 Prize Rey Jaime I in Medical Investigation. Valencia (Spain)

2011 Serono Symposia International Foundation (SSIF) Award. Rewarding Scientific Excellence in Medical Education. 27th Annual Meeting of the European Society of Human Reproduction and Embryology. Stockholm (Sweden)

2011 – 2016 American Society for Reproductive Medicine (ASRM). Star Award (USA)


2009 Society for Gynecologic Investigation. President’s Presenter Award. 56th Annual Meeting, Glasgow (Scotland)

2009 Merck Serono. Award for the Innovation, Quality & Image in Assisted Reproduction.Madrid (Spain)

2009 Lab Times, News Magazine for the European Life Science. 12th Most Cited Author in Reproductive Biomedicine in Europe. Publication Analysis 1996-2007. http://www.labtimes.org/labtimes/ranking/2009_04/index.lasso

2008 American Society for Reproductive Medicine. Prize Paper Award. 64th Annual Meeting, San Francisco, California (USA)

2008 Independent Bibliometric Analysis classifies Carlos Simon as the 9th Most Productive Author in Reproductive Biology in the World, (González-Alcaide G. et al., Fertil Steril 90:941-56, 2008). PMID 18177648

2006 Clinic Hospital Foundation Research Award. Valencia (Spain)

2005 American Society for Reproductive Medicine. Prize Poster Award. 61st Annual Meeting conjoint to 51st Annual Meeting of the Canadian Fertility and Andrology Society. Montreal (Canada)

2004 World Academy of Science, Technology, Education and Humanities Award. “Two

First Stem Cells Lines in Spain”. Madrid (Spain)

2002 Society for Gynecologic Investigation. President’s Poster Award. 49th Annual Meeting, Los Angeles, California (USA)

2002 Spanish Fertility Society. Prize Paper Award. XXIV Annual Meeting, Palma de Mallorca (Spain)

2001 American Society for Reproductive Medicine. Prize Paper Award. 57th Annual Meeting, Orlando, Florida (USA)


2000 Spanish Fertility Society. Prize Paper Award. XXIII Annual Meeting, Sevilla (Spain)

1999 American Society for Reproductive Medicine. Prize Paper Award. 55th Annual Meeting conjoint to 45th Annual Meeting of the Canadian Fertility and Andrology Society, Toronto (Canada)

5


1999 Spanish Obstetrics and Gynecology Society Award. XXV Annual Meeting, Zaragoza (Spain)

1999 Spanish Obstetrics and Gynecology Society. 3rd Best Video Award. XXV Annual Meeting, Zaragoza (Spain)

1997 American Society for Reproductive Medicine. Prize Paper Award. 53th Annual Meeting, Cincinnati, Ohio (USA)

1997 Organon Award for the Best Poster In Contraception. XXV Annual Congress of the Spanish Obstetrics and Gynecology Society, Zaragoza (Spain)

1997 Medical College of Lugo Award. Most Innovative Video. V National Congres in Obstetrics and Gynecology Videos, Lugo (Spain)


1995 American Society for Reproductive Medicine. Prize Paper Award. 51th Annual Meeting, Seattle, Washington (USA)

1995 Valencian Obstetrics and Gynecology Society. Vicente Zaragozá Orts Award. Valencia (Spain)

1993 American Society for Reproductive Medicine. Prize Paper Award. 49th Annual Meeting, Montreal (Canada)

1993 Society for Gynecologic Investigation. President’s Poster Award. 40th Meeting, Toronto (Canada)

1992 Spanish Fertility Society. José A Portuondo Award. XVIII Annual Meeting, XIX Annual Meeting, Alicante (Spain)

1986 School of Medicine, University of Valencia. M.D. Degree Excellence Award. Valencia (Spain)

1984 School of Medicine, University of Valencia. López Sancho Award in Obstetrics and Gynecology. Valencia (Spain)

6

PreviousAppointments

2009 – 2012 President, BIOVAL (The Valencian Biotech Region) Valencia, Spain

2009 – 2011 Scientific Director, Prince Felipe Research Center. Valencia, Spain.

2005 – 2007 Coordinator, Department of Regenerative Medicine; Prince Felipe Research

Center. Valencia, Spain.

2004 – 2011 Director, Valencia Stem Cell Bank; Prince Felipe Research Center. Valencia,

Spain. Valencia Node of the Spanish National Bank of Stem Cells, Instituto de

Salud Carlos III, Ministry of Economy and Competitiveness, Spanish Government.

1999 – 2002 Secretary, Department of Obstetrics and Gynecology, University of Valencia (Spain)

1994 – 2007 Associate Professor, Department of Obstetrics and Gynecology, School of

Medicine, University of Valencia. Valencia, Spain.

1991 – 1994 Fellowship in Reproductive Endocrinology, Dept of Ob/Gyn, Stanford University,

USA

1991 Assistant Professor, Department of Obstetrics and Gynecology, School of


1987 – 1991 Resident in Obstetrics and Gynecology, Department of Obstetrics and

Gynecology, University Clinic Hospital of Valencia / University of Valencia, Spain.

1987 – 1990 Assistant Professor in Obtetrics, Gynecology and Breast Ultrasound,

Department of Obstetrics and Gynecology, University Clinic Hospital of

Valencia. University of Valencia, Spain.

1986 – 1987 Assistant Professor, College of Midwives, Clinic University Hospital. Spain

1983 – 1985 Undergraduate Mentor, Department of Obstetrics and Gynecology, School of


Current Institutional Affiliation

University of Valencia. INCLIVA, Spain.

Stanford University. CA, USA.

Baylor College of Medicine. TX, USA.

Igenomix SL. Valencia, Spain (Headquaters)

7

Committees and Leadership

2017 – present Chair-Elect, Regenerative Medicine and Stem Cell Biology Special Interest Group (RMSCBSIG) American Society for Reproductive Medicine (ASRM) 2016 Member of European Commission Scientific Committee2015 NIH Endometrium, Placenta, Implantation Research Focus Group (EPI RFG) (USA)2013 – present Committee Member for the KY Cha Award in Stem Cell Technology, American Society for Reproductive Medicine (USA)

2011 – present Member of the Advisory Committee, Serono Symposia International Foundation

(SSIF) (Switzerland)

2009 – 2012 President of Valencia Biotech Region of Biotechnology Companies (BIOVAL)

(Spain)

2009 – 2011 Coordinator of the Special Interest Group in Stem Cells, European Society of

Human Reproduction and Embryology (ESHRE) (Belgium)

2009 Member of the Faculty Selection Committee, University of Valencia (Spain)

2008 – 2015 Executive Committee, International Society of Gynecological Endocrinolgy (Italy)

2008 Member of the Educational Committee, Society for Gynecologic Investigation

(SGI) (USA)

2008 Scientific Committee of Honor of the Gynecological Endocrinology Latin-American

Association (ALEG) (Argentina)

2007 – 2017 Member of the International Advisory Committee. American Society for

Reproductive Medicine (ASRM)

2007 – 2009 Deputy of the Special Interest Group in Stem Cells, European Society of Human

Reproduction and Embryology (ESHRE) (Belgium)

2006 – 2011 Member of the National Stem Cell Bank Committee, Ministry of Health, Spanish

Government (Spain)

2006 – present Member of the Committee on Bioethics, University of Valencia (Spain)

2006 – 2008 Member of the International committee International Society for Stem Cell

Research (ISSCR) (USA)

2005 – 2007 Coordinator of Regenerative Medicine Working Group, Spanish Nanomedicine

Platform (Spain)

2004 – 2007 Member of the International Scientific Committee of the International Federation of

Fertility Societies (IFFS) (USA)

2004 – 2006 Secretary of Spanish Fertility Society (Spain)

2004 – 2005 President, Reproductive Inmunology Special Interest Group (RISIG) American

Society for Reproductive Medicine (ASRM) (USA)

2002 – 2004 Treasurer of Spanish Fertility Society (Spain)

2002 – 2003 Deputy of the Endometriosis/Endometrium Special Interest Group, European

Society of Human Reproduction and Embryology (ESHRE) (Belgium)

2002 – 2003 Secretary / Treasurer. Reproductive Inmunology Special Interest Group (RISIG)

American Society for Reproductive Medicine (ASRM) (USA)

2001 Member of Award Committee, Fundación SALUD 2000 (Spain)

2000 – 2002 Spanish Representative in the Advisory Committee of European Society of Human

Reproduction and Embryology (ESHRE) (Belgium)

1999 – present Member of the Scientific Committee, University of Valencia (Spain)

1997 – 2007 International Committee Society of Gynecological Investigation (USA)

1995 – 2004 Member Research Commission Department of Obstetrics and Gynecology,

University of Valencia (Spain)

8

Peer Review Granting Bodies

2001 – present Scientific Reviewer of the Health Research, Charity for Women and Babies

(WELLBEING) (UK)

2000 – present Scientific Reviewer National Health and Medical Research Council (NHMRC)

(Australia)

1997 – present Scientific Reviewer of The Wellcome Trust Foundation (UK)

2008 Scientific Reviewer of The Research Foundation Flanders (FWO) (Belgium)

2008 Scientific Reviewer of the The Estonian Science Foundation (ETF) (Estonia)

2007 Scientific Reviewer of the UK Stem Cells Foundation (UK)

2006 Scientific Reviewer of the Association Française contre les Myopathies (France)

2005 Scientific Reviewer of the Fundación Victor Grífols i Lucas (Spain)

2004 Scientific Reviewer of The Israel Science Foundation (ISF) (Israel)

2003 Scientific Project Advisor, University of California San Francisco (USA)

2002 Scientific Reviewer Fundación Centro Nacional de Investigaciones

Cardiovasculares, Instituto de Salud Carlos III, Spanish Govermment (Spain)

2001 Scientific Reviewer of the Health Research Board in Ireland (UK)

1997 John Guggenheim Memorial Foundation (USA)

1995 –1997 & 2009 German-Israeli Foundation for Scientific Research & Development (Israel)

Involvement in Scientific Disciplines

Professional Societies – Membership

2014 – 2019 Research Task Force, American Society for Reproductive Medicine (ASRM)2013 SGI New Investigator Advisory Group, Society for Gynecologic Investigation (USA)

2009 – present Scientific Reviewer. Endometriosis Association of Spain (Spain)

2007 Member of the Task Force of Clinical Trials, International Society for Stem Cell

Research (USA)

2006 – present Member of the Stem Cells Special Interest Group (ESHRE) (Belgium)

2001 – 2003 External International Advisor of Organon International (The Netherlands)

1998 – 2000 Consultant of Merck Serono SA (Switzerland)

1997 – 2007 Member of the Expert Advisory Panel on Reproductive Medicine, International

Federation of Gynecology & Obstetrics (FIGO) UK

9

Panel of Refereesfor Granting Bodies

Referee for grants from:

2015 Expert Referee to assess the Health System in Reproductive Medicine in Kuwait

1998 – 2014 Member of the Human Reproduction Program. Advisor of the Scientific and Ethical

Review Group, World Health Organization (Switzerland)

1999 – present National Agency of Evaluation and Prospective (ANEP), Spanish Government (Spain)

2002 – present Research Project Referee, Instituto de Salud Carlos III, Spanish Government (Spain)

2002 – 2006 Expert Referee of 6th Framework Program, European Commission (Belgium)

2008 – present Member of the Expert Panel, ACADEMIA Program for the National Accreditation,

National Agency for Quality Assessment and Accreditation (ANECA). Spanish

Government (Spain)

2008 Member of the Scientific Advisory Committee, Valencian Agency of Agency of

Evaluation and Prospective (AVAP). Valencian Govermment (Spain)

2007 Member of the Advisory Committee, Institute for Small and Medium Industry of

the Generalitat Valenciana (IMPIVA) (Spain)

2007 Referee for Projects of Excellence, Ministy of Innovation and Science,

Andalusian Agency of University Quality Evaluation Acreditation (Spain)

2006 Research Project Referee, Colombian Institute for the Development of Science

and Technology (Colombia)

2006, 2007, 2014 Royan International Research Award, Teheran, Iran

10

Panel of Refereesfor Professional Journals

Editor:

•••• Fertility and Sterilily (2016-present) Editorial Editor •••• Fertility and Sterilily (2011-2016) Associate Editor •••• Human Reproduction (2001-2007) Former Associate Editor

Editorial Boards of International Journals

•••• Frontiers in bioscience (since 1995)•••• Journal of Reproductive Immunology (since 1997)•••• American Journal of Reproductive Immunology (1997-2006)•••• Gynecological Endocrinology (since 1997)•••• Reproductive Sciences formerly known as the Journal of the Society for Gynecologic

Investigation (since 2000)•••• Gynecologic and Obstetric Investigation (2001-2004)•••• Reproduction (2002-2007)•••• European Journal of Endocrinology (2001-2004) •••• Reproductive Biomedicine Online (since 2004)•••• Regenerative Medicine (since 2006).•••• Journal of Endometriosis (since 2008)•••• Clinical and experimental reproductive medicine (CERM) (since 2011)•••• ISRN Obstetrics and Gynecology (since 2013)•••• Journal of Reproductive Health and Medicine (since 2014)

Editorial Boards of National Journals • Secretary and Member of the Editorial Board, Revista Iberoamericana de Fertilidad y

Reproducción Humana (since 2000) • Co-Editor, Cuadernos de Medicina Reproductiva (1995-2005)• Revista de Medicina Reproductiva, Centro de Estudios en Ginecología y Reproducción

(CEGYR). Argentina. (1997) • Novedades Terapéuticas en Reproducción Humana (Excerpta Medica, España).• Reproducción Humana. Revista de la Federación Latinoamericana de Sociedades de

Esterilidad y Fertilidad (F.L.A.S.E.F) since 2001• Medicina Reproductiva (Colombia) since 1998• Actualizaciones de la Sociedad Española de Fertilidad 2000 (SEF)• Miembro del Comité Científico del e-medicaljournal.net. sitio web para profesionales de la

medicina (Buenos Aires)• Obstetricia y Ginecología de Postgrado. Universidad de Valencia. Since 2003• Prgresos de Obstetricia y Ginecología. Revista oficial de la Sociedad Española de Obstetricia

y Ginecología.

AD HOC Reviewer for International Journals

• Nature Reviews Endocrinology (2016)• Nature Medicine (since 2011)• The Lancet (since 2007)• Proceeding of the National Academy of Science (since 2007)• Stem Cells (since 2007)• Stem Cells and Development (since 2007)• FASEB Journal, Federation of American Societies for Experimental Biology (since 2006)• Oncogene (since 2011)• Journal of Clinical Endocrinology and Metabolism (since 2000)• Human Reproduction Update (since 1998)

11

• Endocrinology (since 2000)• Human Reproduction (since 1995)• Molecular Human Reproduction (since 1996)• Human Molecular Genetics (since 2011)• Fertility and Sterility (since 1999) • Biology of Reproduction (since1994)• Reproductive Sciences formerly known as the Journal of the Society for

Gynecologic Investigation (since 2007)• Plos One (Since 2014)• Placenta (Since 2014)• Journal of Reproductive Immunology (since 2002)• International Journal of Gynecology and Obstetrics. Official publication of the International

Federation of Gynecology and Obstetrics (FIGO) (since 2004)• American Journal of Obstetrics and Gynecology (2003)• Annals of Biomedical Engineering (since 2002)• Asian Journal of Andrology (since 2002)• Cells Tissues Organs (since 2003)• Clinical Endocrinology (since 2001)• European Journal of Biochemistry (since1998)• European Journal of Obstetrics & Gynecology and Reproductive Biology (since 2000)• Journal of Cellular and Molecular Medicine (since 2006)• Journal of Endocrinological Investigation (since 1997)• Journal of Reproduction and Fertility/Reproduction (since 2000)• NEOPLASIA. An International Journal for Oncology Research (since 2001)• Journal of Assisted Reproduction and Genetics (since 2007)• Rejuvenation Research (since 2007)• Free Radical Biology and Medicine (since 2015)• Molecular and Cellular Endocrinology (since 2015)

12

Previous, and current research experience

Since 1991, I have contributed pioneering work in the study of human endometrial receptivity (Ruiz-Alonso M et al., Biochim Biophys Acta 2012 PMID: 22634130), embryo development and viability(Thouas et al., Endocr Rev 2015 PMID: 25548832), and the cross-communication between them(Vilella F, et al Development. 2015 PMID: 26395145), as well as the mechanisms that regulatehuman embryonic implantation (Cha J, Vilella F, Dey SK and Simón C. Science 2013, pp. [44-48]Science). I discovered the functional relevance of the interleukin-1 system in endometrial receptivity regulationand human embryonic implantation (Simon et al., Endocrinology 1994 PMID: 8299552) anddemonstrated the deleterious effect of high levels of estradiol on endometrial receptivity in patientswith high response to gonadotrophins, modifying established clinical practice and initiating theconcept of mild stimulation (Simon et al., Human Reprod 1995 PMID: 8530680). Using the humanendometrial side population in a xenograft murine model, my lab demonstrated the existence andthe functional proof of concept of human endometrial stem cells (Cervello et al., PlosOne 2010,2011, 2012 PMID: 20585575; PMID: 21712999; PMID: 22276168) that now are ready for clinicaltranslation with the promise to restore endometrium in women suffering from Asherman síndromeand atrophic endometrium (Human Reprod 1–10, 2016 doi:10.1093). Using microarray technology, Idiscovered the transcriptomic signature of human endometrial receptivity, publishing our findings in20 works as first or last author (Diaz-Gimeno et al., Fertil Steril 2011 PMID: 20619403), one of themis the 2nd most cited article in the journal Molecular Human Reproduction (Riesewijk et al, Mol HumRep 2003 PMID: 12728018). Clinical translation of this work resulted in a patent for the creation of acustomized endometrial receptivity array (ERA) EP2333107A1 for the molecular diagnosis ofendometrial receptivity in infertile patients, the creation of a biotech company (www.igenomix.com)and I have produced a free on line human endometrial gene expression database(www.endometrialdatabase.com) managed by University of Valencia. In an independent bibliometricanalysis of publications in Reproductive Biology between 2003 and 2005, I was identified as theninth most productive scientist in the world (Gonzalez-Alcaide et al., Fertil Steril 2008 PMID18177648).Since 2001, my work in human embryology allowed me to expand my research into the field of stemcells, resulting in the derivation, characterization, and registration in the National Stem Cell Bank(BNLC) of ten human embryonic stem cell lines (VAL-3,4,5,6M,7,8,9,9 /Oct-4, 10B & 11B hESCs). Ipioneered the first derivation of embryonic stem cell lines in Spain and described a new system forfreezing these cells in the absence of animal contaminants. I derived VAL-6M, the first Spanish linewith a monogenic disorder (Myotonic Dystrophy Type I VAL-6M) used as disease model by otherresearchers. I participated with the VAL lines in a collaborative study demonstrating the lack ofgenetic diversity in the most common used cell lines in the world (Mosher JT et al. N Engl J Med2009 PMID: 20018958). My pioneering work in this field made possible the creation of the ValenciaNode of the Spanish Stem Cell Bank in 2004, located in the Prince Felipe Research Center andfrom September 2009 to September 2011 I was Scientific Director of this Research Center. My labhas been working on the generation of artificial gametes using direct reprograming with 6 germ line-related factors in human somatic cells (Medrano JV, et al., Scientific Reports 2016).Recently, we have created a prediction model for aneuploidy in early human embryo developmentrevealed by single cell analysis. (Vera-Rodriguez et al., Nat Commun. 2015 PMCID: PMC4506544),together with the impact of mitochondrial DNA content as a viability score in human euploid embryos(Diez-Juan A , et al., Fertil Steril 2015 PMID: 26051102), and my opinion on this topic has beenconsidered in Cell Stem Cell (Diez-Juan A & Simón C. Cell Stem Cell 2015 PMID: 25957899).

13

Research interests

• Human Endometrial Receptivity

• Human Embryology

• Embryonic Implantation

• Endometrium

• Epigenetics and Reproduction

• Endometrial and Myometrial Stem Cells

• Testicular Stem Cells

• Endometriosis

• Reprograming

• Biomarkers in Reproductive Medicine

Patents • Simón C. Non-invasive preimplantation genetic analysis and related methods. Ref: 62/301,825.Owner: Igenomix SL

• Simón C, Medrano JV, Pellcer A. Direct conversion of human somatic cells to meiotic germ-likecells by genetics reprogramming. Ref: 62/048,493. Owner: Equipo IVI Investigación.

• Simón C, Santamaría X, Cervelló I, Pellicer A. Stem cell theraphy in endometrial pathologies.Ref: PCT/IB2015/001715. Owner: Igenomix SL

• Simón C, Garrido-Gómez T, Pellicer A. Early detection of preeclampsia. Ref:PCT/US2015/021495. Owner: Igenomix SL

• Simón C, Horcajadas JA, Diaz-Gimeno P, Pellicer A. Gene Expression profile as an endometrialreceptivity marker. Ref: PCT/ES2009/000386. Owner: Igenomix SL

• Simón C, Pellicer A, Berlanga O. Diagnostic method for endometrial receptivity. Ref:PCT/EP2011/050867. Owner: Igenomix SL.

• Sánchez Madrid F, Yañez Mo M, Domínguez F, Simón C. Use of CD98 as endometrialreceptivity marker. Ref: PCT/ES2010/070744. Owner: Fundación IVI, UAMD - UniversidadAutónoma de Madrid / CNIC - Fundación Centro Nacional de Investigaciones CardiovascularesCarlos III

• Pellicer A, Simón C, Gómez R. The use of dopamine agonist to prevent ovarianhyperstimulation. Ref: PCT/IB2006/000989. Owner: Fundación Instituto Valenciano deInfertilidad, sold to Ferring S.A.

• Pellicer A, Simón C, Novella E. The use of dopamine agonist to treat endometriosis. Ref:PCT/IB2008/001273. Owner: Fundación Instituto Valenciano de Infertilidad, sold to Ferring S.A.

• Simón C, Blesa D, Pellicer A. Massive failure Diagnosis of the mature oocyte generation incontrolled ovarian stimulation treatments. Ref: EP12382032.6. Owner: Igenomix SL.

• Simón C, Ruiz-Vela A, Aguilar-Gallardo C. Methods for tumor treatment and adipogenesisdifferentiation. Ref: PCT/EP2011/004941. Owner: Centro de Investigación Príncipe Felipe.

• Krtolica A, Simón C, Foulk R. Methods and compositions relating to embryonic stem cell lines.Ref: PCT/US2005/046953. Owner: StemLifeLine, Inc.

• Krtolica A, Simón C, Foulk R. Methods and systems relating to embryonic stem cell lines. Ref:PCT/US2005/047178. Owner: StemLifeLine, Inc.

• Polan ML, Simón C. Methods of contraception. Ref: PCT/US1994/011588. Owner: Personal.• Escribá MJ, Simón C, Pellicer A. Method of producing cell lines. Ref: PCT/ES2002/000116.

Owner: Fundación IVI.Commercial translation of research

The technological impact of my clinical research originated 14 international Patent Applications, asinventor or co-inventor, leading to the creation of a Biotech Company in the field of Genomics inReproductive Medicine Igenomix SL. http://www.igenomix.com with operations in Valencia (Spain)Miami, New York & Los Angeles (USA), Mexico City (Mexico), New Delhi (India), Sao Paulo (Brasil),Dubai (UAE), Montreal (Canada), Istanbul (Turkey), London (UK), Tokyo (Japan), Rome (Italy)Igenomix

2012-2015 Scientific Advisory Board of Ovascience (Boston)2005-2007 Scientific Advisory Board of Anecova S.A. (Switzerland)

14

Governmental Grants Held as PI

Grant Title of Project Amount ($)

2016

BFU2015-72131-EXP

Spanish Ministry of Economy and Competitivity

Cryptochromes, the inexplicable presence of light sensors in the darkness conecting early embryo with the cosmos

60,000 €

3 years

SAF2015-67154-R


Maternal Transcriptomic Regulation of the Pre-implantation Embryo. A novel mechanism to understand the origin of adult diseases such as obesity and/or related to tobacco exposure

169,400 €

3 years

2015

2R01HD032067-19

National Institutes of Health Grant (NIH). USA

Bone Morphogenic Protein Signaling Pathways In Uterine Biology.

PI of sub-project 2

328,888 USD

1 year

2014

PTQ-13-06133

Spanish Ministry of Economy and Competitiveness

Endometrial microbiome analysis, diagnosis and treatment using probiotics to improve endometrial receptivity in infertile patients.

69,300 €

4 years

2013

PTQ-12-05320

Spanish Ministry of Economy and Competitiveness

Critical studies for the acquisition of new knowledge to improve the diagnosis service “Endometrial Receptivity Array” (ERA)

85,000 €

3 years

SARM 324509

FP 7. Marie Curie Program. European Commission

Endometrial and Embryonic Genomics, Searching for Biomarkers in Assisted Reproduction.

668,759.63 €

4 years

PROMETEOII/2013/018

Conselleria d’Educació, Generalitat Valenciana.

Specific identification markers of endometrial somatic stem cells. From animal models to cell therapy.

287,000 €

4 years

2012

15

Etorgai ER-2012/00020

Basque Government, Spain

NEOBIO: New products for reproductive and prenatal health 280,601 €

3 years

SAF2012-31017


Demostration of Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 5 (Lgr5) as an Endometrial Stem Cell Marker. From Animal Models to Human Endometrial Stem Cell Therapy and Tissue Engineering.

120,000 €

3 years

EC11-299

Spanish Ministry of Health

New Strategies in the Therapeutics of Asherman’s Syndrome and Endometrial Atrophy Based in the Autologous Tranplantations of BoneMarrow Stem Cells.

91,707 €

2 years

2011

E!6478-NOTED

Eurostars-Eureka Programme, European Comission.

Non-invasive Tests for Endometrial Dysfunction – Novel Clinical Perspectives for Infertility and Endometriosis Diagnostics.

159,082 €

4 years

2010

FI 10/00813

Carlos III Health Institute, Spanish Ministry of Health

(Mentoring PhD Student)

Role of IMPL-1 Receptor and its Ligand in Embryo Implantation. 85,200 €

5 years

2009

SAF2008-02048

Spanish Ministry of Science and Innovation

Isolation and characterization of endometrial somatic stem cells in endometriosis. Pathogenic and therapeutic implications

175,450 €

3 years

AECI. A/018463/08

Spanish Ministry of Foreign Affairs and Cooperation

Localization, isolation and characterization of somatic stem cells in myomas.

20,000 €

1 year

RD09/0076/00063


Biobank network. RETICS 5,750 €

4 years

2008

PROMETEO/2008/163

Conselleria d’Educació, Generalitat Valenciana.

Isolation and characterization of endometrial somatic stem cells in endometriosis. Pathogenic and therapeutic implications.

703,250 €

6 years

16

Etorgai. IEI08-003

Basque Government, Spain

Biomics - Personalized medicine applied to the clinical diagnosis 238,179 €

3 years

2007

RD06/0010/1006


Cell Therapy Network 276,067.05 €

6 years

2005

FP6-2005-LIFESCIHEALTH-6, proposal nº 037820 – EU hESC registry.

European Commission, Research Directorate General, Programme: “Integrating and strengthening the European Research Area”

European human embryonic stem cell registry

Chief Investigator: Joeri Borstlap

1,000,000 €

3 years

2004

SAF2004-00204

Spanish Ministry of Science and Technology

Identification, Characterization and Isolation of Adult Stem Cells in theHuman Endometrium. Endometrial Implications and Endometrial Cancer.

81,750 €

4 years

2003

PI021169

Spanish Ministry of Health.

Study of Gene and Functional Expression of the Leptin System in the Human Endometrium Related with Obesity and Infertility

67,850 €

3 years

GRUPOS03/043

Agència Valenciana de Ciencia i Tecnología. Generalitat Valenciana

Genomics and Proteomics of Human Reproduccion. Grants for R&D Groups

45,509.51 €

3 years

SAF2002-11085-E


“Molecular mechanisms of embryo implantation” Grant for the Project Submission to the European Commission. Grant to prepare the coordination of an European Network.

18,000 €

1 year

2002

CIG-02-85

Program for ContraceptiveResearch & Development. CONRAD

Paan-AG as a Contraceptive Target in Baboon 49,200 $

2 years

2001

17

SAF2001-2948


Gene and Functional Study of the Human Endometrial Receptivity 109,973.19 €

4 years

2000

FIS 00/0643


Induction of Apoptosis in the Endometrial Epithelium as a Key Mechanism of Embryo Implantation

64,623.83 €

3 years

1998

FIS 98/0855 Embryo Effect of the Integrins α1, α2, β3 y αvβ3 Regulation in the Human Endometrial

71,069.68 €

3 years

1996

FIS 96/1263


Production of Interleukin-1P, IL-1P and IL-1 Antagonist Receptor byHuman Embryo Cocultured with Endometrial Cells as PotentialMarker in Endometrial Implantation

48,982.49 €

3 years

FONDECYT n. 1961175 Spanish Ministry of Education and Science. Latin America CooperationProgram

Autocrine-Paracrine Steroid Syntesis Regulation in the Normal Corpus Luteum and Patients with Endomtetriosis. The Role of the Cytokines

17,429.35 €

4 years

1995

FIS 95/1352


Role of Interleukin-1 System in Human Implantation: the Antagonist Receptor as Potential Marker in Endometrial Implantation

49,583.50 €

3 years

1994

931614.

NATO International Scientific Exchange Programmes

Interleukin-1 in Human Implantation. 22,748 $

2 years

Grants from Scientific Societies and Pharma Companies Held as PI

Grant Title of Project Amount ($)

2014

KY Cha Award in Stem Cell Technology

American Society for Reproductive Medicine

Direct conversion of human somatic cells to meiotic germ-like cells by genetic reprogarmming.

20,000 USD

3 years

2013

18

Grant for Fertility Innovation (GFI)EMD Serono Research Institute, Inc.

Analysis of miRNAs in endometrial fluid as a tool for noninvasive diagnosis of endometrial receptivity

239,600 €

2 years

2010

Grant for Fertility Innovation (GFI)

EMD Serono Research Institute, Inc.

A Non-Invasive Diagnostic Method of Human Endometrial Receptivity Status Based on a Specific Lipidomic Profiling in Endometrial Fluid

329,600 €

3 years

Gent per Gent Foundation 08/09

Characterization of Neoplastic Stem Cells in Endometrial Cancer. Pathogenic, Pronostic and Therapeutic implications.

54,418 €

3 years

2004

PR 3034

PANTARHEI BIOSCIENCE B.V.

Prevention of premature LH-surge and enhancement of implantation rate by combined treatment with recombinant LH and a high dose GnRH antagonist.

363,960 €

1 year

Schering AG Project New gene targets for female interception and the adhesion model for screening compounds.

150,000 €

2 years

Bertarelli Foundation Project

Proteomic pattern secreted by viable blastocyst as a diagnostic tool toaccomplish single births after IVF.

67,960 €

3 years

ANECOVA SA. Development of an intrauterine device systemTM using the encapsulation technology for assisted in vivo culture of male and female gametes or preimplantatory embryos in mammalian species.

18,000 €

1 year

2003

IMP-24070

MERCK SERONO

Multicenter, randomized, doble-blind Pilot Study, Placebo-Controlled to compare the efficacy and safety of r-hLIF (emfilermina) to improve embryo implantation after In-Vitro Fertilization and Embryo Transfer inwomen with recurrente implantation Failure

63,000 €

2 years

2002

N. V. ORGANON Effect of IVF treatment on regulation of endometrial receptivity genes in time.

16,666 $

1 year

2001

N. V. ORGANON Embryonic and hormonal gene regulation of human endometrial epithelial cells.

16,666 $

2 years

N. V. ORGANON Differential effect of hCG, FSH and GnRH on the regulation of endometrial receptivity gene expression in superovulated cycles

16,666 $

1 year

19

1999

N. V. ORGANON Regulation of endometrial receptivity in superovulated cycles with gonadotrophins.

41,400 $

2 years

1998

N. V. ORGANON Feasibility study for the analysis of differential gene expression in human endometrium biopsias.

12,500 $

1 year

20

Publications At ISI Web of Knowledge (http://apps.isiknowledge.com) Prof. Carlos Simon is author of 423publications in international peer-review journals, adding up to an accumulated impact factor of1,962.505. His papers have received a total of 16,459 cites with an average of 39 cites/paper. His H-Index is 71. Updated Pubmed Publication List: http://www.ncbi.nlm.nih.gov/myncbi/simon_c

Peer Reviewed Articles in International Journals2017

• Garrido-Gomez T, Dominguez F, Quiñonero A, Diaz-Gimeno P, Kapidzic M, Gormley M, Ona K,Padilla-Iserte P, McMaster M, Genbacev O, Perales A, Fisher SJ, Simón C. Defectivedecidualization during and after severe preeclampsia reveals a possible maternal contribution tothe etiology. Proc Natl Acad Sci U S A. 2017; 114(40):8468-77.

• Salsano S, Quiñonero A, Pérez S, Garrido Gómez T, Simón C, Domínguez F. Dynamicexpression of PGRMC1 and SERBP1 in human endometrium: an implication in the humandecidualization process. Fertil Steril. 2017; 108(5):832-842.e1

• Altmäe S, Koel M, Võsa U, Adler P, Suhorutšenko M, Laisk-Podar T, Kukushkina V, Saare M,Velthut-Meikas A, Krjustškov K, Aghajanova L, Lalitkumar PG, Gemzell-Danielsson K, Giudice L,Simón C, Salumets A. Meta-signature of human endometrial receptivity: a meta-analysis andvalidation study of transcriptomic biomarkers. Sci Rep. 2017; 7(1):10077.

• Díaz-Gimeno P, Ruiz-Alonso M, Sebastian-Leon P, Pellicer A, Valbuena D, Simón C. Window ofimplantation transcriptomic stratification reveals different endometrial subsignatures associatedwith live birth and biochemical pregnancy. Fertil Steril. 2017; 108(4):703-710,e3

• Simón C. Introduction: To transfer or not transfer…a mosaic embryo, that is the question. FertilSteril. 2017; 107(5):1083-1084.

• Valbuena D, Valdes CT, Simón C. Introduction: Endometrial function: facts, urban legends, andan eye to the future. Fertil Steril. 2017; 108(1):4-8.

• Valdes CT, Schutt A, Simón C. Implantation failure of endometrial origin: it is not pathology, butour failure to synchronize the developing embryo with a receptive endometrium. FertilSteril. 2017; 108(1):15-18.033.

• Rubio C, Bellver J, Rodrigo L, Castillón G, Guillén A, Vidal C, Giles J, Ferrando M, Cabanillas S,Remohí J, Pellicer A, Simón C. In vitro fertilization with preimplantation genetic diagnosis foraneuploidies in advanced maternal age: a randomized, controlled study. Fertil Steril. 2017;107(5):1122-1129.

• Domínguez F, Ferrando M, Díaz-Gimeno P, Quintana F, Fernández G, Castells I, Simón C.Lipidomic profiling of endometrial fluid in women with ovarian endometriosis†. Biol Reprod. 2017;96(4):772-779.

• Simón C. Why should patients experience infertility or poor outcomes before using assistedreproductive technologies? Fertil Steril. 2017; 107(4):878-879.

• Garrido-Gomez T, Ona K, Kapidzic M, Gormley M, Simón C, Genbacev O, Fisher SJ. Severepre-eclampsia is associated with alterations in cytotrophoblasts of the smooth chorion.Development. 2017; 144(5):767-777.

• Comstock IA, Diaz-Gimeno P, Cabanillas S, Bellver J, Sebastian-Leon P, Shah M, Schutt A,Valdes CT, Ruiz-Alonso M, Valbuena D, Simón C, Lathi RB. Does an increased body mass indexaffect endometrial gene expression patterns in infertile patients? A functional genomics analysis.Fertil Steril. 2017; 107(3):740-748.e2.

• Mas A, Stone L, O'Connor PM, Yang Q, Kleven D, Simón C, Walker CL, Al-Hendy A.Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem CellCompartment as a Prerequisite to Leiomyoma Tumorigenesis. Stem Cells. 2017; 35(3):666-678.

• Ferrero H, Buigues A, Martínez J, Simón C, Pellicer A, Gómez R. A novel homologous model fornoninvasive monitoring of endometriosis progression. Biol Reprod. 2017; 96(2):302-312.

• Cervelló I, Gil-Sanchis C, Santamaría X, Faus A, Vallvé-Juanico J, Díaz-Gimeno P, Genolet O,Pellicer A, Simón C. Leucine-rich repeat-containing G-protein-coupled receptor 5-positive cells inthe endometrial stem cell niche. Fertil Steril. 2017; 107(2):510-519.e3.

• Campo H, Baptista PM, López-Pérez N, Faus A, Cervelló I, Simón C C. De- and recellularizationof the pig uterus: a bioengineering pilot study. Biol Reprod. 2017; 96(1):34-45.

• Mas A, Prusinski L, Yang Q, Diaz-Gimeno P, Stone L, Diamond MP, Simón C, Al-Hendy A. Roleof Stro1+/CD44+ stem cells in myometrial physiology and uterine remodeling during pregnancy.

22

Biol Reprod. 2017; 96(1):70-80. • Campo H, Cervelló I, Simón C. Bioengineering the Uterus: An Overview of Recent Advances and

Future Perspectives in Reproductive Medicine. Ann Biomed Eng. 2017; 45(7):1710-17172016

• Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, Alonso R,Alamá P, Remohí J, Pellicer A, Ramon D, Simón C. Evidence that the endometrial microbiota hasan effect on implantation success or failure. Am J Obstet Gynecol. 2016 Dec;215(6):684-703. doi:10.1016/j.ajog.2016.09.075. Epub 2016 Oct 4. PubMed PMID: 27717732.

• Sanchez-Delgado M, Court F, Vidal E, Medrano J, Monteagudo-Sánchez A, Martin-Trujillo A,Tayama C, Iglesias-Platas I, Kondova I, Bontrop R, Poo-Llanillo ME, Marques-Bonet T,Nakabayashi K, Simón C, Monk D. Human Oocyte-Derived Methylation Differences Persist in thePlacenta Revealing Widespread Transient Imprinting. PLoS Genet. 2016 Nov11;12(11):e1006427.

• Medrano JV, Rombaut C, Simón C, Pellicer A, Goossens E. Human spermatogonial stem cellsdisplay limited proliferation in vitro under mouse spermatogonial stem cell culture conditions.Fertil Steril. 2016 Aug 1;PubMed PMID: 27490045.

• Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Fiorentino F,Gleicher N, Griesinger G, Grifo J, Handyside A, Harper J, Kokkali G, Mastenbroek S, Meldrum D,Meseguer M, Montag M, Munné S, Rienzi L, Rubio C, Scott K, Scott R, Simón C, Swain J, TreffN, Ubaldi F, Vassena R, Vermeesch JR, Verpoest W, Wells D, Geraedts J. The why, the how andthe when of PGS 20: current practices and expert opinions of fertility specialists, molecularbiologists, and embryologists. Mol Hum Reprod. 2016; 22(8):845-57.

• Santamaria X, Katzorke N, Simón C. Endometrial 'scratching': what the data show. Curr OpinObstet Gynecol. 2016; 28(4):242-9.

• Strug MR, Su R, Young JE, Dodds WG, Shavell VI, Díaz-Gimeno P, Ruiz-Alonso M, Simón C,Lessey BA, Leach RE, Fazleabas AT. Intrauterine human chorionic gonadotropin infusion inoocyte donors promotes endometrial synchrony and induction of early decidual markers forstromal survival: a randomized clinical trial. Hum Reprod. 2016; 31(7):1552-61.

• Katzorke N, Vilella F, Ruiz M, Krüssel JS, Simón C. Diagnosis of Endometrial-Factor Infertility:Current Approaches and New Avenues for Research. Geburtshilfe Frauenheilkd. 2016; 76(6):699-703.

• Medrano JV, Martínez-Arroyo A, Miguez JM, Moreno-Gimeno I, Martinez S, Quiñonero A, Diaz-Gimeno P, Marques-Mari AI, Pellicer A, Remohi J, Simón C. Human somatic cells subjected togenetic reprogramming wiht 6 germ line-related factors display meiotic germ cell-like features.Scientific Reports. 2016; 6:24956.

• Meldrum DR, Casper RF, Diez-Juan A, Simón C, Domar AD, Frydman R. Aging and theenvironment affect gamete and embryo potential: can we intervene? Fertil Steril. 2016; 105(3):548-59

• Franasiak JM, Ruiz-Alonso M, Scott RT, Simón C. Both slowly developing embryos and avariable pace of luteal endometrial progression may conspire to prevent normal birth in spite of acapable embryo. Fertil Steril. 2016; 105(4): 861-6.

• Vera-Rodríguez M, Michel CE, Mercader A, Bladon AJ, Rodrigo L, Kokocinski F, Mateu E, Al-Asmar N, Blesa D, Simón C, Rubio C. Distribution patterns of segmental aneuploidies in humanblastocysts identified by next-generation sequencing. Fertil Steril. 2016; 105(4): 1047-1055.e2.

•••• García-Pascual CM, Ferrero H, Juarez I, Martínez J, Villanueva A, Pozuelo-Rubio M, Soengas M,Tormo D, Simón C, Gómez R, Pellicer A. Evaluation of the antiproliferative, proapoptotic, andantiangiogenic effects of a double-stranded RNA mimic complexed with polycations in anexperimental mouse model of leiomyoma. Fertil Steril. 2016; 105(2): 529-38.

• Santamaria X, Cabanillas S, Cervelló I, Arbona C, Raga F, Ferro J, Palmero J, Remohí J, PellicerA, Simón C. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractoryAsherman's syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016; 31(5):1087–1096.

• Mir P, Mateu E, Mercader A, Herrer R, Rodrigo L, Vera M, Peinado V, Milán-Sánchez M, Campos-

23

Galindo I, García-Herrero S, Simón C, Rubio C. Confirmation rates of array-CGH in day-3embryo and blastocyst biopsies for preimplantation genetic screening. J Assist Reprod Genet.2016; 33(1): 59-66.

• Galán A, Simón C. Monitoring Stemness in Long-Term hESC Cultures by Real-Time PCR.Methods Mol Biol. 2016; 1307: 89-104.

2015

• Vera-Rodriguez M, Chavez SL, Rubio C, Reijo Pera RA, Simón C. Prediction model foraneuploidy in early human embryo development revealed by single cell analysis. Nat Commun.2015; 6:7601.

• Simón C, Sakkas D, Gardner DK, Critchley HO. Biomarkers in reproductive medicine: the questfor new answers. Hum Reprod Update. 2015; 21(6): 695-7.

• Thouas GA, Domínguez F, Green M, Vilella F, Simón C, Gardner DK. Soluble Ligands and theirReceptors in Human Embryo Development and Implantation. Endocr Rev. 2015; 36(1): 92-130.

• Diez-Juan A, Simón C. Converting a Problem into an Opportunity: mtDNA Heteroplasmy Shift.Cell Stem Cell. 2015 May 7; 16(5): 457-8.

• Vilella F, Moreno-Moya JM, Balaguer N, Grasso A, Herrero M, Martínez S, Marcilla A, Simón C.Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryoand might modify its transcriptome. Development. 2015; 142(18): 3210-21.

• Gómez E, Ruíz-Alonso M, Miravet J, Simón C. Human Endometrial Transcriptomics: Implicationsfor Embryonic Implantation. Cold Spring Harb Perspect Med. 2015; 5(7): a022996.

• Zdravkovic T, Nazor KL, Larocque N, Gormley M, Donne M, Hunkapillar N, Giritharan G,Bernstein HS, Wei G, Hebrok M, Zeng X, Genbacev O, Mattis A, McMaster MT, Krtolica A,Valbuena D, Simón C, Laurent LC, Loring JF, Fisher SJ. Human stem cells from singleblastomeres reveal pathways of Embryonic or trophoblast fate specification. Development. 2015;142(23): 4010-25.

• Galliano D, Bellver J, Díaz-García C, Simón C, Pellicer A. ART and uterine pathology: howrelevant is the maternal side for implantation. Hum Reprod Update. 2015; 21(1): 13-38.

• Martin J, Asan, Yi Y, Alberola T, Rodríguez-Iglesias B, Jiménez-Almazán J, Li Q, Du H, Alama P,Ruiz A, Bosch E, Garrido N, Simón C. Comprehensive carrier genetic test using next-generationdeoxyribonucleic acid sequencing in infertile couples wishing to conceive through assistedreproductive technology. Fertil Steril. 2015; 104(5): 1286-93.

• García-Pascual CM, Martínez J, Calvo P, Ferrero H, Villanueva A, Pozuelo-Rubio M, Soengas M,Tormo D, Simón C, Pellicer A, Gómez R. Evaluation of the potential therapeutic effects of adouble-stranded RNA mimic complexed with polycations in an experimental mouse model ofendometriosis. Fertil Steril. 2015; 104(5): 1310-8.

• Kawamura K, Cheng Y, Sun YP, Zhai J, Diaz-Garcia C, Simón C, Pellice A, Hsueh AJ. Ovarytransplantation: to activate or not to activate. Hum Reprod. 2015; 30(11): 2457-60.

• Vassena R, Eguizabal C, Heindryckx B, Sermon K, Simón C, van Pelt AMM, Veiga A, Zambelli F;on behalf of the ESHRE special interest group Stem Cells. Stem cells in reproductive medicine:ready for the patient? Hum Reprod. 2015; 30(9): 2014-21.

• Garcia-Velasco JA, Fassbender A, Ruiz-Alonso M, Blesa D, D'Hooghe T, Simón C. Isendometrial receptivity transcriptomics affected in women with endometriosis? A pilot study.Reprod Biomed Online. 2015; 31(5): 647-54.

• Moreno JM, Núñez MJ, Quiñonero A, Martínez S, de la Orden M, Simón C, Pellicer A, Díaz-García C, Domínguez F. Follicular fluid and mural granulosa cells microRNA profiles vary in invitro fertilization patients depending on their age and oocyte maturation stage. Fertil Steril. 2015;104(4): 1037-1046.e1.

• Rekker K, Saare M, Roost AM, Kaart T, Sõritsa D, Karro H, Sõritsa A, Simón C, Salumets A,Peters M. Circulating miR-200-family micro-RNAs have altered plasma levels in patients withendometriosis and vary with blood collection time. Fertil Steril. 2015; 104(4): 938-946.e2.

24

• Dominguez F, Meseguer M, Aparicio-Ruiz B, Piqueras P, Quiñonero A, Simón C. New strategy fordiagnosing embryo implantation potential by combining proteomics and time-lapse technologies.Fertil Steril. 2015; 104(4): 908-14.

• Ferrero H, García-Pascual CM, Pellicer N, Simón C, Pellicer A, Gómez R. Dopamine agonistinhibits vascular endothelial growth factor protein production and secretion in granulosa cells.Reprod biol Endocrinol. 2015; 13(1): 104.

• Cervelló I, Gil-Sanchis C, Santamaría X, Cabanillas S, Díaz A, Faus A, Pellicer A, Simón C.Human CD133 bone marrow-derived stem cells promote endometrial proliferation in a murinemodel of Asherman syndrome. Fertil Steril. 2015; 104(6): 1552-1560.e3.

• Cervelló I, Santamaría X, Miyazaki K, Maruyama T, Simón C. Cell Therapy and TissueEngineering from and toward the Uterus. Semin Reprod Med. 2015; 33(5): 366-72.

• Moreno I, Míguez-Forjan JM, Simón C. Artificial gametes from stem cells. Clin Exp Reprod Med.2015; 42(2): 33-44.

• Mas A, Nair S, Laknaur A, Simón C, Diamond MP, Al-Hendy A. Stro-1/CD44 asputative humanmyometrial and fibroid stem cell markers. Fertil Steril. 2015; 104(1): 225-34.e3.

• Gil-Sanchis C, Cervelló I, Khurana S, Faus A, Verfaillie C, Simón C. Contribution of different bonemarrow-derived cell types in endometrial regeneration using an irradiated murine model. FertilSteril. 2015; 103(6): 1596-605.

• Aleixandre-Benavent R, Simón C, Fauser BC. Trends in clinical reproductive medicine research:10 years of growth. Fertil Steril. 2015; 104(1): 131-7.e5.

• Diez-Juan A , Rubio C, Marin C, Martinez S, Al-Asmar N, Riboldi M, Díaz-Gimeno P, Valbuena D,Simón C. Mitochondrial DNA content as a viability score in human euploid embryos: Less isbetter. Fertil Steril. 2015; 1004(3): 534-541.e1.

• Mas A, Cervelló I, Fernández-Álvarez A, Faus A, Díaz A, Burgués O, Casado M, Simón C.Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in humanmyometrial cells induces leiomyoma-like tissue formation. Mol Hum Reprod. 2015 Apr;21(4): 330-8.

• Campos-Galindo I, García-Herrero S, Martínez-Conejero JA, Ferro J, Simón C, Rubio C.Molecular analysis of products of conception obtained by hysteroembryoscopy from infertilecouples. J Assist Reprod Genet. 2015 May;32(5):839-48.

• Miravet-Valenciano JA, Rincon-Bertolin A, Vilella F, Simón C. Understanding and improvingendometrial receptivity. Curr Opin Obstet Gynecol. 2015 Jun;27(3): 187-92.

2014

• Martínez-Arroyo AM, Medrano JV, Remohí J, Simón C. Germ line development: lessons learnfrom pluripotent stem cells. Curr Opin Genet Dev. 2014; 28C: 64-70.

• Simón C, Bosch E, Bellver J. Endometrial scratching for women with repeated implantationfailure. Hum Reprod. 2014; 29(8): 1618-21.

• Garrido-Gómez T, Quiñonero A, Antúnez O, Díaz-Gimeno P, Bellver J, Simón C, Domínguez F.Deciphering the proteomic signature of human endometrial receptivity. Hum Reprod. 2014; 29(9):1957-67.

• Blesa D, Ruiz-Alonso M, Simón C. Clinical Management of Endometrial Receptivity. SeminReprod Med. 2014; 32(5): 410-4.

• Medrano JV, Martinez-Arroyo AM, Sukhwani M, Noguera I, Quiñonero A, Martinez-Jabaloyas JM,Pellicer A, Remohí J, Orwig KE, Simón C. Germ cell transplantation into mouse testes procedure.Fertil Steril. 2014; 102(4): e11-2.

• Ferrero H, García-Pascual CM, Gaytán M, Morales C, Simón C, Gaytán F, Pellicer A, Gómez R.Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in anovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSSwith dopamine receptor 2 agonists. Fertil Steril. 2014; 102(5): 1468-76.

• Nejat EJ, Ruiz-Alonso M, Simón C, Meier UT. Timing the window of implantation by nucleolar

25

channel system prevalence matches the accuracy of the endometrial receptivity array. FertilSteril. 2014; 102(5): 1477-81.

• Simón C. Introduction: Are we advancing in our scientific understanding and therapeuticimprovement of uterine fibroids… or not? Fertil Steril. 2014; 102(3): 611-2.

• Glasier AF, Gemzell-Danielsson K, Bouchard P, Genazzani A, Al-Azzawi F, Berga S, BirkhauserM, Brincat M, de Melo NR, Foidart JM, Kenemans P, Lunenfeld B, Maruo T, Milewicz A, NaftolinF, Ng EH, Schindler AE, Simón C, Simoncini T, Simpson E, Siseles N, Smetnik V, Tarlatzis BC,von Schoultz B. ISGE statement on oral emergency contraception. Gynecol Endocrinol. 2014;30(10): 681-2.

• Rodrigo L, Mateu E, Mercader A, Cobo AC, Peinado V, Milán M, Al-Asmar N, Campo- Galindo I,García-Herrero S, Mir P, Simón C, Rubio C. New tools for embryo selection: Comprehensivechromosome screening by array comparative genomic hybridization. BioMed ResearchInternational. 2014: 51712.Más A, Cervello I, Gil-Sanchís C, Simón C. Current understanding ofsomatic stem cells in leiomyoma formation. Fertil Steril. 2014; 102(3): 613-20.

• Simón C, Bosch E, Bellver J. Endometrial scratching for women with repeated implantationfailure. Reply. Hum Reprod. 2014; 29(12): 2856-7.

• García-Pascual CM, Ferrero H, Zimmermann RC, Simón C, Pellicer A, Gómez R. Inhibition ofDelta-like 4 mediated signaling induces abortion in mice due to deregulation of decidualangiogenesis. Placenta. 2014; 35(7): 501-8.

• Medrano JV, Simón C, Pera RR. Human germ cell differentiation from pluripotent embryonicstem cells and induced pluripotent stem cells. Methods Mol Biol. 2014; 1154: 563-78.

• García-Herrero S, Campos-Galindo I, Martínez-Conejero JA, Serra V, Olmo I, Lara C, Simón C,Rubio C. BACs-on-Beads Technology: A reliable test for rapid detection of aneuploidies andmicrodeletions in prenatal diagnosis. Biomed Res Int. 2014: 590298.

• Ruiz-Alonso M, Galindo N, Pellicer A, Simón C. what a difference two days make: “personalized”embryo tranfer (pET) paradigm: a case report and pilot study. Hum Reprod. 2014; 29(6): 1244-7.

• Bermejo A, Iglesias C, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, Gracía-Velasco J. Theimpact of using the combined oral contraceptive pill for cycle scheduling on gene expressionrelated to endometrial receptivity. Hum Reprod. 2014; 19(6): 1271-8.

• Moreno-Moya JM, Vilella F, Martínez S, Pellicer A, Simón C. The transcriptomic and proteomiceffects of ectopic overexpression of miR-30d in human endometrial epithelial cells. Mol HumReprod. 2014; 20(6): 550-66.

• Romanelli V, Nakabayashi K, Vizoso M, Moran S, Iglesias-Platas I, Sugahara N, Simón C, HataK, Esteller M, Court F, Monk D. Variable maternal methylation overlapping the nc886/vtRNA2-1locus is locked between hypermethylated repeats and is frequently altered in cancer. Epigenetics.2014; 9(5): 783-90.

• Court F, Tayama C, Romanelli V, Martin-Trujillo A, Iglesias-Platas I, Okamura K, Sugahara N,Simón C, Moore H, Harness JV, Keirstead H, Sanchez-Mut JV, Kaneki E, Lapunzina P, SoejimaH, Wake N, Esteller M, Ogata T, Hata K, Nakabayashi K, Monk D. Genome-wide parent-of-originDNA methylation analysis reveals the intricacies of human imprinting and suggests a germlinemethylation-independent mechanism of establishment. Genome Res. 2014; 24(4): 554-69.

• Ferrero H, García-Pascual CM, Gómez R, Delgado-Rosas F, Cauli O, Simón C, Gaytán F,Pellicer A. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factorsecretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopaminereceptor 2 agonists. Fertil Steril. 2014;101(5):1411-18.

• Díaz-Gimeno P, Ruiz-Alonso M, Blesa D, Simón C. Transcriptomics of the human endometrium.Int J Dev Biol. 2014; 58(2-3-4): 127-37.

• Moreno-Moya JM, Vilella F, Simón C. MicroRNA: key gene expression regulators. Fertil Steril.2014; 101(6): 1516-23.

• Dominguez F, Moreno-Moya JM, Lozoya T, Romero-Espinos A, Martínez S, Monterde M, GurreaM, Ferri B, Núñez MJ, Simón C, Pellicer A. Embryonic miRNA profiles of normal and ectopicpregnancies. PloS One. 2014; 9(7): 102185.

• Moreno-Moya JM, Ramírez L, Vilella F, Martínez S, Quiñonero A, Noguera I, Pellicer A, Simón C.Complete method to obtain, culture, and transfer mouse blastocysts nonsurgically to studyimplantation and development. Fertil Steril. 2014 Mar;101(3):e13.

26

• Bermejo A, Cerrillo M, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, Garcia-Velasco JA. Impactof final oocyte maturation using gonadotropin-releasing hormone agonist triggering and differentluteal support protocols on endometrial gene expression. Fertil Steril. 2014 Jan;101(1):138-146.e3.

• Altmäe S, Esteban FJ, Stavreus-Evers A, Simón C, Giudice L, Lessey BA, Horcajadas JA,Macklon NS, D'Hooghe T, Campoy C, Fauser BC, Salamonsen LA, Salumets A. Guidelines forthe design, analysis and interpretation of 'omics' data: focus on human endometrium. HumReprod Update. 2014 Jan-Feb;20(1):12-28.

• Lozoya T, Dominguez F, Romero-Ruiz A, Steffani L, Martínez S, Monterde M, Ferri B, Núñez MJ,Romero-Espinos A, Zamora O, Gurrea M, Sangiao-Alvarellos S, Vega O, Simón C, Pellicer A,Tena-Sempere M. The Lin28/Let-7 system in early human embryonic tissue and ectopicpregnancy. PloS One. 2014; 9(1):e87698

2013

• Cha J, Vilella F, Dey SK and Simón C. “Molecular Interplay in Successful Implantation” in TenCriticalTopics in Reproductive Medicine, S. Sanders, Ed. (Science/AAAS, Washington, DC,2013), pp. [44-48].

• Vilella F, Ramirez L, Berlanga O, Martínez S, Alamá P, Meseguer M, Pellicer A, Simón C. PGE2and PGF2α concentrations in human endometrial fluid as biomarkers for embryonic implantation.J Clin Endocrinol Metab. 2013; 98(10): 4123-32.

• Belmar-Lopez C, Mendoza G, Oberg D, Burnet J, Simón C, Cervello I, Iglesias M, Ramirez JC,Lopez-Larrubia P, Quintanilla M, Martin-Duque P. Tissue-derived mesenchymal stromal cells usedas vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumorgrowth. BMC Med. 2013; 28(11): 139.

• García-Pascual CM, Zimmermann RC, Ferrero H, Shawber CJ, Kitajewski J, Simón C, Pellicer A,Gómez R. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven lutealangiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells. FertilSteril. 2013; 100(6): 1768-76.

• Simón C. Personalized ART. Fertil Steril. 2013; 100(4): 922-3.• Gil-Sanchis C, Cervello I, Más A, Faus A, Pellicer A, Simón C. Leucine-rich repeat-containing G-

protein-coupled receptor 5 (Lgr5) as a putative human endometrial stem cell marker. Mol HumReprod. 2013; 19(7): 407-14.

• Vilella F, Ramirez LB, Simón C. Lipidomics as an emerging tool to predict endometrial receptivity.Fertil Steril. 2013; 99(4): 1100-6.

• Garrido-Gómez T, Ruiz-Alonso M, Blesa D, Diaz-Gimeno P, Vilella F, Simón C. Profiling the genesignature of endometrial receptivity: clinical results. Fertil Steril. 2013; 99(4): 1078-85.

• Martín J, Cerveró A, Mir P, Martínez-Conejero JA, Simón C. The impact of next-generationsequencing technology on preimplantation genetic diagnosis and screening. Fertil Steril. 2013;99(4): 1054-61.

• Rubio C, Rodrigo L, Mir P, Mateu E, Peinado V, Milán M, Al-Asmar N, Campos-Galindo I, GarciaS, Simón C. Use of array comparative genomic hybridization (array-CGH) for embryoassessment: clinical results. Fertil Steril. 2013; 99(4): 1044-8.

• Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De Los Santos MJ, Giles J, LabartaE, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C. Preimplantation genetic screening usingfluorescence in situ hybridization in patients with repetitive implantation failure and advancedmaternal age: two randomized trials. Fertil Steril. 2013; 99(5): 1400-7.

• Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, CarreraJ, Vilella F, Pellicer A, Simón C. The endometrial receptivity array (ERA) for diagnosis andpersonalised embryo transfer (pET) as a treatment for patients with repeated implantation failure(RIF). Fertil Steril. 2013; 100(3): 818-24.

• Galan A, Diaz-Gimeno P, Poo ME, Valbuena D, Sanchez E, Ruiz V, Dopazo J, Montaner D,Conesa A, Simón C. Defining the genomic signature of totipotency and pluripotency during earlyhuman development. PLoS One. 2013; 8(4): e62135.

• Simón C, Barnhart K. Preface. Biomarkers in reproductive medicine. Fertil Steril. 2013; 99(4): 953.• Dominguez F, Castello D, Remohí J, Simón C, Cobo A. Effect of vitrification on human oocytes: a

metabolic profiling study. Fertil Steril. 2013; 99(2): 565-572.e3. • Díaz-Gimeno P, Ruiz-Alonso M, Blesa D, Bosch N, Martínez-Conejero JA, Alamá P, Garrido N,

Pellicer A, Simón C. The accuracy and reproducibility of the endometrial receptivity array is superior

27

to histology as a diagnostic method for endometrial receptivity. Fertil Steril. 2013; 99(2): 508-17. • Mir P, Rodrigo L, Mercader A, Buendía P, Mateu E, Milán-Sánchez M, Peinado V, Pellicer A,

Remohí J, Simón C, Rubio C. False positive rate of an arrayCGH platform for single-cellpreimplantation genetic screening and subsequent clinical application on day-3. J Assist ReprodGenet. 2013; 30(1): 143-9.

• Cervelló I, Mas A, Gil-Sanchis C, Simón C. Somatic stem cells in the human endometrium.Semin Reprod Med. 2013; 31(1): 69-76.

• Medrano JV, Pera RA, Simón C. Germ cell differentiation from pluripotent cells. Semin ReprodMed. 2013; 31(1): 14-23.

• Aguilar-Gallardo C, Simón C. Cells, stem cells, and cancer stem cells. Semin Reprod Med. 2013;31(1): 5-13.

• Simón C. Stem cells helping reproductive medicine. Semin Reprod Med. 2013; 31(1): 3-4. •••• Ruiz-Alonso M, Vilella F, Blesa D, Simón C. Genomics and secretomics of endometrial

receptivity. Clinical translation (Conference Paper). Giornale Italiano di Obstetricia e Ginecologia.2013; 35(1) 100-9.

2012

• Ruiz-Alonso M, Blesa D, Simón C. The genomics of the human endometrium. Biochim BiophysActa. 2012; 1822(12): 1931-42.

• Sánchez-Ribas I, Riqueros M, Vime P, Puchades-Carrasco L, Jönsson T, Pineda-Lucena A,Ballesteros A, Domínguez F, Simón C. Differential metabolic profiling of non-pure trisomy 21human preimplantation embryos. Fertil Steril. 2012; 98(5): 1157-64.

• Garrido-Gómez T, Dominguez F, Quiñonero A, Estella C, Vilella F, Pellicer A, Simón C. AnnexinA2 is critical for embryo adhesiveness to the human endometrium by RhoA activation through F-actin regulation. FASEB J. 2012; 26(9): 3715-27.

• Riboldi M, Rubio C, Pellicer A, Gil-Salom M, Simón C. In vitro production of haploid cells aftercoculture of CD49f+ with Sertoli cells from testicular sperm extraction in nonobstructiveazoospermic patients. Fertil Steril. 2012; 98(3): 580-590.e4.

• Mas A, Cervelló I, Gil-Sanchis C, Faus A, Ferro J, Pellicer A, Simón C. Identification andcharacterization of the human leiomyoma side population as putative tumor-initiating cells. FertilSteril. 2012; 98(3): 741-751.e6.

• Paule S, Aljofan M, Simón C, Rombauts LJ, Nie G. Cleavage of endometrial α-integrins into theirfunctional forms is mediated by proprotein convertase 5/6. Hum Reprod. 2012; 27(9): 2766-74.

• Aguilar-Gallardo C, Rutledge EC, Martínez-Arroyo AM, Hidalgo JJ, Domingo S, Simón C.Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches. Stem CellRev. 2012; 8(3): 994-1010.

• Simón C. Somatic stem cells and tissue engineering shed light on unsolved clinical issues inreproductive medicine: in stem cells we trust. Fertil Steril. 2012; 98(1): 1-2.

• Al-Asmar N, Peinado V, Vera M, Remohí J, Pellicer A, Simón C, Hassold T, Rubio C.Chromosomal abnormalities in embryos from couples with a previous aneuploid miscarriage.Fertil Steril. 2012; 98(1): 145-50.

• Evans GE, Martínez-Conejero JA, Phillipson GT, Simón C, McNoe LA, Sykes PH, HorcajadasJA, Lam EY, Print CG, Sin IL, Evans JJ. Gene and protein expression signature of endometrialglandular and stromal compartments during the window of implantation. Fertil Steril. 2012; 97(6):1365-73.e1-2.

• Ferrero H, Delgado-Rosas F, Garcia-Pascual CM, Monterde M, Zimmermann RC, Simón C,Pellicer A, Gómez R. Efficiency and purity provided by the existing methods for the isolation ofluteinized granulosa cells: a comparative study. Hum Reprod. 2012; 27(6): 1781-9.

• Niakan KK, Han J, Pedersen RA, Simón C, Pera RA. Human pre-implantation embryodevelopment. Development. 2012; 139(5): 829-41.

• Medrano JV, Ramathal C, Nguyen HN, Simón C, Reijo Pera RA. Divergent RNA-bindingproteins, DAZL and VASA, induce meiotic progression in human germ cells derived in vitro. StemCells. 2012; 30(3): 441-51.

• García-Velasco JA, Kupesic S, Pellicer A, Bourgain C, Simón C, Mrazek M, Devroey P, Arce JC.Follicular and endocrine profiles associated with different GnRH-antagonist regimens: arandomized controlled trial. Reprod Biomed Online. 2012; 24(2): 153-62.

• Valbuena D, Póo ME, Aguilar-Gallardo C, Martinez S, Cobo AC, Pellicer A, Simón C. Comparison

28

of Cryotip vs. Cryotop for mouse and human blastomere vitrification. Fertil Steril. 2012; 97(1):209-17.

• Galán A, Simón C. Human embryonic stem cells derived in xeno-free conditions. Methods MolBiol. 2012; 873: 13-32.

• Estella C, Herrer I, Moreno-Moya JM, Quiñonero A, Martínez S, Pellicer A, Simón C. miRNAsignature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoSOne. 2012; 7(7): e41080.

• Estella C, Herrer I, Atkinson SP, Quiñonero A, Martínez S, Pellicer A, Simón C. Inhibition ofhistone deacetylase activity in human endometrial stromal cells promotes extracellular matrixremodelling and limits embryo invasion. PLoS One. 2012; 7(1): e30508.

• Cervelló I, Gil-Sanchis C, Mas A, Faus A, Sanz J, Moscardó F, Higueras G, Sanz MA, Pellicer A,Simón C. Bone marrow-derived cells from male donors do not contribute to the endometrial sidepopulation of the recipient. PLoS One. 2012; 7(1): e30260.

• Carcel-Trullols J, Aguilar-Gallardo C, Garcia-Alcalde F, Pardo-Cea MA, Dopazo J, Conesa A,Simón C. Transdifferentiation of MALME-3M and MCF-7 cells toward adipocyte-like cells isdependent on clathrin-mediated endocytosis. Springerplus. 2012; 1: 44.

2011

• Heng S, Cervero A, Simón C, Stephens AN, Li Y, Zhang J, Paule S, Rainczuk A, Singh H,Quinonero A, Tapia A, Velasquez L, Salamonsen L, Rombauts LJ, Nie G. Proprotein convertase5/6 is critical for embryo implantation in women: regulating receptivity by cleaving EBP50,modulating ezrin binding, and membrane-cytoskeletal interactions. Endocrinology. 2011; 152(12):5041-52.

• Evian Annual Reproduction (EVAR) Workshop Group 2010, Fauser BC, Diedrich K, Bouchard P,Domínguez F, Matzuk M, Franks S, Hamamah S, Simón C, Devroey P, Ezcurra D, Howles CM.Contemporary genetic technologies and female reproduction. Hum Reprod Update. 2011; 17(6):829-47. Erratum in: Hum Reprod Update. 2012; 18(2): 231.

• Delgado-Rosas F, Gómez R, Ferrero H, Gaytan F, Garcia-Velasco J, Simón C, Pellicer A. Theeffects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model ofendometriosis. Reproduction. 2011; 142(5): 745-55.

• Ruiz-Vela A, Aguilar-Gallardo C, Martínez-Arroyo AM, Soriano-Navarro M, Ruiz V, Simón C.Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells towardadipocyte-like cells. Stem Cell Rev. 2011; 7(4): 898-909.

• Martínez-Conejero JA, Morgan M, Montesinos M, Fortuño S, Meseguer M, Simón C, HorcajadasJA, Pellicer A. Adenomyosis does not affect implantation, but is associated with miscarriage inpatients undergoing oocyte donation. Fertil Steril. 2011; 96(4): 943-50.

• Díaz-García C, Estella C, Perales-Puchalt A, Simón C. Reproductive medicine and inheritance ofinfertility by offspring: the role of fetal programming. Fertil Steril. 2011; 96(3): 536-45.

• Berlanga O, Bradshaw HB, Vilella-Mitjana F, Garrido-Gómez T, Simón C. How endometrialsecretomics can help in predicting implantation. Placenta. 2011; 32 Suppl 3: S271-5.

• Gómez R, Ferrero H, Delgado-Rosas F, Gaytan M, Morales C, Zimmermann RC, Simón C,Gaytan F, Pellicer A. Evidences for the existence of a low dopaminergic tone in polycystic ovariansyndrome: implications for OHSS development and treatment. J Clin Endocrinol Metab. 2011;96(8): 2484-92.

• Garrido N, Bellver J, Remohí J, Simón C, Pellicer A. Cumulative live-birth rates per total numberof embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a newapproach to measuring the likelihood of IVF success. Fertil Steril. 2011; 96(1): 40-6.

• Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C, Bosch E.Endometrial receptivity is affected in women with high circulating progesterone levels at the end ofthe follicular phase: a functional genomics analysis. Hum Reprod. 2011; 26(7): 1813-25.

• Cervelló I, Mirantes C, Santamaria X, Dolcet X, Matias-Guiu X, Simón C. Stem cells in humanendometrium and endometrial carcinoma. Int J Gynecol Pathol. 2011; 30(4): 317-27.

• Pellicer B, Herraiz S, Táboas E, Felipo V, Simón C, Pellicer A. Ultrasound bioeffects in rats:quantification of cellular damage in the fetal liver after pulsed Doppler imaging. Ultrasound ObstetGynecol. 2011; 37(6): 643-8.

• Pellicer B, Herraiz S, Cauli O, Rodrigo R, Asensi M, Cortijo J, Serra V, Morcillo E, Felipo V,Simón C, Pellicer A. Haemodynamic effects of long-term administration of sildenafil in

29

normotensive pregnant and non-pregnant rats. BJOG. 2011; 118(5): 615-23. • Rodrigo L, Rubio C, Peinado V, Villamón R, Al-Asmar N, Remohí J, Pellicer A, Simón C, Gil-

Salom M. Testicular sperm from patients with obstructive and nonobstructive azoospermia:aneuploidy risk and reproductive prognosis using testicular sperm from fertile donors as controlsamples. Fertil Steril. 2011; 95(3): 1005-12.

• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact of luteinizing hormoneadministration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis.Fertil Steril. 2011; 95(3): 1031-6.

• Gómez R, Abad A, Delgado F, Tamarit S, Simón C, Pellicer A. Effects of hyperprolactinemiatreatment with the dopamine agonist quinagolide on endometriotic lesions in patients withendometriosis-associated hyperprolactinemia. Fertil Steril. 2011; 95(3): 882-8.e1.

• Garrido-Gomez T, Dominguez F, Lopez JA, Camafeita E, Quiñonero A, Martinez-Conejero JA,Pellicer A, Conesa A, Simón C. Modeling human endometrial decidualization from the interactionbetween proteome and secretome. J Clin Endocrinol Metab. 2011; 96(3): 706-16.

• Panula S, Medrano JV, Kee K, Bergström R, Nguyen HN, Byers B, Wilson KD, Wu JC, Simón C,Hovatta O, Reijo Pera RA. Human germ cell differentiation from fetal- and adult-derived inducedpluripotent stem cells. Hum Mol Genet. 2011; 20(4): 752-62.

• Garcia-Velasco JA, Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simón C. High-doserecombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocolcompared with standard GnRH antagonist. Reprod Biomed Online. 2011; 22 Suppl 1: S52-9.

• Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, SimónC. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomicsignature. Fertil Steril. 2011; 95(1): 50-60, 60.e1-15.

• Pellicer B, Herraiz S, Leal A, Simón C, Pellicer A. Prenatal brain damage in preeclamptic animalmodel induced by gestational nitric oxide synthase inhibition. J Pregnancy. 2011; 2011: 809569.

• Cervelló I, Mas A, Gil-Sanchis C, Peris L, Faus A, Saunders PT, Critchley HO, Simón C.Reconstruction of endometrium from human endometrial side population cell lines. PLoS One.2011; 6(6): e21221.

2010

• Novella-Maestre E, Carda C, Ruiz-Sauri A, Garcia-Velasco JA, Simón C, Pellicer A. Identification andquantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel moleculartarget for endometriosis therapy. Biol Reprod. 2010; 83(5): 866-73.

• Masip M, Veiga A, Izpisúa Belmonte JC, Simón C. Reprogramming with defined factors: frominduced pluripotency to induced transdifferentiation. Mol Hum Reprod. 2010; 16(11): 856-68.

• Medrano JV, Marqués-Marí AI, Aguilar CE, Riboldi M, Garrido N, Martínez-Romero A, O'ConnorE, Gil-Salom M, Simón C. Comparative analysis of the germ cell markers c-KIT, SSEA-1 andVASA in testicular biopsies from secretory and obstructive azoospermias. Mol Hum Reprod. 2010;16(11): 811-7.

• Milán M, Cobo AC, Rodrigo L, Mateu E, Mercader A, Buendía P, Peinado V, Delgado A, Mir P,Simón C, Remohí J, Pellicer A, Rubio C. Redefining advanced maternal age as an indication forpreimplantation genetic screening. Reprod Biomed Online. 2010; 21(5): 649-57.

• Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A. Physiology andpathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010; 28(6): 448-57.

• Galán A, Montaner D, Póo ME, Valbuena D, Ruiz V, Aguilar C, Dopazo J, Simón C. Functionalgenomics of 5- to 8-cell stage human embryos by blastomere single-cell cDNA analysis. PLoSOne. 2010; 5(10): e13615.

• Domínguez F, Simón C, Quiñonero A, Ramírez MÁ, González-Muñoz E, Burghardt H, Cervero A,Martínez S, Pellicer A, Palacín M, Sánchez-Madrid F, Yáñez-Mó M. Human endometrial CD98 isessential for blastocyst adhesion. PLoS One. 2010; 5(10): e13380.

• Rodrigo L, Peinado V, Mateu E, Remohí J, Pellicer A, Simón C, Gil-Salom M, Rubio C. Impact ofdifferent patterns of sperm chromosomal abnormalities on the chromosomal constitution ofpreimplantation embryos. Fertil Steril. 2010; 94(4): 1380-6.

• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A. Circulatingprogesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for invitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010; 25(8): 2092-100.

• Cervelló I, Gil-Sanchis C, Mas A, Delgado-Rosas F, Martínez-Conejero JA, Galán A, Martínez-

30

Romero A, Martínez S, Navarro I, Ferro J, Horcajadas JA, Esteban FJ, O'Connor JE, Pellicer A,Simón C. Human endometrial side population cells exhibit genotypic, phenotypic and functionalfeatures of somatic stem cells. PLoS One. 2010; 5(6): e10964.

• Busso C, Fernández-Sánchez M, García-Velasco JA, Landeras J, Ballesteros A, Muñoz E,González S, Simón C, Arce JC, Pellicer A. The non-ergot derived dopamine agonist quinagolidein prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial. Hum Reprod. 2010; 25(4): 995-1004.

• Aguilar-Gallardo C, Poo M, Gomez E, Galan A, Sanchez E, Marques-Mari A, Ruiz V, Medrano J,Riboldi M, Valbuena D, Simón C. Derivation, characterization, differentiation, and registration ofseven human embryonic stem cell lines (VAL-3, -4, -5, -6M, -7, -8, and -9) on human feeder. InVitro Cell Dev Biol Anim. 2010; 46(3-4): 317-26.

• Altmäe S, Martínez-Conejero JA, Salumets A, Simón C, Horcajadas JA, Stavreus-Evers A.Endometrial gene expression analysis at the time of embryo implantation in women withunexplained infertility. Mol Hum Reprod. 2010; 16(3): 178-87.

• Dominguez F, Gadea B, Mercader A, Esteban FJ, Pellicer A, Simón C. Embryologic outcome andsecretome profile of implanted blastocysts obtained after coculture in human endometrialepithelial cells versus the sequential system. Fertil Steril. 2010; 93(3): 774-782.e1.

• Mosher JT, Pemberton TJ, Harter K, Wang C, Buzbas EO, Dvorak P, Simón C, Morrison SJ,Rosenberg NA. Lack of population diversity in commonly used human embryonic stem-cell lines.N Engl J Med. 2010; 362(2): 183-5.

• Sánchez-Serrano M, Crespo J, Mirabet V, Cobo AC, Escribá MJ, Simón C, Pellicer A. Twins bornafter transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril. 2010; 93(1):268.e11-3.

• Garrido-Gómez T, Dominguez F, Simón C. Proteomics of embryonic implantation. Handb ExpPharmacol. 2010; (198): 67-78.

• Galán A, Simón C. Monitoring stemness in long-term hESC cultures by real-time PCR. MethodsMol Biol. 2010; 584: 135-50.

• Simón C. A mother’s gift, minus mitochondria. Nat Med. 2010; 16(6): 645.2009

• Ruiz-Vela A, Aguilar-Gallardo C, Simón C. Building a framework for embryonicmicroenvironments and cancer stem cells. Stem Cell Rev. 2009; 5(4): 319-27.

• International Stem Cell Banking Initiative. Consensus guidance for banking and supply of humanembryonic stem cell lines for research purposes. Stem Cell Rev. 2009; 5(4): 301-14.

• Domínguez F, Garrido-Gómez T, López JA, Camafeita E, Quiñonero A, Pellicer A, Simón C.Proteomic analysis of the human receptive versus non-receptive endometrium using differentialin-gel electrophoresis and MALDI-MS unveils stathmin 1 and annexin A2 as differentiallyregulated. Hum Reprod. 2009; 24(10): 2607-17.

• Unger C, Gao S, Cohen M, Jaconi M, Bergstrom R, Holm F, Galan A, Sanchez E, Irion O,Dubuisson JB, Giry-Laterriere M, Salmon P, Simón C, Hovatta O, Feki A. Immortalized humanskin fibroblast feeder cells support growth and maintenance of both human embryonic andinduced pluripotent stem cells. Hum Reprod. 2009; 24(10): 2567-81.

• Sermon KD, Simón C, Braude P, Viville S, Borstlap J, Veiga A. Creation of a registry for humanembryonic stem cells carrying an inherited defect: joint collaboration between ESHRE andhESCreg. Hum Reprod. 2009; 24(7): 1556-60.

• Busso CE, Garcia-Velasco J, Gomez R, Alvarez C, Simón C, Pellicer A. Symposium: Update onprediction and management of OHSS. Prevention of OHSS--dopamine agonists. Reprod BiomedOnline. 2009; 19(1): 43-51.

• Riboldi M, Simón C. Extraembryonic tissues as a source of stem cells. Gynecol Endocrinol.2009; 25(6): 351-5.

• Novella-Maestre E, Carda C, Noguera I, Ruiz-Saurí A, García-Velasco JA, Simón C, Pellicer A.Dopamine agonist administration causes a reduction in endometrial implants through modulationof angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009; 24(5): 1025-35.

• Marques-Mari AI, Lacham-Kaplan O, Medrano JV, Pellicer A, Simón C. Differentiation of germcells and gametes from stem cells. Hum Reprod Update. 2009; 15(3): 379-90.

• Rubio C, Buendía P, Rodrigo L, Mercader A, Mateu E, Peinado V, Delgado A, Milán M, Mir P,Simón C, Remohí J, Pellicer A. Prognostic factors for preimplantation genetic screening in

31

repeated pregnancy loss. Reprod Biomed Online. 2009; 18(5): 687-93. • Ensenat-Waser R, Pellicer A, Simón C. Reprogrammed induced pluripotent stem cells: how

suitable could they be in reproductive medicine? Fertil Steril. 2009; 91(4): 971-4. • Garrido N, Martínez-Conejero JA, Jauregui J, Horcajadas JA, Simón C, Remohí J, Meseguer M.

Microarray analysis in sperm from fertile and infertile men without basic sperm analysisabnormalities reveals a significantly different transcriptome. Fertil Steril. 2009; 91(4 Suppl): 1307-10.

• Blockeel C, Mock P, Verheyen G, Bouche N, Le Goff P, Heyman Y, Wrenzycki C, Höffmann K,Niemann H, Haentjens P, de Los Santos MJ, Fernandez-Sanchez M, Velasco M, Aebischer P,Devroey P, Simón C. An in vivo culture system for human embryos using an encapsulationtechnology: a pilot study. Hum Reprod. 2009; 24(4): 790-6.

• Cervelló I, Simón C. Somatic stem cells in the endometrium. Reprod Sci. 2009; 16(2): 200-5. • Dominguez F, Pellicer A, Simón C. The human embryo proteome. Reprod Sci. 2009; 16(2): 188-

90.• Cervelló I, Gil-Sanchís C, Más A, Simón C. Current Understanding of endometrial stem cells.

Expert. Rev. Obstet. Gynecol. 2009; 4(3): 273-82.2008

• Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, Pellicer A, SimónC. Controlled ovarian stimulation induces a functional genomic delay of the endometrium withpotential clinical implications. J Clin Endocrinol Metab. 2008; 93(11): 4500-10.

• Bosch E, Vidal C, Labarta E, Simón C, Remohi J, Pellicer A. Highly purified hMG versusrecombinant FSH in ovarian hyperstimulation with GnRH antagonists—a randomized study. HumReprod. 2008; 23(10): 2346-51.

• Simón C. New perspectives in medically assisted procreation. Gynecol Endocrinol. 2008; 24(9):485.

• Domínguez F, Gadea B, Esteban FJ, Horcajadas JA, Pellicer A, Simón C. Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod. 2008; 23(9):1993-2000.

• Horcajadas JA, Goyri E, Higón MA, Martínez-Conejero JA, Gambadauro P, García G, MeseguerM, Simón C, Pellicer A. Endometrial receptivity and implantation are not affected by the presenceof uterine intramural leiomyomas: a clinical and functional genomics analysis. J Clin EndocrinolMetab. 2008; 93(9): 3490-8.

• Martínez-Conejero JA, Garrido N, Remohí J, Pellicer A, Simón C, Meseguer M. MUC1 in humantestis and ejaculated spermatozoa and its relationship to male fertility status. Fertil Steril. 2008;90(2): 450-2.

• Aleckovic M, Simón C. Is teratoma formation in stem cell research a characterization tool or awindow to developmental biology? Reprod Biomed Online. 2008; 17(2): 270-80.

• Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A. Targeting the vascular endothelialgrowth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14(4): 321-33.

• Dominguez F, Martínez S, Quiñonero A, Loro F, Horcajadas JA, Pellicer A, Simón C. CXCL10and IL-6 induce chemotaxis in human trophoblast cell lines. Mol Hum Reprod. 2008; 14(7): 423-30.

• Valbuena D, Sánchez-Luengo S, Galán A, Sánchez E, Gómez E, Poo ME, Ruiz V, Genbacev O,Krtolica A, Pellicer A, Moreno R, Simón C. Efficient method for slow cryopreservation of humanembryonic stem cells in xeno-free conditions. Reprod Biomed Online. 2008; 17(1): 127-35.

• Soares SR, Velasco JA, Fernandez M, Bosch E, Remohí J, Pellicer A, Simón C. Clinical factorsaffecting endometrial receptiveness in oocyte donation cycles. Fertil Steril. 2008; 89(3): 491-501.

• Horne AW, Phillips JA 3rd, Kane N, Lourenco PC, McDonald SE, Williams AR, Simón C, Dey SK,Critchley HO. CB1 expression is attenuated in Fallopian tube and decidua of women with ectopicpregnancy. PLoS One. 2008; 3(12): e3969.

• Aghajanova L, Simón C, Horcajadas JA. Functional genomic of human implantation: are favoritemolecules of endometrial receptivity still in favor? Expert Review of Obstetrics and Gynecology.2008; 3(4): 487-501.

• Simón C. European funding for reproduction research-A multinational perspective. Nat Med.2008; 14(11): 1222.

• Hyun I, Lindvall O, Ährlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Lucra M,

32

Ira J. Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, OkKim H, Lee HP, Levy-Lahad E,Li, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Simón C,Srivastava A, Sugarman J, Taylor PL, Veiga A, Way AL, Zoloth L, Daley GQ. New ISSCRguidelines underscore major principles for responsible translational stem cell research. Cell StemCell. 2008; 3(6): 607-60.

2007

• Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C, Pellicer A. Implantation isapparently unaffected by the dopamine agonist Cabergoline when administered to preventovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilotstudy. Hum Reprod. 2007; 22(12): 3210-4.

• Horcajadas JA, Díaz-Gimeno P, Pellicer A, Simón C. Uterine receptivity and the ramifications ofovarian stimulation on endometrial function. Semin Reprod Med. 2007; 25(6): 454-60.

• Cervero A, Domínguez F, Horcajadas JA, Quiñonero A, Pellicer A, Simón C. Embryonic adhesionis not affected by endometrial leptin receptor gene silencing. Fertil Steril. 2007; 88(4 Suppl):1086-92.

• Garcia-Velasco JA, Coelingh Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simón C. High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovativeprotocol compared with standard GnRH antagonist. Reprod Biomed Online. 2007; 15(3): 280-7.

• Krtolica A, Genbacev O, Escobedo C, Zdravkovic T, Nordstrom A, Vabuena D, Nath A, Simón C,Mostov K, Fisher SJ. Disruption of apical-basal polarity of human embryonic stem cells enhanceshematoendothelial differentiation. Stem Cells. 2007; 25(9): 2215-23.

• Alvarez C, Martí-Bonmatí L, Novella-Maestre E, Sanz R, Gómez R, Fernández-Sánchez M, Simón C,Pellicer A. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulatedwomen undergoing assisted reproduction. J Clin Endocrinol Metab. 2007; 92(8): 2931-7.

• Rubio C, Rodrigo L, Mercader A, Mateu E, Buendía P, Pehlivan T, Viloria T, De los Santos MJ,Simón C, Remohí J, Pellicer A. Impact of chromosomal abnormalities on preimplantation embryodevelopment. Prenat Diagn. 2007; 27(8): 748-56.

• Martínez-Conejero JA, Simón C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental tothe endometrium? Reprod Biomed Online. 2007; 15(1): 45-50.

• Sánchez M, Alamá P, Gadea B, Soares SR, Simón C, Pellicer A. Fresh human orthotopic ovariancortex transplantation: long-term results. Hum Reprod. 2007; 22(3): 786-91.

• Martínez S, Garrido N, Coperias JL, Pardo F, Desco J, García-Velasco JA, Simón C, Pellicer A.Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod.2007; 22(3): 836-42.

• Soares SR, Simón C, Remohí J, Pellicer A. Cigarette smoking affects uterine receptiveness.Hum Reprod. 2007; 22(2): 543-7.

• Cervelló I, Martínez-Conejero JA, Horcajadas JA, Pellicer A, Simón C. Identification,characterization and co-localization of label-retaining cell population in mouse endometrium withtypical undifferentiated markers. Hum Reprod. 2007; 22(1): 45-51.

• Horcajadas JA, Pellicer A, Simón C. Wide genomic analysis of human endometrial receptivity:new times, new opportunities. Hum Reprod Update. 2007; 13(1): 77-86.

• Garrido N, Melo MAB, Simón C, Remohí J, Pellicer A, Meseguer M. Ovarian stimulation length,number of follicles higher than 17 mm and estradiol on the day of human chorionic gonadotropinadministration are risk factors for multiple pregnancy in intrauterine insemination. Reprod. Med.Biol. 2007; 6: 19-26.

• Diedrich K, Fauser BCJM, Devroy P, Griesinger G on behalf of the Evian Annual Reproduction(EVAR) Workshop Group. The role of endometrium and embryo in human implantation. HumReprod Update. 2007; 13(4): 365-77.

2006 • Escribá MJ, Martín J, Rubio C, Valbuena D, Remohí J, Pellicer A, Simón C. Heteroparental

blastocyst production from microsurgically corrected tripronucleated human embryos. Fertil Steril.2006; 86(6): 1601-7.

• Valbuena D, Galán A, Sánchez E, Poo ME, Gómez E, Sánchez-Luengo S, Melguizo D, García A,Ruiz V, Moreno R, Pellicer A, Simón C. Derivation and characterization of three new Spanishhuman embryonic stem cell lines (VAL -3 -4 -5) on human feeder and in serum-free conditions.Reprod Biomed Online. 2006; 13(6): 875-86.

33

• Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, Novella-Maestre E, Alonso-Muriel I,Sanchez-Criado J, Remohi J, Simón C, Pellicer A. Low-dose dopamine agonist administrationblocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability withoutaltering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.Endocrinology. 2006; 147(11): 5400-11.

• Meseguer M, de los Santos MJ, Simón C, Pellicer A, Remohí J, Garrido N. Effect of spermglutathione peroxidases 1 and 4 on embryo asymmetry and blastocyst quality in oocyte donationcycles. Fertil Steril. 2006; 86(5): 1376-85.

• Busso CE, Melo MA, Fernandez M, Pellicer A, Simón C. Implantation in IVF. Int Surg. 2006; 91(5Suppl): S63-76.

• Horcajadas JA, Sharkey AM, Catalano RD, Sherwin JR, Domínguez F, Burgos LA, Castro A,Peraza MR, Pellicer A, Simón C. Effect of an intrauterine device on the gene expression profile ofthe endometrium. J Clin Endocrinol Metab. 2006; 91(8): 3199-207.

• Cervero A, Domínguez F, Horcajadas JA, Quiñonero A, Pellicer A, Simón C. The role of the leptinin reproduction. Curr Opin Obstet Gynecol. 2006; 18(3): 297-303.

• Budak E, Fernández Sánchez M, Bellver J, Cerveró A, Simón C, Pellicer A. Interactions of thehormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. FertilSteril. 2006; 85(6): 1563-81.

• Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset ofearly and late ovarian hyperstimulation syndrome. Hum Reprod. 2006; 21(6): 1453-60

• Bellver J, Busso C, Pellicer A, Remohí J, Simón C. Obesity and assisted reproductive technologyoutcomes. Reprod Biomed Online. 2006; 12(5): 562-8.

• Bischof P, Aplin JD, Bentin-Ley U, Brannstrom M, Casslen B, Castrillo JL, Classen-Linke I,Critchley HO, Devoto L, D'Hooghe T, Horcajadas JA, Groothuis P, Ivell R, Pongrantz I, MacklonNS, Sharkey A, Vicovac L, White JO, Winterhager E, von Wolff M, Simón C, Stavreus-Evers A.Implantation of the human embryo: research lines and models. From the implantation researchnetwork 'Fruitful'. Gynecol Obstet Invest. 2006; 62(4): 206-16.

• Mercader A, Valbuena D, Simón C. Human embryo culture. Methods Enzymol. 2006; 420: 3-18. • Rodríguez CI, Simón C. Human embryonic stem cell derivation: from the IVF perspective to

therapeutic applications. Regen Med. 2006; 1(1): 103-9. • Rodríguez CI, Galán A, Valbuena D, Simón C. Derivation of clinical-grade human embryonic

stem cells. Reprod Biomed Online. 2006; 12(1): 112-8.• Simón C, Domínguez F. Embryo-endometrial interaction. Chang Gung Med J.2006; 29(1): 9-14.• Tarlatzis A, Fauser B, Kolibianakis EM, Diedrich K, Devroey P, On behalf of the Brussels GnRH

antagonist consensus workshop group. GnRH antagonist in ovarian stimulation for IVF. HumReprod Update. 2006; 12(4): 333-340.

2005

• Simón C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, RiesewijkA, Mannaerts B, Pellicer A. Similar endometrial development in oocyte donors treated with eitherhigh- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or innatural cycles. Hum Reprod. 2005; 20(12): 3318-27.

• Bosch E, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Serum luteinizing hormone inpatients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists andrecombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril.2005; 84(5): 1529-32.

• Matorras R, Matorras F, Mendoza R, Rodríguez M, Remohí J, Rodríguez-Escudero FJ, Simón C.The implantation of every embryo facilitates the chances of the remaining embryos to implant inan IVF programme: a mathematical model to predict pregnancy and multiple pregnancy rates.Hum Reprod. 2005; 20(10): 2923-31.

• Rubio C, Rodrigo L, Pérez-Cano I, Mercader A, Mateu E, Buendía P, Remohí J, Simón C,Pellicer A. FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome.Reprod Biomed Online. 2005; 11(4): 497-506.

• Dominguez F, Yáñez-Mó M, Sanchez-Madrid F, Simón C. Embryonic implantation and leukocytetransendothelial migration: different processes with similar players? FASEB J. 2005; 19(9): 1056-60.

• Soares SR, Troncoso C, Bosch E, Serra V, Simón C, Remohí J, Pellicer A. Age and uterine

34

receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab. 2005;90(7): 4399-404.

• Rubio C, Pehlivan T, Rodrigo L, Simón C, Remohí J, Pellicer A. Embryo aneuploidy screening forunexplained recurrent miscarriage: a minireview. Am J Reprod Immunol. 2005; 53(4): 159-65.

• Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A. Semen characteristics in humanimmunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of thesuccess of viral removal after sperm washing. Hum Reprod. 2005; 20(4): 1028-34.

• Escudero EL, Boerrigter PJ, Bennink HJ, Epifanio R, Horcajadas JA, Olivennes F, Pellicer A,Simón C. Mifepristone is an effective oral alternative for the prevention of premature luteinizinghormone surges and/or premature luteinization in women undergoing controlled ovarianhyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2005; 90(4): 2081-8.

• Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S, Simón C. Effect ofcontrolled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol HumReprod. 2005; 11(3): 195-205.

• Cervero A, Horcajadas JA, Domínguez F, Pellicer A, Simón C. Leptin system in embryodevelopment and implantation: a protein in search of a function. Reprod Biomed Online. 2005;10(2): 217-23.

• Simón C, Escobedo C, Valbuena D, Genbacev O, Galan A, Krtolica A, Asensi A, Sánchez E,Esplugues J, Fisher S, Pellicer A. First derivation in Spain of human embryonic stem cell lines: useof long-term cryopreserved embryos and animal-free conditions. Fertil Steril. 2005; 83(1): 246-9.

2004

• Horcajadas JA, Riesewijk A, Domínguez F, Cervero A, Pellicer A, Simón C. Determinants ofendometrial receptivity. Ann N Y Acad Sci. 2004; 1034:166-75.

• Meseguer M, Garrido N, Martínez-Conejero JA, Simón C, Pellicer A, Remohí J. Relationshipbetween standard semen parameters, calcium, cholesterol contents, and mitochondrial activity inejaculated spermatozoa from fertile and infertile males. J Assist Reprod Genet. 2004; 21(12): 445-51.

• Garrido N, Meseguer M, Bellver J, Remohí J, Simón C, Pellicer A. Report of the results of a 2year programme of sperm wash and ICSI treatment for human immunodeficiency virus andhepatitis C virus serodiscordant couples. Hum Reprod. 2004; 19(11): 2581-6.

• Lima-Couy I, Cervero A, Bonilla-Musoles F, Pellicer A, Simón C. Endometrial leptin and leptinreceptor expression in women with severe/moderate endometriosis. Mol Hum Reprod. 2004;10(11): 777-82.

• Garrido N, Meseguer M, Alvarez J, Simón C, Pellicer A, Remohí J. Relationship among standardsemen parameters, glutathione peroxidase/glutathione reductase activity, and mRNA expressionand reduced glutathione content in ejaculated spermatozoa from fertile and infertile men. FertilSteril. 2004; 82 Suppl 3: 1059-66.

• Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. Concentration of glutathione andexpression of glutathione peroxidases 1 and 4 in fresh sperm provide a forecast of the outcomeof cryopreservation of human spermatozoa. J Androl. 2004; 25(5): 773-80.

• Horcajadas JA, Riesewijk A, Martín J, Cervero A, Mosselman S, Pellicer A, Simón C. Globalgene expression profiling of human endometrial receptivity. J Reprod Immunol. 2004; 63(1): 41-9.

• García-Velasco JA, Zúñiga A, Pacheco A, Gómez R, Simón C, Remohí J, Pellicer A. Coastingacts through downregulation of VEGF gene expression and protein secretion. Hum Reprod. 2004;19(7): 1530-8.

• Cervero A, Horcajadas JA, MartIn J, Pellicer A, Simón C. The leptin system during human endometrialreceptivity and preimplantation development. J Clin Endocrinol Metab. 2004; 89(5): 2442-51.

• Zuzuarregui JL, Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. Parameters affectingthe results in a program of artificial insemination with donor sperm. A 12-year retrospective reviewof more than 1800 cycles. J Assist Reprod Genet. 2004; 21(4): 109-18.

• Gómez R, Lima I, Simón C, Pellicer A. Administration of low-dose LH induces ovulation andprevents vascular hyperpermeability and vascular endothelial growth factor expression insuperovulated rats. Reproduction. 2004; 127(4): 483-9.

• Garrido N, Meseguer M, Simón C, Pellicer A, Remohi J. Assisted reproduction in HIV and HCVinfected men of serodiscordant couples. Arch Androl. 2004; 50(2): 105-11.

• Garrido N, Meseguer M, Simón C, Pellicer A, Remohi J. Pro-oxidative and anti-oxidativeimbalance in human semen and its relation with male fertility. Asian J Androl. 2004; 6(1): 59-65.

35

• Meseguer M, Garrido N, Martínez-Conejero JA, Simón C, Pellicer A, Remohí J. Role ofcholesterol, calcium, and mitochondrial activity in the susceptibility for cryodamage after a cycleof freezing and thawing. Fertil Steril. 2004; 81(3): 588-94.

• Escudero E, Bosch E, Crespo J, Simón C, Remohí J, Pellicer A. Comparison of two differentstarting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected groupof in vitro fertilization-embryo transfer patients. Fertil Steril. 2004; 81(3): 562-6.

• Pehlivan T, Rubio C, Ruiz A, Navarro J, Remohí J, Pellicer A, Simón C. Embryonic chromosomalabnormalities obtained after rescue intracytoplasmic sperm injection of 1-day-old unfertilizedoocytes. J Assist Reprod Genet. 2004; 21(2): 55-7.

• Luna JJ, Riesewijk A, Horcajadas JA, Van Os Rd Rd, Domínguez F, Mosselman S, Pellicer A,Simón C. Gene expression pattern and immunoreactive protein localization of LGR7 receptor inhuman endometrium throughout the menstrual cycle. Mol Hum Reprod. 2004; 10(2): 85-90.

• Simón C, García-Velasco J. Medical treatment of endometriosis. Gynecol Obstet Invest. 2004;57(1): 51-2.

• Simón C, Dominguez F. Embryonic-endometrial interactions at implantation in humans. GynecolObstet Invest. 2004; 57(1): 28-30.

• Rodrigo L, Rubio C, Mateu E, Simón C, Remohí J, Pellicer A, Gil-Salom M. Analysis ofchromosomal abnormalities in testicular and epididymal spermatozoa from azoospermic ICSIpatients by fluorescence in-situ hybridization. Hum Reprod. 2004; 19(1): 118-23.

• Simón C, Pellicer A. Guest editorial. J Reprod Immunol. 2004; 63(1): 39.2003

• Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Prematureluteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with invitro fertilization outcome. Fertil Steril. 2003; 80(6): 1444-9.

• Mercader A, Garcia-Velasco JA, Escudero E, Remohí J, Pellicer A, Simón C. Clinical experienceand perinatal outcome of blastocyst transfer after coculture of human embryos with humanendometrial epithelial cells: a 5-year follow-up study. Fertil Steril. 2003; 80(5): 1162-8.

• Gámiz P, Rubio C, de los Santos MJ, Mercader A, Simón C, Remohí J, Pellicer A. The effect ofpronuclear morphology on early development and chromosomal abnormalities in cleavage-stageembryos. Hum Reprod. 2003; 18(11): 2413-9.

• Bellver J, Muñoz EA, Ballesteros A, Soares SR, Bosch E, Simón C, Pellicer A, Remohí J.Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome inhigh-risk IVF patients: a randomized controlled study. Hum Reprod. 2003; 18(11): 2283-8.

• Dominguez F, Pellicer A, Simón C. The chemokine connection: hormonal and embryonicregulation at the human maternal-embryonic interface--a review. Placenta. 2003; 24 Suppl B:S48-55.

• Krüssel JS, Bielfeld P, Polan ML, Simón C. Regulation of embryonic implantation. Eur J ObstetGynecol Reprod Biol. 2003; 10 Suppl 1: S2-9.

• Reis Soares S, Rubio C, Rodrigo L, Simón C, Remohí J, Pellicer A. High frequency ofchromosomal abnormalities in embryos obtained from oocyte donation cycles. Fertil Steril. 2003;80(3): 656-7.

• Pehlivan T, Rubio C, Rodrigo L, Remohí J, Pellicer A, Simón C. Preimplantation geneticdiagnosis by fluorescence in situ hybridization: clinical possibilities and pitfalls. J Soc GynecolInvestig. 2003; 10(6): 315-22.

• Garcia-Velasco JA, Isaza V, Caligara C, Pellicer A, Remohí J, Simón C. Factors that determinediscordant outcome from shared oocytes. Fertil Steril. 2003; 80(1): 54-60.

• Simón C, Domínguez F, Valbuena D, Pellicer A. The role of estrogen in uterine receptivity andblastocyst implantation. Trends Endocrinol Metab. 2003; 14(5): 197-9.

• Gómez R, Simón C, Remohí J, Pellicer A. Administration of moderate and high doses ofgonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) andVEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod. 2003;68(6): 2164-71.

• Meseguer M, Garrido N, Remohí J, Pellicer A, Simón C, Martínez-Jabaloyas JM, Gil-Salom M.Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia afterchemotherapy. Hum Reprod. 2003; 18(6): 1281-5.

• Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, Gómez E, Simón C, Remohí J,

36

Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003;79(5): 1136-40.

• Riesewijk A, Martín J, van Os R, Horcajadas JA, Polman J, Pellicer A, Mosselman S, Simón C.Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 bymicroarray technology. Mol Hum Reprod. 2003; 9(5):253-64.

• Garrido N, Pellicer A, Remohí J, Simón C. Uterine and ovarian function in endometriosis. SeminReprod Med. 2003; 21(2): 183-92.

• Domínguez F, Avila S, Cervero A, Martín J, Pellicer A, Castrillo JL, Simón C. A combinedapproach for gene discovery identifies insulin-like growth factor-binding protein-related protein 1as a new gene implicated in human endometrial receptivity. J Clin Endocrinol Metab. 2003; 88(4):1849-57.

• Dominguez F, Galan A, Martin JJ, Remohi J, Pellicer A, Simón C. Hormonal and embryonicregulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the humanendometrium and the human blastocyst. Mol Hum Reprod. 2003; 9(4): 189-98.

• Domínguez F, Remohí J, Pellicer A, Simón C. Human endometrial receptivity: a genomicapproach. Reprod Biomed Online. 2003; 6(3): 332-8.

• Pehlivan T, Rubio C, Rodrigo L, Romero J, Remohi J, Simón C, Pellicer A. Impact ofpreimplantation genetic diagnosis on IVF outcome in implantation failure patients. ReprodBiomed Online. 2003; 6(2): 232-7.

• Troncoso C, Bosch E, Rubio C, Remohí J, Simón C, Pellicer A. The origin of biochemicalpregnancies: lessons learned from preimplantation genetic diagnosis. Fertil Steril. 2003; 79(2):449-50.

• Isaza V, Requena A, García-Velasco JA, Remohí J, Pellicer A, Simón C. Recombinant vs. urinaryfollicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.J Reprod Med. 2003; 48(2): 112-8.

• Hey NA, Meseguer M, Simón C, Smorodinsky NI, Wreschner DH, Ortíz ME, Aplin JD.Transmembrane and truncated (SEC) isoforms of MUC1 in the human endometrium andFallopian tube. Reprod Biol Endocrinol. 2003; 1: 2.

• Rubio C, Simón C, Vidal F, Rodrigo L, Pehlivan T, Remohí J, Pellicer A. Chromosomalabnormalities and embryo development in recurrent miscarriage couples. Hum Reprod. 2003;18(1): 182-8.

2002

• Meseguer M, Garrido N, Gimeno C, Remohí J, Simón C, Pellicer A. Comparison of polymerasechain reaction-dependent methods for determining the presence of human immunodeficiencyvirus and hepatitis C virus in washed sperm. Fertil Steril. 2002; 78(6): 1199-202.

• Garrido N, Meseguer M, Remohi J, Pellicer A, Simón C. Flow cytometry in human reproductivebiology. Gynecol Endocrinol. 2002; 16(6): 505-21.

• Garrido N, Zuzuarregui JL, Meseguer M, Simón C, Remohí J, Pellicer A. Sperm and oocytedonor selection and management: experience of a 10 year follow-up of more than 2100candidates. Hum Reprod. 2002; 17(12): 3142-8.

• Gómez R, Simón C, Remohí J, Pellicer A. Vascular endothelial growth factor receptor-2activation induces vascular permeability in hyperstimulated rats, and this effect is prevented byreceptor blockade. Endocrinology. 2002; 143(11): 4339-48.

• Pellicer A, Simón C. Ethics of oocyte cryopreservation in Spain. Reprod Biomed Online. 2002;5(3): 230.

• Bellver J, Simón C, Pellicer A. Estrogen levels and thrombophilia—an intervening variable or aconfounder? Fertil Steril. 2002; 78(4): 887-8

• García-Velasco JA, Isaza V, Martinez-Salazar J, Landazábal A, Requena A, Remohí J, Simón C.Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyterecipients. Fertil Steril. 2002; 78(3): 534-9.

• Meseguer M, Garrido N, Remohí J, Simón C, Pellicer A. Gender selection: ethical, scientific,legal, and practical issues. J Assist Reprod Genet. 2002; 19(9): 443-6.

• Pellicer A, Valbuena D, Simón C. An experimental bagatelle or a wrong mistake? Fertil Steril.2002; 78(2): 434-5;

• Isaza V, García-Velasco JA, Aragonés M, Remohí J, Simón C, Pellicer A. Oocyte and embryoquality after coasting: the experience from oocyte donation. Hum Reprod. 2002; 17(7): 1777-82..

37

• Escribá MJ, Valbuena D, Remohí J, Pellicer A, Simón C. New techniques on embryomanipulation. J Reprod Immunol. 2002; 55(1-2): 149-61.

• Martín J, Domínguez F, Avila S, Castrillo JL, Remohí J, Pellicer A, Simón C. Human endometrialreceptivity: gene regulation. J Reprod Immunol. 2002; 55(1-2): 131-9.

• Albert C, Garrido N, Mercader A, Rao CV, Remohí J, Simón C, Pellicer A. The role of endothelialcells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod. 2002; 8(5):409-18.

• Domínguez F, Remohí J, Pellicer A, Simón C. Paracrine interactions during human implantation.Rev Endocr Metab Disord. 2002; 3(2): 97-105.

• Caballero-Campo P, Domínguez F, Coloma J, Meseguer M, Remohí J, Pellicer A, Simón C.Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the humanendometrium during the window of implantation. Mol Hum Reprod. 2002; 8(4): 375-84.

• Dominguez F, Pellicer A, Simón C. Paracrine dialogue in implantation. Mol Cell Endocrinol. 2002;186(2): 175-81.

• Garrido N, Navarro J, García-Velasco J, Remoh J, Pellice A, Simón C. The endometrium versusembryonic quality in endometriosis-related infertility. Hum Reprod Update. 2002; 8(1): 95-103.

• Garrido N, Krüssel JS, Remohí J, Simón C, Pellicer A. Expression and function of 3betahydroxisteroid dehydrogenase (3beta HSD) type II and corticosteroid binding globulin (CBG) ingranulosa cells from ovaries of women with and without endometriosis. J Assist Reprod Genet.2002; 19(1): 24-30.

• Pellicer A, Dominguez F, Remohi J, Simón C. Molecular basis of implantation. Reprod BiomedOnline. 2002; 5 Suppl 1(3): 44-51.

• Krüssel J-S, Polan M.L, Simón C. Cytokine and growth factor network in human endometrium.Immunology and allergy Clinics of North America. 2002; 22: 529-43.

2001

• Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A. Humanovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). HumReprod. 2001; 16(12): 2533-9.

• Valbuena D, Martin J, de Pablo JL, Remohí J, Pellicer A, Simón C. Increasing levels of estradiolare deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril.2001; 76(5): 962-8.

• Caligara C, Navarro J, Vargas G, Simón C, Pellicer A, Remohí J. The effect of repeatedcontrolled ovarian stimulation in donors. Hum Reprod. 2001; 16(11): 2320-3.

• Rubio C, Gil-Salom M, Simón C, Vidal F, Rodrigo L, Mínguez Y, Remohí J, Pellicer A. Incidenceof sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSIoutcome. Hum Reprod. 2001; 16(10): 2084-92.

• Pellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco JA, Remohí J, Simón C. Endometrialquality in infertile women with endometriosis. Ann N Y Acad Sci. 2001; 943: 122-30.

• Simón C, Dominguez F, Remohí J, Pellicer A. Embryo effects in human implantation: embryonicregulation of endometrial molecules in human implantation. Ann N Y Acad Sci. 2001; 943: 1-16.

• Garrido N, Albert C, Krüssel JS, O'Connor JE, Remohí J, Simón C, Pellicer A. Expression,production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosacells is comparable in women with and without endometriosis. Fertil Steril. 2001; 76(3): 568-75.

• Requena A, Neuspiller F, Cobo AC, Aragonés M, García-Velasco JA, Remohí J, Simón C,Pellicer A. Endocrinological and ultrasonographic variations after immature oocyte retrieval in anatural cycle. Hum Reprod. 2001; 16(9): 1833-7.

• Garcia-Velasco JA, Simón C. Blastocyst transfer: does it really affect the outcome? Curr OpinObstet Gynecol. 2001; 13(3): 299-304.

• Garcia-Velasco JA, Nikas G, Remohí J, Pellicer A, Simón C. Endometrial receptivity in terms ofpinopode expression is not impaired in women with endometriosis in artificially prepared cycles.Fertil Steril. 2001; 75(6): 1231-3.

• Mercader A, Simón C, Galán A, Herrer R, Albert C, Remohí J, Pellicer A. An analysis ofspontaneous hatching in a human endometrial epithelial coculture system: is assisted hatchingjustified? J Assist Reprod Genet. 2001; 18(6): 315-9.

• Aplin JD, Meseguer M, Simón C, Ortíz ME, Croxatto H, Jones CJ. MUC1, glycans and the cell-surface barrier to embryo implantation. Biochem Soc Trans. 2001; 29(Pt 2): 153-6.

38

• Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martín JC, Remohí J, Pellicer A,Simón C. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulatedin vitro by the human blastocyst. Biol Reprod. 2001; 64(2): 590-601.

2000

• Galán A, Herrer R, Remohí J, Pellicer A, Simón C. Embryonic regulation of endometrial epithelialapoptosis during human implantation. Hum Reprod. 2000; 15 Suppl 6: 74-80.

• Rubio C, Simón C, Mercader A, Garcia-Velasco J, Remohí J, Pellicer A. Clinical experienceemploying co-culture of human embryos with autologous human endometrial epithelial cells. HumReprod. 2000; 15 Suppl 6: 31-8.

• Tremellen KP, Valbuena D, Landeras J, Ballesteros A, Martinez J, Mendoza S, Norman RJ,Robertson SA, Simón C. The effect of intercourse on pregnancy rates during assisted humanreproduction. Hum Reprod. 2000; 15(12): 2653-8.

• González RR, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Pellicer A, Simón C. Leptinand leptin receptor are expressed in the human endometrium and endometrial leptin secretion isregulated by the human blastocyst. J Clin Endocrinol Metab. 2000; 85(12): 4883-8.

• Martín JC, Jasper MJ, Valbuena D, Meseguer M, Remohí J, Pellicer A, Simón C. Increasedadhesiveness in cultured endometrial-derived cells is related to the absence of moesinexpression. Biol Reprod. 2000; 63(5): 1370-6.

• Garcia-Velasco JA, Isaza V, Requena A, Martínez-Salazar FJ, Landazábal A, Remohí J, PellicerA, Simón C. High doses of gonadotrophins combined with stop versus non-stop protocol ofGnRH analogue administration in low responder IVF patients: a prospective, randomized,controlled trial. Hum Reprod. 2000; 15(11): 2292-6.

• Simón C, Martín JC, Pellicer A. Paracrine regulators of implantation. Baillieres Best Pract ResClin Obstet Gynaecol. 2000; 14(5): 815-26.

• Ibérico G, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Embryo reduction of multifetalpregnancies following assisted reproduction treatment: a modification of the transvaginalultrasound-guided technique. Hum Reprod. 2000; 15(10): 2228-33.

• Galán A, O'Connor JE, Valbuena D, Herrer R, Remohí J, Pampfer S, Pellicer A, Simón C. Thehuman blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion. Biol Reprod.2000 Aug;63(2):430-9. Erratum in: Biol Reprod 2001; 64(4): 1283.

• Díaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Impact of stage III-IV endometriosison recipients of sibling oocytes: matched case-control study. Fertil Steril. 2000; 74(1): 31-4.

• González RR, Simón C, Caballero-Campo P, Norman R, Chardonnens D, Devoto L, Bischof P.Leptin and reproduction. Hum Reprod Update. 2000; 6(3): 290-300.

• Requena A, Neuspiller F, Cobo AC, Aragonés M, Remohí J, Simón C, Pellicer A. The potentialuse of maturation in vitro of human oocytes in low responder patients. J Assist Reprod Genet.2000; 17(5): 239-44.

• Simón C, Pellicer A. Blastocyst transfer for couples with multiple IVF failures? Fertil Steril. 2000;73(4): 872.

• Garrido N, Navarro J, Remohí J, Simón C, Pellicer A. Follicular hormonal environment andembryo quality in women with endometriosis. Hum Reprod Update. 2000; 6(1): 67-74.

• Vidal F, Rubio C, Simón C, Giménez C, Mínguez Y, Pellicer A, Santaló J, Remohí J, Egozcue J.Is there a place for preimplantation genetic diagnosis screening in recurrent miscarriage patients?J Reprod Fertil Suppl. 2000; 55: 143-6.

• Pellicer A, Albert C, Garrido N, Navarro J, Remohí J, Simón C. The pathophysiology ofendometriosis-associated infertility: follicular environment and embryo quality. J Reprod FertilSuppl. 2000; 55: 109-19.

• Simón C, Martin JC, Meseguer M, Caballero-Campo P, Valbuena D, Pellicer A. Embryonicregulation of endometrial molecules in human implantation. J Reprod Fertil Suppl. 2000; 55: 43-53.

• Caligara C, Navarro J, Vargas G, Simón C, Pellicer A, Remohí J. Repeated controlled ovarianstimulation and oocyte retrieval rate in donors. Reprod Technol. 2000; 10(5): 248-252.

1999

• Simón C, Landeras J, Zuzuarregui JL, Martín JC, Remohí J, Pellicer A. Early pregnancy losses inin vitro fertilization and oocyte donation. Fertil Steril. 1999; 72(6): 1061-5.

• Valbuena D, Jasper M, Remohí J, Pellicer A, Simón C. Ovarian stimulation and endometrial

39

receptivity. Hum Reprod. 1999; 14 Suppl 2: 107-11. • Kohen P, Castro A, Caballero-Campo P, Castro O, Vega M, Makrigiannakis A, Simón C, Carvallo

P, Devoto L. Interleukin-1beta (IL-1beta) is a modulator of human luteal cell steroidogenesis:localization of the IL type I system in the corpus luteum. J Clin Endocrinol Metab. 1999; 84(11):4239-45.

• Simón C, Mercader A, Garcia-Velasco J, Nikas G, Moreno C, Remohí J, Pellicer A. Coculture ofhuman embryos with autologous human endometrial epithelial cells in patients with implantationfailure. J Clin Endocrinol Metab. 1999; 84(8):2638-46.

• Simón C, Valbuena D. Embryonic implantation. Ann Endocrinol (Paris). 1999; 60(2): 134-6. • Pellicer A, Simón C. Relationships in medicine--causal vs. casual. Fertil Steril. 1999; 72(1): 188-

90. • Cobo AC, Requena A, Neuspiller F, Aragon s M, Mercader A, Navarro J, Simón C, Remohí J,

Pellicer A. Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimalday for ovum retrieval based on follicular size. Hum Reprod. 1999; 14(7): 1864-8.

• Pellicer A, Rubio C, Vidal F, Mínguez Y, Giménez C, Egozcue J, Remohí J, Simón C. In vitrofertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: ananalysis of chromosome abnormalities in human preimplantation embryos. Fertil Steril. 1999;71(6): 1033-9

• Rubio C, Simón C, Blanco J, Vidal F, Mínguez Y, Egozcue J, Crespo J, Remohí J, Pellicer A.Implications of sperm chromosome abnormalities in recurrent miscarriage. J Assist ReprodGenet. 1999; 16(5): 253-8.

• Pellicer A, Garrido N, Albert C, Navarro J, Remohí J, Simón C. Cytokines in older patientsundergoing in vitro fertilization: the relationship to the response to controlled ovarianhyperstimulation. J Assist Reprod Genet. 1999; 16(5): 247-52.

• Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C. The pathogenesis ofovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta,interleukin-6, and vascular endothelial growth factor. Fertil Steril. 1999; 71(3): 482-9.

• Sánchez-Cuenca J, Martín JC, Pellicer A, Simón C. Cytokine pleiotropy and redundancy--gp130cytokines in human implantation. Immunol Today. 1999; 20(2): 57-9.

• Simón C, Martín JC, Galan A, Valbuena D, Pellicer A. Embryonic regulation in implantation.Semin Reprod Endocrinol. 1999; 17(3): 267-74.

• Simón C, Pellicer A. Low and high responders- at what levels of serum estradiol do things start toget fuzzy. Fertil Steril. 1999; 71(3): 582-7.

1998

• de los Santos MJ, Anderson DJ, Racowsky C, Simón C, Hill JA. Expression of interleukin-1system genes in human gametes. Biol Reprod. 1998; 59(6): 1419-24.

• Meseguer M, Pellicer A, Simón C. MUC1 and endometrial receptivity. Mol Hum Reprod. 1998;4(12): 1089-98.

• Simón C, Valbuena D, Krüssel J, Bernal A, Murphy CR, Shaw T, Pellicer A, Polan ML. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrialepithelium. Fertil Steril. 1998; 70(5): 896-906.

• Pellicer A, Ardiles G, Neuspiller F, Remohí J, Simón C, Bonilla-Musoles F. Evaluation of theovarian reserve in young low responders with normal basal levels of follicle-stimulating hormoneusing three-dimensional ultrasonography. Fertil Steril. 1998; 70(4): 671-5.

• Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C. The follicular andendocrine environment in women with endometriosis: local and systemic cytokine production.Fertil Steril. 1998; 70(3): 425-31.

• Simón C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remohí J, Pellicer A.Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period inhigh responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril.1998; 70(2): 234-9.

• Krüssel JS, Simón C, Rubio MC, Pape AR, Wen Y, Huang HY, Bielfeld P, Polan ML. Expressionof interleukin-1 system mRNA in single blastomeres from human preimplantation embryos. HumReprod. 1998; 13(8): 2206-11.

• Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J. Intracytoplasmic sperm injection as a routineindication in low responder patients. Hum Reprod. 1998; 13(8): 2126-9.

40

• Simón C, Moreno C, Remohí J, Pellicer A. Cytokines and embryo implantation. J ReprodImmunol. 1998; 39(1-2): 117-31.

• Pellicer A, Gaitán P, Neuspiller F, Ardiles G, Albert C, Remohí J, Simón C. Ovarian folliculardynamics: from basic science to clinical practice. J Reprod Immunol. 1998; 39(1-2): 29-61.

• Simón C, Caballero-Campo P, García-Velasco JA, Pellicer A. Potential implications ofchemokines in reproductive function: an attractive idea. J Reprod Immunol. 1998; 38(2): 169-93.

• Pellicer A, Valbuena D, Bauset C, Albert C, Bonilla-Musoles F, Remohí J, Simón C. The follicularendocrine environment in stimulated cycles of women with endometriosis: steroid levels andembryo quality. Fertil Steril. 1998; 69(6): 1135-41.

• Simón C, Moreno C, Remohí J, Pellicer A. Molecular interactions between embryo and uterus inthe adhesion phase of human implantation. Hum Reprod. 1998; 13 Suppl 3: 219-32; discussion233-6.

• Castro A, Castro O, Troncoso JL, Kohen P, Simón C, Vega M, Devoto L. Luteal leukocytes aremodulators of the steroidogenic process of human mid-luteal cells. Hum Reprod. 1998; 13(6):1584-9

• Neuspiller F, Levy M, Remohí J, Ruiz A, Simón C, Pellicer A. The use of long- and short-actingforms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation.Hum Reprod. 1998; 13(5): 1148-51.

• Vidal F, Giménez C, Rubio C, Simón C, Pellicer A, Santaló J, Egozcue J. FISH preimplantationdiagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet.1998; 15(5): 310-3.

• Krüssel JS, Huang HY, Simón C, Behr B, Pape AR, Wen Y, Bielfeld P, Polan ML. Singleblastomeres within human preimplantation embryos express different amounts of messengerribonucleic acid for beta-actin and interleukin-1 receptor type I. J Clin Endocrinol Metab. 1998;83(3): 953-9.

• Simón C, Rubio C, Vidal F, Gimenez C, Moreno C, Parrilla JJ, Pellicer A. Increased chromosomeabnormalities in human preimplantation embryos after in-vitro fertilization in patients withrecurrent miscarriage. Reprod Fertil Dev. 1998; 10(1): 87-92.

1997

• Gartner B, Moreno C, Marinaro A, Remohí J, Simón C, Pellicer A. Accidental exposure to dailylong-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle. Hum Reprod. 1997; 12(11): 2557-9.

• Mínguez Y, Rubio C, Bernal A, Gaitán P, Remohí J, Simón C, Pellicer A. The impact ofendometriosis in couples undergoing intracytoplasmic sperm injection because of male infertility.Hum Reprod. 1997; 12(10): 2282-5.

• Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simón C, Pellicer A. Reproductive impact ofcongenital Müllerian anomalies. Hum Reprod. 1997; 12(10): 2277-81.

• Remohí J, Ardiles G, García-Velasco JA, Gaitán P, Simón C, Pellicer A. Endometrial thicknessand serum oestradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod.1997; 12(10): 2271-6.

• Valbuena D, Pellicer A, Guanes PP, Remohí J, Simón C. Effect of disruption versus continuationof gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpusluteum function in patients undergoing ovulation induction for in-vitro fertilization. Hum Reprod.1997; 12(10): 2118-22.

• Simón C, Gimeno MJ, Mercader A, O'Connor JE, Remohí J, Polan ML, Pellicer A. Embryonicregulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro. JClin Endocrinol Metab. 1997; 82(8): 2607-16.

• Ruiz A, Remohí J, Minguez Y, Guanes PP, Simón C, Pellicer A. The role of in vitro fertilizationand intracytoplasmic sperm injection in couples with unexplained infertility after failed intrauterineinsemination. Fertil Steril. 1997; 68(1): 171-3.

• Cano F, García-Velasco JA, Millet A, Remohí J, Simón C, Pellicer A. Oocyte quality in polycysticovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet. 1997;14(5): 254-61.

• Remohí J, Gartner B, Gallardo E, Yalil S, Simón C, Pellicer A. Pregnancy and birth rates afteroocyte donation. Fertil Steril. 1997; 67(4): 717-23.

• Blanco J, Rubio C, Simón C, Egozcue J, Vidal F. Increased incidence of disomic sperm nuclei in

41

a 47,XYY male assessed by fluorescent in situ hybridization (FISH). Hum Genet. 1997; 99(3):413-6.

• Simón C, Mercader A, Gimeno MJ, Pellicer A. The interleukin-1 system and human implantation.Am J Reprod Immunol. 1997; 37(1): 64-72.

• Simón C, García-Velasco JA , Caballero-Campo P, Polan ML. Cytokines and reproductivefunction. Current Opinion in Endocrinology and Diabetes. 1997; 4: 377-86.

1996 • Simón C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohí J, Pellicer A. Hormonal

regulation of serum and endometrial IL-1 alpha, IL-1 beta and IL-1ra: IL-1 endometrialmicroenvironment of the human embryo at the apposition phase under physiological andsupraphysiological steroid level conditions. J Reprod Immunol. 1996; 31(3): 165-84.

• Remohí J, Gallardo E, Levy M, Valbuena D, de los Santos MJ, Simón C, Pellicer A. Oocytedonation in women with recurrent pregnancy loss. Hum Reprod. 1996; 11(9): 2048-51.

• Valbuena D, Simón C, Romero JL, Remohí J, Pellicer A. Factors responsable for multiplepregnancies after ovarian stimulation and intrauterine insemination with gonadotropins. J AssistReprod Genet. 1996; 13(8): 663-8.

• Guanes PP, Remohí J, Gallardo E, Valbuena D, Simón C, Pellicer A. Age does not affect uterineresistance to vascular flow in patients undergoing oocyte donation. Fertil Steril. 1996; 66(2): 265-70.

• Gallardo E, Simón C, Levy M, Guanes PP, Remohí J, Pellicer A. Effect of age on sperm fertilitypotential: oocyte donation as a model. Fertil Steril. 1996; 66(2): 260-4.

• Simón C. Potential molecular mechanisms for the contraceptive control of implantation. Mol HumReprod. 1996; 2(7): 475-9.

• Pellicer A, Valbuena D, Cano F, Remohí J, Simón C. Lower implantation rates in highresponders: evidence for an altered endocrine milieu during the preimplantation period. FertilSteril. 1996; 65(6): 1190-5.

• Simón C, Gimeno MJ, Mercader A, Francés A, Garcia Velasco J, Remohí J, Polan ML, Pellicer A.Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link inembryonic implantation? Mol Hum Reprod. 1996; 2(6): 405-24.

• De los Santos MJ, Mercader A, Francés A, Portolés E, Remohí J, Pellicer A, Simón C. Role ofendometrial factors in regulating secretion of components of the immunoreactive humanembryonic interleukin-1 system during embryonic development. Biol Reprod. 1996; 54(3): 563-74.

• Simón C, García-Velasco JA, Polan ML. Cytokines and reproductive function. Current Opinion inEndocrinology and Diabetes. 1996; 3: 463-71.

• Simón C, Tsafriri A, Pellicer A, Polan ML. The role of interleukins in the ovary. ReproductiveMedicine Review. 1996; 5(1): 51-63.

1995

• Pellicer A, Oliveira N, Ruiz A, Remohí J, Simón C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryodevelopment and implantation in assisted reproduction.Hum Reprod. 1995; 10 Suppl 2: 91-7.

• Remohí J, Gallardo E, Guanes PP, Simón C, Pellicer A. Donor-recipient synchronization and theuse of gonadotrophin-releasing hormone agonists to avoid the premature luteinizing hormonesurge in oocyte donation. Hum Reprod. 1995; 10 Suppl 2: 84-90.

• Pellicer A, Simón C, Remohí J. Effects of aging on the female reproductive system. Hum Reprod.1995; 10 Suppl 2: 77-83.

• Simón C, Pellicer A, Polan ML. Interleukin-1 system crosstalk between embryo and endometriumin implantation. Hum Reprod. 1995; 10 Suppl 2 :43-54.

• Polan ML, Simón C, Frances A, Lee BY, Prichard LE. Role of embryonic factors in humanimplantation. Hum Reprod. 1995; 10 Suppl 2: 22-9.

• Simón C, Mercader A, Portolés E, Francés A, Pellicer A. [The interleukin-1 system during humanimplantation]. Contracept Fertil Sex. 1995; 23(10): 626-30.

• Cano F, Simón C, Remohí J, Pellicer A. Effect of aging on the female reproductive system:evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril. 1995;64(3): 584-9.

• Simón C, Frances A, Lee BY, Mercader A, Huynh T, Remohi J, Polan ML, Pellicer A.Immunohistochemical localization, identification and regulation of the interleukin-1 receptor

42

antagonist in the human endometrium. Hum Reprod. 1995; 10(9): 2472-7. • Simón C, Cano F, Valbuena D, Remohí J, Pellicer A. Clinical evidence for a detrimental effect on

uterine receptivity of high serum oestradiol concentrations in high and normal responder patients.Hum Reprod. 1995; 10(9): 2432-7.

• Remohí J, Gutiérrez A, Cano F, Ruiz A, Simón C, Pellicer A. Long oestradiol replacement in anoocyte donation programme. Hum Reprod. 1995; 10(6): 1387-91.

• Simón C, Francés A, Pellicer A, Polan ML. Cytokines in Implantation. Semin Reprod Endocr.1995; 13: 142-51.

1994

• Simón C, Tsafriri A, Chun SY, Piquette GN, Dang W, Polan ML. Interleukin-1 receptor antagonistsuppresses human chorionic gonadotropin-induced ovulation in the rat. Biol Reprod. 1994; 51(4):662-7.

• Piquette GN, Simón C, el Danasouri I, Frances A, Polan ML. Gene regulation of interleukin-1beta, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in humangranulosa-luteal cells. Fertil Steril. 1994; 62(4): 760-70.

• Piquette GN, Tilly JL, Prichard LE, Simón C, Polan ML. Detection of apoptosis in human and ratovarian follicles. J Soc Gynecol Investig. 1994; 1(4): 297-301.

• Simón C, Polan ML. Cytokines and reproduction. West J Med. 1994; 160(5): 425-9. • Pellicer A, Marí M, de los Santos MJ, Simón C, Remohí J, Tarín JJ. Effects of aging on the

human ovary: the secretion of immunoreactive alpha-inhibin and progesterone. Fertil Steril. 1994;61(4): 663-8.

• Simón C, Gutiérrez A, Vidal A, de los Santos MJ, Tarín JJ, Remohí J, Pellicer A. Outcome ofpatients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocytedonation. Hum Reprod. 1994; 9(4): 725-9.

• Simón C, Frances A, Piquette G, Hendrickson M, Milki A, Polan ML. Interleukin-1 system in thematerno-trophoblast unit in human implantation: immunohistochemical evidence forautocrine/paracrine function. J Clin Endocrinol Metab. 1994; 78(4): 847-54.

• Simón C, Piquette GN, Frances A, el-Danasouri I, Irwin JC, Polan ML. The effect of interleukin-1beta (IL-1 beta) on the regulation of IL-1 receptor type I messenger ribonucleic acid and proteinlevels in cultured human endometrial stromal and glandular cells. J Clin Endocrinol Metab. 1994;78(3): 675-82.

• Simón C, Frances A, Piquette G, Polan ML. Immunohistochemical localization of the interleukin-1system in the mouse ovary during follicular growth, ovulation, and luteinization. Biol Reprod.1994; 50(2): 449-57.

• Simón C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, Polan ML. Embryonicimplantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology. 1994; 134(2):521-8.

• Simón C. Editorial: A Critical Role for Interleukin-1 (IL-1) and the type 1 IL-1 receptor inblastocyst implantation. Endocrinology. 1994; 134: 519-20.

• Gutiérrez A, Oliveira N, Cano F, Ruiz A, Simón C, Remohí J, Pellicer A. In Vitro Fertilization inInfertile Patients with Endometriosis. Assist Reprod Rev. 1994; 4: 162-71.

1993

• Simón C, Piquette GN, Frances A, Polan ML. Localization of interleukin-1 type I receptor andinterleukin-1 beta in human endometrium throughout the menstrual cycle. J Clin EndocrinolMetab. 1993; 77(2): 549-55.

• Simón C, Piquette GN, Frances A, Westphal LM, Heinrichs WL, Polan ML. Interleukin-1 type Ireceptor messenger ribonucleic acid expression in human endometrium throughout the menstrualcycle. Fertil Steril. 1993; 59(4): 791-6.

• Bonilla-Musoles F, Ballester MJ, Simón C, Serra V, Raga F. Is avoidance of surgery possible inpatients with perimenopausal ovarian tumors using transvaginal ultrasound and duplex colorDoppler sonography? J Ultrasound Med. 1993; 12(1): 33-9.

1992

• Simón C, Gómez E, Mir A, De los Santos MJ, Pellicer A. Glucocorticoid treatment decreasessera embryotoxicity in endometriosis patients. Fertil Steril. 1992; 58(2): 284-9.

• Bonilla-Musoles F, Simón C, Serra V, Sampaio M, Pellicer A. An assessment ofhysterosalpingosonography (HSSG) as a diagnostic tool for uterine cavity defects and tubal

43

patency. J Clin Ultrasound. 1992; 20(3): 175-81.• Raga F, Simón C, Strasser J, Bonilla-Musoles F. Abdominal, perineal and vaginal sonographic

diagnosis of cervix insufficiency. Ultraschall Med. 1992; 13(1): 24-7.1991

• Simón C, Martinez L, Pardo F, Tortajada M, Pellicer A. Müllerian defects in women with normalreproductive outcome. Fertil Steril. 1991; 56(6): 1192-3.

• Bonilla-Musoles F, Pardo G, Sampaio M, Simón C, Fernandes H, Matallín P, Blanes J.Immunisierüngstherapie mit einer neuen vakzine. Therapiewoche Schweiz. 1991; 12: 859-64.

1990

• Simón C, Raga F, Strasser J, Bonilla-Musoles F. [Hysterosalpingography: synechiae? Gartner'sducts?]. Geburtshilfe Frauenheilkd. 1990; 50(12): 977-81.

• Bonilla-Musoles F, Pardo G, Simón C. How accurate is ultrasonography in monitoring IUDplacement? J Clin Ultrasound. 1990; 18(5): 395-9.

• Bonilla-Musoles F, Sampaio M, Simón C, Serra V, Strasser J. [Pathology of the yolk sac:endosonographic results]. Ultraschall Med. 1990; 11(1): 24-8.

1989

• Bonilla-Musoles F, Pardo G, Sampaio M, Pellicer A, Simón C, Strasser J. [Vaginalendosonography in extrauterine pregnancy]. Ultraschall Med. 1989; 10(4): 215-21.

• Pellicer A, Simón C, Miró F, Castellví RM, Ruiz A, Ruiz M, Pérez M, Bonilla-Musoles F. Ovarianresponse and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasinghormone analogues in different phases of the menstrual cycle. Hum Reprod. 1989; 4(3): 285-9.

• Bonilla-Musoles F, Monmeneu RM, Simón C, Serra V. Can the uterine cervix grow a moustache?Eur J Gynaecol Oncol. 1989; 10(2): 145-6.

1987

• Bonilla-Musoles F, Monmeneu S, Pardo G, Simón C, Serra V, Pellicer A. Granular cellmyoblastoma (GCM): contribution of three cases with genital involvement. Eur J Gynaecol Oncol.1987; 8(2): 110-4.

• Bonilla-Musoles F, Castells A, Simón C, Serra V, Pellicer A, Ramírez A, Pardo G. Importance ofLangerhans cells in the immune origin of carcinoma of the uterine cervix. Eur J Gynaecol Oncol.1987; 8(1): 44-60.

1985

• Bonilla-Musoles F, Pellicer A, Perez Gil M, Simón C, Meyer A. [Has intrauterine surgery usingultrasound a future?]. Ultraschall Med. 1985; 6(4): 208-14.

Peer Reviewed Articles in National Journals

2007

• Sánchez-Luengo S, Simón C. Tratamiento con células madre. Anales de Pediatría Continuada.2007; 5(3): 172-175.

2006

• Simón C, Pellicer A. Encuentro de expertos sobre gestaciones múltiples. Rev Iberoam FertilReprod Hum. 2006; 22(5): 309-337.

• Marqueta J, Cabello Y, Hernández J, Coroleu B, Simón C, Pérez-Milán F, Arnott I, Blanes R,Monzó A, Matorras R. Registro FIV-ICSI de la Sociedad Española de Fertilidad. Año 2002. RevIberoam Fertil Reprod Hum. 2006; 23(2): 87-96.

2005

• Marqueta J, Cabello Y, Hernández J, Coroleu B, Simón C, Pérez-Milán F, Arnott I, Blanes R,Monzó A, Matorras R. Registro FIV-ICSI de la Sociedad Española de Fertilidad. Año 2001. RevIberoam Fertil Reprod Hum. 2005; 24(4): 237-248.

• Simón C. Regeneración de células germinales: ¿una quimera? Actualidad y controversias enginecología nº 5, la opinión de los expertos nº 17. 2005; 5: 3-5.

• Simón C, Pellicer A. Patrón proteómico secretado por blastocistos viables como una posiblearma diagnóstica para obtener embarazos únicos después de fecundación in Vitro. Rev IberoamFertil Reprod Hum. 2005; 22(5): 327-38.

2004

• Cervero A, Horcajadas JA, Martín J, Pellicer A, Simón C. Beca de investigación S.E.F 2001: El

44

sistema de la leptina durante la receptividad endometrial y el desarrollo preimplantatorio. RevIberoam Fertil Reprod Hum. 2004; XXV Congreso Nacional SEF: 109-19.

• Galán A, Simón C. Regeneración germinal a partir de células madre embrionarias. Rev IberoamFertil Reprod Hum. 2004; XXV Congreso Nacional SEF: 173-8.

• Martín J, Rubio C, Mercader A, Simón C, Remohí J, Pellicer A. Diagnóstico GenéticoPreimplantacional dirigido al estudio de enfermedades monogénicas. Rev Iberoam Fertil ReprodHum. 2004; XXV Congreso Nacional SEF: 179-86

• Pellicer A, Simón C. Fallo repetido de implantación: Aspectos clínicos. Rev Iberoam FertilReprod Hum. 2004; XXV Congreso Nacional SEF: 192-6.

• Martínez-Conejero JA, Garrido N, Simón C, Pellicer A, Remohí J, Meseguer M. MUC-1 e IL-6:Posibles Marcadores de Fertilidad en Reproducción Humana. Revisión. ASEBIR. 2004; 9(1): 12-22.

•••• Rubio C, Rodrigo L, Mercader A, Mateu E, Simón C, Remohí J, Pellicer A. El diagnósticogenético preimplantacional y sus nuevas indicaciones en reproducción asistida. Clin Invest GinObst. 2004; 31(9): 314-22.

2003

• Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. Criopreservación en semen: parámetrosque afectan a la supervivencia del espermatozoide. Temas de actualidad en Andrología. 2003; III:245-66.

• Simón C, García-Velasco J.A. Endometriosis y reproducción asistida. Prog Obstet Ginecol. 2003;46(S1): 95-8.

• Meseguer M, Martínez-Conejero JA, Aplin JD, Remohí J, Pellicer A, Simón C. TGF-β1 regula invitro a la mucina endometrial humana MUC1 durante la implantación embrionaria. Rev IberoamFertil Reprod Hum. 2003; 20(3): 167-76. (Premio al mejor artículo básico del año 2003)

2002

• Meseguer M, Garrido de Lomas J, Gimeno C, Bellver J, Simón C, Pellicer A, Remohí J.Presencia del virus de inmunodeficiencia humana y el virus de la hepatitis C en el semen lavado:¿ausentes o presentes pero no infectivos?. Rev Iberoam Fertil Reprod Hum. 2002; 24: 128-135.

• Garrido N, Meseguer M, Gámiz P, Simón C, Pellicer A, Remohí J. Factor Masculino y técnicas de

Reproducción Asistida. ASEBIR. 2002; 7(1): 10-24.• Muñoz E.A, García-Velasco J, Scheffer B, Muñoz M, Remohí J, Pellicer A, Simón C. El uso de

FSH recombinante a dosis de 100 UI por día alcanza resultados similares a 150 UI eninseminación intrauterine (IU). Rev Iberoam Fertil Reprod Hum. 2002; 19(4): 253-9.

• Garrido N, Meseguer M, Simón C, Pellicer A, Remohí J. Factores influyentes en los resultadosde la congelación y descongelación del semen humano. ASEBIR. 2002; 7(2): 21-7.

•••• Zuzuarregui JL, Garrido N, Meseguer M, Simón C, Pellicer A, Remohí J. Parámetros que afectana los resultados de la inseminación artificial con semen de donante. Rev Iberoam Fertil ReprodHum. 2002; 19(6): 387-97.

2001

• Domínguez F, Martín J, Remohí J, Pellicer A, Simón C. Impronta genómica. Un mecanismofisiológico de silenciamiento de genes. Rev Iberoam Fertil Reprod Hum. 2001; XVII(6): 289-98.

• Remohí J, Muñoz E, Gaytán J, Navarro J, Simón C, Pellicer A. Evaluación de la pareja estéril.Salud Total de la Mujer. 2001; 3: 144-54.

• Garrido N, Meseguer M, Simón C, Pellicer A, Remohí J. Detección del virus de la Hepatitis C ensemen lavado de varones seropositivos para su posterior uso en reproducción asistida:resultados preliminares. Actualidad Andrológica. 2001; 9(2-3): 56-60.

• Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. ¿Es segura la utilización del semen dedonante? Seguimiento de enfermedades infecciosas y desórdenes hereditarios en la poblaciónde donantes de semen y el programa de IAD; experiencia de 10 años. Actualidad Andrológica.2001; 9(2-3): 61-7.

• González I, Bosch E, Camargo F, Caligara C, Simón C, Pellicer A, Remohí J. Efecto del usoprevio de los anticonceptivos hormonales orales sobre la estimulación ovárica controlada. RevIberoam Fertil Reprod Hum. 2001; 18(6): 455-9.

• Ramos-González P, García-Velasco J.A, Villasante A, Scheffer B, Remohí J, Pellicer A, Simón C.Transferencia de embriones: la gran olvidada. Rev Iberoam Fertil Reprod Hum. 2001; 18(6): 435-

45

42. • Escudero E, Valbuena D, Remohí J, Simón C, Pellicer A. Repercusión de los altos niveles de

estrógeno en la fase de implantación embrionaria. Obst y Ginecol Españ. 2001; X: 101-107.2000

• Muñoz E, Valbuena D, Landazábal A, Remohí J, Pellicer A, Simón C. Infección por el virus de lahepatitis C y embarazo. Revisión de conjunto. Prog Obstet Ginecol. 2000; 43: 105-16.

• Ibérico G, Crespo J, Serra V, Lara V, Muñoz E, Simón C, Pellicer A, Remohí J. Síndromeantifosfolipídico y reproducción asistida: a propósito de un caso. Rev Iberoam Fertil ReprodHum. 2000; XVII(2): 167-74.

• González R.R, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Bishof P, Simón C. Laleptina: un nuevo factor regulador de la implantación humana. Rev Iberoam Fertil ReprodHum. 2000; XVII(4): 59-74.

• Landazábal A, Valbuena D, Remohí J, Pellicer A, Simón C. Estrategias de mejora de laimplantación embrionaria. Cienc Ginecol. 2000; 4: 191-8.

• Vidal C, Romero J, Rubio C, Pérez-Cano I, Ruiz A, Navarro J, Simón C, Pellicer A, Remohí J.Indicaciones clínicas de la microinyección intracitoplasmática de espermatozoides (ICSI). CiencGinecol. 2000; 4: 177-84.

• Caligara C, Moreno C, Valbuena D, Mercader A, Navarro J, Remohí J, Pellicer A, Simón C. Eldesarrollo embrionario preimplantatorio tras FIV es superior a ICSI debido a la calidadespermática y no a la técnica. Prog Obstet Ginecol. 2000; 43: 303-9.

• Bellver J, Navarro J, Albert C, Simón C, Pellicer A, Remohí J. Curso natural, clínica, diagnóstico,fisiopatología y factores de riesgo. Folia Clin Obstet Ginec. 2000; 24: 10-34.

• Ibérico G, Vergara F, Navarro J, Vargas G, Remohí J, Pellicer A, Simón C. Caso clínico:Acumulación de líquido en cavidad endometrial e hidrosálpinx. Rev Iberoam Fertil ReprodHum. 2000; XVII(5): 251-6.

• Cuneo S, Camargo F, Vargas G, Caligara C, Pellicer A, Simón C, Remohí J. Importancia deldiagnóstico de la fibrosis quística asociada a agenesia congénita de los conductos deferentes ydel adecuado tratamiento de la infertilidad masculina para evitarla en la descendencia. RevIberoam Fertil Reprod Hum. 2000; XVII(5): 219-23.

1999

• Díaz I, Navarro J, Torres JV, Simón C, Pellicer A, Remohí J. Donación de ovocitos: Indicacionesy Resultados. Rev Iberoam Fertil Reprod Hum. 1999; XVI(2): 121-6.

• Ibérico G, Simón C, Remohí J, Pellicer A. Diálogo endometrio materno embrión: como mejorar laimplantación embrionaria en FIV. Rev Iberoam Fertil Reprod Hum. 1999; XVI(2): 141-9.

• Vergara F, Muñoz E, Alvarez J.C, Simón C, Remohí J, Pellicer A. Metformina y troglitazona en elsindrome de ovario poliquístico. Rev Iberoam Fertil Reprod Hum. 1999; XVI(3). 175-82.

• Muñoz E, Alvarez J.C, Landazábal A, Díaz I, Crespo J, Simón C, Pellicer A, Remohí J. Síndromede hiperestimulación ovárica y accidentes cerebrovasculares: A propósito de un caso. RevIberoam Fertil Reprod Hum. 1999; XVI(3): 239-44.

• Alvarez J.C, Navarro J, Crespo J, Rodríguez M, Vergara F, Díaz I, Bonilla F, Simón C, Pellicer A,Remohí J. Embarazo ectópico ovárico momificado y gestación tripe con gemelos monocigóticostras la transferencia de cinco embriones en estadio de blastocisto. A propósito de un caso. RevIberoam Fertil Reprod Hum. 1999; XVI(3): 245-48.

• García Velasco JA, Martínez-Salazar J, Requena A, Caballero P, Remohí J, Pellicer A, Simón C.Implicaciones hormonales que comprometen la implantación. Rev Iberoam Fertil ReprodHum. 1999; XVI(5): 327-34.

• García-Velasco J.A, Martínez-Salazar FJ, Requena A, Simón C, Pellicer A, Remohí J.Reproducción asistida y el síndrome de inmunodeficiencia adquirida. Medicina Reproductiva.1999; 2: 38-46.

• Garrido N, Albert C, Remohí J, Simón C, Pellicer A. Microambiente autocrino y paracrino foliculary calidad embrionaria en mujeres con endometriosis. Rev Iberoam Fertil Reprod Hum. 1999;XVI(6): 413-8.

• Albert C, Garrido N, Mercader A, Remohí J, Simón C, Pellicer A. Fisiopatología del Síndrome deHiperestimulación Ovárica: Implicación del endotelio. Rev Iberoam Fertil Reprod Hum. 1999;XVI(6): 455-63.

1998

46

• García-Velasco J.A, Valbuena D, Simón C, Remohí J, Pellicer A. La alta respuesta en FIV. RevIberoam Fertil Reprod Hum. 1998; XV(3): 247-52.

• Rubio C, Mínguez Y, Romer JL, Ruiz A, Cobo A, Simón C, Pellicer A, Remohí J. Diagnósticopreimplantatorio de enfermedades ligadas al sexo: indicaciones y resultados preliminares. Obst yGinecol Españ. 1998; VII: 7-11.

• Neuspiller F, Ardiles G, Yalil S, Simón C, Pellicer A, Remohí J. Resultados de ICSI enazoospermia obstructiva. Obst y Ginecol Españ. 1998; VII: 29-35.

• Cobo A, Ruiz A, Bernal A, Romero J, Rubio C, Mínguez Y, Molero MD, Simón C, Pellicer A,Remohí J. Fecundación y desarrollo embrionario tras la ICSI de ovocitos madurados in vitro.Obst y Ginecol Españ. 1998; VII: 117-22.

• Remohí J, Neuspiller F, Ardiles G, Yalil S, Simón C, Pellicer A. Azoospermias secretoras;posibilidades terapéuticas actuales. Obst y Ginecol Españ. 1998; VII: 123-26.

• Nuñez R, Caballero P, Remohí J, Simón C, Pellicer A, Bonilla-Musoles F. Bancos de semen en laera del ICSI. Obst y Ginecol Españ. 1998; VII: 127-34.

• Landeras J, Martínez-Salazar FJ, García-Velasco JA, Levy M, Simón C, Pellicer A, Remohí J.Posibilidades reproductivas tras vasectomía. Obst y Ginecol Españ. 1998, VII: 135-38.

• Ardiles G, Neuspiller F, Guaman W, Moreno C, Simón C, Pellicer A, Remohí J. InseminaciónArtificial conyugal en mujeres mayores de 35 años. Obst y Ginecol Españ. 1998; VII: 165-68

• Mercader A, Herrer R, Valbuena D, Remohí J, Simón C. Cocultivo embrionario. Rev IberoamFertil Reprod Hum. 1998; XV(4): 283-7.

• Galán A, Pellicer A, Simón C. Apoptosis y reproducción. Rev Iberoam Fertil Reprod Hum.1998; XV(4): 307-15.

• Mercader A, Simón C, Herrer R, Albert C, Galán A, Remohí J, Pellicer A. Estudio del desarrolloen embriones cocultivados con células del epitelio endometrial humano. Arch. Esp. Morfol. 1998;3: 113-8.

1997

• Yalil S, García-Velasco J.A, Silvestri I, Levy M, Minguez Y, Simón C , Remohí J, Pellicer A.Microinyección intracitoplasmática de espermatozoides en fallo de fecundación en FIV. ObstGinecol Españ. 1997; VI: 5-8.

• Caballero P., García Velasco J.A., Pellicer A, Simón C. Quimoquinas una atrayente familia demediadores específicos. Prog Obst Gin. 1997; 40: 525-37.

• Levy M, García-Velasco J.A, Gallardo E, Yalil S, Guanes J.J, Landeras J, Remohí J, Simón C,Pellicer A. Incidencia de embarazo ectópico en las diferentes técnicas de reproducción asistida(TRA). Prog Obst Gin. 1997; 40: 413-8.

• Amorocho B, De los Santos M.J, Rubio M.C, Mínguez Y, Ballesteros A, Simón C, Remohí J,Pellicer A, Gómez E. Efectos de la microinyección espermática en la congelación de embriones.Obst Ginecol Españ. 1997; VI: 97-9.

• Neuspiller F, Rubio C, Mínguez Y, Simón C, Pellicer A, Remohí J. Inyección intracitoplasmáticade espermatozoides -ICSI- en casos extremos. Rev. Lat. Amer. Est. Fert. 1997; 11(1): 21-9.

• Neuspiller F, Ardiles G, Yalil S, Simón C, Pellicer A, Remohí J. Resultado de la ICSI enazoospermias obstructivas. Rev. Lat. Amer. Est. Fert. 1997; 11(2): 51-9.

•••• Moreno C, Simón C, Pellicer A, Remohí J. Donación de ovocitos como opción reproductiva enpacientes con disgenesia gonadal. Rev. Lat. Amer. Est. Fert. 1997; 11: 94-100.

1996

• Valbuena D, Cano F, Simón C. La ventana de implantación. Rev Iberoam Fertil ReprodHum. 1996; XIII(2): 127-32.

• Rubio C, Remohí J, Pellicer A, Simón C. Diagnóstico preimplantatorio. Biopsia embrionaria ytécnicas de análisis genético. Rev Iberoam Fertil Reprod Hum. 1996; XIII(3): 151-9.

• Remohí J, Gallardo E, Guanes PP, Gartner B, Simón C y Pellicer A. Nuevos enfoques en ladonación de ovocitos. Rev. Lat. Amer. Est. Fert. 1996; 10(2): 51-63.

• Gallardo E, Guanes PP, Levy M, Simón C, Pellicer A y Remohí J. Donación de ovocitos:resultados de 5 años de experiencia en el Instituto Valenciano de Infertilidad. Obst GinecolEspañ. 1996; V: 89-97.

• Gallardo E, Guanes PP, Valbuena D, Yalil S, Simón C, Pellicer A y Remohí J. La utilidad de lainyección intracitoplasmática de espermatozoides (ICSI) en la donación de ovocitos. ObstGinecol Españ. 1996; V: 125-9.

47

• Cobo A.C, Rubio M.C, Minguez Y, Ruiz A, Romero J, Simón C , Pellicer A, Remohí J. ICSI yespermatozoides de eyaculado. Solución a la esterilidad de origen masculino. Obst GinecolEspañ. 1996; V: 99-103.

1995

• Romero J, De los Santos MJ, Ruiz A, Rubio MC, Mínguez Y, Simón C, Remohí J, Pellicer A.Morfología del acrosoma anómala: nueva indicación para ICSI. Rev Iberoam Fertil ReprodHum. 1995; XII(1): 61-3.

• Pellicer A., Guanes P.P., Simón C. Tratamiento del hiperandrogenismo sin deseo reproductivo. • Prog Obst Gin. 1995; 38(supl 1): S127-S143. • Gutiérrez A, Gallardo E, Cano F, Romero JL, Simón C, Pellicer A, Remohí J. Donación de

ovocitos: influencia de la edad de la receptora en los resultados clínicos. Prog Obst Gin. 1995;38: 327-32.

• Simón C y Cano F. Fisiopatología, inmunología y endometriosis. Rev Iberoam Fertil ReprodHum. 1995; XII(4): 259-66.

• Oliveira N, Pellicer A, Remohí J, Cano F, Simón C. Alteración del desarrollo embrionario precozen pacientes con endometriosis. Prog Obst Gin. 1995; 38: 465-70.

1994

• Mercader A y Simón C. Citokinas en la implantación. Obstet Ginecol Españ. 1994; III: 149-53.

• Simón C. Fisiología de la Implantación. Obstet Ginecol Españ. 1994; III: 135-141.1992

• Bonilla-Musoles F, Ballester MJ, Raga F, Serra V, Simón C. Aplicaciones del Doppler DuplexColor Transvaginal en Obstetricia y Ginecología. Rev Fed Centroam Soc Obst Ginec. 1992; 2: 9-22.

• Simón C, Bonilla-Musoles F, Pellicer A. Etiopatogenia de la endometriosis. AspectosInmunológicos. Revisión de conjunto. Obstet Ginecol Españ. 1992; II. 105-8.

1991

• Simón C, Matallín P, Martorell M, Torres JV. Citometría de flujo en el carcinoma verrucoso vulvar.Clin Invest Gin Obst. 1991; 18(9): 366-9.

• Matallín P, Martorell MA, Torres JV, Simón C. Citometría de flujo en melanomas malignosvulvares. Clin Invest Gin Obst. 1991; 18(5): 172-7.

• Simón C, Pellicer A, Millet A. Tomografía axial computarizada versus resonancia magnéticanuclear en el diagnóstico de la patología hipofisaria. Clin Invest Gin Obst. 1991; 18(3): 88-91.

• Simón C, Tarín J, Gómez E, Remohí J, Bonilla-Musoles F, Pellicer A. Comparación entredistintos protocolos de estimulación ovárica en un programa FIV. Obstet Ginecol Españ. 1991; I:85-9.

• Simón C, Millet A, Losada J, Pellicer A. Inducción de una gestación con análogos de la GnRH ygonadotrofinas en una paciente con fallo ovárico precoz. Rev Iberoam Fertil Reprod Hum. 1991;VIII(2): 95-7

1990

• Tarín J, Simón C, Bonilla-Musoles F, Pellicer A. Efectos del tabaco en ovocitos humanos: Análisiscitogenético. Obst Ginec Españ. 1990; I. 38-42.

1989

• Matallín P, Torres JV, Martorell M, Simón C. Transformación maligna del quiste de ovario. Apropósito de dos casos de carcinomas epidermoides desarrollados sobre quistes dermoides deovario. Rev Esp Obst y Gin. 1989; 48: 291-6.

• Bonilla-Musoles F, Sampaio M, Simón C, Raga F. Posibilidades de diagnóstico precoz en elcáncer de ovario. Rev Esp Obst y Gin. 1989; 48: 81-95.

• Bonilla-Musoles F, Sampaio M, Vilela M, Simón C, Serra V, Fernandes H. Ultrasonidos enincontinencia urinaria. Rev Esp Obst y Gin. 1989; 48: 139-48.

• Simón C, Sampaio M, Pardo G, Matallín P, Bonilla-Musoles F. Tratamiento conservador delembarazo ectópico. Revisión de conjunto. Rev Esp Obst y Gin. 1989; 48: 43-50.

• Bonilla-Musoles F, Pardo G, Simón C, Sampaio M, Pellicer A. Alternativas actuales a lafertilización in vitro y transferencia de embriones. Importancia de la endosonografia vaginal. RevEsp Obst y Gin. 1989; 48. 7-18

• Simón C, Pellicer A, Millet A, Navarro S, Navarro E, Tortajada M, Bonilla-Musoles F. Gestación

48

ovárica en portadora de dispositivo intrauterino (DIU). Caso clínico. Rev Iberoam Fertil ReprodHum. 1989; VI(2): 139-42.

1988

• Bonilla-Musoles F, Serra V, Pardo G, Simón C, Ramírez A. Condiloma atípico del cuello uterino.Clin Ginecol. 1988; 12/1. 13-42.

1987

• Simón C, Bonilla-Musoles F. Tabaco y cáncer de cérvix. Rev Esp Obst y Gin. 1987; 46. 391-404.

1986

• Simón C, Martínez-Ramón A, Serra V, Tortajada M, Bonilla-Musoles F. Biopsia Corial Alternativade diagnóstico precoz en el primer trimestre del embarazo. Rev Esp Obst y Gin. 1986; 45: 645-56.

• Bonilla-Musoles F, Castells A, Serra V, Simón C, Pellicer A, Pardo G. Importancia de las célulasde Langerhans en el origen inmunológico del cáncer de cerviz uterino. Obst y Gin Lat Amer.1986; 44. 81-96

1985

• Bonilla-Musoles F, Pardo G, Simón C, Serra V, Remohí J. Ensayo clínico del tratamientomonodosis con comprimidos vaginales de clotrimazol 500 mg en micosis vaginales. Rev EspObst y Gin. 1985; 44: 589-602.

• Bonilla-Musoles F, Legua V, Ramírez JV, Remohí J, Blanes J, Ruiz A, Serra V, Simón C,Pellicer A. El condiloma del cuello uterino I. Etiopatogenia y Epidemiología. Progr Obstet Ginecol.1985; 28(8): 493-504.

• Bonilla-Musoles F, Legua V, Ramírez JV, Remohí J, Blanes J, Ruiz A, Serra V, Simón C, PellicerA. El condiloma del cuello uterino II. Anatomía Patológica. Progr Obstet Ginecol. 1985; 28(9):545-61.

• Bonilla-Musoles F, Legua V, Ramírez JV, Remohí J, Blanes J, Ruiz A, Serra V, Simón C,Pellicer A. El condiloma del cuello uterino III. Diagnóstico y Tratamiento. Progr Obstet Ginecol.1985; 28(10): 601-35.

Books Published (Editor)

• Simón C, Pellicer A, editors. Regulators of human implantation. Oxford (UK): Oxford UniversityPress; 1995.

• Remohí J, Simón C, Pellicer A, Bonilla-Musoles F, editors. Reproducción humana. Madrid (ESP):McGraw-Hill Interamericana; 1996.

• Rodríguez L, Bonilla F, Pellicer A, Simón C, Remohí J, editors. Manual práctico de reproducaóhumana. Rio de Janeiro (BRA): Livraria e Editora Revinter Ltda; 1998.

• Pellicer A, Simón C, Bonilla-Musoles F, Remohí J, editors. Ovarian hyperstimulation syndrome.Pathophysiology, prevention and treatment. Rome (ITA): Serono Fertility Series; 1999.

• Simón C, Pellicer A, Remohí J, editors. Emerging concepts on human implantation. Oxford (UK):Oxford University Press; 1999.

• Remohí J, Romero J.L, Pellicer A, Simón C, Navarro J, editors. Manual práctico de esterilidad yreproducción humana. Madrid (ESP): McGraw-Hill Interamericana; 2000.

• Simón C, Pellicer A, Doberska C, editors. Human implantation: recent advances and clinicalaspects. Cambridge (UK): The Journal of Reproduction and Fertility Ltd; 2000.

• Simón C, Pellicer A, editors. Procedings of de 2nd international workshop on human implantationrecent advances and clinical aspects. Elsevier; 2001.

• Remohí J, Pellicer A, Simón C, Navarro J, editors. Reproducción humana. 2nd ed. Madrid (ESP):McGraw-Hill Interamericana; 2002.

• Scheffer BB, Remohí J, García-Velasco JA, Pellicer A, Simón C, editors. Reprodução humanaasistida. Sao Paulo (BRA): Atheneu; 2003.

• Remohí J, Cobo A, Romero JL, Pellicer A, Simón C, editors. Manual práctico de esterilidad yreproducción humana. 2nd ed. Madrid (ESP): Mc Graw-Hill. Interamericana; 2004.

• Simón C, Pellicer A, editors. Stem cells in human reproduction, basic science and therapeuticpotential. London (UK): Informa Healthcare; 2007.

• Simón C, Horcajadas JA, García-Velasco JA, Pellicer A, editors. El endometrio humano. Desde

49

la investigación a la clínica. Buenos Aires (ARG); Madrid (ESP): Médica Panamericana; 2009.• Simón C, Pellicer A, editors. Stem cells in human reproduction, basic science and therapeutic

potential. 2nd ed. London (UK): Informa Healthcare; 2009. • Simón C, Pellicer A, Reijo-Pera R, editors. Stem cells in reproductive medicine, basic science

and therapeutic potential. 3nd ed. London (UK): Cambridge University Press; 2013. • Gardner DK, Simón C, editors. Handbook of In Vitro Fertilization. 4th ed. (USA); CRC Press; 2017• Simón C, Giudice L, editors. The Essential Uterine Handbook: Current Applications in Clinical

Medicine. (USA) CRC Press; 2017.• Simón C, Rubio C, editors. Handbook of New Genetic Diagnostic Technologies in Reproductive

Medicine. (USA) CRC Press; 2017.• Flaws J, Jegou B, McCarrey J, Niederberger C, Simón C, Skinner M, Spenccer T, Swanson P,

Yan W. Encyclopedia of Reproduction, 2nd EditionEncyclopedia. (USA) Elsevier; in process.

Monographs

Cuadernos de Medicina Reproductiva Editors: Pellicer A, Simón C.Editorial Médica Panamericana. Spain

1995

• Volumen 1 nº1. INSEMINACIÓN ARTIFICIAL.• Volumen 1 nº2. ENDOMETRIOSIS.1996

• Volumen 2 nº1. EMBARAZO ECTÓPICO. • Volumen 2 nº2. HIPERANDROGENISMO. 1997

• Volumen 3 nº1. IMPLANTACION EMBRIONARIA. ASPECTOS BÁSICOS Y APLICACIONESCLÍNICAS.

• Volumen 3 nº2. ABORTO RECURRENTE. 1998

• Volumen 4 nº1. OVARIO POLIQUÍSTICO. • Volumen 4 nº2. CLIMATERIO Y MENOPAUSIA.1999

• Volumen 5 nº1. MIOMAS. • Volumen 5 nº2. ULTRASONIDOS Y REPRODUCCIÓN.2000Volumen 6 nº1. AMENORREAS.Volumen 6 nº2. REPRODUCCIÓN ASISTIDA DEL SIGLO XXI.2001Volumen 7 nº1. DIAGNÓSTICO PRENATAL.Volumen 7 nº2. CONTRACEPCIÓN EN EL SIGLO XXI.2002Volumen 8 nº1. CIRUGÍA ENDOSCÓPICA REPRODUCTIVA.Volumen 8 nº2. BIOLOGÍA MOLECULAR EN MEDICINA REPRODUCTIVA.2003Volumen 9 nº1. NEUROENDOCRINOLOGÍA REPRODUCTIVA. Volumen 9 nº2. ENDOCRINOLOGÍA DEL EMBARAZO. 2004.Volumen 10 nº1. ESTUDIO DE LOS NIÑOS NACIDOS MEDIANTE TÉCNICAS DE

REPRODUCCIÓN ASISTIDA.2006Coordinator Volumen 12 nº2. NUEVOS AVANCES EN MEDICINA REPRODUCTIVA.Editorial Adalia Farma.

Chapters Published in International Books2017

• Miravet-Valenciano J, Balaguer N, Vilella F, Simón C. Molecular diagnosis of endometrial

50

receptivity. In: the Endometrial factor, a reproductive precision medicine approach, USA; CRCPress, 2017: 36-49.

• Moreno I, Simón C. Microbiological diagnosis: the human endometrial microbiome – endometritis.In: the Endometrial Factor, A Reproductive precision medicine approach, USA; CRC Press, 2017:65-77.

• Balaguer N, Domínguez F, Simón C, Vilella F. Embryo/fetal-maternal cross talk. In: theEndometrial Factor, A Reproductive precision medicine approach, USA; CRC Press, 2017:243-255.

• Lalitkumar S, Gomez E, Ruiz-Alonso M, Valbuena D, Vilella F, Simon C. Endometrial receptivity.In: Handbook of in Vitro Fertilization 4th Edition, USA; CRC Press, 2017: 317-330.

• Rincon A, Ruiz-Alonso M, Diaz-Gimeno P, Vilella F, Simón C. Endometrial development and geneexpression. In: Early pregnancy. 2nd Edition, UK; Cambridge University Press, 2017: 1-12.

• Miravet-Valenciano J, Marin C, Ruiz-Alonso M, Simón C. How to assiss the receptivity of thehuman endometrium? In: Infertility Management Series. Investigating Infertility. Jaypee BrothersMedical Publishers, 2017: 98-121.

2016

• Cervelló I, Medrano JV, Simón C. Regenerative Medicine and Tissue Engineering inReproductive Medicine: Future Clinical Applications in Human Infertility. In: TranslatingRegenerative Medicine to the Clinic. Academic Press, 2016: 139-51.

2015

• Mir P, Al-Asmar N, Rodrigo L, Simón C, Rubio C. Debate: Should preimplantation geneticscreening be performed in recurrent pregnancy loss? In: Recurrent pregnancy Loss. Causes,controversies and treatment. 2nd Edition, UK; CRC press, 2015: 55-8.

2014

• Medrano, JV, Simón C, Reijo- Pera R. Human germ cell differentiation from pluripotentembryonic stem cells and induced pluripotent stem cells. In: Human Fertility: Methods andProtocols (Methods in Molecular Biology 1154), USA: Springer; 2014: 563-78.

2013

•••• Mondión M, Garrido-Gómez T, Ruiz M, Simón C. Las ómicas en la preparación hormonalendometrial para la transferencia embrionaria. In: Donación de embriones, Spain: MomentoMedico s.r.l; 2013: 237-50.

•••• Medrano JV, Martínez-Arroyo A, Simón C, Reijo Pera RA. Germ-cell differentiation frompluripotent cells. In: Stem Cell in Reproductive Medicine, Basic Science adn TherapeuticPotential. 3rd Edition, UK; Cambridge University Press, 2013: 15-29.

• Simón C, Reijo Pera RA. Gene expression dynamics during human embryonic development. In:Stem Cell in Reproductive Medicine, Basic Science adn Therapeutic Potential. 3rd Edition, UK;Cambridge University Press, 2013: 76-83.

• Gargett CE, Cervelló I, Nguyen PT, Simón C. Adult stem cells in the human endometrium. In:Stem Cell in Reproductive Medicine, Basic Science adn Therapeutic Potential. 3rd Edition, UK;Cambridge University Press, 2013: 115-32.

2012

• Garrido-Gómez T, Domínguez F, Ruiz-Alonso M, Simón C. The Analysis of Endometrialreceptivity. In: Textbook of Assisted Reproductive Techniques. UK; Informa Healthcare; 2012:366-79.

2011

• Horcajadas JA, Martínez-Conejero JA, Simón C. Endometrial Receptivity in Natural andControlled Ovarian Stimulated Cycles. In: Biennial review of infertility. Vol 2. USA; Springer; 2011:43-57.

• Novella-Maestre E, Simón C, García-Velasco JA, Pellicer A. Antiangiogenic agents forendometriosis. In: Human Assisted Reproductive Technology Future Trends in Laboratory andClinical Practice. UK: Cambridge University Press

• Domínguez F, Garrido T, Simón C. Proteomics analysis of the endometrium and embryo. Canwe improve IVF outcome?. In: Human Assisted Reproductive Technology Future Trends inLaboratory and Clinical Practice. UK: Cambridge University Press

2010

• Garrido-Gómez T, Domínguez F, Simón C. Proteomics of embryonic implantation. In: Handbookof experimental pharmacology. Germany: Springer; 2010: 67-78

51

• Medrano JV, Marqués-Marí AI, Simón C. Germline differentiation from stem cells. In: Stem Cells:From Bench to Bedside, 2nd Edition. USA: World Scientific Publishing Co. Pte. Ltd; 2010: 557-582.

2009

•••• Domínguez F, Horcajadas JA, Simón C. Embryonic and maternal dialogue and the analysis ofuterine receptivity. In: Textbook of Assisted Reproductive Technologies, Laboratory and ClinicalPerspectives. 3rd Edition. UK: Informa Healthcare; 2009: 427-34.

• Marqués-Marí AI, Medrano JV, Simón C. Differentiating gametes from stem cells. In: Trends inStem Cell Biology and Technology. USA; Humana Press; 2009: 137-47.

•••• Mercader A, Valbuena D, Simón C. Human Embryo Culture. In: Essential Stem Cells Methods.USA; Academic Press, Elsevier; 2009: 341-57.

• Galán A, Simón C. Monitoring stemness in long-term hESC cultures by real-time PCR. In:Human embryonic stem cells. USA; Humana Press Inc; 2009: 135-50.

• Cervero A, Simón C. Involvement of leptin in the endometrial function. In: Leptin and leptinantagonists. USA; Landes Bioscience; 2009: 108-15.

•••• Pellicer A, Garrido N, Budak E, Domingo S, Marqués-Marí AI, Simón C. Gamete generation fromstem cells: will it ever be applicable? A clinical view. In: Stem cells in human reproduction, Basicscience and therapeutic potencial. UK; Informa healthcare; 2009: 1-13.

• Gargett CE, Cervelló I, Hubbard S, Simón C. Adult stem cells in the human endometrium. In:Stem cells in human reproduction, Basic science and therapeutic potencial. UK; Informahealthcare; 2009: 160-76.

2008

• García-Velasco JA, Cerillo M, Simón C. Dysfunctional uterine bleeding. In: Non-invasivemanagement of gynaecologic disorders. UK; Informa healthcare; 2008: 63-8.

• Domínguez F, Simón C, García-Velasco JA. Molecular mechanisms of implantation. In: Infertilityand Assisted Reproduction. UK; Cambridge University Press, 2008: 46-52.

• Busso CE, García-Velasco JA, Gómez R, Alvarez C, Simón C, Pellicer A. Ovarianhyperstimulation sindrome. In: Infertility and Assisted Reproduction. UK; Cambridge UniversityPress, 2008: 243-57.

• Poo ME, Simón C. Stem cell research. In: Infertility and Assisted Reproduction. UK; CambridgeUniversity Press, 2008: 695-705

• Domínguez F, Simón C. Embryo-endometrial signalling. In: The endometrium. Molecular, Cellularand Clinical Perspectives. UK; Informa Healthcare, 2008: 296-304.

2007

• Romeu M, Simón C, Pellicer A. Adult stem cells in the human ovary: hope or fiction? In: Stemcells in human reproduction, basic science and therapeutic potential. UK; Informa healthcare,2007: 45-52.

• Galán A, Pellicer A, Simón C. Human embryonic stem cell culture in feeder-free, xeno-freeconditions. In: Stem cells in human reproduction, basic science and therapeutic potential. UK;Informa healthcare, 2007: 169-81.

•••• Cervelló I, Simón C. Adult stem cells in the uterus. In: Advances in fertility studies andreproductive medicine. South Africa; Besins healthcare, 2007: 161-6

2006

• Galán A, Escobedo C, Valbuena D, Berna A, Simón C. From animal free to feeder freeconditions. The desired derivation process for human embryonic stem cells. In: Embryonic stemcell research. USA; Nova science, 2006: 123-41.

• Garrido N, Meseguer M, Remohí J, Pellicer A, Simón C. Anormalidades implantatorias enendometriosis. In: Endometriosis, fundamentos etiopatogénicos, diagnóstico y tratamiento.Argentina; Corpus, 2006: 227-43.

• Gómez R, Zimmermann R, García-Velasco JA, Remohí J, Simón C, Pellicer A. Potential newtreatment implications derived from recent molecular developments in ovarian hyperstimulationsyndrome. In: Ovarian Hyperstimulation Syndrome. USA; Informa healthcare, 2006: 131-49.

2005

• Domínguez F, Horcajadas JA, Cervero A, Pellicer A, Simón C. Embryo interactions in humanimplantation. In: Implantation and early pregnancy. UK; Royal College of Obstetricians andGynaecologist Press, 2005: 79-89.

52

• Horcajadas JA, Simón C . Is endometrial receptivity altered in COH cycles? In: Controversies inObstetrics, Gynecology and Infertility. Israel; Oren Publisher Ltd, 2005: 84-90.

• Bosch E, Mercader A, Simón C . Blastocyst versus cleavage stage embryo transfer: is oneapproach better than another? In: Contemporary Perspectives on Assisted ReproductiveTechnology. India; Elsevier, 2005: 144-52.

2004

• Horcajadas JA, Domínguez F, Martín J, Pellicer A, Simón C. Implantation and uterine receptivity.In: Advances in Fertility and Reproductive Medicine. The Netherlands; Elsevier B.V, 2004: 177-82.

• Domínguez F, Pellicer A, Simón C. Embryonic regulation in the implantation process. In:Textbook of Assisted Reproductive Technologies, Laboratory and Clinical Perspectives 2ndEdition. UK; Taylor & Francis, 2004: 413-23.

•••• García-Velasco JA, Simón C. Control neuroendocrino de la reproducción. In: Ginecología yObstetricia. Paraguay; Sivero, 2004: 27-34.

2003

• Valbuena D, Simón C. Implantação Embrionaria. In: Reprodução Humana Assistida. Brazil;Atheneu, 2003: 211-28.

• Simón C. Clonagem. In: Reprodução Humana Assistida. In: Reprodução Humana Assistida.Brazil; Atheneu, 2003: 537-39.

2002

• Simón C, Caballero-Campo P, Galán A, Martín J, Meseguer M, Herrer R, Valbuena D, Jasper M,Mercader A. The endometrial epithelium. In: The endometrium. UK; Taylor & Francis, 2002: 194-207.

• Aplin J, Lacey H, Chen Ch, Jones C, Kimber S, Blissett M, Simón C . Model systems for theinvestigation of implantation. In: Cell-cell interactions 2ª Edición. UK; Oxford University Press,2002: 229-58.

• Krüssel J-S, Polan M.L, Simón C. Cytokine and growth factor network in human endometrium. In:Infertility and Reproductive Medicine Clinics of North America. USA; W.B Saunders Company,2002: 97-112.

• Simón C, Domínguez F., Pellicer A. Embryonic Regulation of Endometrial Receptivity in Humans.In: Advances in infertility treatment. Italy; Monduzzi Editore, 2002: 381-96.

2001

• García-Velasco JA, Gaitán P, Navarro J, Remohí J, Simón C , Pellicer A. In vitro fertilization. In:Polycystic ovary syndrome. UK; Martin Dunitz, 2001: 169-85.

• Simón C, Rubio C, Rodrigo L. Preimplantation genetic diagnosis in assisted reproductivetechnologies. In: Diagnostic procedure and latest development in gynecologic and obstetricinvestigation. Italy; CIC Ed. Internazionali, 2001: 1.

• De Pablo J.L, Meseguer M, Caballero-Campo P, Pellicer A, Simón C. Embryonic regulation in theprocess of implantation. In: Textbook of Assisted Reproductive Techniques. Laboratory andclinical perspectives. UK; Martin Dunitz, 2001: 341-5.

• Domínguez F, Martín J, Navarro J, Pellicer A, Simón C. Embryo-endometrial interactions.Lessons from art. In: Infertility and Reproductive Medicine Clinics of North America. USA; W.BSaunders Company, 2001: 373-88.

• Simón C, De Pablo J.L, Martin J, Meseguer M, Galán A, Pellicer A. Embryo-Maternal dialogue inthe apposition and adhesion phases of human implantation. In: ART and the Human Blastocyst.USA; Springer, 2001: 199-209.

• Pellicer A, Ruiz A, Valbuena D, García-Velasco J.A, Remohí J, Simón C. The effects of GnRHagonists (GnRHa) in the luteal phase of assisted reproduction cycles. In: Ovulation Induction.Italy; CIC Edizioni Internazionali, 2001: 65-75.

• Pellicer A, Albert C, Garrido N, Ruiz A, Navarro J, Remohí J, Simón C. The role of theendothelium in the pathogenesis of ovarian hyperstimulation syndrome (OHSS). In: OvulationInduction. Italy; CIC Edizioni Internazionali, 2001: 327-34.

2000

• Neuspiller F, Ardiles G, Zalategui J, Requena A, Simón C, Pellicer A, Remohí J. Induçao daovulaçao com gonadotrofinas recombinantes. In: Induçao da ovulaçao. Brazil; Atheneu, 2000:153-9.

53

• Neuspiller F, Ardiles G, Zalategui J, Requena A, Simón C, Pellicer A, Remohí J. Induçao daovulaçao na inseminaçao artificial. In: Induçao da ovulaçao. Brazil; Atheneu, 2000: 137-48.

• Moreno C, Simón C, Pellicer A, Remohí J. Análogos agonistas do Gnrh utilidades em reproduçaoassistida. In: Induçao da ovulaçao. Brazil; Atheneu, 2000: 121-9.

• Simón C, Martín J.C, Pellicer A. Oocyte quality versus endometrium quality in in vitro fertilization.In: Female reproductive aging. UK; Parthenon Publishing Group, 2000: 261-9.

• Pellicer A, Rubio C, Ruiz A, Navarro J, RemohÌ J, Simón C. Preimplantation assessment ofhuman embryos from women of advanced age and patients with recurrent miscarriage. In:Female reproductive aging. UK; Parthenon Publishing Group, 2000: 271-83.

• Simón C, Valbuena D, Martín J.C, Pellicer A. Basic aspects of implantation and its disorders. In:Endocrine basis of reproductive function. Italy; Monduzzi Editore, 2000: 385-94.

1999

• Bernal A, Remohí J, Rubio C, Simón C. Fisiología de la concepción e implantación. In:Endocrinología reproductiva e infertilidad. Colombia; Catorse, 1999: 153-78.

• Simón C, Moreno C, Pellicer A. The implantation process: lessons from ART. In: Female infertilitytherapy. Current practice. UK; Martin Dunitz, 1999: 394-406.

• Remohí J, Guanes P, Amorocho B, Simón C, Pellicer A. Envejecimiento de la mujer y lacapacidad de reproducción. In: Ginecología y obstetricia. Peru; José Pacheco Romero y MADCorp S.A., 1999: 358-64.

• Cobo A, Requena A, Neuspiller F, Aragonés M, Simón C, Remohí J, Pellicer A. In vitro maturationof human oocytes in unstimulated cycles: selection of the optimal day for ovum pick-up based onfollicular size. In: Ovarian hyperstimulation syndrome. Pathophysiology, prevention and treatment.Italy; Serono Fertility Series, 1999: 157-66.

• Albert C, Garrido N, Mercader A, Remohí J, Simón C, Pellicer A. The endothelium as the origin ofOHSS. In: Ovarian hyperstimulation syndrome. Pathophysiology, prevention and treatment. Italy;Serono Fertility Series, 1999: 89-103.

1998

• Levy M, Mota K, Yalil S, García-Velasco J, Landeras J, Neuzpiller F, Simón C, Pellicer A, RemohíJ. Critérios atuais no estudo da esterilidade. In: Manual prático de reprodução humana. Brazil;Revinter, 1998: 1-6.

• Rodriguez M, Rodrigues de Sousa L, Remohí J, Simón C. Endometriose. In: Manual prático dereprodução humana. Brazil; Revinter, 1998: 13-21.

• Ardiles G, Gartner B, Mota K, Marinaro A, Moreno C, Gaitán P, Pellicer A, Simón C, Remohí J.Protocolos de indução da ovulação. In: Manual prático de reprodução humana. Brazil; Revinter,1998: 23-33.

• Gartner B, Gallardo E, Marinaro A, Ardiles G, Mota K, García-Velasco J, Simón C, Pellicer A,Remohí J. Gonadotrofinas na indução da ovulação. In: Manual prático de reprodução humana.Brazil; Revinter, 1998: 35-42.

• Ballesteros A, Simón C, Pellicer A, Rodrigues de Sousa L, Molero M.D, Remohí J. Profilaxia etratamento da síndrome de hiperestimulação ovariana severa em fertilização assistida. In:Manual prático de reprodução humana. Brazil; Revinter, 1998: 43-51.

• Gartner B, Simón C, Pellicer A, Rodrigues de Sousa L, Remohí J. Mulheres com baixa respostaà estimulação ovárica- Atitudes clínicas. In: Manual prático de reprodução humana. Brazil;Revinter, 1998: 53-6.

• Guamán W, Neuspiller F, Mota K, Levy M, Yalil S, Landeras J, García-Velasco J, Simón C,Pellicer A, Remohí J. Técnicas de reprodução asistida. In: Manual prático de reproduçãohumana. Brazil; Revinter, 1998: 135-43.

• Gallardo E, Romero J, Mínguez Y, Molero M.D, Gil-Salom M, Simón C, Pellicer A, Rodrigues deSousa L, Remohí J. Reprodução assistida na infertilidade masculina. In: Manual prático dereprodução humana. Brazil; Revinter, 1998: 145-54.

• Guanes P. P, Yalil S, Neuspiller F, García-Velasco J.A, Simón C, Pellicer A, Bonilla-Musoles F,Remohí J. Endoscopia diagnóstica en esterilidad. In: Esterilidad. Argentina; Lara produccioneseditoriales, 1998: 101-7.

•••• Simón C, Portolés E, Mercader A, Francés A, Remohí J. Implantación embrionaria. In: Temas dereprodução assistida. Brazil; Revinter, 1998: 10-6.

1997

54

• Simón C, Mercader A. Citocinas e infertilidade. In: Fertilidade e infertilidade humana. Brazil;Medsi Ed, 1997: 115-29.

• Simón C, Sánchez-Cuenca J, Herrer R, Pellicer A. Molecular mechanisms of implantation. In: InVitro fertilization and assisted reproduction. Italy; Monduzzi Editore, 1997: 737-41.

• Simón C, Valbuena D, Pellicer A. Recent research on the interleukin-1 system in embryonicimplantation. In: New horizons in reproductive medicine. USA; The parthenon publising group,1997: 321-7.

• Remohí J, Gallardo E, Romero J, Rubio M.C, Gil-Salom M, Simón C, Pellicer A. La esterilidadmasculina en medicina reproductiva. In: Reproduçao humana II. Brazil; Febrasgo, 1997: 105-22.

• Simón C, Sanchez-Cuenca J, Herrer R, Pellicer A. Adhesión molecules in implantation. In:Infertility and assisted reproductive technology. Italy; Monduzzi editore, 1997: 151-4.

1995

• Pellicer A, Oliveira N, Gutiérrez A, Cano F, Ruiz A, Remohí J, Simón C. Implantation inendometriosis: lessons learned from IVF and oocyte donation. In: Progress in the management ofendometriosis. USA; The Parthenon Publishing Group, 1995: 177-83.

• Simón C, Francés A, Pellicer A, Polan M.L. Role of Interleukin-1 (IL-1) system in humanimplantation: Evidence for alteration of the IL-1 system in endometriosis. In: Progress in themanagement of endometriosis. USA; The Parthenon Publishing Group, 1995: 233-41.

• Bonilla-Musoles F, Simón C, Raga F, Pellicer A, Bailao L. Transvaginal ultrasonic detection ofmarkers of embryonic malformations. In: Geburtshilfe-Geburtsmedizin. Germany; Springer, 1995:101-15.

•••• Pellicer A, Simón C, Remohí J. Effects of aging on the female reproductive system. In: Recentdevelopments in gynecology and obstetrics. USA; The Partenon Publishing Group, 1995: 107-11.

1992

•••• Pellicer A, Miró F, Sampaio M, Simón C , Gómez E, Remohí J. Effects of GnRH analogues onhuman granulosa and luteal cells. In: The basic science of GnRH analogues. USA, TheParthenon Publishing Group, 1992: 77-84.

1991

• Bonilla-Musoles F, Bailao LA, Simón C, Raga F, Pina-Neto JM. Malformações embrionarias. In:Ultra-sonografía transvaginal. Brazil; Diagnosis, 1991: 125-30.

• Bonilla-Musoles F, Bailao LA, Simón C. Endometriose. In: Ultra-sonografía transvaginal. Brazil;Diagnosis, 1991: 203-7.

• Bonilla-Musoles F, Bailao LA, Pellicer A, Simón C, Raga F, Pérez-Gil M. Endosonografia efertilidade. In: Ultra-sonografía transvaginal. Brazil; Diagnosis, 1991: 27-49.

1990

• Pellicer A, Simón C. Desarrollo folicular, ovulación y fase lútea. In: Infertilidad. Paraguay;FLASEF, 1990: 2-27.

Chapters Published in National Books2017

2015

• Miravet-Valenciano JA, Ruiz-Alonso M, Domínguez F, Vilella F, Simón C. Estudio de lareceptividad endometrial. In: 5º Manual Práctico de Esterilidad y Reproducción Humana-Aspectos clínicos. 2015 in process

• Garrido N, Martín J, Alamá P, Ruiz A, Bosch E, Pérez-Aytes A, Simón C. Test preconcepcional decompatibilidad genética y su uso en reproducción asistida. In: 5º Manual Práctico de Esterilidad yReproducción Humana- Aspectos clínicos. 2015 in process

2014

• Milán M, Mateu E, Campos I, Rodrigo L, Peinado V, Gracía S, Mir P, Al-Asmar N, Rubio C,Simón C. Marcadores cromosómicos embrionarios. Aplicaciones clínicas. In: Cuadernos deMedicina Reproductiva, Biomarcadores, Spain; ANARR. Nuevo Siglo SL, 2014; 20(1): 25-34.

• Sánchez I, Simón C, Domínguez F. Biomarcadores. In: Cuadernos de Medicina Reproductiva,Biomarcadores, Spain; ANARR. Nuevo Siglo SL, 2014; 20(1): 43-54.

• Díaz-Gimeno P, Ruiz M, Blesa D, Simón C. Diagnóstico Invasivo de receptividad endometrialmediante marcadores moleculares. In: Cuadernos de Medicina Reproductiva, Biomarcadores,

55

Spain; ANARR. Nuevo Siglo SL, 2014; 20(1): 67-80.• Ramírez LB, Vilella F, Simón C. Diagnóstico no invasivo de receptividad endometrial mediante

marcadores secretómicos. In: Cuadernos de Medicina Reproductiva, Biomarcadores, Spain;ANARR. Nuevo Siglo SL, 2014; 20(1): 81-92.

2013

• Mondión M, Garrido-Gómez T, Ruiz M, Simón C. Las ómicas en la preparación hormonalendometrial para la transferencia embrionaria. In: Donación de Embriones, Spain; MomentoMedico s.r.l., 2013: 237 – 250.

2012

• Muñoz M, Fortuño S, Galindo N, Simón C, Pellicer A, Remohí J. Apiración Ovocitaria. In: ManualPráctico de Esterilidad y Reproducción Humana. Aspectos Clínicos, Spain; Médicapanamericana, 2012: 413-21.

• Simón C, Gómez-Garrido T. Establecimiento de la gestación, gametogénesis, fecundación,desarrollo embrionario e implantación. In: Tratado de Ginecología y Obstetricia. Ginecología yMedicina de la Reproducción, Spain; Médica panamericana, 2012: 971-77.

2009

• Simón C. Células madre, presente y future. In: La medicina del future, Spain; IVADIS, 2009: 217-226.

• Simón C. El endometrio humano. In: El endometrio humano, desde la investigación a la clínica,Spain; Médica panamericana, 2009: 2-9.

• Valbuena D, Simón C. Regulación hormonal del endometrio humano. In: El endometrio humano,desde la investigación a la clínica, Spain; Médica panamericana, 2009: 12-17.

• Domínguez F, Loro F, Simón C. Funcionalidad del endometrio. In: El endometrio humano, desdela investigación a la clínica, Spain; Médica panamericana, 2009: 20-37.

• Cervello I, Simón C. Células madre adultas en el endometrio. In: El endometrio humano, desdela investigación a la clínica, Spain; Médica panamericana, 2009: 184-89.

2008

• Simón C, Escudero E. Establecimiento de la gestación: gametogénesis, fecundación y desarrollodel huevo hasta la formación de las tres hojas germinales. Implantación. In: Tratado deGinecología Obstetricia y Medicina de la Reproducción 2ª Edición, Spain; MédicaPanamericana, 2008: 196-205.

• Oriol B, Bellver J, Requena A, García-Velasco JA, Simón C, Pellicer A, Remohí J. Tratamientoreproductivo en el aborto de repetición. In: Manual Práctico de Esterilidad y ReproducciónHumana. 3ª Edición. Aspectos Clínicos, Spain; Mc Graw Hill / Interamericana, 2008: 157-170.

• Labarta E, Bosch E, Bellver J, Melo M, Simón C. Luteinización prematura. Origen eimplicaciones. In: Manual Práctico de Esterilidad y Reproducción Humana. 3ª Edición. AspectosClínicos, Spain; Mc Graw Hill / Interamericana, 2008: 210-7.

• Muñoz M, Simón C, Domingo J, Lizán C, Pellicer A, Remohí J. Aspiración de ovocitos. In:Manual Práctico de Esterilidad y Reproducción Humana. 3ª Edición. Aspectos Clínicos, Spain;Mc Graw Hill / Interamericana, 2008: 281-8.

• Crespo J, Vergara V, Goyri E, Coelho G, Simón C, Remohí J, Pellicer A. Transferenciaembrionaria. In: Manual Práctico de Esterilidad y Reproducción Humana. 3ª Edición. AspectosClínicos, Spain; Mc Graw Hill / Interamericana, 2008: 289-96.

2007

• Domínguez F, Simón C. La Implantación. In: Obstetricia y Medicina Materno-Fetal, Spain;Médica Panamericana, 2007: 161-165.

• Galán A, Simón C. Modelo de investigación básica con células madre embrionarias. In:Investigación biomédica en España: aspectos bioéticos, jurídicos y científicos, Spain;COMARES, 2007: 113- 150.

• Marqués-Marí AI, Simón C. Diferenciación de ovocitos a partir de células madre. In: Cuadernosde Medicina Reproductiva, Spain; Adalia Farma, 2007; 13(3): 83-90

• Bonilla-Musoles F, Raga F, Bonilla F Jr, Simón C, De los Santos MJ. Fecundación y anidación.In: Obstetricia, Reproducción y Ginecología Básicas, Spain; Médica Panamericana, 2007: 701-34

• Labarta E, Bosch E, Simón C, Pellicer A, Remohí J. Anovulación (I). In: Obstetricia,Reproducción y Ginecología Básicas, Spain; Médica Panamericana, 2007: 789-99.

• Bosch E, Labarta E, Simón C, Pellicer A, Remohí J. Anovulación (II). In: Obstetricia,

56

Reproducción y Ginecología Básicas, Spain; Médica Panamericana, 2007: 801-82006

• Romeu M, Cervelló I, Sanchéz M, Pellicer A, Simón C. Células madre adultas en ovario. Unahipótesis atractiva. In: Nuevos avances en medicina reproductiva. Cuadernos de MedicinaReproductiva, Spain; Adalia Farma, 2006; 12(2): 53

• Cervelló I, Pellicer A, Simón C. Células madre adultas en el útero. In: Nuevos avances enmedicina reproductiva. Cuadernos de Medicina Reproductiva, Spain; Adalia Farma, 2006; 12(2):73-8.

• Berna A, Galán A, Valbuena D, Sánchez-Luengo S, Melguizo D, Simón C Células madre.Posibilidades terapéuticas In: Nuevos avances en medicina reproductiva. Cuadernos deMedicina Reproductiva, Spain; Adalia Farma, 2006; 12(2): 79-90.

• Bosch E, Reis S, Troncoso C, Epifanio R, Serra V, Simón C, Remohí J, Pellicer A. Donación deovocitos en pacientes añosas. In: Nuevos avances en medicina reproductiva. Cuadernos deMedicina Reproductiva, Spain; Adalia Farma, 2006; 12(2): 91-102.

2005

• Garrido N, Meseguer M, Martínez-Conejero JA, Simón C, Pellicer A, Remohí J. Impacto de loscriterios estrictos de morfología espermática en reproducción asistida. In: Andrología. Cuadernosde Medicina Reproductiva, Spain; Adalia Farma, 2005; 11(1): 9-14.

• Galán A, Simón C. De la célula madre al ovocito/espermatozoide: ¿podemos crear gametos? In:Cáncer y reproducción. Cuadernos de Medicina Reproductiva, Spain; Adalia Farma, 2005; 11(2):103-109.

2004

• Vidal C, Fernández M, Simón C, Gaytán J, Pellicer A, Remohí J. Planteamientos dereproducción en el síndrome de ovarios poliquísticos. In: Manual práctico de esterilidad yreproducción humana. 2ª edición, Spain; Mc Graw-Hill. Interamericana, 2004: 15-23.

• Bosch E, Crespo J, Simón C, Pellicer A, Remohí J. Antagonistas de la GnRH. In: Manualpráctico de esterilidad y reproducción humana. 2ª edición, Spain; Mc Graw-Hill. Interamericana,2004: 97-106.

• Crespo J, Bellver J, Bosch E, Ferro J, Pellicer A, Remohí J, Simón C, Vidal C. Transferenciaembrionaria. In: Manual práctico de esterilidad y reproducción humana. 2ª edición, Spain; McGraw-Hill. Interamericana, 2004: 165-71.

• Mercader A, Albert C, Galán A, Florensa M, de los Santos MJ, Simón C. Cultivo prolongado delembrión hasta blastocisto. In: Manual práctico de esterilidad y reproducción humana. 2ª edición,Spain; Mc Graw-Hill. Interamericana, 2004: 414-24.

2003

• Simón C, Escudero E. Establecimiento de la gestación: gametogénesis, fecundación y desarrollodel huevo hasta la formación de las tres hojas germinales. Implantación. In: Tratado deGinecología Obstetricia y Medicina de la Reproducción, Spain; Médica Panamericana, 2003:196-203.

2002

• Simón C, Escribá Mª J, Pellicer A. El punto de vista de la investigación en reproducción humanaasistida. In: Etica y Clonación. Realidades y Exageraciones, Spain; Fundación Valenciana deEstudios Avanzados, 2002: 41-46.

• Cervero A, Simón C. Proteómica. In: Biología molecular en medicina reproductiva. Cuadernos demedicina reproductive, Spain; Médica Panamericana, 2002; 68(2): 49-61.

• Escribá MJ, Pellicer A, Remohí J, Simón C. Células madre: terapia de futuro. In: Biologíamolecular en medicina reproductiva. Cuadernos de medicina reproductive, Spain; MédicaPanamericana, 2002; 6(2): 210-19.

• Domínguez F, Simón C. Impronta genómica. In: Biología molecular en medicina reproductiva.Cuadernos de medicina reproductive, Spain; Médica Panamericana, 2002; 6(2): 107-18.

• Domínguez F, Pellicer A, Simón C. Biología molecular de la implantación embrionaria. In:Biología molecular en medicina reproductiva. Cuadernos de medicina reproductive, Spain;Médica Panamericana, 2002; 6(2): 95-106.

• Meseguer M, Garrido N, Pellicer A, Remohí J, Simón C. Biología molecular de laespermatogénesis. In: Biología molecular en medicina reproductiva. Cuadernos de medicinareproductive, Spain; Médica Panamericana, 2002; 6(2): 65-77.

57

• Valbuena D, Vidal D, Crespo J, Escudero E, Remohí J, Pellicer A, Simón C. Alta respuesta a lasgonadotropinas e implantación. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 129-137.

• Muñoz E, Muñoz M, Gaytán J, Rosal LP, Escudero E, Simón C, Pellicer A, Remohí J. Síndromede Hiperestimulación Ovárica. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 139-51.

• Muñoz M, Muñoz M, Campos I, López D, Simón C, Pellicer A, Remohí J. Reducción embrionariatras técnicas de Reproducción asistida. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill. Interamericana, 2002: 153-9.

• Gaytán J, Rosal JP, Escudero E, Camargo F, Molina N, Simón C, Pellicer A, Remohí J.Hidrosálpinx y Reproducción. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 237-43.

• Requena A, Martínez-Salazar J, Párraga M, Isaza V, Landazábal A, Villasante A, García-VelascoJA, Simón C, Pellicer A, Remohí J. Inseminación Artificial. In: Reproducción Humana 2ª Edición,Spain; McGraw-Hill. Interamericana, 2002: 263-72.

• Gil Salom M, Bellver J, Romero JL, Rossal LP, Gutiérrez A, Escudero E, Simón C, Pellicer A,Remohí J. Espermatogénesis: conceptos básicos. In: Reproducción Humana 2ª Edición, Spain;McGraw-Hill. Interamericana, 2002: 273-8

• Garrido N, Meseguer M, Simón C, Ferro J, Galán A, Mercader A, Pellicer A, Remohí J. ElCitómetro de flujo: aplicaciones en el estudio de la reproducción humana. In: ReproducciónHumana 2ª Edición, Spain; McGraw-Hill. Interamericana, 2002: 319-25.

• Galán A, Simón C, Valbuena D, Troncoso C, Meseguer M, Crespo J, Pellicer A, Remohí J.Factores de supervivencia embrionaria y apoptosis. In: Reproducción Humana 2ª Edición, Spain;McGraw-Hill. Interamericana, 2002: 401-5

• Simón C, Valbuena D, Martín J, Mercader A, Garrido N, Rosal LP, Pellicer A, Remohí J. LaImplantación embrionaria. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 421-29.

• Mercader A, Simón C, Valbuena D, Escudero E, Bellver J, Crespo J, Pellicer A, Remohí J.Cocultivo. Cultivo de embriones humanos. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill. Interamericana, 2002: 469-73.

• Rubio C, Rodrigo L, Vidal F, Mateu E, Bosch E, Simón C, Pellicer A, Remohí J. Diagnósticopreimplantatorio, de anomalías cromosómicas. In: Reproducción Humana 2ª Edición, Spain;McGraw-Hill. Interamericana, 2002: 513-19.

• Ferro J, Rossal JP, Rodríguez M, Escudero E, Simón C, Pellicer A, Remohí J.Histeroembrioscopia. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill. Interamericana,2002: 599-605.

• Martín J, Escribá MJ, Simón C, Pellicer A, Remohí J. Técnicas de Reproducción asistida:investigación con células madre. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 619-21.

• Martín J, Domínguez F, Simón C, Pellicer A, Remohí J. Nuevas tecnologías en medicinareproductora: Microarrays de DNA. In: Reproducción Humana 2ª Edición, Spain; McGraw-Hill.Interamericana, 2002: 623-7.

2001

• Simón C, Requena A. Agonistas y antagonistas en reproducción asistida. In: Ginecología.Temas actuales, Spain; Grapic-Lugo S.L., 2001: 99-114

2000

• Moreno C, Zuzuarregui J, Muñoz E, Landazábal A, Simón C, Pellicer A, Remohí J. Inseminaciónartificial. In: Manual Práctico de Esterilidad y Reproducción Humana, Spain; McGraw-Hill.Interamericana, 2000: 81-95

• Requena A, Martínez Salazar J, Vidal C, Simón C, Pellicer A, Remohí J. La estimulación ováricaen reproducción asistida. In: Manual Práctico de Esterilidad y Reproducción Humana, Spain;McGraw-Hill. Interamericana, 2000: 65-79.

• Muñoz M, Neuspiller F, Alvarez J.C, Ibérico G, Landeras J, Ballesteros A, Simón C, Remohí J.Aspiración de ovocitos para fecundación in Vitro. In: Manual Práctico de Esterilidad yReproducción Humana, Spain; McGraw-Hill. Interamericana, 2000: 167-74

• Mercader A, Herrer R, Galán A, Albert A, Pellicer A, Remohí J, Simón C. Desarrollo del embrión

58

hasta el estadio de blastocisto. In: Manual Práctico de Esterilidad y Reproducción Humana,Spain; McGraw-Hill. Interamericana, 2000: 287-302

• Rubio C, Vidal F, Mínguez Y, Giménez C, Romero J.L, Zulategui J, Simón C, Pellicer A, EgozcueJ, Remohí J. Diagnóstico genético preimplantatorio: biopsia embrionaria e hibridación in situfluorescente (FISH). In: Manual Práctico de Esterilidad y Reproducción Humana, Spain; McGraw-Hill. Interamericana, 2000: 303-15

• Rubio C, Vidal F, Blanco J, Romero J.L, Pérez-Cano I, Simón C, Pellicer A, Egozcue J, RemohíJ. Estudio de las anomalías cromosómicas de los espermatozoides mediante hibridación in situfluorescente (FISH). In: Manual Práctico de Esterilidad y Reproducción Humana, Spain; McGraw-Hill. Interamericana, 2000: 317-22

• Mercader A, Mínguez Y, Herrer R, Remohí J, Pellicer A, Simón C. Cultivo embrionarioprolongado: métodos, estrategias y resultados. In: Reproducción asistida del siglo XXI.Cuadernos de Medicina Reproductiva, Spain; Médica Panamericana, 2000; 6(2): 99-110.

• Martín J.C, Valbuena D, Simón C, Ruiz A, Crespo J, Pellicer A. Nuevas tecnologías en el estudiode las ciencias de la reproducción: aplicaciones clínicas. In: Reproducción asistida del siglo XXI.Cuadernos de Medicina Reproductiva, Spain; Médica Panamericana, 2000; 6(2): 253-70.

1999

• Vergara F, Navarro J, Díaz I, Alvarez JC, Simón C, Remohí J, Pellicer A. Miomas yesterilidad/infertilidad. In: Miomas. Cuadernos de Medicina Reproductiva, Spain; MédicaPanamericana, 1999; 5(1): 75-90

• Vanrell JA, Simón C. Gametogénesis, Espermiomigración, Fecundación e Implantación. InEsterilidad e Infertilidad, Spain; Masson, 1999: 37-50.

1998

• Simón C, Moreno C, Pellicer A. Técnicas para mejorar la implantación embrionaria. In:Inseminación artificial y fertilización in Vitro, Spain; Semfar S.L., 1998: 171-81.

1997

• Simón C, Herrer R. La implantación embrionaria. In: Implantación embrionaria. Aspectos básicosy aplicaciones clínicas. Cuadernos de medicina reproductiva, Spain; Médica Panamericana,1997; 3(1): 41-54.

• Gaitán P, Valbuena D, Simón C. Moléculas de antiadhesión en el aborto de repetición. In:Implantación embrionaria. Aspectos básicos y aplicaciones clínicas. Cuadernos de medicinareproductiva, Spain; Médica Panamericana, 1997; 3(1): 83-90.

• Landeras J, Zuzuarregui JL, Simón C. Pérdida gestacional precoz. In: Implantación embrionaria.Aspectos básicos y aplicaciones clínicas. Cuadernos de medicina reproductiva, Spain; MédicaPanamericana, 1997; 3(1): 91-101.

• Valbuena D, Gaitán P, García Velasco JA, Simón C. Implicación de los niveles de estradiol sobrela implantación embrionaria. In: Implantación embrionaria. Aspectos básicos y aplicacionesclínicas. Cuadernos de medicina reproductiva, Spain; Médica Panamericana, 1997; 3(1): 103-118.

• García Velasco JA, Mercader A, Simón C. Fallo de implantación. In: Implantación embrionaria.Aspectos básicos y aplicaciones clínicas. Cuadernos de medicina reproductiva, Spain; MédicaPanamericana, 1997; 3(1): 119-131.

• Mercader A, Albert C, Caballero Campo P, Simón C. Mejora clínica de la implantaciónembrionaria: cocultivo, el endometrio materno. In: Implantación embrionaria. Aspectos básicos yaplicaciones clínicas. Cuadernos de medicina reproductiva, Spain; Médica Panamericana, 1997;3(1): 133-43.

• Simón C, Sánchez Cuenca J, Moreno C. Presente y futuro de la implantación embrionaria. ¿Quépodemos hacer para mejorarla?. In: Implantación embrionaria. Aspectos básicos y aplicacionesclínicas. Cuadernos de medicina reproductiva, Spain; Médica Panamericana, 1997; 3(1): 175-84.

1996

• Pellicer A, García-Velasco JA, Gallardo E, Remohí J, Simón C. El impacto de las técnicas dereproducción asistida en la incidencia del embarazo ectópico. In: Embarazo Ectópico. Cuadernosde Medicina Reproductiva, Spain; Médica Panamericana, 1996: 2(1): 19-30.

• García-Velasco JA, Yalil S, Remohí J, Simón C, Pellicer A. La fecundación in Vitro en pacientescon ovarios poliquísticos. In: Hiperandrogenismos. Cuadernos de Medicina Reproductiva.Cuadernos de Medicina Reproductiva, Spain; Médica Panamericana, 1996: 2(2):165-83.

• García-Velasco JA, Yalil S, Remohí J, Simón C, Pellicer A. Tratamiento del hiperandrogenismo

59

sin deseo reproductivo. In: Hiperandrogenismos. Cuadernos de Medicina Reproductiva, Spain;Médica Panamericana, 1996; 2(2):183-210.

• Tsafriri A, Simón C. Ovulación. In: Reproducción humana, Spain; McGraw-Hill. Interamericana,1996: 36-50.

• Simón C, Portolés E, Mercader A, Francés A, Remohí J. Implantación embrionaria. In:Reproducción humana, Spain; McGraw-Hill. Interamericana, 1996: 70-6.

• Francés A, Mercader A, Portolés E, Simón C. Citocinas: su implicación en la reproducciónhumana. In: Reproducción humana, Spain; McGraw-Hill. Interamericana, 1996: 88-100.

1992

• Bonilla-Musoles F, Raga F, Simón C, Pellicer A, Branco J, Remohí J. Reducción embrionariatransvaginal. In: Tratado de Endosonografía en Obstetricia y Ginecología, Spain; Masson-Salvat,1992: 389-96.

• Remohí J, Bonilla-Musoles F, Simón C, Serra V, Sampaio M, Millet A, Matallín P, Fernandes H.Endometriosis. In: Tratado de Endosonografía en Obstetricia y Ginecología, Spain; Masson-Salvat, 1992: 367-82.

• Bonilla-Musoles F, Vilela M, Simón C. Diagnóstico endosonográfico de la incontinencia urinaria.In: Tratado de Endosonografía en Obstetricia y Ginecología, Spain; Masson-Salvat, 1992: 319-329

• Bonilla-Musoles F, Sampaio M, Simón C, Serra V, Fernandes H, Pellicer A.Histerosalpingosonografía vaginal. In: Tratado de Endosonografía en Obstetricia y Ginecología,Spain; Masson-Salvat, 1992: 307-10

• Bonilla-Musoles F, Sampaio M, Simón C, Raga F. Posibilidades de diagnóstico precoz en elcáncer de ovario. In: Tratado de Endosonografía en Obstetricia y Ginecología, Spain; Masson-Salvat, 1992: 269-278

• Bonilla-Musoles F, Machado L, Chagas K, Pérez-Gil M, Simón C. Endosonografía del carcinomade cérvix. In: Tratado de Endosonografía en Obstetricia y Ginecología, Spain; Masson-Salvat,1992: 255-8

• Bonilla-Musoles F, Raga F Jr. García-Escobar M, Sampaio M, Fernandes H, Simón C. Laincompetencia cervical: Valor de las distintas técnicas ecográficas. In: Tratado de Endosonografíaen Obstetricia y Ginecología, Spain; Masson-Salvat, 1992: 211-23

• Bonilla-Musoles F, Pardo G, Simón C, Sampaio M, Pellicer A. Alternativas actuales a lafertilización in Vitro y transferencia de embriones. In: Tratado de Endosonografía en Obstetricia yGinecología, Spain; Masson-Salvat, 1992: 193-210

• Bonilla-Musoles F, Pardo G, Sampaio M, Pérez-Gil M, Simón C, Jiménez LC, Serra V.Endosonografía vaginal en el embarazo ectópico. In: Tratado de Endosonografía en Obstetricia yGinecología, Spain; Masson-Salvat, 1992: 83-95

• Bonilla-Musoles F, Simón C, Raga F, Blanes J. Endosonografía e Infertilidad. In: Avances enReproducción Asistida, Spain; Diaz de Santos, 1992: 401-34 .

1988

• Bonilla-Musoles F, Machado L, Chagas K, Pérez-Gil M, Simón C. Endosonografía del carcinomade cérvix. In: Sonografía transvaginal en Obstetricia y Ginecología, Spain; Salvat, 1988: 113-7.

60

Summary of Educational Accomplishments (CME)

Declaration of the academic teaching courses held as Lecturer or Professor

• Professor of Obstetrics and Gynecology, School of Medicine, University of Valencia.Theory and Practice of Obstetrics and Gynecology to medical students at the 4th year of the Degree of Medicine at the school of Medicine since 1994

• Adjunct Clinical Professor. Department of Obstetrics and Gynecology. Stanford Schoolof Medicine. Stanford University, Ca , USA. (2013-2019)

• Adjunct Professor. Department of Obstetrics and Gynecology. Bayllor College of Medicine, TX, USA. (2013-2019)

• Theoretical and practical training in Postgraduate and Master Courses since 1994.

Director of National Masters & Postgraduate Courses.

• Master on basic research techniques applied to Obstetrics and Gynecology. Universityof Valencia – IVI University Institute. Valencia, Spain. 1994 – Present.

• Master in Human Reproduction, University of Valencia – IVI University Institute. Valencia, Spain. 1994 – Present.

• Master in Biotechnology of assisted human reproduction. University of Valencia – IVI University Institute. Valencia, Spain. 2006 – Present.

• Coordinator of the basic course for the use and analysis of microarrays. Fundación IVI, Instituto Universitario IVI, University of Valencia. Valencia, Spain. 2007 – 2009.

• President of the teaching committee and Professor of the advanced course of biotechnology. Association of Biotechnology Companies of Valencia (BIOVAL). Valencia, Spain. 2008 – 2011.

Director of International Postgraduate Courses

• Treating with Cell-based Therapies What Cannot Be Treated with Drugs. Postgraduate course 73rd Annual Meeting American Society for Reproductive Medicine(ASRM). San Antonio, Texas, USA. 2017

• Biomarkers in Reproductive Medicine. Postgraduate course 70th Annual Meeting American Society for Reproductive Medicine (ASRM). Honolulu, Hawaii, USA. 2014

• Embryo Development: New Technologies and Science. Postgraduate course 68th Annual Meeting American Society for Reproductive Medicine (ASRM). San Diego, California, USA. 2012

• Stem cells in reproductive medicine. Postgraduate Course 26th Annual Meeting European Society of Human Reproduction & Embryology (ESHRE). Rome, Italy. 2010.

• Alternatives for the production of pluripotent stem cells. Postgraduate Course 25th Annual Meeting. European Society of Human Reproduction & Embryology (ESHRE). Amsterdam, The Netherlands. 2009

• Stem Cells in Reproductive Medicine. Postgraduate Course 64th annual meeting American Society for Reproductive Medicine (ASRM). San Francisco, USA. 2008.

• Stem Cells in Reproductive Medicine: The circle of life. Postgraduate course. 62nd annual meeting American Society for Reproductive Medicine (ASRM). New Orleans, USA. 2006.

• Innate immunity in the Reproductive Tract. Postgraduate course 61st Annual Meeting American Society for Reproductive Medicine (ASRM) & 51st Canadian Fertility and Andrology Society (CFAS). Montreal, Canada. 2005.

• Controversies in Reproductive Loss. Postgraduate course 60th annual meeting American Society for Reproductive Medicine (ASRM). Philadelphia, USA. 2004.

• Assisted reproduction. Annual Meeting Postgraduate Course European Society for Gynecologic and Obstetric Investigation. Madonna di Campliglio, Italy. 2001

• New advances in the pathogenesis and management of endometriosis. Postgraduate

61

Course 17th Annual Meeting European Society of Human Reproduction and Embryology (ESHRE). Lausanne, Switzerland. 2001.

• Endometrial receptivity, molecular aspects and clinical implications. Postgraduate Course 56th Annual Meeting American Society for Reproductive Medicine (ASRM). San Diego, California, USA. 2000

Professor in International Postgraduate Courses

• Eight technical innovations designed to improve reproductive outcome: promising or sobering facts? Pre-congress course 32nd Annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). Helsinki, Finland. 2016.

• Early Pregnancy and the role of stem cells. Pre-congress course 31st Annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). Lisbon, Portugal. 2015.

• Biomarkers in Reproductive Medicine. Postgraduate course 70th Annual Meeting American Society for Reproductive Medicine (ASRM). Honolulu, Hawaii, USA. 2014.

• ESHRE Campus. Making OHSS a complication of the past: State-of-the-art use ofGnRH agonist triggering (ESHRE). Thessaloniki, Greece. 2014.

• From Early Implantation to Later in Life. ESHRE Campus, Special Interest GroupEarly Pregnancy and the Task Force Basic Scientists in Reproductive Medicine(ESHRE). Brussels, Belgium. 2013.

• How to Optimize IVF Results Based on High Quality Evidence. Middle East Fertility Society – Precongress Course, 29th Annual European Society of Human Reproduction and Embryology (ESHRE). London, UK. 2013.

• Embryo Development: New Technologies and Science. Postgraduate course 68th Annual Meeting American Society for Reproductive Medicine (ASRM). San Diego, California, USA. 2012.

• The maternal embryonic interface. ESHRE Campus Workshop. Valencia, Spain. 2010.• ESHRE basic course on “Update on pluripotent stem cells (HESC and IPS). Valencia,

Spain. 2010.• Stem cells in reproductive medicine, Pre-congress course 26th Annual meeting of the

European Society of Human Reproduction and Embryology (ESHRE). Rome, Italy. 2010.

• Endometriosis: How new technologies may help, Pre-congress course 26th Annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). Rome, Italy. 2010.

• New hESC derivation strategies maintaining embryo viability. Course and workshop on Pluripotent Stem Cells. European Society of Human Reproduction & Embryology (ESHRE). Barcelona, Spain. 2010.

• System biology tools and preclinical models for translational research in endometriosisand adhesion formation: lessons from cancer and inflammation biology. European Society ofHuman Reproduction and Embryology (ESHRE). Leuven, Belgium. 2009.

• Introduction to regenerative medicine: biology & application of human stem cells. Prince Felipe Research Center. Valencia, Spain. 2008.

• Stem cells in reproductive medicine. Postgraduate course 64th annual meeting American Society for Reproductive Medicine (ASRM). San Francisco, USA. 2008.

• Gene regulation of endometrial receptivity. Postgraduate course on endometrial receptivity. 59th annual meeting of the American Society for Reproductive Medicine (ASRM). San Antonio, Texas, USA. 2003.

• Non-viable embryos as a source of hESc. Pre-Congress course organized by the special interest group on stem cells. European Society of Human Reproduction and Embryology (ESHRE). Madrid, Spain. 2003.

62

• Chromosomal abnormalities and embryonic development. Pre-Congress course organized by the special interest group in early pregnancy. 18th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). Vienna, Austria.2002.

• 5th European Society of Human Reproduction and Embryology (ESHRE) course in reproductive endocrinology. Athens, Greece. 2001.

• New advances in ovulation induction. Postgraduate course on assisted reproduction. 5th Congress of the European Society for Gynecologic and Obstetric Investigation (ESGOI). Madonna di Campliglio, Italy. 2001.

• Postgraduate course: Endometrial receptivity, molecular aspects and clinical implications. 56th Annual Meeting of the American Society for Reproductive Medicine. San Diego, California, USA. 2000.

• Postgraduate course, advances on reproductive medicine. Facultad de Medicina Pontificia, Universidad Javeriana. Santafé de Bogotá, Colombia. 2000.

• Pre-Congress Course on endometriosis “pathology of endometriosis related infertility”.16th annual meeting European Society of Human Reproduction and Embryology (ESHRE). Bologna, Italy. 2000.

• Assisted reproductive techniques in the 21st Century, 55th annual meeting of the American Fertility Society for Reproductive Medicine (ASRM). Toronto, Canada. 1999.

• Postgraduate course on reproductive medicine: Current concepts and new perspectives a review course. Venice, Italy. 1998.

• Postgraduate course: human conception from oocyte to blastocyst and implantation. 54th Annual Meeting of the American Fertility Society for Reproductive Medicine (ASRM) & 16th World Congress on Fertility and Sterility. San Francisco, USA. 1998.

• Postgraduate course: immunology in reproductive medicine 1998. 54th Annual Meeting of the American Society for ReproductiveMedicine (ASRM) & 16th World Congress on Fertility and Sterility. San Francisco, USA. 1998.

Professor in National Postgraduate Courses

• V Updating Course: medical diseases, pregnancy and assisted reproductive techniques. Instituto Valenciano de Infertilidad.Vigo, Spain. 2010.

• Update in stem cells and cell therapy. Colegio Profesional de Técnicos Superiores Sanitarios de la Comunidad Valenciana & Prince Felipe Research Center. Valencia, Spain. 2009.

• II course on assisted reproduction and oncology. Instituto Valenciano de Infertilidad. Seville, Spain. 2009.

• Course title: Advanced Course on Biotechnology in the company. Asociación de Empresas Biotecnológicas de la Comunidad Valenciana (BIOVAL) Valencia Bioregion.Valencia, Spain. 2009.

• The frontiers of biology, 200 years after the birth of Darwin. The challenges of science journalism. Menendez y Pelayo International University. Santander, Spain. 2009.

• When the chemistry is biology and vice versa. University of Málaga. Ronda, Málaga, Spain. 2009.

• Master in establishment and management of innovate and technology companies. New business models in biomedicine. Valencia, Spain. 2008.

• Cell therapy: a new strategy for regenerative medicine. University of Málaga. Vélez Malaga, Spain. 2007.

• Basic course on the use and analysis of microarrays. Fundación Instituto Valenciano de Infertilidad & IVI University Institute. Valencia, Spain. 2007.

• Training course for senior technicians clinical diagnostic laboratory. Asociación de Técnicos Superiores Sanitarios de la Comunidad Valenciana & Miguel Hernández

63

University San Juan, Alicante, Spain. 2007.• Endocrine gynecology (including menopause), endometriosis and infertility. Spanish

Gynecology and Obstetrics Society. Alicante, Spain. 2006.• Advances in research on neuromuscular diseases. University of the Basque Country.

San Sebastian, The Basque Country, Spain. 2005.• Cell Therapy, regenerative medicine. Complutense University of Madrid, Genetrix and

Lilly Foundation. San Lorenzo de El Escorial, Madrid, Spain. 2005.• Human reproduction and cancer. University Rey Juan Carlos. Aranjuez, Madrid,

Spain. 2004.• Basic research techniques in reproductive medicine. Fundación Instituto Valenciano

de Infertilidad. Valencia, Spain. 2004 – Present.• Cardiovascular disease. Perspective from molecular medicine. Complutense

University of Madrid & National Cardiovascular Research Center. San Lorenzo de El Escorial, Madrid, Spain. 2003.

• Human fertility, infertility, contraception and ethics. School of Medicine, University of Valencia. Valencia, Spain. 2002.

• V Doctorate and III Neonatology course. Advances in perinatology. School of Medicine, University of Valencia. Valencia, Spain. 2002.

• Course title: Basic course in human reproduction. Spanish Fertility Society. Madrid, Spain. 2001.

• Family Planning. School of Medicine, University of Valencia. Valencia, Spain. 2000.• Training course on In Vitro fertilization from year 2000. Dexeus University Institute.

Barcelona, Spain. 2000.• Physiology and endocrinology of reproduction. School of Medicine, University of

Valencia. Valencia, Spain. 2000.• Assisted Reproduction. Ph D degree course. Barcelona Clinic Hospital. Barcelona,

Spain. 1999.• Family planning. Ph D degree course. School of Medicine, University of Valencia.

Valencia, Spain. 1999.• III Doctorate and I Neonatology course. Advances in perinatology. School of Medicine,

University of Valencia. Valencia, Spain. 1998.• Sterility and infertility. Spanish Gynecology and Obstetrics Society. Marbella, Spain.

1997.• Artificial insemination and In Vitro fertilization course. Hospital 12 de Octubre. Madrid,

Spain. 1997.• Reproductive endocrinology and endometriosis. Ph D degree course. School of

Medicine, University of Alicante. Alicante, Spain. 1996.• VI international course on advances 95 in ginecology, obstetrics and human

reproduction. Barcelona, Spain. 1995.• Current problems in human reproduction. University of the Basque Country. San

Sebastián, The Basque Country, Spain. 1994.• Implantation. Spanish Fertility Society. Valencia, Spain. 1994.

Other Teaching

Postdoctoral Fellows:

Currently, I have 4 postdoctoral fellows that joined my laboratory after finishing their PhDsand have completed postdoctoral visits at various universities such as Stanford, UCSF,Harvard, Yale. To date, my fellows have succeeded in both academic and private venueswith positions at Igenomix SL, University of Valencia, University of Seville, and Autónomade Madrid.

64

Medical Fellows/Residents/Mentorships:

I have trained or am currently training many medical fellows in my laboratory primarily fromMedicine, Genetics, Ob-Gyn and Urology (50 fellows total). I also host internationalmedical fellows mainly from South America/Mexico,and Europe funding programme:Brazilian Research Council (CnPQ),Santiago Grisolia and Leonardo da Vinci “Mobil 2012”

Graduate Students:

Currently I am supervising 10 PhD students and I have been the supervisor of a total of 33PhD students that graduated from my laboratory (section Undergraduate & Post-GraduateTeaching). These students are obtaining, or have already obtained, degrees in Genetics,Biology and Biochemistry and conducted their research in my laboratory.

Undergraduates:

Undergraduates are a source of energy and inspiration in my laboratory. We have asummer program (2 months) for graduate students from University of Valencia, and othernational or international universities.

Medical Fellows/Residents/Mentorships:

I have trained or am currently training many medical fellows in my laboratory primarily fromMedicine, Genetics, Ob-Gyn and Urology (50 fellows total). I also host international medical fellows mainly from South America/Mexico,and Europe funding programme: Brazilian Research Council (CnPQ),Santiago Grisolia and Leonardo da Vinci “Mobil 2012”

65

Invited Seminars/ Symposium Presentations International Invitations

2017

• Translational Reproductive Biology and Clinical Reproductive Endocrinology,Paradigm Changes you May not Hear About Elsewhere and Think Differently; NewYork City NY, USA; November 2017. “How Important is the Implantation Window?Absolutely Important”, “Bone Marrow-Derived Stem Cells to Treat Asherman’sSyndrome”

• 62nd Annual Meeting of Japan Society for Reproductive Medicine; Shimonoseki City,Yamaguchi, Japan; November 2017. “How the Mother Communicates and Modifiesthe Preimplantation Embryo – Implications and Onset of Adult Diseases”

• 73rd Annual Meeting of the American Society for Reproductive Medicine, PrecongressCourse, Treating with Cell-based Therapies What Cannot Be Treated with Drugs; SanAntonio TX, USA; October 2017. “Recent Developments in Tissue Engineering andRegenerative Medicine”, “Cell Therapy and Tissue Engineering from and Towards theUterus”

• 73rd Annual Meeting of the American Society for Reproductive Medicine, PrecongressCourse, Emerging Therapeutic Tools in the Assisted Reproductive TechnologyLaboratory; San Antonio TX, USA; October 2017. “Embryo/Endometrium DialogueDuring Implantation: Why Sometimes Healthy Embryos Fail To Implant”, “Stem Cellsand Artificial Gametes”

• 73rd Annual Meeting of the American Society for Reproductive Medicine, PrecongressCourse, Actualidades en Reproducción Asistida: El Punto de Vista Clínico para elBiólogo y un Punto de Vista del Biólogo para el Clínico. Presentado en Español; SanAntonio TX, USA; October 2017.” Fallas de Implantación en Transferencias deEmbriones Euploides”, “Rol del ERA (Endometrial Receptivity Assay” en Técnicas deReproducción Asistida?”

• 73rd Annual Meeting of the American Society for Reproductive Medicine, ExpertEncounters; San Antonio TX, USA; October 2017. “Embryonic and Uterine CheckpointNeeded for a Succesful Pregnancy”

• 73rd Annual Meeting of the American Society for Reproductive Medicine, Round TableRegenerartive Medicine and Stem Cell Biology; San Antonio TX, USA; October 2017.“Stem Cell Therapy in Asherman’s Syndrome”

• 50th Annual Meeting Society for the Study of Reproduction; Washington DC, USA;July 2017. “Met and unmet needs in human endometrial biology and medicine”

• OvaTools ART Institute Grand Opening Symposium; Fort Lauderdale, Florida, USA;July 2017. “Endometrial receptivity assay and personalized embryo transfer”

• 54th Congreso Mexicano de la Medicina de la Reproducción, Asociación Mexicana deMedicina de la Reproducción; Rivera Maya, Mexico;L July 2017. “Análisis genéticopreimplantacional. ¿Para todas?” Plenary Lecture

• 32nd Annual Meeting of European Society of Human Reproduction and Embryology(ESHRE); Geneva, Switzerland; July 2017. Human Reproduction keynote lecture. “Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractoryAsherman’s syndrome and endometrial atrophy: a pilot cohort study”

•••• 32nd Annual Meeting of European Society of Human Reproduction and Embryology(ESHRE); Precongress Course. Geneva, Switzerland; July 2017. “Stem cell therapy toimprove implantation failure”

•••• 2º Congresso Internacional Huntington de Reprodução Humana; São Paulo, Brazil;May 2017. “Implantation failure and endometrial dysfunction”

• 3º Simpósio Internacional Nilo Frantz, Porto Alegre, Brazil; May 2017. “O futuro damedicina reprodutiva”, “Personalização do endométrio humano utilizando o "ERA"para o ajuste da janela de implantação”

•••• 7th International IVI Congress; Bilbao, Spain; May 2017. “Wrong timing. Theendometrial perspective”

• 2nd International EXPERMED Congress, Expert Meeting in PersonalizedReproductive Medicine; Kyrenia, Cyprus; April 2017. “Personalized ReproductiveTreatment & Care: Where are we now and what does the future hold?“ Keynotelecture

•••• 16th International Conference on Preimplantation Genetic Diagnosis, organized by the

66

Preimplantation Genetic Diagnosis International Society; Valencia, Spain; March 2017.“Diagnosis of Endometrial Receptivity from the Bench to the Patient using an evidencebased medicine approach”, “What about the maternal endometrium. The search forthe personalized WOI and Microbiota”

• 63th Annual Scientific Meeting Society for Reproductive Investigation; Orlando, USA;March 2017. “Transcriptomic Assessment of Endometrial Receptivity: ERA Testing”

2016

• Hong Kong University - Queen Mary Hospital Assisted Reproduction Programme. 30thAnniversary Celebration Symposium; Hong Kong and Shenzhen, Hong Kong andChina; December 2016. “Personalized reproductive medicine”, “Omics of endometrialreceptivity”

• Ovarian Club VII. Building a bridge between science and clinical practice; París,France; November 2016. ”The Symphony between the blastocyst and theendometrium”

• IVI Middle East Fertility Clinic. Latest Advances in enhancing success rates in ART;Abu Dhabi, United Arab Emirates; November 2016. “Embryo mitocondrial status: anew tool for viability”, “ERA and personalized embryo transfer for endometrialreceptivity assessment”, “Why euploid embryos may not implant”

• XXX. Jahrestreffen der Deutschen IVF-Zentren; Dresden, Germany; November 2016.“Optimizing the lutheal support: synchrony between the endometrium and the embryois what matters”

• 1er Encuentro Binacional México-España de Reproducción Humana; México DF,México; November 2016. “Human endometrial receptivity. From basic research to aclinically validated diagnostic test”, “PGS, How, When and to Whom”

• 4º training course in reproductive medicine reproduction reloaded, Humanitas FertilityCenter; Milan, Italy; October 2016. “Personalized embryo transfer (pET) usingendometrial receptivity analysis to adjust the window of implantation”

• 19th anual conference of the Japan Society of Asisted Reproduction; Kobe City,Japan; October 2016. “Identifying the personalized window of implantation

• 4th State Key Laboratory of Stem Cell and Reproductive Biology Symposium; Beijing,China; October 2016. “How the mother communicates with the preimplantationembryo and modifies its transcriptome. Implications in pregnancy and the potentialimpact on the onset of adult diseases”

• 72nd Congress of the American Society for Reproductive Medicine; Salt Lake City,Utah, USA; October 2016. “Optimizing endometrial receptivity”, “the advancement ofcell theraphy in reproductive medicine: Asherman syndrome and atrophicendometrium”

• XVII Congreso Argentino de Medicina Reproductiva SAMeR 2016; Tucumán, Argentina; Agosto-Septiembre 2016. “Interacción molecular en la implantación embrionaria”, “Screening genético preimplantatorio (PGS)”, “Futuro de las stem cells en medicina reproductiva”, “Biomarcadores de receptividad uterina: validez del ERA”

• 20º Congresso Brasileiro de Reproduçao Assistida; Belo Horizonte, Brazil; September2016. “Human embryonic implantation today. What are the clinical translation of the basic knowledge”, “Porque embriões euploides não implantam”

• 49th Annual Meeting Society for the Study of Reproduction. Systems Biology ofReproduction. Workshop on Emerging Technologies in Reproductive Research in theERA of Big Data; San Diego, CA, USA; July 2016. “Development of prediction modelsof the human endometrium in health and disease”

• 29th Annual In vitro fertilization and embryo transfer. A comprehensive Update – 2016;San Diego, CA, USA; July 2016. “Personalized embryo transfer using the endometrialreceptivity array to adjust the window of implantation”, “The future on reproductive

67

medicine – extensive genetic screening, stem cells, biomarkers and tissueengineering – a future full of promise”,

• 29th Annual In vitro fertilization and embryo transfer. A comprehensive Update – 2016.MINI-SYMPOSIUM: ¿Qué hacer cuando todos las embriones son normales; SanDiego, CA, USA; July 2016. “El papel del Estradiol elevado sobre el endometrio. Tienesentido la estrategia freeze-all? La importancia de la receptividad endometrial. Endefinitiva: una estrategia global vs personalizada para preparar el endometrioadecuadamente”

• 32nd Annual Meeting of European Society of Human Reproduction and Embryology(ESHRE) Precongress Course; Helsinki, Finland; July 2016. “Gene profiling inendometrium: Does personalized embryo transfer correct for implantation failure?”

• Merck Symposium at ESHRE 2016. Reducing time to birth through precisión,prediction & personalized medicine; Helsinki, Finland; July 2016. “New technologies inpredictable and personalized to reduce time to birth”

• 13th Congress of the International Society for Immunology of Reproduction (ISIR) andEuropean Society for Reproductive Immunology (ESRI); Erfurt, Germany; June 2016.“The "personalized" embryo transfer paradigm”

• 18 Journées Nationales de la Société de Médecine de la Reproduction (SMR);Bourdeaux, France; May 2016. “Cellules souches et traitement de la fertilité”

• New England Fertility Society 2nd Quarterly Meeting; Newton, MA, USA; May 2106.“Human endometrial receptivity, clinical diagnostic test in use and in progress”

• University of California San Francisco; San Francisco, CA, USA; May 2016. “How themother communicates and modifies the preimplantation embryo - implications forimplantation and onset of adult diseases”

• 3rd Biomarker Meeting in Personalized Reproductive Medicine; Valencia, Spain; April2016. “Diagnosis of endometrial receptivity using ERA. clinical application”,“Identifying and personalizing the window of implantation. ERA clinical results”

• Einladung zur Eröffnung der tagesklinik mit mini-symposium; Küsnacht, Switzerland;April 2016. “Pre-implantation genetic screening: an invaluable tool for the difficult ARTpatient“

• 63rd Annual Scientific Meeting Society for Reproductive Investigation; Montreal,Canada; March 2016. “Stem cell therapy in Asherman síndrome and atrophicendometrium”

• Queens University, Seminar Series; Kingston, Canada; March 2016. “Human somaticcells subjected to genetic reprogramming with 6 germ line-related factors displaymeiotic germ cell-like features”.

• 35th Scientific Meeting Belgian Society for Reproductive Medicine (BSRM); Mechelen,Belgium; March 2016. “Is ERA really the holy grail?”

• 17th World Congress of the International Society of Gynecology; Florence, Italy;March 2016. “Stem Cell Therapy of the Endometrium in Asherman´s syndrome andatrophic endometrium”

• Upper Egypt assisted reproductive symposium, an international symposium in theland of the Pharaohs; Cairo, Egypt; February 2016.” What is The Best Day for EmbryoTransfer? The Uterine View”, “Carrier Screening for Couples Wishing to Conceive -What is Possible, What is Reasonable?”, “The Dialogue Between The MaternalEndometrium and The Embryo - Potential Impact on The Onset of Adult Diseases”,“Stem Cell Therapy for Endometrial Regeneration”

2015

• European Fertility Meeting: Strategies to improve IVF success rate; Rome, Italy;December 2015. “Methods for improving endometrial receptivity”

• 10th Biennial Meeting of the Pacific Society for Reproductive Medicine, 69th Annual

68

Meeting of the Korean Society for Reproductive Medicine and The InternationalOvarian Conference 2015; Seoul, Korea; November 2015. ”New Technologies MayImprove Patient Success Rates: How to Integrate It into Practice?”

• Northern California Association of Reproductive Biologists; San Francisco, CA, USA;Novembrer 2015. “Building the Future of Reproductive Medicine. Work in Progress”

• Ovarian Club VI. It’s All About Energy: what More Can We Do to Improve PregnancySuccess Rates?; Barcelona, Spain; November 2015. “Mitochondrial DNA content asviability score in human euploid embryos: Less is better”

• Ferring Microbiota Workshop; St-Prex, Switzerland; November 2015. “ReproductiveTract Microbiome during Fertility Treatment”

• 71st American Society for Reproductive Medicine Annual Meeting. InteractiveSession. Baltimore, MD, USA; October 2015. “Implantation Failure – EndometrialReceptivity Assessment vs. Preimplantation Genetic Screening”

• 71st American Society for Reproductive Medicine Annual Meeting. Howard andGeorgeanna Jones Symposium. Baltimore, MD, USA; October 2015. “Elective FreezeAll: What is the Scientific Evidence”

• Focus 2015 Advances in Reproductive Medicine; Ragusa Ibla, Italy; September 2015.“Which is the best day for embryo transfer? The uterine view”

• Primer Simposio Nacional sobre Genética y Medicina Reproductiva, AsociaciónGuatemalteca de Fertilidad y Reproducción Humana; Ciudad de Guatemala,Guatemala; September 2015. “Células Madre Endometriales”

• XXIII Nordic Fertility Society Meeting; Reykjavík, Iceland; August 2015. “EndometrialReceptivity and Biomarkers”

• 28th Annual in Vitro Fertilization and Embryo Transfer; Santa Barbara, CA, USA; July2015. “Uterine Receptivity and the Importance of Embryo-Endometrial Synchrony”“Stem Cells and Tissue Engineering in Reproductive Medicine – Can We FashionNew Eggs, Sperm adn Endometrium”

• 31st Annual meeting of the European Society of Human Reproduction andEmbryology (ESHRE). Pre-congress course Early Pregnancy and the role of stemcells. Lisbon, Portugal. June 2015. “Asherman syndrome as a complication ofcurettage for miscarriage: endometrial stem cells as a solution? This is near future”

• 31st Annual meeting of the European Society of Human Reproduction andEmbryology (ESHRE). MSD Company Simposium. Lisbon, Portugal. June 2015. “NewTechnologies May Improve Patient Success Rates: How to Integrate into Practice”

• 31st Annual meeting of the European Society of Human Reproduction andEmbryology (ESHRE). Illumina Company Simposium. Lisbon, Portugal. June 2015.“Personalized Medicine in Reproductive Medicine Applied to Embryos. ClinicalBenefits of PGS”

• NIH Reproductive Sciences Branch Directors’ meeting, Endometrium, Placentationand Implantation (EPI) Research Focus Group (RFG); Bethesda, Maryland, USA; May2015. “Endometrium, Endometriosis, and Implantation/Placenta”

• 14th International Conference on Preimplantation Genetic Diagnosis (PGD); Chicago,Illinois, USA; May 2015. “Future Clinical Strategies in PGD to further Improve itsEffectiveness and Outcome”

• MSD Clinical Observation Program for Fertility; Valencia, Spain; May 2015. “Diagnosisof Endometrial Receptivity”

• Teva Women's Health EU Summit; Vienna, Austria; April 2015. “Endometriosis as adriver of infertility”

• 6th International IVI Congress; Alicante, Spain; Arpil 2015. “Diagnosis andimprovement of the endometrial factor: Facts and fallacies”

• Visiting Professor CHA Fertility Center, CHA University; Seoul, Korea; April 2015.“Edometrial Receptivity Array”, “Preimplantation Genetic Screening”

• 67th Annual Congress of Japan Society of Obstetrics and Gynecology; Yokohama,Japan; April 2015. “Human Endometrial Receptivity - From Basic Science toDiagnostic Applications”, “Uterine Fibroids”

•••• Ministry of Health, Working Visit; The Role of Endometrial & Genetic Testing in Modern

69

Reproductive Medicine; Jahra Hospital, Jahra, Kuwati; April 2015. “Current & FutureRole of Carrier Screening”. “Current & future Role of PGS and PGD”. “Current &Future Role of Non invasive Prenatal Genetic Testing”. “Current & Future EndometrialReceptivity Testing”

• 62nd Annual Meeting, Society for Reproductive Investigation (SRI) EndometrialSatellite; San Francisco, USA; March 2015. “Human endometrial microbiota, reality orfiction?”

• Stanford Reproductive and Stem Cell Biology Symposium for 2015; StanfordUniversity, USA; March 2015. “Human somatic cells subjected to geneticreprogramming with 6 germ line-related factors display meiotic germ cell-like features”

• 63rd Annual Meeting Pacific Coast of Reproductive Society; Rancho Mirage,California, USA; March 2015.”Invasive and non-invasive diagnosis of endometrialreceptivity”, “Stem cells therapy for endometrial Regeneration”

• GENERA and BIOROMA Symposium 2015. The new era of PGS application in ART;Rome, Italy; February 2015. “Endometrial receptivity evaluation”

• AGRBM-DGRM meeting; Düsserldorf, Germany; January 2015. “Genetic matching ofoocyte donor and recipient couple: what is possible, what is reasonable?”

• Fertility 2015; Birmingham, UK; January 2015. “Human endometrial receptivity.Clinical application”

2014

• ESHRE Campus. Making OHSS a complication of the past: State-of-the-art use ofGnRH agonist triggering; Thessaloniki, Greece; November 2014. “Invasive and non-invasive diagnosis of endometrial receptivity”

• 26º Congresso Brasileiro de Reproduçao Humana; Porto Alegre, Brazil; November2014. “Reconstrução endometrial a partir de células-tronco”, “Implantaçãoembrionária: o que nos falta entender?”, “A importância das análises genéticas nostratamentos de RA”

• Divisão de Clínica Ginecológica, Hospital das Clínicas da Faculdade de Medicina daUniversidade de São Paulo; Sao Paulo, Brazil; November 2014. “Medicinapersonalizada em reprodução humana”

• 15ème Journeé sur l’Assistance Médicale à la Procréation de l’Hôspital Américan deParis; Paris, France; November 2014. “ERA (Endometrial Receptivity Array)”,“Endomètre hypotrophique et cellule souche”

• Revolutionizing infertility treatments, showcasing the global advancements;Bangalore, India; September 2014. “What does epigenetics mean in IVF?”, “PGS:pros and cons in AMA, RM and RIF”, “Endometrial receptivity and genomics”

• Latest updates in assisted reproductive technology. NOVA IVI Fertility; New Delhi,Hyderabad & Chennai, India; September 2014. “New horizons in PGS & endometrialreceptivity”

• 19e Journées de la Fédération Française d’Étude de la Reproduction; Paris, France;September 2014. “Cellules souches et implantation”

• 8th IVF Preceptorship: current practice in the 21st century; Madrid & Valencia, Spain;September 2014. “Scratch or not to scratch?” “Case study on lecture: individualizedembryo transfer: future or reality?”

• Gordon Research Conference on Mammalian Reproduction. Translating Basic Science into Clinical Applications; New London, NH, USA; August 2014. “Infertility andcontraception. Discussion leader”

• Living innovation in ART: blending medicine, science and technologies to maximizesuccess for the benefit of the patients. Merck Serono Sponsored Symposium ESHRE2014; Munich, Germany; July 2014. “Breakthrough innovation in uterine receptivitydiagnostics”

• 27th Annual In Vitro Fertilization and Embryo Transfer. A Comprehensive Update –2014. David Geffen School of Medicine, University of California Los Angeles; SantaBarbara, California, USA; July 2014. “Stem Cells and tissue engineering inreproductive medicine – can we fashion new eggs, sperm and endometrium?”,“Uterine receptivity - arrays, scratching, and more?”

• Advisory Board Meeting, Merck Sharp & Dohme (MSD); Saint-Petersburg, Russia;

70

June 2014. “Diagnosis of the endometrial receptivity status”• Academic Visit to ART Unit, Department of Obstetrics & Gynaecology, Chinese

University of Hong Kong; Hong Kong; May 2014. “Stem cell theraphy at theendometrium”

• 4th Annual Scientific Meeting of the Obstetrical and Gynaecological Society of HongKong; Hong Kong; May 2014. “Genomics of the endometrial around the time ofimplantation”

• Personalized Medicine in ART, Taiwanese Society for Reproductive Medicine; Taipei,Taiwan; May 2014. “Stem cells and its translation”, “Clinical application of theendometrial receptivity array: personalized medicine applied to implantation”

• ALPHA 2014 10th Biennial Conference; Antalya, Turkey; May 2014. “The endometrium:role of stimulation and adjuvants on receptivity”

• Congreso Nacional de Obstetricia y Ginecología, Sociedad Panameña de Obstetriciay Ginecología; Panama, Panama; May 2014. “Evidencia actual sobre las célulasmadre”, “Nuevas técnicas aplicadas en reproducción asistida”

• 2nd Biomarkers Meeting in Personalized Reproductive Medicine: Biomarkers for theAssessment of Ovarian Reserve, Gametes, Embryos, Endometrium and Pregnancy inHealth and Disease. Industrial Supported Lunch Symposium; Valencia, Spain; April2014. “New developments on biomarkers of endometrial receptivity”, “Identifiying andpersonalizing the window of implantation: ERA clinical results”

• Obstetrics and Gynecology Grand Round Series, Texas Children’s Hospital. BaylorCollege of Medicine; Houston, Texas, USA; April 2014. “A new theory for the maternalorigin of preeclampsia”

• 2014 Reproductive and Stem Cell Biology Retreat, Stanford University; StanfordUniversity, USA; April 2014. “MicroRNAs secreted by the human endometrium act astranscriptomic regulators of the preimplantation embryo”

• 2014 Fertilink. Individualized Controlled Ovarian Stimulation in ART; Gyeongju, Korea;March 2014. “Personalized medicine applied to endometrial receptivity and embryotransfer”

• The Hong Kong Society for Reproductive Medicine; Kowloon, Hong Kong; March2014. “Personalized medicine applied to endometrial receptivity and embryo transfer”

• 16th World Congress of Gynecological Endocrinology. IV Congresso AIGE; Firenze,Itally; March 2014. “Endometrial reconstruction from stem cells”

• The Best of ASRM & ESHRE; Cortina d’Ampezzo, Italy; February – March 2014.“Implantation failure: uterocentric”

2013

• VIII Congresso Paulista de Medicina Reprodutiva e Climatério, 25º ano Associação deObstetrícia e Ginecologia de São Paulo (SOGESP); Sao Paulo, Brazil; December2013. “State of the ART in the generation of artificial gametes”, “Genetic screening inpatients with advanced age, male factor and implantation failure”

• 69th American Society for Reproductive Medicine Annual Meeting held Conjoint withInternational Federation of Fertility Societies; Boston, Massachusetts, USA; October2013. “Clinical Applications of Endometrial Stem Cells”

• 7th IVF Preceptorship: current practice in the 21st century, Serono Symposia International Foundation; Madrid and Valencia, Spain; September 2013. “Challenge to improve the endometrial receptivity”

• Advanced Reproductive Medical Treatments; Rome, Italy; September 2013. “MedicalStrategy to optimize the implantation process”

• Serono Symposia International Foundation, IVF Preceptorship: the state of the ART;Sao Paulo, Brazil; August 2013. “Scientific evidence and clinical approach to improveimplantation”

• 2013 Gordon Research Conference on Germinal Stem Cell Biology; Hong Kong; July 2013. “Direct conversion of human somatic cells to germ cells by genetic modification”

• 61st National Institute for Basic Biology Conference, Cellular community in mammalianembryogenesis; Okazaki, Japan; July 2013. “Blastomere fate during human pre-implantation embryo development”

71

• 30th Annual Meeting, European Society of Human Reproduction and Embryology. Pre-Congres Course: Optimizing IVF outcome; London, UK; July 2013. “Improving implantation”

• 14th Internatonal Symposium for Immunology o Reproduction; Boston, Massachusetts,USA; May – June 2013. “Human endometrial receptivity: from the basic research toclinical translation”

• International Conference on Genomics in Europe (ICG); Ghent, Belgium; June 2013. “Clinical Application of the endometrial receptivity array”

• Latin Society of Biology and Reproductive Medicine (SOLAMER); Tunis, Tunisia; June2013. “How to identify a receptive endometrium?”

• Boston IVF Grand Rounds. Beth Israel Deaconess Medical Center, A major teachinghospital of Harward Medical School. Division of Reproductive Endocrinology andInfertility. (Video Conference); Boston, Massachusetts, USA; May 2013. “HumanEndometrial Receptivity. From Research to Clinical Translation”

•••• 12th International Conference on Preimplantation Genetic Diagnosis, Clinical and Technical Aspects of PGD; Istanbul, Turkey; May 2013. “Is there effect of controlled ovarian stimulation on uterine receptivity and aneuploidy rates”

• Serono Symposia International Foundation, Improving success in ART: how to define itand key strategies to get the best outcomes; Athens, Greece; April 2013. “The Uterineenvironment and endometrial receptivity: new frontiers for ART”

• Merck Serono India. Fertiltiy Sceintific Advisory Board Meeting (Video conference);Mumbai, India; April 2013. “Implantation: Current concepts and practical applications”

• 3rd Malaysian Reproductive Medicine Congress. ART as a continuum – looking to thefuture; Kuala Lumpur, Malaysia; April 2013. “Reconstruction of endometrium fromhuman endometrial side population cells. Application in Asherman’s Syndrome”,“Human endometrial receptivity. From basic research to clinical translation”

• 5th International IVI Congress. Reproductive Medicine and Beyond; Seville, Spain;April 2013. “Clinical application of the endometrial receptivity array”

• 60th Annual Meeting, Society for Gynecologic Investigation, Endometrial SatelliteSymposium 2013 Contribution to Fertility; Orlando, Florida, USA, March 2013.“Clinical translation of endometrial transcriptomics”

• 15th World Congress of Human Reproduction; Venice, Italy; March 2013. “Genomicsand secretomic of endometrial receptivity. Clinical translation”

• Latin Society of Biology and Reproductive Medicine (SOLAMER); Bourdeaux, France;January 2013. “How to identify a receptive endometrium?”

• 2013 Reproductive and Stem cell biology retreat. Center for Human Embryonic StemCell Research and Education. Institute for Stem Cell Biology & RegenerativeMedicine, Department of Obstetrics and Gynecology. Stanford University School ofMedicine; Stanford, California, USA; January 2013. “Human endometrial receptivityfrom the transcriptomic research to the clinical translation in patients with implantationfailure”

2012

• XXVI Annual German IVF Meeting; Cologne, Germany; December 2012. “Profiling thegene signature of endometrial receptivity”

• Emirates Obs-Gyn & Fertility Forum 2012; Dubai, United Arab Emirates; November2012. “Endometrial stem cells – basic studies & application in Asherman Syndrome”,“New technologies in the IVF lab – video time lapse & vitrification” and “PGD with cGHarrays in 2012 – indications & results”

• 67th Annual Meeting of the American Society for Reproductive Medicine (ASRM);Orlando, USA; October 2012. “Generation of artificial gametes from pluripotent stemcells”

• Beyond Frontiers in AR. Merck Serono; Mexico D.F., Mexico; September 2012.“Endometrial and myometrial somatic stem cells”, “Monitoring methods of humanendometrial receptivity” and “Human embryonic stem cells”

• Merck Serono Satellite Symposium During Annual Meeting of the European Society ofHuman Reproduction and Embryology (ESHRE). Innovation and technologies in ART

72

to become best in class in take home baby rate; Istanbul, Turkey; July 2012.“Utilization of biomarkers of uterine receptivity in clinical practice”

• 28th Annual Meeting of the European Society of Human Reproduction andEmbryology; Istanbul, Turkey; July 2012. “Endometrial regeneration”

• Born after ART: from the laboratory towards the delivery room; Kos, Greece; June2012. “Implantation and obstetric complications”

• Federazione Italiana delle Società Scientifiche della Reproduzione; Riccione, Italy;May 2012. “Endometrial Receptivity: monitoring methods”

• Serono Symposia International Foundation, The multi-factorial equations of ART:defining and maximizing success in pregnancy rates; Sorrento, Italy; May 2012.“Other potential non-invasive technologies to assess the most receptive endometrium:lipidomics”

• World Congress on Building Consensus in Gynecology, Infertility and Perinatology;Barcelona, Spain; May 2012. “Invasive diagnosis: endometrial receptivitiy array”

• ALPHA 2012 - 9th Biennial Conference, Merck Serono Symposium; London, UK; April2012. “Lipidomics: A new Non-Invasive Diagnostic Method of Human EndometrialReceptivity”

• Grant for Fertility Innovation: Developing Innovative Technologies to Become Best inClass in Take Home Baby Rate. Merck Serono Symposia, During the 1st BiomarkerMeeting in Reproductive Medicine: Emergence of a New Field; Valencia, Spain; March2012. “Lipidomics: A non-invasive diagnostic method of human endometrialreceptivity”

• 1st Biomarker Meeting in Reproductive Medicine: Emergence of a New Field; Valencia,Spain; March 2012. “Profiling the gene signature of endometrial receptivity. Clinicalresults”

• 15th World Congress of Gynecological Endocrinology; Florence, Italy; March 2012.“Modeling Human Endometrial Decidualization from the Interaction between Proteomeand Secretome”

• University of Oxford, Institute of Reproductive Sciences; Oxford, UK; February 2012.“Clinical translation of genetics in endometrial receptivity and embryo assessment”

2011

• Serono Symposia International Foundation, IVF Preceptorship: current practice in the21st century; Madrid, Spain; December 2011. “Scientific evidence and clinicalapproach to improve implantation”

• Expert Meeting Contraception on Demand; Berlin, Germany; November 2011.“Potential targets for Contraception on Demand: Endometrium”

• Serono Symposia International Foundation, advanced workshop on oocyte retrievaland embryo transfer; Dubai, United Arab Emirates; November 2011.

• Nature Group Conferences, The Herrenhausen Symposium on Reproductive Biology;Kloster Seeon, Munich, Germany; October 2011. “Clinical Issues”

• A Window into the Reproductive Era Research; Milan, Italy; October 2011. “Howendometrial secretomics can help in predicting implantation”

• SMART VII, Merck Serono Meeting in ART; Valencia, Spain; May 2011. “PGD & PGScases”, “State of the art of the genetic diagnostic techniques used on the embryos andtheir clinical relevance”

• 13th Congress of the French Reproductive Medicine Society; Paris, France; May 2011.“Autologous coculture of embryos: an old new thing?”

• Serono Symposia International Foundation, Reproductive ageing-a basic and clinicalupdate; Taormina, Italy; April 2011. “Generation of artificial gametes from stem cells”

• 2nd International Congress on Controversies in Cryopreservation of Stem Cells,Reproductive Cells, Tissue and Organs (CRYO); Valencia, Spain; April 2011.“Guidance for banking and supply of human embryonic stem cell lines for researchpurposes”

• 4th International Instituto Valenciano de Infertilidad (IVI) Congress; Valencia, Spain;April 2011. “Endometrial stem cells and its translation”

• 58th Annual Meeting of the Society for Gynecologic Investigation (SGI); Miami Beach,

73

USA; March 2011. “Germ Cells Differentiation from Human Embryonic Stem Cells”• PEBS 2010-2011. Cancer Epigenetic and Biology Program. Bellvitge Biomedical

Research Institut. IDIBELL, L´hospitalet de Llobregat, Barcelona, Spain; January2011. “Adult vs embryonic vs induced pluripotent stem cells”

2010

• 66th Annual Meeting of the American Society for Reproductive Medicine (ASRM);Denver, USA; October 2010. “Stem Cells in Reproduction”

•••• Instituto de Ginecología y Fertilidad (IFER), XVII convivencia en infertilidad; BuenosAires, Argentina; September 2010. “Conferencia Perspectivas futuras en MedicinaReproductiva”, “Avances en el diagnóstico de la receptividad endometrial”,“Diagnóstico no invasivo de calidad embrionaria y aneuploidias”, “Células madre enendometrio y miometrio. Implicancias en endometriosis y miomas”

• European Society of Human Reproduction and Embryology Campus 2010; Basiccourse on “Update on pluripotent stem cells (hESC and iPS)”; Valencia andBarcelona, Spain; February and November 2010. “New hESC derivation strategiesmaintaining embryo viability”

• The 1st International Congress on Controversies in Cryopreservation of Stem Cells,Reproductive cells, Tissue & Organs; Valencia, May 2010. “Adults stem cells vs.Embryonic stem cells”

• SKLRB Symposia on Frontiers in Periimplantational Biology; Beijing, China; May2010. “Human endometrial CD98 is essential for blastocyst adhesion”

• 2nd Annual LIFE Advanced ART Course; Beijing, China; May 2010. “Derivation ofgametes from stem cells”, “Endometrial receptivity diagnosis: What is new?”

• Evian Annual Reproduction Meetings, Contemporary genetic technologies and humanreproduction; Evian, France; April 2010. “Genetics of endometriosis”, “Effect of ovarianstimulation protocols on the endometrium”

2009

• Challenges in Reproductive Medicine. Artemis Health Institute; Gourgaon, India;December 2009. “Endometrial factors governing implantation failure”, “Effect ofovarian stimulation protocols on the endometrium”

• Serono Symposia International Foundation, IVF Preceptorship: current practice in the21st century; Madrid, Spain; December 2009. “Future perspective in ART”

• Scitech Europe 09. Innovation Across Europe; Brussels, Belgium; November 2009.“Embryonic stem cells for therapy”

• Serono Symposia International Foundation, Defining patient subgroups to personalizeinfertility treatments; Stockholm, Sweden; September 2009. “Why and how to predictthe endometrial status”

• Serono Symposia International Foundation, Fertility Academia. Advanced Course inHuman Reproduction and Embryology; Amsterdam, The Netherlands; June 2009.“Future perspectives in ART”

• 3rd International Instituto Valenciano de Infertilidad (IVI) Congress; Valencia, Spain;April 2009. “Generation of artificial gametes from stem cells”

• UK- Spain Stem Cells Workshop: from Bench to Clinic; London, UK; March 2009.“hESC derivation maintainig embryo viability”

• New Frontiers in Fertility: Lisbon, Portugal; February 2009. “Endometrial receptivity:monitoring and managing”

• Keystone Symposia on Molecular and Cellular Biology. Frontiers in ReproductiveBiology and Regulation of Fertility; Nuevo Mexico, USA; February 2009. “PathwaysGoverning Human Endometrial Receptivity”

2008

• XXXVI World Congress of the International College of Surgeons, Vienna, Austria;December 2008. “Stem Cells and Regenerative Medicine – Current status”

• Celebration 30 years of IVF: New Technology in Reproductive Medicine; Paris,France; November 2008. “Where are we now in the understanding of endometrialstem cells?”

• International Workshop on Infertility and Assisted Reproduction; Geneva, Switzerland;

74

November 2008. “Endometrial stem cells”, “Endometrial receptivity”• 64th Annual Meeting, American Society for Reproductive Medicine (ASRM); San

Francisco, USA; November 2008. “Success and failure of embryo implantation in ART”• Optimal Infertility Management Issues and innovations; Tel Aviv, Israel; September

2008. “Basics and clinical translation of OHSS research”, “What is new from theendometrium that may impact ART?”

• 13th World Congress of Ginecological Endocrinology. International Society ofGynecological Endocrinology; Florence, Italy; March 2008. “The creation of gametesfrom stem cells”

• International Society of Mild Approaches in Assisted Reproduction; London, UK; April2008. “In vivo development of human embryos in IVF”

• 55th Annual Meeting of the Society for Gynecologic Investigation (SGI); San Diego,USA; March 2008. “Embryonic Stem Cells”

• Updates in Infertility treatment; Cape Town, South Africa; January-February 2008.“Human embryonic stem cells. New times, new opportunities”

2007

• Clinica Mangiagalli, Universit Degli Studi di Milano, La gravidanza da riproduzioneassistida: fattori di rischio e management; Milan, Italy; November 2007. “The embryoand its implantation in spontaneous and assisted pregnancies”

• 2nd International Summit on Reproductive Medicine. Society for GynecologicInvestigacion (SGI); Valencia, Spain; November 2007. “Adult progenitor stem cellpopulation in the human and mice endometrium”

• Serono Symposia International Foundation, IVF Preceptorship: current practice in the21st century; Madrid, Spain; October 2007. “Implantation”

• 2nd International Congress of the Instituto Valenciano de Infertilidad (IVI); Barcelona,Spain; Septiembre 2007. “Stem cells in reproductive medicine”

• Royan International Twin Congress: 8th Congress on Reproductive Biomedicine and3rd Congress on Stem Cells Biotechnology; Teheran, Iran; September 2007. “StemCells in reproductive medicine”, “Genomics of endometrial receptivity”

• Skibo event, The Carnegie Club, Skibo Castle; Dornoch, Sutherland, Scotland; June2007. “Stem Cells, therapeutic applications and the future of regenerative medicine”

• Anglo-Spanish Workshop on stem cells in disease and therapy; Madrid, Spain; May2007. “Policies, strategies and objectives of public cell line banks”

• 1st International Symposium in Genetics and Assisted Reproduction Techniques.Eurogene Genetics Lab. Biogenetics, Molecular Biology Lab; Athens, Greece; May2007. “PGD in recurrent miscarriage of unknown aetiology: identification of goodprognostic factors”, “Genomics of endometrial receptivity”

• XIX World Congress on Fertility & Sterility; Durban, South Africa; April-May 2007.“Adult stem cell in the uterus”

• 2nd World Congress on Gender-Specific Medicine and Aging; Rome, Italy; March 2007.“Gender issues in the differentiation of embryonic stem cells to gametes”

• 17th Scientific Meeting of Belgian Society for Reproductive Medicine; Zemst, Brussels;February 2007. “Genomic impact of controlled ovarian stimulation in humanendometrial receptivity”

2006

• Frontiers in Biomedical research; Hong Kong; December 2006. “Human embryonicstem cells, facts and hopes”

• Workshop on reproductive medicine. Hospital of Sun Yat-Sen University; Guangzhou,China; December 2006. “Stem cells in reproductive medicine”, “What are the markersof endometrial receptivity?”

• Biosymposia Inc, Endometrial Biology and Pathologies; San Francisco, USA;November 2006. “Altered gene profiles following ovarian hyperstimulation”

• 2nd Course on Molecular Biology for Reproductive Medicine Specialists; Siena, Italy;September 2006. “Mechanism of human embryonic implantation”

• 15th Simpson Symposium: The Queen’s Medical Research Institute, University ofEdinburgh; Edinburgh, Scotland; September 2006. “hESC derivation in feeder-free,

75

xeno-free and embryo-friendly conditions”• Serono Symposia International Foundation. ART in the 21st century: a time for

reflection and new horizons; Amsterdam, The Netherlands; November 2006. “What are the markers of endometrial receptivity?”

• Instituto Quinteño de Infertilidad; Quito, Ecuador; July 2006. “Implantaciónembrionaria”, “Receptividad endometrial humana”, “Células madre, expectativas ylimitaciones”

• Serono Symposia International Foundation, Human implantation: the new frontiers ofhuman assisted reproductive technologies; Erice, Italy; May 2006. “Genomics ofhuman endometrial receptivity”

• Serono Symposia International Foundation, Therapeutic potential of stem cells inreproductive medicine; Valencia, Spain; March – April 2006. “Adult stem cells in theuterus”, “Adult stem cells in the human ovary”, “hESC culture in feeder-free, xeno-freeconditions”

• 53rd Annual Meeting of the Society for Gynecologic Investigation (SGI), Endometrialsatellite symposium. Toronto, Canada; March 2006. “Genomics of endometrialreceptivity”, “Only nonhuman primate research can clarify the “black box” ofembryonic-endometrial implantation in vivo in humans”

• 12th World Congress of Gynecological Endocrinology; Florence, Italy; March 2006.“Stem cells: the future ahead”

• Evian Annual Reproduction Meetings, Expert meeting on implantation research.Evian, France; February 2006. “Genomic impact of COH in human endometrialreceptivity”

• Updates in infertility treatment 2006; Cape Town, South Africa; January 2006.“Endometrial features and embryo transfer outcome”

2005

• Serono Symposia International Foundation, Endometrium and embryo implantation;Paris, France; December 2005. “The impact of controlled ovarian stimulation in humanendometrial receptivity”

• New Developments in Reproductive Medicine. Cátedra Santiago Grisolía, FundaciónCiudad de las Artes y las Ciencias; Valencia, Spain, October 2005. “Embryonic stemcell research in Spain”

• In Vitro Testing Industrial Platform; Rotterdam, The Netherlands; October 2005.“Ethical aspects of using human stem cells”

• Sociedad Uruguaya de Reproducción Humana (SURH) y Taller Regional(Argentina/Paraguay/ Uruguay) de la Red Latinoamericana de Reproducción Asistida(Redlara); Colonia del Sacramento, Uruguay; September – October 2005. “Diagnosisand treatment of implantation failure”, “Advances in understanding of the biology ofembryo implantation”

• European Society of Human Reproduction and Embryology (ESHRE) organized bySpecial Interest Group Reproductive Endocrinology, 1st Course on Molecular Biologyfor Reproductive Medicine Specialists; Siena, Italy; September 2005. “Endometrialreceptivity, embryo-endometrial interaction and implantation”

• Serono Symposia International Foundation, New frontiers in reproductive medicine:clinical and laboratory advances; Siem Reap, Cambodia; September 2005. “Causesand diagnosis of implantation failure”

• 13th World Congress on In Vitro Fertilization, Assisted Reproduction & Genetics;Istanbul, Turkey; May 2005. “Factors that determine success on oocyte donationcycles”, “Molecular basis of implantation”

• New trends in Human Reproduction 2005, Chang Gung Memorial Hospital and Schoolof Medicine; Taipei, Taiwan; May 2005. “Genome wide analysis of endometrialreceptivity: the impact of ovarian stimulation”

• Multiple Gestation: Expert Meeting, Bertarelli Foundation; Valencia, Spain; April 2005.“Proteomic pattern secreted by viable blastocyst as a diagnostic tool to accomplishsingle births after IVF”

• 1st International Congress of the Instituto Valenciano de Infertilidad (IVI); Valencia,Spain; April 2005. “Derivation of the first embryonic stem cell lines in Spain”

76

• 4th Mediterranean Society for Reproductive Medicine; Cannes, France; April 2005.“Genomic and proteomic of implantation”

• Federation of Biomedical Scientific Societies in The Netherlands; Leiden, TheNetherlands; February 2005. “Embryonic-endometrial interactions at implantation inhumans”

2004

• European Society of Human Reproduction and Embryology (ESHRE) Campus 2004,GnRH antagonist in IVF; Brussels, Belgium; December 2004. “Endometrialdevelopment on GnRH antagonist cycles”

• Swiss Society for Reproductive Medicine; Bern, Switzerland; November 2004. “Whichtreatments are transferred to other countries? How is the collaboration with a centreabroad organized?”

• Instituto de Ginecología y Fertilidad (IFER), XIII convivencia en infertilidad; BuenosAires, Argentina; October 2004. “Fallas recurrentes de implatación en FIV”,“Aplicaciones prácticas del tratamiento con antagonistas GnRh”, “Células madre enmedicina reproductiva”, “Receptividad uterina”, “La transferencia embrionaria. ¿Cómose debe realizar?”

• 1st International Congress of Reproductive Medicine. Society of ReproductiveMedicine-Turkey; Istanbul, Turkey; September 2004. “Genomics in endometrialreceptivity”, “Leptin and endometriosis”

• Serono Symposia International Foundation; From oocyte to embryo: a pathway to life;Stressa, Italy; September 2004. “Leptin system in embryo development andimplantation”

• Medifertil Stem Cells Bank; Bogota, Colombia; August 2004. “Células madreembrionarias. Expectativas e incertidumbres”

• 24th Annual Meeting of American Society for Reproductive Immunology; Missouri, St.Louis, USA; June 2004. “Embryo aneuploidy screening: a diagnostic tool forunexplained recurrent miscarriage”

• 4th World Congress on Ovulation Induction; Bologna, Italy; May 2004. “Use ofrecombinant LH”, “Pathophysiology of embryo implantation”

• International Federation of Fertility Societies, World Congress on Fertility and Sterility;Montreal, Canada; May 2004. “Implantation and uterine receptivity”

• 52nd Annual meeting, Pacific Coast Reproductive Society; Rancho Mirage, USA; April-May 2004. “Blastocyst and uterine interactions at implantation”, “Future prospects forREI”

• Centre for Reproductive Medicine and Gleneagles IVF Centre; Singapore; April 2004.“Role of endometrium in implantation-special note on endometrial culture-Recentadvances”, “Future directions in ART”

• 11th World Congress of Gynecological Endocrinology; Florence, Italy; February 2004.“Genomics of endometrial receptivity”

2003

• Serono Symposia International Foundation, Ovum Donation and beyond: frontiers inMedicine; New York, USA; December 2003. “International Ovum Donation”

• European Society of Human Reproduction and Embryology (ESHRE), Course SpecialInterest Groups Reproductive Genetics and Early Pregnancy; Amsterdam, TheNetherlands; December 2013. “Human endometrial receptivity; a wide-genomeanalysis”

• TWIN-Meeting Alpha-Andrology 2003; Antwerp, Belgium; September 2003.“Implantation processes of the human embryo”

• Serono Symposia International Foundation, From Genetics to Implantation and EarlyFetal Development in Infertile Couples; Milan, Italy; October 2003. “Hormonal andembryonic regulation of human implantation”

• Serono Symposia International Foundation, Reproductive Ageing; Palma de Mallorca,Spain; September 2003. “Embryo development in vitro in older patients. The IVIexperience”

• Imperial College, New Horizons in Recurrent pregnancy loss; London, UK; September

77

2003. “Embryo aneuploidy screening- a diagnostic tool for unexplained recurrentmiscarriage”

• III International workshop on Human Implantation: Discovery in the Reproductive Tractin Health and Disease Using Genomics/ Proteomics. Serono Foundation for theAdvancement of Medical Science; Madrid, Spain; June 2003. “Human endometrialreceptivity, a wide-genome analysis”

• International Conference on the Female Reproductive Tract; Frauenchiemsee,Germany; May-June 2003. “Genomic of human endometrial receptivity”

• 2nd Mediterranean Congress of Reproductive Medicine. Lessons gained from 25 yearsof IVF; Alexandria, Egypt; May 2003. “Human Endometrial Receptivity- a genomic approach”

• Fortpflanzungsmedizin aktuell. Was gibt es Neues in Klinik und Labor?; Donnerstag,Baden; Switzerland; May 2003. “Human Implantation. From science to clinicalpractise”, “Die schwierige ovarielle stimulation. Ursachen und neue Therapiekonzepte“

• Workshop funded by the Wellcome Trust in collaboration with The Royal Society ofEdinburg and supported by the Munro Kerr Society; Edinburgh, Scotland; January2003. “The importance and investigation of cell-cell interaction: human blastocyst-endometrial/epithelial interaction”

2002

• Federación Latinoamericana de Sociedades de Esterilidad y Fertilidad; Montevideo,Uruguay; November 2002. “Chromosomal abnormalities in recurrent abortion”,“Adolescence preservation of the reproductive future. Criopreservation of the ovariantissue”

• 1st Mediterranean Congress on Reproductive Medicine; Taormina, Sicily, Italy;November 2002. “The leptin system in human implantation”

• 5th Workshop on Assisted Reproductive Techniques. Reproductive Medicine ResearchCenter of 1st Affiliated Hospital of Sun Yat-Sen University; Guangzhou, China;November 2002. “Molecular mechanism of implantation and assessment of uterinereceptivity”, “Embryonic regulation of endometrial molecules in human implantation”

• Centro de Estudios Santa Joana Pro Matre; São Paulo, Brazil; August 2002. “Meiosde cultura comerciais vs co-culturas”, “hCG recombinante vs urinário”, “Indução daovulação com Cetrotide: Resultados”

• Asociación Colombiana de Fertilidad y Esterilidad; Bogota, Colombia; 2002. “Pasado, presente y futuro de la T.R.A.”, “Receptividad uterina e implantación embrionaria”, “Importancia del diagnostico genetico preimplantatorio”

• Serono Symposia International Foundation, Embryo Implantation: Cellular changesfrom bench to bedside; Connecticut, USA; July 2002. “In vitro models for humanimplantation: lessons learned”

• 18th Annual meeting of the European Society of Human Reproduction andEmbryology (ESHRE); Vienna, Austria; July 2002. “Preimplantation genetic diagnosisin implantation failure and recurrent pregnancy loss”

• Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), Instituto deSalud Carlos III; Madrid, Spain, June 2002. “Human embryonic stem cells from non-viable human embryos”

• XXII Annual Meeting of the American Society for Reproductive Immunology (ASRI),Adapting New Technologies to Reproductive Immunology; Chicago Illinois, USA; June2002. “Embryonic regulation of endometrial molecules in human implantation”

• Congreso Colombiano de Obstetricia y Ginecología; Cartagena de Indias, Colombia;April 2002. “Nuevos avances en el síndrome de hiperestimulación ovárica”,“Reproducción Asistida”

• Serono Symposia USA, Inc., Toward optimizing ART: a tribute to Howard andGeorgeanna Jones; Williamsburg, Virginia, USA; April 2002. “Uterine receptivityissues”

• III Congreso Nacional Avances en la ginecología y obstetricia panameña en el sigloXXI; Panama; March 2002. “Manejo del fallo de implantación embrionaria”, “Presentey futuro de la reproducción asistida”, “Nuevas tecnologías de manipulaciónembrionaria”

78

• Advances In Infertility Treatment; Fort Lauderdale, Florida, USA; January 2002.“Embryonic regulation of endometrial receptivity in humans”

2001

• 9th World Congress of Gynecological Endocrinology; Hong Kong, China; December2001. “Leptin system in the human maternal-embryonic interface”

• 57th Annual Meeting of the American Society for Reproductive Medicine (ASRM); Orlando, Florida, USA; October 2001. “Human Implantation: What do we need to know?”, “Basic Research on the molecular mechanisms regulating OHSS”

• IV Congress of the European Society of Gynaecology; Barcelona, Spain; October2001. “Future possibilities for improving implantation”

• XXVIII International Symposium Fertility 2001, Institut Universitari Dexeus; Barcelona,Spain; October 2001. “Fracaso implantatorio”

• 1er Simposio Internacional sobre Medicina de la Reproducción Humana; Buenos Aires,Argentina; September 2001. “Manejo del fallo de implantación”

• 5º Congreso Colombiano de Fertilidad y Esterilidad; Barranquilla, Colombia; August2001. “Presente y futuro de la reproducción asistida”, “Manejo del fallo deimplantación”, “Cocultivos”, “Papel de la progesterona en la ventana de implantación”

• II International Workshop on Human Implantation: Recent Advances & Clinical Aspects; Mardrid, Spain; May 2001. “Human endometrial receptivity. Gene regulation”

• Human Blastocyst 2001. Genk Institute for Fertility Technology & αlpha, theInternational Society for Scientists in Reproduction; Genk, Belgium; April 2001.“Embryo-maternal dialogue”, “Co-culture of blastocysts”

• Preimplantation Genetic diagnosis (PGD). International experiences and nationalexpectations; Ahrensburg, Germany; March 2001. “PGD by fluorescence in-situhybridization: possibilities and pitfalls”

2000

• Sociedad de Ginecología y Obstetricia de la Ciudad de La Plata, Colegio de Médicos– Distrito I y Laboratorio ELEA; La Plata, Argentina; December 2000. “Transferenciade blastocistos en reproducción asistida”

• Sociedad Argentina de Biología; Buenos Aires, Argentina; December 2000.“Moléculas de reconocimiento en la implantación embrionaria”

• Serono Symposia International Foundation, unraveling topics in reproductivemedicine; Santiago de Chile, Chile; December 2000. “Endometrial receptivity.Molecular and clinical aspects”

• Serono Symposia International Foundation, Reproductive competence:Pathophysiology and therapeutic interventions; Santiago de Chile, Chile; November2000. “Paracrine dialogue in human implantation”

• Geman IVF Center Federation; Hamburg, Germany; November 2000. “Embryonale aspekte der implantation“

• Third World Congress on Ovulation Induction; Bologna, Italy; October 2000. “The roleof the endothelium in the pathogenesis of ovarian hyperstimulation syndrome(OHSS)”, “Luteal function during leuprorelin administration in ovulation induction”

• Human implantation, basic and clinical aspects; Palermo, Italy; October 2000.“Ovarian stimulation and endometrial receptivity”, “Basic aspects of implantation andits disorders. Biochemical dialogue between embryo and endometrial tissue”

• New York University, School of Medicine, Human Fertility And Reproduction: The Oocyte, The Embryo And The Uterus; New York, USA; October 2000. “Embryonic regulation of endometrial molecules in implantation”

• European Society of Human Reproduction & Embryology (ESHRE) CampusSymposium; Tel-Aviv, Israel; September 2000. “Basic aspects of implantation and itsdisorders”

• The Early Human Life; Vatican City; September 2000. “The local factors in theimplantation”

• Pontificia Universidad Javeriana, Avances en Medicina Reproductiva; Bogotá,Colombia; August 2000. “Presente y futuro de las técnicas de reproducción asistida”,“Diagnóstico genético preimplantación en mujeres con aborto habitual”, “Implantación

79

Embrionaria: aposición, adhesión e implantación”• Imperial College School of Medicine. Division of Paediatrics, Obstetrics &

Gynaecology; London, UK; June-July 2000. “Embryo aneuploidy in recurrentpregnancy loss”

• 16th Annual Meeting European Society of Human Reproduction and Embryology(ESHRE); Bologna, Italy; June 2000. “Critical assessment of human blastocysttransfer”

• 10th International Conference on Prenatal Diagnosis and Therapy; Barcelona, Spain;June 2000. “PGD and repeated abortion”

• 10º Congreso Sociedad Argentina de Esterilidad y Fertilidad; Buenos Aires, Argentina;2000. “Marcadores de implantación”, “Fisiología de la implantación: diálogo embrión-endometrio”

• International Symposium on ART and the Human Blastocyst. Serono Symposia USA; Dana Point, USA; March – April 2000. “Embryo-Maternal Dialogue”

• International Society of Reproductive Endocrinology, Endocrine basis of reproductive function; Tampa, USA; January 2000. “Basic aspects of implantation and its disorders”

1999

• Société Médecine de la Reproduction ; Paris, France ; December 1999. “Existe-t-il une corrélation entre maturation ovocytaire et aptitude de l’endomètre à nider? »

• 6th Annual Meeting of the Middle East Fertility Society; Southern Sinai, Egypt;November 1999. “How to improve implantation in ART”

• 3rd Congress European Society of Gynecology; Bruges, Belgium, October 1999.“Cytokines and implantation”

• Instituto de Ginecología y Fertilidad (IFER), XIII convivencia en infertilidad; BuenosAires, Argentina; November 1999. “Pérdidas embrionarias precoces y reiteradas decausa cromosómica”, “Cómo mejorar la calidad embrionaria en Fertilización Asistida”,“El endometrio en ciclos de estimulación ovárica”, “Regulación embrionaria demoléculas endometriales”, “Fisiología y fisiopatología de la implantación”, “Reflejo delos avances de la investigación en las técnicas de Fertilización Asistida”

• European Meeting of Immunology and Reproduction; Roma, Italy; October 1999.“Embryonic Implantation”

• German Society for Reproductive Medicine; Rolduc/Aachen, Germany; October 1999.“Coordinated regulation of endometrial epithelial apoptosis by the human embryo”

• Sociedad Latina de Biología y Medicina de la Reproducción; Barcelona, Spain;October 1999. “Fisiología del proceso implantatorio”

• Société Française d’Endocrinologie; Bourdeaux, France ; October 1999. “L’approcheendométriale de la contraception »

• 10th Reinier de Graaf Symposium; Zeist, The Netherlands; September 1999.“Preimplantation assessment of aged embryo’s”

• 7th World Congress of gynecological endocrinology, The International Society ofGynecological Gndocrinology; Buenos Aires, Argentina; April 1999. “Normal humanimplantation”, “Cytokine crosstalk between embryo and endometrium”, “Implantationand its disorders: how to improve implantation in ART”

• University of Lund, Workshop on Blastocyst Development and Early Implantation;Lund, Sweden; April 1999. “Embryonic regulation of endometrial epithelial molecules”

• VI Congreso de la Federación Latinoamericana de Sociedades de Esterilidad yfertilidad. I Congreso panameño de infertilidad y endoscopia ginecológica. II Forolatinoamericano de reproducción humana; Panama, Republic of Panama; March1999. “Receptividad uterina, aspectos básicos y clínicos”, “Implantación”,“Alteraciones cromosómicas de novo en los embriones de las pacientes con abortosde repetición”

• Ares-Serono Foundation, International Workshop on Human Implantation: RecentAdvances & Clinical Aspects; Valencia, Spain; March 1999. “Embryonic regulation ofadhesion molecules and chemokines”

• ART 2000- New Horizons; Aschau/Munich, Germany; January 1999. “Molecular and

80

cellular developments in implantation research”1998

• Workshop on Human Implantation; Geneva, Switzerland; November 1998.“Endometrial competency including ultrastructure”

• 18 Congreso Brasileiro de Reproducao Humana; Porto Alegre, Brazil; November1998. “How to increase implantation rates in assisted reproduction”, “Basics aspectsof human implantation”

• Flemish Society of Gynecology, Brussels, Belgium; October 1998. “New concepts ofImplantation”

• French National Institute of Health and Medical Research, Aix Les Bains, France;September-October 1998. “The IL-1 system and embryonic implantation”

• European Society of Human Reproduction & Embryology (ESHRE); Tel Aviv, Israel;September 1998. “Long term co-culture to the blastocyst stage: coculture versussynthetic medium”

• New Frontiers in Infertility Management; Bangalore, India; July 1998. “Endometrialstatus as a predictor of IVF”, “Prognostic factors in IVF-ET”

• Samsung Medical Center; Seoul, Korea; July 1998. “Endocrine factors affectingembryonic implantation in human”, “Molecular interactions between embryo andendometrium in implantation”

• Société Française d´Endocrinologie; Paris, France; June 1998. “Implantation »• II Congreso argentino de endocrinología ginecológica y reproductiva. Sociedad

Argentina de Endocrinología Ginecológica y Reproductiva (SAEGRE); Buenos Aires, Argentina; May 1998. “Estrategias para mejorar la implantación”, “Implantación. Aspectos básicos. Comunicación entre embrión y endometrio”

• International Congress on Ovulation Induction and Menopause 98; Antalya, Turkey;May 1998. “The detrimental effect of ovulation induction on fertility”, “Apoptosis inReproductive Biology. An overview (Key note lecture)”, “Cytokines, adhesionmolecules and invasive proteinases: The missing paracrine-autocrine link inembryonic implantation (Keynote lecture)”

• International Symposium on Reproductive Medicine, Co-Sponsored by ASRM ESHRE– IVI. State of the Art of Human Implantation. Basic and Clinical Aspects; Madrid, Spain; May 1998. “Update of the role of IL-1 system in human implantation”, “Co-cultures II. Using primary cultures. Endometrial epithelium”

• New developments in diagnosis and treatment of infertility; Antwerpen, Belgium, May 1998. “State of the art lecture. Endometrial receptivity”

• 20 years of IVF. A Celebration Meeting; Marrakech, Morocco; March 1998. “Cross-talkbetween uterus and embryo”

• 6th Congress of the International Society of Gynecological Endocrinology (ISGE); Crans-Montana, Switzerland; March 1998. “Embryonic implantation in high responder patients. How to improve it?”

1997

• Fertility Society of Australia; Adelaide, Australia; December 1997. “Immunology ofimplantation”

• Genes and Environment in Human Reproductive Disorders. Serono ColloquiaAustralasia; Adelaide, Australia; November – December 1997. “Recurrent PregnancyLoss. Maternal or/and Embryonic Fault?”

• Sociedad Chilena de Reproducción y Desarrollo; La Serena, Chile; August 1997. “Roldel sistema de la IL-1 en la implantación”

• Universidad de Chile, Avances en Reproducción Humana; Santiago de Chile, Chile;August 1997. “Desarrollo embrionario e implantación en pacientes conendometriosis”, “Señales embrionarias en la implantación humana”, “Basesfisiológicas y moleculares de la implantación. Rol del sistema interleuquina”

• Asociación Colombiana de Fertilidad y Esterilidad, Controversias en Reproducción Humana; Santa Fe de Bogotá, Colombia; August 1997. “Cocultivos en reproducción asistida”, “Conceptos actuales en la endometriosis”, “Bases Moleculares de la Implantación”

81

• International Workshop on Paracrine Mechanisms in Female Reproduction; Seville,Spain; June 1997. “Cytokines and embryo implantation”

• 4th Bourn Hall Meeting on Reproductive Medicine; Cambridge, UK, June 1997.“Molecular Interactions between embryo and uterus”

• International Meeting on Infertility and Assisted Reproductive Technology; PortoCervo, Italy; June 1997. “Adhesion proteins in implantation”

• World Congress on In Vitro Fertilitation & Assisted Reproduction; Vancouver, Canada;May 1997. “Molecular mechanisms of implantation”

• VII Symposium Internacional del IVI, la capacidad reproductiva del varón; Valencia,Spain; February 1997. “Anticoncepción preimplantatoria”

• II Symposium Internacional de Ginecología Endocrinológica y Menopausia; Madrid,Spain; January 1997. “Ciclos estimulados e implantación embrionaria”

1996

• Fundación Argentina para el Tratamiento de la Esterilidad; Buenos Aires, Argentina;November 1996. “Legislación en la comunidad económica europea”, “Factoresendometriales y embrionarios de posible aplicación clínica para mejorar laimplantación embrionaria”, “Citokinas e implantación”, “Importancia del estradiol en laimplantación embrionaria de las altas respondedoras”, “Implantación embrionaria,fisiología y fisiopatología”

• Symposium Internacional Actualización sobre Función ovárica y sus trastornos.Hospital Universitario La Fe; Valencia, Spain; October 1996. “Fisiología delendometrio e implantación”

• 5th World Congress of Gynecological Endocrinology; Barcelona, Spain; October 1996.“Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation”

• XVI Annual Meeting, American Society for Reproductive Immunology (ASRI);Knoxville, Tenesse, USA; June 1996. “The IL-1 system and human implantation”

• IXth World Congress on Human Reproduction and Vth World Conference on FallopianTube in Health and Disease; Philadelphia, USA; June 1996. “Recent research on theIL-1 system and implantation”

• European Meeting on Medically Assisted Procreation; Siena, Italy; May 1996.“Adhesion molecules in embryonic implantation”

• Materno-Fetal Immunobiology Group (MFIG) Workshop British Society of Immunology; Bristol, England, April 1996. “Cytokines in implantation”

• Second Mediterranean Gynecological Club Conference: Controversies in Obstetricsand Gynecology; Eilat, Israel; March 1996. “Should we screen for infectious disease inthe case of repeated abortion?”

• 4th International Symposium on GnRH Analogues in Cancer and HumanReproduction; Geneva, Switzerland; February 1996. “GnRHa in IVF. Targeting thecorpus luteum function”

1995

• Simposio Internacional de Histeroscopia; Barcelona, Spain; October 1995.“Histeroscopia diagnóstica (Video)”, “Histeroscopia diagnóstica. Material eIndicaciones”

• 15th World Congress on Fertility and Sterility; Montpellier, France; September 1995.“Immunological aspects of implantation failure (IL1)”

• Instituto de Ciencias de la Salud; Medellin, Colombia; August 1995. “Implantación enreproducción asistida”, “Complicaciones de la reproducción asistida”

• 11th Annual Meeting of the European Society of Human Reproduction & Embryology(ESHRE); Hamburg, Germany; June – July 1995. “Interleukins”

• European Association of Gynecologists and Obstetricians; Monaco; March-April 1995.“Molecular mechanism of endometrial tumori-genesis”

• European Society of Human Reproduction & Embryology (ESHRE), Symposium onReproductive Medicine "Maternal-Embryo Interactions"; Valencia, Spain; March1995. “Interleukin-1 system as a paradigm of dialogue between embryo andendometrium in implantation”

82

• V Simposium Internacional of the Instituto Valenciano de Infertilidad (IVI); Valencia,Spain; March 1995. “Stromal and epithelial endometrial cell culture”

1994

• 4th World Congress on Endometriosis; Salvador de Bahia, Brazil; May 1994. “The roleof the IL-1 system in human implantation: Evidence for alteration of the IL-1 system inendometriosis"

• Early embryo development, uterus preparation and role of cytokines in implantationand labour; Annecy, France; May 1994. “The role of IL-1β system during implantation”

1991

• I Symposium Internacional del Instituto Valenciano de Infertilidad: Endoscopia Operatoria; Valencia; Spain; May 1991. “¿Es conveniente el tratamiento conservador del embarazo ectópico?”

1990

• III Symposium Hispano-Luso-Brasileiro de Ecografía en Obstetricia y Ginecología. ISymposium Hispano-Luso-Brasileiro de Reproducción Asistida; Lisbon, Portugal;November 1990. “Reducción embrionaria transvaginal”

1989

• II Symposium Hispano-Luso-Brasileiro de Ecografía Obstétrico-Ginecológica;Salvador de Bahía, Brazil; July 1989. “Patología de la vesícula vitelina”,“Endosonografía del embarazo ectópico”, “Endosonografía del cáncer ovárico”

1987

• Spanish/German Society of Obstetrics and Gynecology; Valencia, Spain; April 1987.“Amniocentesis precoz y biopsia corial”

1985

• Reunión Hispano-Portuguesa de las Secciones de Ecografía de la AsociaciónGinecológica Española y de la Sociedad Portuguesa de Obstetricia y Ginecología;Valencia, Spain; December 1985. “Cirugía fetal intraútero en la patología renal”,“Cirugía fetal intraútero en la hidrocefalia”

83

Invited Seminars/ Symposium Presentations National Invitations

2017

• V Jornadas IVI Sevilla. La Reproducción Asistida: Superando las Barreras Fisiológicas; Sevilla, España; November 2017. “Reproducción Asistida: Presente y Futuro”

2016

• IV Simposio nacional fertilidad hoy; Palma de Mallorca, Spain; April 2016. “Avances tecnológicos aplicados a la Medicina Reproductiva: ¿Ciencia Ficción o una realidad en el Siglo XXI?”

• Now. Tomorrow. Fertility. Definiendo las claves en reproducción asistida. Simposio Merck durante el 31º Congreso Nacional de la Sociedad Española de Fertilidad (SEF); Málaga, Spain; May 2016. “Tomorrowland in Reproductive Medicine”

2015

• IV Jornadas IVI Sevilla. El Futuro en la Reproducción Asistida; Sevilla, Spain; Octubre 2015. “Reproducción Assistida: Presente y Futuro”

• X Curso Diatros; Barcelona, Spain; April 2015. “El factor endometrial en la medicina reproductiva”

• Gran reunión Nacional Innuva. MSD; Madrid, Spain; February 2015. “¿Qué es la innovación?”

2014

• XXIV Congreso Nacional de la Sección de Medicina Perinatal de la SEGO; Zaragoza, Spain; June 2014. “La resistencia a la dedidualización endometrial mediada por déficit de ANXA2, muestra una causa materna de preeclampsia”

2013

• IV Jornadas de Endocrinología Reproductiva: Abordaje del fallo de Implantación; Madrid, Spain; November 2013. “Abordaje por studio perfil genético endometrio”

2012

• Controversias en Reproducción, Obstetricia y Ginecología; Valencia, Spain 2012. “Nuevos enfoques al diagnóstico prenatal”

2010

• Forging Partnerships an INTERBIO meeting; Valencia, Spain; January 2010. “Regenerative Medicine”

• 7º Congreso Nacional de Enfermería Quirúrgica. “Algo más que cirugía”; Valencia, Spain; March 2010. “Células Madre”

• 1ª jornada La sangre del cordón umbilical: fuente de vida; Barcelona, Spain; April 2010. “Conceptos básicos sobre células madre embrionarias, inducidas y adultas”

• Simposio satélite. Ómicas, avanzando hacia el futuro de la fertilidad. XXVIII Congreso Nacional de la Sociedad Española de Fertilidad, V Reunión Iberoamericana, III Congreso Nacional de Enfermería de la Reproducción; Valencia,Spain; May 2010. “Como mejorar la implantación embrionaria, nuevas perspectivas”

2009

• Ciclo de conferencias el legado de Prometeo. Científicos Valencianos deExcelencia; Valencia, Spain; April 2009. “Cuando la medicina reproductivaencuentra la medicina regenerativa”

• 1er Simposio Internacional en Medicina Regenerativa Traslacional. Fundación Eduardo Anitua; Vitoria, Spain; October 2009. “Potencial de las células madre en medicina regenerativa”

2008

• Ley 14/2007: Un nuevo escenario para la Investigación Biomédica Fundación salud2000; Madrid, Spain; January 2008. ”Muestras biológicas e investigación con célulasmadre”

• Jornadas Asociación Endometriosis España; Valencia, Spain; April 2008.“Investigación”, “¿Qué es la endometriosis”

• I Simposio sobre Terapia Celular y Medicina Regenerativa. Centro de Cirugía deMínima Invasión Jesús Usón; Cáceres, Spain; May 2008. “Células madreembrionarias”

84

• XXVII Congreso Nacional de la Sociedad Española de Fertilidad; Oviedo, Spain;May 2008. “Receptividad endometrial en edad avanzada”

• II Jornadas de Medicina Regenerativa. Fundación Investigación regenerativa y salud– Hospital universitario Gregorio Marañón; Madrid, Spain; May 2008. “La excelenciaen las técnicas de diagnóstico pre-implantacional como seguro de la viabilidadposterior a la extracción celular del embrión. Su futuro”

• Conferencia Ayuntamiento de Sueca; Sueca, Valencia, Spain; June 2008. “CélulasMadre”

• 2028, de qué hablaremos cuando hablemos de salud. XX aniversario de la ediciónde Viure en Salut, Valencia, Spain; June 2008. “Uso de células madre paradesarrollo y aplicación de terapia regeneradora”

• 45 congreso nacional de la Sociedad Española de Cirugía Ortopédica yTraumatología; Valencia, Spain; October 2008. “Terapia Celular en Traumatología yOrtopedia”

2007

• Osteoinducción y regeneración ósea, fundamentos, experiencia y perspectivasfuturas; Valencia, Spain; February 2007. “Perspectivas futuras”

• Producción Científica de la Comunidad Valenciana en materias de Biomedicina yCiencias de la Salud; Valencia, Spain; March 2007. “Desarrollo de investigaciónpuntera desde una Unidad Mixta”

• Foro Sobre Reproducción Humana Asistida, Instituto Europeo de salud y BienestarSocial; Madrid, Spain, March 2007. “I+D+I en Reproducción Humana Asistida”

• XLII Congreso Nacional de la Sociedad Española de Cirugía Plástica, Reparadora yEstética; Valencia, Spain; May 2007. “Células madre y cirugía plástica”

• IV encuentro del ciclo sobre la medicina del futuro. Grupo Valenciano CapítuloEspañol del Club de Roma; Valencia, Spain; May 2007. “Presente y futuro de lascélulas madre”

• IV Congreso de la Sociedad Española de Terapia Génica y Celular; Madrid, Spain;September 2007. “hESC derivation in feeder-free, xeno-free and embryo-friendlyconditions”

2006

• Jornada sobre bioética, Escuela Valenciana de Estudios de la Salud (EVES).Universidad Internacional Menendez Pelayo (UIMP); Valencia, Spain; February2006. “La investigación con células troncales embrionarias. Aspectos científicos yéticos”

• I Curso de actualidad en factor masculino y en técnicas de reproducción asistida.Organizado por IVI Vigo; Vigo, Spain; April 2006. “Células madre para creargametos”

• Ciclo de Conferencias España 2006; Torrelodones, Madrid, Spain; May 2006. “Lascélulas madre embrionarias. Aportación de la medicina reproductiva a lahumanidad”

• XXVI Congreso nacional de la Sociedad Española de Fertilidad; Zaragoza, Spain;May – June 2006. “Receptividad uterina e implantación”

• 55 congreso de la Asociación Española de Pediatría (AEP); Valencia, Spain; June2006. “Células madre embrionarias como herramienta terapéutica en enfermedadesdegenerativas”

• IX Congreso nacional de la asociación española para el estudio de la menopausia(AEEM) y sección de menopausia de la SEGO; Santiago de Compostela, A Coruña,Spain; June 2006. “Donación de ovocitos en la perimenopausia”

• II Jornadas de actualización en investigación oftalmológica. Unidad de InvestigaciónOftalmológica “Santiago Grisolía”. Hospital Universitario Doctor Peset. FundaciónValenciana de Estudios Avanzados (FVEA); Valencia, Spain; October 2006. “Célulasmadre en Valencia”

• X Jornada de enfermos renales. ALCER TURIA; Valencia, Spain; November 2006.“El futuro esperanzador de la investigación con células madre”

2005

85

• Nuevos retos en tecnologías de la salud. Universidad Politécnica de Valencia; Valencia, Spain; February 2005. “Terapias de regeneración”

• Los límites de la reproducción humana, CosmoCaixa (Fundación la Caixa); Madrid,Spain; March 2005. “Reproducirnos para curar: las promesas de las células madre”

• Hospital General Universitario de Alicante y Centro de Especialidades Babel;Alicante, Spain; March 2005. “Situación actual de los avances en la terapia basadaen las células madre en nuestro país”

• 5º Curso Diatros, Hormonas y envejecimiento saludable; Barcelona, Spain; April2005. “Regeneración germinal a partir de células madre”

• III Jornadas para médicos residentes sobre reproducción asistida; Bétera, Valencia,Spain. “Células madre. Medicina regenerativa”

• XVI Congreso Nacional de la Sociedad Española de Transfusión Sanguínea; SanSebastián, Spain; June 2005. “Células troncales embrionarias: verdades eincertidumbres”

• Nuevos conceptos en Ciencias de la Salud y la Vida; Universidad Europea deMadrid; Altea, Alicante, Spain; July 2005. “Investigación con células madre:esperanzas e incertidumbres”

• IV Jornadas de Reproducción Humana. Centro Gutemberg; Valencia, Spain;October 2005. “Células madre embrionarias: diferenciación celular y rechazoinmunológico”

• Jornadas Sobre Medicina Reproductiva. Hospital Universitario La Fe; Valencia,Spain; November 2005. “Desarrollo de células progenitoras”

• 32 Symposium Internacional Fertilidad 2005, Fundación Santiago Dexeus Font;Barcelona, Spain; November 2005. “Derivación de gametos a partir de célulasmadre”

• II Congreso Autonómico. Presente y futuro de la discapacidad. Confederación Coordinadora de Discapacitados Físicos de la Comunidad Valenciana. COCEMFE-CV; Valencia, Spain; November 2005. “Estado Actual de las Células Madre Embrionaria en la Medicina Regenerativa”

2004

• XII Reunión Nacional del Grupo Uro-Andrológico de la Asociación Española deUrología; Valencia, Spain; March 2004. “Células madre y reproducción”

• II Jornadas sobre reproducción asistida para médicos residentes; Barcelona, Spain;April 2004. “Células madre. Terapia de futuro”

• Aula de las provincias; Valencia, Spain; April 2004. “Células madre. Verdades,esperanzas e incertidumbres”

• XXV Congreso Nacional de la SEF; A Coruña, Spain; May 2004. “Fallo repetido deimplantación: Aspectos clínicos”, “Diagnóstico Genético Preimplantacional dirigido alestudio de enfermedades monogénicas”, “Regeneración germinal a partir de célulasmadre”, “Beca de investigación S.E.F. 2001: El sistema de la leptina durante lareceptividad endometrial y el desarrollo preimplantatorio”

• I Foro Mundial Valencia en Biotecnología, Universidad de verano Campus TI 2004;Valencia, Spain; July 2004. “Derivación de líneas de células madre embrionarias enEspaña. Obtención células embrionarias”

• IX Congreso Nacional de Reales Académias de Medicina de España; Valencia,Spain; October 2004. “Células Madre embrionarias de origen humano”

• XXI Congreso de la Asociación de Enfermedades Neuromusculares, ComunidadValenciana (ASEMCV); Valencia, Spain; November 2004. “Derivación de las dosprimeras líneas de células madre embrionarias”

• Foro de debate científico, ético y legal a partir de casos clínicos FIV-EXTREME,Conceptum; Reus, Spain; November 2004. “Técnicas de reproducción asistida ydiagnóstico pre-implantacional en enfermedades que se manifiestan clínicamenteen edad juvenil y adulta. ¿cerramos la puerta?”

• Ciclo de conferencias sobre sociedad, salud y derecho en el siglo XXI; Madrid,Spain; November 2004. “Investigación con células madre, esperanzas eincertidumbres”

86

2003

• Metodología de la investigación médica: de los conocimientos básicos a la clínica.(Fundación para la investigación del Hospital Clínico de Valencia); Valencia, Spain;January 2003. “Células madre como futuro de la medicina reparativa”

• 4º Curso Diatros. Cuidados en la Salud de la Mujer. De la menarquia a lamenopausia; Barcelona, Spain; March 2003. “Técnicas de reproducción asistida ycélulas madre embrionarias”

• Presente y futuro de la ataxia, Asociación Ataxias; Fuenlabrada, Madrid, Spain;March 2003. “Células Madre. Utilización de células embrionarias con finesterapéuticos”

• XXVII Congreso español de Ginecología y Obstetricia; Santander, Spain; June2003. “Endometriosis y reproducción asistida”

2002

• 3ª Reunión anual de AVCRA (Asociación vasca de centros de reproducciónasistida); Vitoria, Spain; June 2002. “Receptividad endometrial y transferenciaembrionaria”

• Ética y clonación: Realidades y Exageraciones; Valencia, Spain; January 2002. “Elpunto de vista de la ciencia”

• XI Reunión Científica, Sociedad Vasca de Ginecología y Obstetricia (SVGO). Vitoria,Spain; December 2002. “Investigación en células madre embrionarias, importanciaen Biomedicina”

2001

• VII Ginevideo. Certamen Nacional De Vídeo En Obstetricia Y Ginecología; Lugo,Spain; September 2001. “Agonistas y antagonistas en reproducción humana”

• Últimas novedades en el tratamiento de la infertilidad; Madrid, Spain; November2001. “Diagnóstico preimplantatorio”

2000

• XXIII Congreso Nacional de la Sociedad Española de Fertilidad; Seville, Spain; May2000. “Influencia de las anomalías cromosómicas en el desarrollo preimplantatoriode embriones humanos”, “Control de la Implantación: Posibilidades”

• Jornadas sobre infertilidad; Valencia, Spain; November 2000. “Últimos avancesclínicos en la mejora de la implantación embrionaria”

1999

• Medicina molecular: genética molecular, inflamación e infertilidad. I Jornada LXXVAniversario; Madrid, Spain; March 1999. “Aspectos básicos y clínicos de laimplantación del embrión humano”

• II Jornadas Sobre Reproducción Asistida; Córdoba, Spain; May 1999.“Conocimiento actual del proceso de implantación”

•••• XXV Congreso Nacional de Ginecología; Zaragoza, Spain; June 1999. “Nuevosconceptos de la implantación”

• II Congreso ibérico de Reproducción animal; Lugo, Spain; July 1999. “Inseminaciónintracitoplásmica, ICSI”

• Jornadas sobre infertilidad 1999; Madrid, Spain; October 1999. “Nuevasindicaciones y actualizaciones”

1998

• Symposium sobre reproducción humana; Elche, Alicante, Spain; November 1998.“Implantación embrionaria”

1997

• Reunión de la Sección de Reproducción de la Sociedad de Obstetricia yGinecología de la Comunidad Valenciana; Alicante, Spain; January 1997. “Aborto deRepetición. Implantación Embrionaria” .

• Curso sobre Inseminación Artificial y Fertilización in Vitro; Madrid, Spain; March1997. “Factores Pronósticos de la Implantación”

• XX Aniversario del Hospital Ramon y Cajal; Madrid, Spain; October 1997.“Cocultivos: Evaluación de criterios de actuación”

• Jornada sobre infertilidad en la pareja. Universidad Internacional Menéndez Pelayo;

87

Valencia, Spain; October 1997. “Cocultivo embrionario”1996

• XXI Congreso Nacional de la Sociedad Española de Fertilidad. Tenerife, Spain; June1996. “Fisiología de la implantación”

1995

• III Simposio sobre reproducción humana, Temas actuales en reproducción asistida.Hospital Ramón y Cajal; Madrid, Spain; January 1995. “Ventana de implantación”

1994

• XX Congreso Nacional de la Sociedad Española de Fertilidad; Valencia, Spain; May1994. “Implantación”.

• I Reunión de la Sección de Reproducción de la Sociedad de Obstetricia y Ginecología de laComunidad Valenciana; Valencia, Spain; October 1994. “Uso de las gonadotrofinas en laestimulación ovárica”

88

Undergraduate &Postgraduate Teaching, Past & Present Students

Scientific Fellows. PhDs

2016 – present David Bolumar, ‘Study and characterization of different secreted vesicles from the endometrium to endometrial fluid’.

2016 – present Iolanda García, ‘Analysis of endometrial microbiome and its relation with endometrial receptivity in infertile patients’.

2016 – present Laura Rubert, ‘Deficit of annexin-2 as maternal cause of severe and early preeclampsia and possible predictor’.

2015 – present Stefania Salsano, ‘Expression, localization and functional study of protein PGRMC1 (Progesterone Receptor Membrane Component 1) in human endometrium’

2015 – present Silvia Pérez, ‘Endometrial proteomic in implantation failure’.

2015 – present Hannes Campo, ‘Advanced theraphies and biotechnology innovation in reproductive health’.

2015 – present Nuria López, ‘Specific markers in somatic endometrial stem cells’.

2014 – 2017 Jose Manuel Míguez, ‘Direct reprograming from somatic to human germ cells’

2014 – present Nuria Balaguer, ‘Determination of the differential expression of miRNAs inendometrial fluid as the presence of obesity and type 2 diabetes in women’.

2014 – present Alessia Grasso, ‘Analysis of specific miRNAs in human endometrial fluid for use as a non-invasive diagnosis of endometrial receptivity’.

2012 – 2016 Gemma Castillón, ‘Prospective and randomized study about the utility of HCG Array in embryonic aneuploidies in servere male factor’. Co-supervisor with Dr. Carmen Rubio and Inmaculada Sánchez.

2012 – 2016 Sevkiye Tudge Pehlivan Budak, ‘New therapeutic possibilities in implantation failure’. Co-supervisor with Dr. Carmen Rubio.

2011 – 2015 Pablo Padilla, ‘Decidualization pattern in women with preeclampsia applying Proteomics and Transcriptomic methods’. Co-supervisor with Dr. Alfredo Perales

2010 – 2014 Ana Martínez-Arroyo, ‘Direct reprogramming for Adult Somatic Cells to Meiotic

Germinal Cells’. Co-supervisor with Dr. Jose Vicente Medrano.

2010 – 2014 Juan Manuel Moreno Moya, ‘miRNAs analysis in endometrial fluid as non-invasive method of endometrial receptivity’. Co-supervisor with Dr. Felipe Vilella.

2010 – 2014 Leslie Ramírez Lima, ‘A non-invasive diagnosis method of human endometrial receptivity status based on a specific lipidomic profiling in the endometrial fluid’. Co-supervisor with Dr. Felipe Vilella. European PhD.

2010 – 2014 Lorena Rodrigo Vivó, ‘Value of sperm chromosome studies using the technique of fluorescent in situ hybridization (FISH) in infertile couples’. Co-supervisor with Dr. Manuel Gil-Salom and Dr. Carmen Rubio

2009 – 2013 Claudia Gil Sanchis, ‘Identification, characterization and isolation of somatic stem cells in the human endometrium’. Co-supervisor with Dr. Irene Cervelló. European PhD.

2009 – 2013 Inmaculada Sánchez Ribas, ‘Metabolomic profiling of human pre-embryos as potential marker for noninvasive aneuploidy’. Co-supervisor with Dr. Francisco Domínguez. Co-supervisor with Dr. Francisco Domínguez and Dr. Agustín Ballesteros.

2008 – 2013 Marcia Riboldi, ‘ Isolation, culture, characterization and maturation of undifferentiated cells from human testicular biopsies’.

2009 – 2012 Isabel Herrer Mambrona, ‘Epigenetic mechanisms in endometrial stromal

89

cells during the process of decidualization” Co-supervisor with Dr. CarlosEstella

2009 – 2012 Manuel Fernández Sánchez, ‘Endometrial study of a novel in vivo embryoculture’. European PhD. Co-supervisor with Dr. Antonio Pellicer and Dr. José Antonio Horcajadas.

2008 – 2012 Aymara Más Perucho, ‘Identification, characterization and isolation of somatic stem cells in humans myomas’. Co-supervisor with Dr. Irene Cervelló

2008 – 2012 Tamara Gómez Garrido, ‘Proteomic study of the human endometrium’. Co-supervisor with Dr. Francisco Domínguez.

2008 – 2012 Jose Vicente Medrano Plaza. ‘Meiotic induction in vitro derived germ cellsobtained from human pluripotent stem cells by ectopic expression of the RNA binding proteins DAZL and VASA’.

2007 – 2011 Patricia Díaz Gimeno, ‘Developing a molecular diagnostic tool for the endometrial receptivity’. Co-supervisor with Dr. Jose Antonio Horcajadas.

2004 – 2008 Irene Cervello Alcaraz, ‘Identification, characterization and isolation of somatic stem cells of the murine and human endometrium’

2003 – 2006 Ana Cristina Cerveró Sanz. ‘The leptin system in the maternal-embryonic interface: impact in the implantation’

2001 – 2005 Mª Carmen Escobedo Lucea, ‘First derivation in Spain of two lines of human embryonic stem cells with therapeutic grade, VAL-1 and VAL-2’. Co-supervisor with Dr. Antonio Pellicer

2001 – 2005 Julia Desco Blay, ‘Contribution of preimplantation genetic diagnosis to the origin of early pregnancy loss’. Co-supervisor with Dr. Antonio Pellicer

2001 – 2004 Raúl Gómez Gallego, ‘Blocking VEGFR-2 as a key mechanism for the inhibition of vascular permeability in Ovarian Hyperstimulation Syndrome’. Co-supervisor with Dr. Antonio Pellicer

2001 – 2004 Carmen Rubio Lluesa, ‘Study of the Chromosomal abnormalities in embryos and sperm in couples with recurrent miscarriage and unexplained causes’. Co-supervisor with Dr. Francesca Vidal

2001 – 2004 Amparo Mercader Bayarri. ‘Embryo coculture with human endometrial epithelial cells as a technique for implantation failure’. Co-supervisor withDr. Antonio Pellicer

2000 – 2003 Diana Valbuena Perilla.’ Effects of high serum estradiol levels on embryo implantation in patients undergoing in vitro fertilization’. Co-supervisor with Dr. José Remohí.

2000 – 2003 Francisco Domínguez Hernández. ‘Implication of IL-8, MCP^-1, RANTES,chemokines, CXR1, CXCR4, CCR2, CCR5 receptors and IGFBP-rP1 factor in the maternal-embryonic interface’. Co-supervisor with Dr. Antonio Pellicer

1999 – 2003 Arancha Galán Rivas, ‘Embryonic regulation of the apoptosis in the human endometrial epithelium’. Co-supervisor with Dr. Antonio Pellicer

1999 – 2002 Manuel Rodríguez González, ‘Predictive mathematical method of the gestational and implantation rate in an IVF particular cycle, depending on the age of the patient, number of previous attempts, embryo quality and number of previous attempts, embryo quality and number of embryos transferred’. Dr. José Remohí and Dr. Amparo Ruiz

1999 – 2001 Marcos Meseguer Escrivá, ‘Hormonal and embryonic regulation of humanmucin MUC1 in endometrial epithelium’. European PhD.

1998 – 2001 Nicolas Garrido Puchalt, ‘Alterations in folliculogenesis as cause of the low oocyte quality in patients with endometriosis; In vivo and in vitro studies of the granulosa cells and follicular leukocytes’. Co-supervisor

90

with Dr. Antonio Pellicer

1998 – 2001 Carmela Albert Rodríguez, ‘Pathophysiology of ovarian hyperstimulation syndrome: implicaton of the endothelium’. Co-supervisor with Dr. AntonioPellicer.

1997 – 2000 Pedro Caballero Campo, ‘Hormonal and embryonic regulation in human endometrial chemokines: Interleukin-8 (IL-8), Quimiotrayente Monocyte Protein-1 (MCP-1) and Regulated upon Activation, Normal T Expressed and Secreted (RANTES)’. Co-supervisor with Dr. Antonio Pellicer

1996 – 1999 Mª José Gimeno Almela, ’Embryonic regulation of the integrins in the human endometrial epithelium’. Co-supervisor with Dr. Julio Coloma.

1991 – 1995 Mª José de los Santos Molina, ‘Immunohistochemical localization and regulatory endometrial factors of the interleukin-1 secretion during preimplantation development of the human embryo’. Co-supervisor with Dr. Antonio Pellicer.

Clinical Fellows. MDs

2015 – Present Dra. Nora Katzorke (Germany)

2013 – Present Dr. Sergio Cabanillas (Argentina).

2013 – Present Dr. Albeiro Muñoz (Colombia).

2013 – Present Dr. Miguel Ramírez (Mexico).

2012 – Present Dr. Gilberto Ibérico (Lima).

2012 – Present Dr. Bruno Araujo (Brazil).

2012 – Present Dr. Alejandro Rivas (Peru).

2011 – 2013 Dra. Adriana Landazábal (Colombia).

2011 – 2013 Dr. Felipe Camargo (Colombia).

2011 – 2013 Dra. Gabriela Villaquiran (Colombia).

2010 – 2012 Dr. Juan Vargas (Chile).

2010 – 2012 Dr. Marcos Cuneo (Mexico).

2010 – 2012 Dr. Fernando Gonzalez (Guatemala).

2009 – 2011 Dra. Cinzia Caligara (Italy).

2009 – 2011 Dr. Antonio Romero (Mexico).

2009 – 2011 Dr. Claudio Álvarez (Chile).

2008 – 2010 Dr. Ismael Gutierrez (Peru).

2008 – 2010 Dra. Isabel Isaza (Colombia).

2008 – 2010 Dr. Rafael Freire (Venezuela).

2007 – 2009 Dr. Bruno Sheffer (Brazil).

2007 – 2009 Dr. Roberto Friche (Brazil).

2007 – 2009 Dr. Cristiano Busso (Brazil).

2006 – 2008 Dr. Ernesto Escudero (Peru).

2006 – 2008 Dra. Mercedes Molina (Lima).

2006 – 2008 Dr. Alberto Guanes (Paraguay).

2005 – 2007 Dr. Norberto Rossal (Guatemala).

2005 – 2007 Dr. Elkin Muñoz (Colombia).

2005 – 2007 Dr. Alberto Levy (Venezuela).

2004 – 2006 Dra. Camila Sagástegui (Peru).

2004 – 2006 Dr. Carlos Gaytán (Mexico).

2004 – 2006 Dra. Elsa Yalil (Paraguay).

91

2003 – 2005 Dra. Eugenia Maquera (Argentina).

2003 – 2005 Dr. Alonso Martín (Mexico).

2002 – 2004 Dr. Carlos Troncoso (Chile).

2002 – 2004 Dra. Claudia Barrientos (Peru).

2002 – 2004 Dr. Juan José Gallardo (Mexico).

2001 – 2003 Dr. Ismael Garza (Mexico).

2001 – 2003 Dr. Gustavo Meléndez (Guatemala).

2000 – 2002 Dr. Carlos Zúñiga (Colombia).

2000 – 2002 Dr. Pablo Tabeo (Venezuela).

1999 – 2001 Dr. Juan Ruiz (Spain).

1999 – 2001 Dr. John Anyakora (USA).

1998 – 2000 Dra. Juana Fernández (Uruguay).

1998 – 2000 Dr. Antonio Díaz (Mexico).

1997 – 1999 Dra. Diana Valbuena (Colombia).

1997 – 1999 Dr. Roberto Epifanio (Panama).

1996 – 1998 Dr. Juan Manuel Moreno (Panama).

1996 – 1998 Dr. Ignacio Paredes (Venezuela).

1996 – 1998 Dr. Juan Felipe Valdes (Mexico).

1995 – 1997 Dr. Julián Villalobos (Venezuela).

1995 – 1997 Dr. Claudio Scheffer (Brazil).

1995 – 1997 Dra. Daniela Gerulewicz (Venezuela).

1994 – 1996 Dr. Juan Carlos Cano (Colombia).

1994 – 1996 Dra. Clara Isabel Gaytan (Colombia).

1994 – 1996 Dr. Felipe Gutierrez (Mexico).

Conference Organization

2016 Meeting Organizer, 3rd Biomarker meeting in Reproductive Medicine:Personalized Reproductive Medicine. April 7 – 9. Valencia, Spain.

2014 Meeting Chairperson Organizer, 2nd Biomarker meeting in ReproductiveMedicine: Personalized Reproductive Medicine. March 19 – 22. Valencia,Spain.

2013 Scientific Organiser, The Top ten in reproductive medicine: debatingbreathrough basic and clinical papers with their authors. Serono SymposiaInternational Foundation. September 20 – 21. Florence, Italy.

2012 Meeting Chairperson Organizer, 1st Biomarker meeting in ReproductiveMedicine: Emergence of a New Field. March 30 – 31. 2012. Valencia,Spain.

2007 Chairman, 2nd Summit of the Society for Gynecologic Investigation onReproductive Medicine. November 8-10, 2007. Valencia, Spain.

2006 Scientific Organiser, Therapeutic Potencial of Stem Cells in ReproductiveMedicine. Serono Symposia International Foundation. March 31 – April 1,2006. Valencia, Spain.

2005 Organizer, International Symposium on Reproductive Medicine. CátedraSantiago Grisolía. October 27 – 28, 2005. Valencia, Spain.

2003 Secretary of the Local Organising Committee, 19th Annual Meeting, European Society of Human Reproduction and Embrylogy (ESHRE). June29 – July 2. Madrid, Spain.

2003 Scientific Organiser, III Human Implantation Workshop. Serono Foundation.June 28, 2003. Madrid, Spain.

2001 Scientific Organiser, II International Workshop on Human Implantation. May4-5, 2001. Madrid, Spain.

2000 Scientific Advisory Committee, Reproductive competence: Pathophysiologyand Therapeutic Interventions. November 28-30, 2000. Santiago de Chile,Chile.

92

1999 Scientific Organiser, I International Workshop on Human Implantation:Recent Advances & Clinical Aspects. Ares Serono Foundation. March 22-23, 1999. Valencia, Spain.

1998 Organiser, Ovarian Hyperstimulation Syndrome (OHSS), European Societyof Human Reproduction and Embrylogy (ESHRE) Campus 98. December4-5, 1998. Valencia, Spain.

1998 Organiser, State of the ART of Human Implantation, Basic and ClinicalAspects, International Symposium on Reproductive Medicine, Co-Sponsored by ASRM – ESHRE – IVI. May 18-19, 1998. Madrid, Spain.

1996 Scientific Organiser, El Mundo en el Siglo XXI: Crear la vida. Universidadde Valencia. February-May, 1996. Valencia, Spain.

1995 Scientific Organiser, V international Symposium of the IVI, Newtechnologies applied to research in reproduction and ESHRE Symposiumon Reproductive Medicine “Maternal-Embryo Interactions. March 9-11,1995. Valencia (Spain).

93

Conference presentations & abstracts

Internationals2017• Nuria Balaguer, Inmaculada Moreno, María Herrero, Marta González-Montfort,

Carlos Simón, Felipe Vilella. Maternal MiR-30d Deficiency Is Associated withDefects in Endometrial Receptivity, Embryonic Implantation and Fetal Development.63rd Annual Meeting of the Society for Reproductive Investigation. March 2017;Orlando, FL, USA. Oral Presentation.

• Stefania Salsano, Alicia Quiñonero, Silvia Pérez, Carlos Simón, FranciscoDomínguez. Non-Classical Progesterone Receptor (PGRMC1) and SERPINE1mRNA Binding Protein (SERBP1) Interaction Influences the Human DecidualizationProcess. 63rd Annual Meeting of the Society for Reproductive Investigation. March2017; Orlando, FL, USA. Oral Presentation.

• Inmaculada Moreno, Iolanda Garcia-Grau, Angela Silva, Felipe Vilella, DianaValbuena, Daniel Ramon, Carlos Simon. In Vitro Model of Bacterial Colonization forthe Study of the Effect of the Endometrial Microbiota on the Reproductive Function.63rd Annual Meeting of the Society for Reproductive Investigation. March 2017;Orlando, FL, USA. Oral Presentation.

• Tamara Garrido-Gomez, Francisco Dominguez, Alicia Quiñonero, Patricia Diaz-Gimeno, Mirhan Kapidzic, Matthew Gormley, Katherine Ona, Pablo Padilla, OlgaGenbacev, Alfredo Perales, Susan J Fisher, Carlos Simon. Severe Preeclampsia IsAssociated with Resistance to Decidualization. 63rd Annual Meeting of the Societyfor Reproductive Investigation. March 2017; Orlando, FL, USA. Oral Presentation.

• Patricia Sebastian-Leon, Ana Conesa, Vicente Arnau, Jose Remohí, AntonioPellicer, Carlos Simon, Patricia Diaz-Gimeno. Network Biology of Menstrual Cycle toUnderstand the Key Drivers of Endometrial Receptivity. 63rd Annual Meeting of theSociety for Reproductive Investigation. March 2017; Orlando, FL, USA. PosterPresentation.

• Patricia Diaz-Gimeno, María Ruiz-Alonso, Patricia Sebastián-León, Vineeta Singh,Antonio Pellicer, Diana Valbuena, Carlos Simón. Improvement of the EndometrialReceptivity Signature Reveals a Possible Maternal Origin of BiochemicalPregnancies. 63rd Annual Meeting of the Society for Reproductive Investigation.March 2017; Orlando, FL, USA. Poster Presentation.

• Meera S Shah, Felipe Vilella, Barry Behr, Vikrant Reddy, Wanxin Wang, RoserrNavarro, Jorge Jimenez, Steven Quake, Carlos Simon. Maternal Endometrial hsa-miR-30d Is Taken Up by the Human Blastocyst and Induces TranscriptionalModifications. 63rd Annual Meeting of the Society for Reproductive Investigation.March 2017; Orlando, FL, USA. Poster Presentation.

• David Bolumar, Inmaculada Moreno, María Herrero, Sergio Cabanillas, FelipeVilella, Carlos Simon. Extracellular Vesicles Secreted by the Human EndometriumContain Specific DNA Sequences That Are Uptaken by Murine Embryos. 63rdAnnual Meeting of the Society for Reproductive Investigation. March 2017; Orlando,FL, USA. Poster Presentation.

• Nuria López-Pérez, Claudia Gil-Sanchis, Amparo Faus, Ana Díaz, Hannes Campo,Antonio Pellicer, Irene Cervelló, Carlos Simón. Human Endometrial ReconstitutionUsing W5C5+, ICAM1+ Cells andSide Population Cell Lines in a Xenograft Model.63rd Annual Meeting of the Society for Reproductive Investigation. March 2017;Orlando, FL, USA. Poster Presentation.

• Rajni Khajuria, Lorena Rodrigo, Diana Valbuena, Carmen Rubio, Carlos Simon.Incidence of chromosomal aneuploidies at embryonic level with comparison basedon type of biopsy and maternal age: First Indian experience. 16th InternationalSymposium on Preimplantation Genetics organized by the Preimplantation GeneticDiagnosis International Society. March 2017; Valencia, Spain. Poster Presentation.

• Mateu, Emilia; Rodrigo, Lorena; Peinado, Vanesa; Milán, Miguel; Campos,Inmaculada; García-Herrero, Sandra; Mercader, Amparo; Bronet, Fernando;Larreategui, Zaloa; Florensa, Mireia; Remohí, José; Pellicer, Antonio; Simón, Carlos;Rubio, Carmen. Preimplantation Genetic Diagnosis for translocations andinterchromosomal effect assessed by array CGH. 16th International Symposium on

94

Preimplantation Genetics organized by the Preimplantation Genetic DiagnosisInternational Society. March 2017; Valencia, Spain. Poster Presentation.

• Bruno Coprerski, Mariane Souza, Carmen Rubio, Carlos Simon, Marcia Riboldi.Does the change of technology from ACGH to NGS impact aneuploidy rates? 16thInternational Symposium on Preimplantation Genetics organized by thePreimplantation Genetic Diagnosis International Society. March 2017; Valencia,Spain. Poster Presentation.

• S. Garcia_Herrero, J. Ferro, I. Campos-Galindo, E. Mateu, M. Milán, V. Peinado, L.Rodrigo, C. Rubio, C. Simón. Feto-Placental discrepancies in the analysis ofproducts of conception in clinical miscarriages reveals that mosaicism is notrestricted to trophoblast cells. 33nd Annual Meeting of European Society for HumanReproduction and Embryology. July 2017; Geneva, Switzerland. Oral Presentation.

• M. Vera-Rodriguez, A. Diez-Juan, S. Martinez, V. Peinado, A. Mercader, I. Moreno,D. Valbuena, D. Blesa, C. Simon, C. Rubio. Non-Invasive PGS reveals the existenceof complementary aneuploidy between DNA obtained from trophectoderm biopsyversus DNA in spent culture medium in the same embryo. 33nd Annual Meeting ofEuropean Society for Human Reproduction and Embryology. July 2017; Geneva,Switzerland. Oral Presentation.

• I. Garcia-Grau, E. Cicinelli, M. Gonzalez-Monfort, F. Vilella, D. Valbuena, C. Simon,I. Moreno. Sensibility and specificity of the molecular vs classical diagnosis ofchronic endometritis. 33nd Annual Meeting of European Society for HumanReproduction and Embryology. July 2017; Geneva, Switzerland. PosterPresentation.

• Alessia Grasso, Roser Navarro, Inmaculada Moreno, María Herrero, Pilar Alama,Felipe Vilella, Carlos Simón. Differential microRNA profile in the endometrial fluid(EF) in natural cycles, HRT, and controlled ovarian stimulation (COS) triggered withhCG (COS+hCG) or GnRHa (COS+GnRHa). 33nd Annual Meeting of EuropeanSociety for Human Reproduction and Embryology. July 2017; Geneva, Switzerland.Poster Presentation.

• J. Miravet, M. Ruiz-Alonso, S. Taguchi, M. Clemente, M. Funabiki, E. Gomez, C.Marin, Y. Nakamura, C. Simon. Endometrial injury does not affect the endometrialtranscriptomic profile during the window of implantation. 33nd Annual Meeting ofEuropean Society for Human Reproduction and Embryology. July 2017; Geneva,Switzerland. Poster Presentation.

• K. Krjutškov , A. Reddy , M. Saare , S. Katayama , L. Kumar , K. GemzellDanielsson , F. Lanner , E. Einarsdottir , D. Blesa , C. Simon , J. Kere , A. Salumets ,S. Altmäe. Interactome between embryo trophectoderm cells and endometrialepithelial and stromal cells: novel insights into implantation process in human. 33ndAnnual Meeting of European Society for Human Reproduction and Embryology. July2017; Geneva, Switzerland. Poster Presentation.

• M. Suhorutshenko , V. Kukushkina , A. Velthut-Meikas , R. Mägi , M. Peters , S.Altmäe , K. Krjutškov , J. Martinez-Blanch , F. Codoñer , F. Vilella , C. Simon , A.Salumets . Novel endometrial receptivity markers detected in large-scale RNA-sequencing study combining samples from different populations. 33nd AnnualMeeting of European Society for Human Reproduction and Embryology. July 2017;Geneva, Switzerland. Poster Presentation.

• A. Liñán Tegedor, A. Bayram, A. Arnanz, C. Rubio, R. Chopra, I. Elkhatib, C.Simón, H. Fatemi. Concordance rates between single blastomere day-3 (D3) andtrophectoderm biopsies (D5) using Next Generation Sequencing (NGS). 33ndAnnual Meeting of European Society for Human Reproduction and Embryology. July2017; Geneva, Switzerland. Poster Presentation.

• S. Herraiz, M. Romeu, S. Martínez, P. Solves, I. Gómez, J. Martínez, A. Buigues, D.Galliano, C. Simón, C. Díaz-García, A. Pellicer. Two live birth after Stem cell ovarianauto-transplantation in Poor Responder women. 33nd Annual Meeting of EuropeanSociety for Human Reproduction and Embryology. July 2017; Geneva, Switzerland.Oral Presentation.

2016

95

• Rodrigues FP, Bonetti TC, Carvalho CV, Vigo F, Fraietta R, Vilella F, Simon C, MottaE. miRNA expression in receptive versus post-receptive endometrium in patientsundergoing IVF. 72nd Scientific Congress of the American Society for ReproductiveMedicine (ASRM) October 2016; Salt Lake City, Utah, USA. Poster Presentation.

• Medrano JV, Miguez JM, Moreno I, Simon C. Special research presentation: directconversion of human somatic cells to induced germ-like cells by geneticreprogramming. 72nd Scientific Congress of the American Society for ReproductiveMedicine (ASRM) October 2016; Salt Lake City, Utah, USA. Oral Presentation.

•••• Simon C, Vladimirov IK, Castillon Cortes G, Ortega I, Cabanillas S, Vidal C, Giles J,Izquierdo A, Portela S, Fernandez I, Ferrando M, Mackens S, Barrera A, Pellicer A.Prospective, randomized study of the endometrial receptivity analysis (ERA) test inthe infertility work-up to guide personalized embryo transfer versus fresh trasnfer ordeferred embryo transfer. 72nd Scientific Congress of the American Society forReproductive Medicine (ASRM) October 2016; Salt Lake City, Utah, USA. OralPresentation. SREI PRIZE PAPER

• Rubio C, Campos-Galindo I, Rivera Egea R, Garrido N, Simón C, Domínguez F.Effect of environmental endocrine disruptor’s exposure on sperm quality andaneuploidy rates in fertile sperm donors. 72nd Scientific Congress of the AmericanSociety for Reproductive Medicine (ASRM) October 2016; Salt Lake City, Utah,USA. Oral Presentation.

• Bolumar D, Moreno I, Cabanillas S, Simon C, Vilella F. Isolation and identification ofextracellular vesicles in the human endometrial fluid. 72nd Scientific Congress of theAmerican Society for Reproductive Medicine (ASRM) October 2016; Salt Lake City,Utah, USA. Oral Presentation.

• Dominguez F, Campos-Galindo I, Alama P, Romero JL Simon C, Rubio C. Impact ofenvironmental endocrine disruptor’s expsure in controlled ovarian stimulationoutcome in egg donors. 32nd Annual Meeting of European Society for HumanReproduction and Embryology (ESHRE). July 2016; Helsinki, Finland. OralPresentation.

• Valbuena-Perilla D, Ruiz-Alonso M, Marin C, Soria J, Simon C, Garcia-Velasco JA.Endometrial thickness does not predict endometrial receptivity. 32nd Annual Meetingof European Society for Human Reproduction and Embryology (ESHRE). July 2016;Helsinki, Finland. Poster Presentation.

• Cerillo-Martinez M, Ruiz M, Bermejo A, Blesa D, Mayoral M, Garcia-Velasco JA,Simon C. The window of endometrial receptivity might be displaced under differentprotocols for endometrial preparation. 32nd Annual Meeting of European Society forHuman Reproduction and Embryology (ESHRE). July 2016; Helsinki, Finland.Poster Presentation.

• Altmäe S, Võsa U, Suhorutsenko M, Aghajanova L, Adler P, Giudice L, Simon C,Salumets. Meta-analysis of endometrial receptivity-associated genes. 32nd AnnualMeeting of European Society for Human Reproduction and Embryology (ESHRE).July 2016; Helsinki, Finland. Poster Presentation.

• Simon B, Moreno I, Bolumar D, Vilella F, Simón C. Trophoectoderm Cells ofEmbryos Secrete Extracellular Vesicles to the Conditioned Media. 63rd AnnualScientific Meeting of the Society for Reproductive Investigation (SRI). March 2016;Montreal, Canada. Oral Presentation. Pfizer-SRI President's Presenter's Award

• Balaguer N, Moreno I, Herrero M, Simón C, Vilella F. Maternal Endometrial hsa-miR-30d Is Internalized and Secreted in Exosomes by Binding with hnRNPC1. 63rdAnnual Scientific Meeting of the Society for Reproductive Investigation (SRI). March2016; Montreal, Canada. Oral Presentation. Pfizer-SRI President's Presenter'sAward

• Perez-Deben S, Bellver J, Alama P, Salsano S, Quiñonero A, Simón C, Domínguez F. iTraq Proteomic Comparative Analysis of Endometrium from Fertile Donors, IUD Carriers and Patients with Recurrent Implantation Failure (RIF) Reveals No Differential Proteomic Profile in RIF versus Fertile Donors. 63rd Annual Scientific Meeting of the Society for Reproductive Investigation (SRI). March 2016; Montreal,

96

Canada. Poster Presentation.• Campo H, Baptista P, Lopez-Perez Nuria, Faus A, Cervelló I, Simón C. De- and

Recellularization of the Pig Uterus: A Pilot Study in Uterus Bioengineering. 63rd Annual Scientific Meeting of the Society for Reproductive Investigation (SRI). March 2016; Montreal, Canada. Poster Presentation.

• Mas A, Prusinski L, Yang Q, Elam L, Diamond MP, Simón C, Al-Hendy A. Role of Stro1(+)/CD44(+) Myometrial Stem Cells in Pregnancy-Induced Uterine Remodeling.63rd Annual Scientific Meeting of the Society for Reproductive Investigation (SRI). March 2016; Montreal, Canada. Poster Presentation.

• García-Herrero S, Campos-Galindo I, Mateu I, Milán M, Peinado V, Ferro J, RodrigoL, Simón C, Rubio C. Molecular analysis of fetoplacental discrepancies in Productsof Conception (POCS) obtained by hysteroembryoscopy. Third Annual Advances inPrenatal Molecular Diagnostics. Trends, Advances & Prospects. April 2016; Lisbon.Poster Presentation.

2015• Milan M, Mateu E, López P, Blesa D, Diez A, Rubio C, Simón C. Non-invasive

prenatal testing using massively parallel sequencing. First experience in Spain. ThirdAnnual Advances in Prenatal Molecular Diagnostics. November 2015; Boston, USA.Poster Presentation.

• Milan M, Rodrigo L, Peinado V, Campos I, García S, Vera M, Simón C, Rubio C.Preimplantation genetic screening on the stage at which biopsies are performed.Reproductive Geentic Diagnostics. November 2015; Boston, USA. PosterPresentation.

• Mas A, Elam L, Wlaker C, Simón C, Diamond MP, Thompson W, Al-Hendy A. Earlylife exposure to estrogen-mimics increase the occurrence of uterine fibroids viaexpansion of myometrial stem cell population. 71st Annual Meeting of the AmericanSociety for Reproductive Medicine. October 2015; Baltimore, MD, USA. OralPresentation.

• Rubio C, Rodrigo L, Bellver J, Castillon G, Guillen A, Vidal C, Giles J, Simón C.Improved clinical outcome in women between 38 and 41 years of age by 24-chromosome aneuploidy screening. 71st Annual Meeting of the American Society forReproductive Medicine. October 2015; Baltimore, MD, USA. Oral Presentation.

• Mas A, Elam L, Diamond MP, Simón C. Synergistic effect of estrogen andprogesterone on myometrial stem cell expansion in vivo. 71st Annual Meeting of theAmerican Society for Reproductive Medicine. October 2015; Baltimore, MD, USA.Oral Presentation.

• Santamaria X, Cabanillas S, Arbona C, Simón C. Autologous cell therapy withCD133+ bone marrow stem cells in refractory Asherman’s Syndrome and edometrialatrophy: a pilot cohort study. 71st Annual Meeting of the American Society forReproductive Medicine. October 2015; Baltimore, MD, USA. Oral Presentation.

• Martin J, Rodriguez-Iglesias B, San A, Yuting Y, Jimenez J, Li Q, Du H, Simón C.Development, validation and clinical use of and expanded pan-ethnic preconceptioncarrier genetic screening test in assited reproductive technology patients anddonors. 71st Annual Meeting of the American Society for Reproductive Medicine.October 2015; Baltimore, MD, USA. Poster Presentation.

• Rubio C, Marin C, Martinez S, Diaz-Gimeno P, Riboldi M, Al-Asmar N, Valbuena D,Simón C. Mitochondrial DNA content as a viability score in human euploid embryos:less is better. 71st Annual Meeting of the American Society for ReproductiveMedicine. October 2015; Baltimore, MD, USA. Poster Presentation.

• Mateu E, Rodrigo L, Peinado V, Milán M, Campos-Galindo I, García-Herrero S,Simón C, Rubio C. Sperm concentration and inter-chromosomal effect in malecarriers of Robertsonian translocations. 1st Meeting on Controversies inpreconception, preimplantation and prenatal genetic diagnosis: How will geneticstechnology drive the future? Controversies in preconception, preimplantation andprenatal genetic diagnosis (CoGEN): How will genetics technology drive the future?.September 2015; Paris, France; Poster Presentation.

• Martinez-Conejero JA, Al-Asmar N, García-Herrero S, Campos-Galindo I, Akinwole A,

97

Cinnioglu C, Simon C, Rubio C. Increasing aneuploidy detection in Products ofConception (POC) by molecular analysis and multisdissection of fetal tissue.Controversies in preconception, preimplantation and prenatal genetic diagnosis(CoGEN): How will genetics technology drive the future?. September 2015; Paris,France; Poster Presentation.

• Navarro-Gaya R, Conesa A, Ruíz-Alonso M, Simón C, Díaz-Gimeno P. Looking forbiological functionality In gene set networks. Smodia 2015, Statistical methods foromics data integration and analysis. September 2015; Valencia, Spain. PosterPresentation.

• Peinado V, Al-Asmar N, Alegre L, Vera M, Rodrigo L, Martínez-Jabaloyas JM, Gil-Salom M, Remohí J, Simón C, Hassold T, Rubio C. Increased risk of spermchromosomal abnormalities and decreased recombination frequency in non-obstructive azoospermic males. 31st Annual Meeting of the European Society forHuman Reproduction and Embryology. June 2015; Lisbon, Portugal. OralPresentation.

• Riboldi M, Poo ME, Coprerski B, Santos M, Bandeira CL, Al-Asmar Piñar N, RodrigoL, Simón C, Rubio C. Decrease to complex aneuploidies during embryodevelopment from day-3 to blastocyst stage. 31st Annual Meeting of the EuropeanSociety for Human Reproduction and Embryology. June 2015; Lisbon, Portugal.Poster Presentation.

• Rubio C, Rodrigo L, Florensa M, Mateu E, Mercader A, Peinado V, Bronet F, MilanM, Garcia-Herrero S, Campos-Galindo I, Simón C. Differences in chromosomalabnormalities observed in preimplantation embryos according to male or femalemeiosis disruption in isolated male factor (MF) and advanced maternal age (AMA).31st Annual Meeting of the European Society for Human Reproduction andEmbryology. June 2015; Lisbon, Portugal. Poster Presentation.

• Mir Pardo P, Mateu E, Mercader A, Herer R, Rodrigo L, Vera M, Peinado V, Milán-Sánchez M, Campos-Galindo I, García-Herrero S, Simón C, Rubio C. Are falsepositive rates comparable at day-3 blastomere versus day-5 trophectoderm biopsiesusing array cgh for preimplantation genetic screening?. 31st Annual Meeting of theEuropean Society for Human Reproduction and Embryology. June 2015; Lisbon,Portugal. Poster Presentation.

• Meseguer M, Dominguez F, Tejera A, Quiñonero A, Aparicio-Ruiz B, Simón C. A newstrategy to diagnose embryo viability combining protearray and time-lapsetechnologies. 31st Annual Meeting of the European Society for Human Reproductionand Embryology. June 2015; Lisbon, Portugal. Poster Presentation.

• Rodrigo L, Mateu E, Peinado V, Milán M, García-Herrero S, Campos-Galindo I, VeraM, Mercader A, Bronet F, Simón C, Rubio C. Why preimplantation geneticScreening (PGS) improves clinical outcome in couples with low sperm counts?Impact of spermaneuploidy. 14th International Conference of Preimplantation GeneticDiagnosis, A Quarter Century of PGD. May 2015; Chicago, Illinois, USA. OralPresentation.

• Cervero A, Martínez-Conejero JA, Mir P, Rodrigo L, Rubio C, Al Asmar N, Kayali R,Cinnioglu C Simón C, Martín J. Clinical outcome of preimplantation geneticdiagnosis for single-gene disorders could be improved with simultaneouscomprehensive chromosome screening. 14th International Conference ofPreimplantation Genetic Diagnosis, A Quarter Century of PGD. May 2015; Chicago,Illinois, USA. Oral Presentation.

• Altmäe S, Tamm-Rosenstein K, Esteban FJ, Martinez-Conejero JA, Simm J, Ruiz-Alonso M, Metsis M, Simón C, Horcajadas JA, Salumets A, Stavreus-Evers A.Endometrial gene expression analysis in natural cycle vs. hormonally replaced cyclefor frozen embryo transfere in patients with recurrent implantation failulre. April 2015;Alicante, Spain. Poster Presentation.

• García-Herrero S, Campos-Galindo I, Mateu E, Milán M, Peinado V, Rodrigo L,Ferro J, Rubio C, Simón C. Case report of confined placental mosaicism afterpreimplantation genètic screening (PGS) by comparative genòmic hybridizationarrays (aCGH). April 2015; Alicante, Spain. Poster Presentation.

98

• Mas A, Nair S, Laknaur A, Eroglu A, Diamond MP, Simón C, Al-Hendy A.Establishment of stro1/CD44 as new markers for human myometrial/fibroid stemcells. 62nd Annual Meeting of the Society for Reproductive Investigation. March2015; San Francisco, USA. Poster Presentation

• Mas A, Laknaur A, O’Connor PM, Walker CL, Diamond MP, Simón C, Al-Hendy A.Myometrial tumor-forming stem cells in a murine model of uterine fibroids reside inhypoxic niches. 62nd Annual Meeting of the Society for Reproductive Investigation.March 2015; San Francisco, USA. Poster Presentation

• Cervelló I, Santamaria X, Gil-Sanchís C, Faus A, Cabanillas S, Simón C. Humanbone marrow-derived stem cells improve endometrial regeneration in a murineexperimental Asherman’s Syndrome. 62nd Annual Meeting of the Society forReproductive Investigation. March 2015; San Francisco, USA. Poster Presentation.

• Salsano S, Quiñonero A, Garrido T, Simón C, Domínguez F. Progesterone receptormembrane component 1 (PGRMC1) localization in human endometrial stromal cells(hESC) and its impact of decidualization. 62nd Annual Meeting of the Society forReproductive Investigation. March 2015; San Francisco, USA. Poster Presentation.

• Moreno I, Vilella F, Martínez JF, Codoñer FM, Ramón D, Simón C. Impact of theendometrial microbiome on uterine receptivity and pregnancy outcome. 62nd AnnualMeeting of the Society for Reproductive Investigation. March 2015; San Francisco,USA. Poster Presentation.

• Balaguer N, Vilella F, Moreno JM, Herrero M, Simón C. Hsa-miR-30d is transportedby exosomes from human endometrial epithelium to the trophectoderm ofpreimplantation embryos and modulates embryo adhesion. 62nd Annual Meeting ofthe Society for Reproductive Investigation. March 2015; San Francisco, USA. OralPresentation.

2014• García-Herrero S, Mateu E, Milán M, Vera M, Campos-Galindo I, Peinado V,

Rodrigo L, Simón C, Rubio C. Impact of male factor (MF) in the clinical outcome ofrepetitive implantation failure (RIF) patients undergoing comprehensiveChromosome Screening (CCS). Preimplantation Genetic Diagnosis InternationalSociety (PGDIS) Annual Meeting. April-May 2014; Canterbury, UK. OralPresentation.

• Mateu E, Rodrigo L, Al-Asmar N, Cinnioglu C, Peinado V, Milán M, García-HerreroS, Campos-Galindo I, Vera M, Simón C, Rubio C. Inter-chromosomal effect on day-3 embryos and blastocysts from carriers of Robertsonian and reciprocaltranslocations. Preimplantation Genetic Diagnosis International Society (PGDIS)Annual Meeting. April-May 2014; Canterbury, UK. Poster Presentation.

• Rubio C, Bellver J, Castillón G, Guillem A, Vidal C, Giles J, Remohí J, Pellicer A,Simón C. RCT study in advanced maternal age patients using array-CGH: interimanalysis. 30th Annual Meeting of the European Society of Human Reproduction andEmbryology. June-July 2014; Munich, Germany. Oral Presentation.

• Gil-Sanchés, Cervelló I, Khurana S, Faus A, Verfaillie CM, Simón C. Endothelialprogenitors and multipotent Oct4+ cells from bone marrow contributeto endometrialregeneration in an irradiated mice model. 30th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. June-July 2014; Munich,Germany. Oral Presentation.

• Vera M, Michel CE, Mercader A, Kokocinski F, Rodrigo L, Bladon AJ, Mateu E, Al-Asmar N, Blesa D, Simón C, Rubio C. NGS vs. a CGH for the detection ofsegmental aneuploidies in human blastocyst. 30th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. June-July 2014; Munich,Germany. Oral Presentation.

• Mir Pardo P, Banker M, Nahajan N, Chopra R, Khajuria R, Sachdeva K, Rodrigo L,Velasco JA, Simón C, Rubio C. Re-defining the concept of advanced maternal agein Indian patients with implantation failure. 30th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. June-July 2014; Munich,Germany. Poster Presentation.

• Milán Sánchez M, Rodrigo L, Mateu E, Peinado V, García Herrero S, Campos

99

Galindo I, Poo ME, Simón C, Rubio C. What is the minimal number of MII oocytesor day-3 embryos for a successful comprehensive chromosomal screening (CCS)cycle. 30th Annual Meeting of the European Society of Human Reproduction andEmbryology. June-July 2014; Munich, Germany. Poster Presentation.

• Medrano JV, Martínez-Arroyo AM, Simón C. Human meiotic germ-like cells obtainedby direct reprograming colonize the basal layer of mouse seminiferous tubulesfollowing germ cell xeno-transplantation. Gordon Research Conference. Mammalianreproduction. Translating basic science into clinical applications. August 2014; NewLondon, USA. Poster Presentation.

• Vilella F, Moreno M, Balaguer N, Pellicer A, Simón C. MicroRNAs secreted by thehuman endometrium regulates the transcriptome of the preimplantation embryo.Gordon Research Conference. Mammalian reproduction. Translating basic scienceinto clinical applications. August 2014; New London, USA. Poster Presentation.

• Riboldi M, Vera M, Michel CE, Al-Asmar N, Simón C, Rubio C. Validation of NGStechnology for the detection of embryonic segmental aneuploidies. 18th AnnualCongress of the Sociedade Brasileira de Reprodução Assistida. August 2014;Salvador, Brazil. Oral Presentation.

• Riboldi M, Ruiz-Alonso M, Gómez-Sánchez E, Rincón-Bertolín A, Coprerski, SimónC. Role of endometrial receptivity array (ERA) in the orientation of personalizedembryo transfer (pET). 18th Annual Congress of the Sociedade Brasileira deReprodução Assistida. August 2014; Salvador, Brazil. Oral Presentation.

• Riboldi M, Rodrigo L, Rubio C, Al-Asmar N, Coprerski B, Simón C. Impact of severemale factor in genetic screening preimplantation. 18th Annual Congress of theSociedade Brasileira de Reprodução Assistida. August 2014; Salvador, Brazil.Poster Presentation.

• Vera M, Chavez S, Rubio C, Reijo Pera R, Simón C. Prediction model foraneuploidy in early human embryos based on the transcriptomic signature. 70thAmerican Society for Reproductive Medicine Annual Meeting. October 2014;Honolulu, Hawaii, USA. Oral Presentation.

• Rubio C, Castillón G, Rodrigo L, Bellver J, Guillen A, Remohí J, Pellicer A, Simón C.Improvement of clinical outcome in severe male factor infertility with embryoselection based on Array-CGH: a randomized controlled trial. 70th American Societyfor Reproductive Medicine Annual Meeting. October 2014; Honolulu, Hawaii, USA.Oral Presentation.

• Al-Asmar N, Vera M, Michel CE, Cinnioglu C, Blesa D, Simón C, Rubio C. NGSversus CGH for the detection of whole chromosome and segmental aneuploidies inhuman blastocysts. 70th American Society for Reproductive Medicine AnnualMeeting. October 2014; Honolulu, Hawaii, USA. Oral Presentation.

• Ruiz-Alonso M, Díaz-Gimeno P, Gómez E, Rincón-Bertolín A, Vladimirov Y, GarridoN, Simón C. Clinical efficiency of embryo transfer performed in receptive vs non-receptive endometrium diagnosed by the endometrial receptivity array (ERA) test.70th American Society for Reproductive Medicine Annual Meeting. October 2014;Honolulu, Hawaii, USA. Poster Presentation

• Garrido- Gomez T, Domínguez F, Quiñonero A, Padilla P, Perales A, Simón C.Decidualization defect in patients that suffered severe preeclampsia in mediatedthorugh ANXA2 deficiency. 61st Annual Meeting Society for GynecologicInvestigation. March 2014; Florence, Italy. Oral Presentation. SGI President’sPresenter Awards

• Genolet O, Cervello I, Gil-Sanchís C, Más A, Faus A, Moreno JM, Martínez-ConejeroJA, Simón C. Gene expression profile of the Lgr5 cell population in the humanendometrium. 61st Annual Meeting Society for Gynecologic Investigation. March2014; Florence, Italy. Poster Presentation

• Moreno-Moya JM, Vilella F, Pellicer A, Simón C. Proteomic regulation of has.miR-30d over-expression in human endometrial epithelial cells (hEEC). 61st AnnualMeeting Society for Gynecologic Investigation. March 2014; Florence, Italy. PosterPresentation

• Moreno-Moya JM, Díaz-García C, Martínez S, Nuñez MJ, Simón C, Pellicer A,

100

Domínguez F. miRNAs Profiles of the human follicular fluid are differentiallyexpressed according to the maturation stage of the oocyte. 61st Annual MeetingSociety for Gynecologic Investigation. March 2014; Florence, Italy. PosterPresentation

2013• Moreno-Moya JM, Vilella F, Martínez-Escribano S, Pellicer A, Simón C.

Transcriptomic effects of hsa-miR-30d over-expression in human endometrialepithelial cells (hEEC). 60th Annual Meeting, Society for Gynecologic Investigation.March 2013; Orlando, Florida, USA. Oral Presentation

• Domínguez F, Garrido-Gómez T, Quiñonero A, Antunez O, Sánchez Del Pino M,Simón C. Proteomic analysis of receptive versus non-receptive endometrialdiagnosed by the endometrial receptivity array revealed differential protein profiles,highlighting the down-regulation of progesterone receptor membrane component 1(PGRMC1). 60th Annual Meeting, Society for Gynecologic Investigation. March2013; Orlando, Florida, USA. Poster Presentation

•••• Garrido-Gómez T, Domínguez F, Quiñonero A, Simón C. ANXA2 inhibition disruptsendometrial stromal cells (ESCs) decidualization. 60th Annual Meeting, Society forGynecologic Investigation. March 2013; Orlando, Florida, USA. Poster Presentation

•••• Ramírez L, Vilella F, Martínez S, Pellicer A, Simón C. EP2 and FP receptoractivation promote blastocyst adhesiveness to endometrial epithelial cells. 60thAnnual Meeting, Society for Gynecologic Investigation. March 2013; Orlando,Florida, USA. Poster Presentation

•••• García-Pascual CM, Zimmermann RC, Ferrero H, Shawber CJ, Simón C, Pellicer A,Gómez R. Notch pathway promotes and controls uterine decidual angiogenesisduring early pregnancy in mouse. 60th Annual Meeting, Society for GynecologicInvestigation. March 2013; Orlando, Florida, USA. Poster Presentation

• Milán M, Rubio C, Rodrigo L, Mateu E, Peinado V, Campos I, García-Herrero S,Simón C. Age related chromosomal abnormalities in preimplantation embryosassessed by a CGH. 9th European Cytogenetics Conference. June – July 2013;Dublin, Ireland. Poster Presentation

•••• Mir P, Rodrigo L, Mateu E, Peinado V, Milán-Sánchez M, Al-Asmar N, García-Herrero S, Campos-Galindo I, Mercader A, Poo ME, Simón C, Rubio C. Re-analysisof whole day-5 embryos using the same arrayCGH platform used for day-3diagnosis showed a high confirmation rate. 29th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. July 2013; London, UK. OralPresentation

•••• Bermejo A, Iglesias C, Cerillo M, Ruiz M, Blesa D, Simón C, García-Velasco JA.Impact of oral contraceptive pill (OCP) for cycle scheduling on gene expressionrelated to endometrial receptivity. 29th Annual Meeting of the European Society ofHuman Reproduction and Embryology. July 2013; London, UK. Poster Presentation

•••• Rubio C, Rodrigo L, Mateu E, Mercader A, Peinado V, Buendía P, Milán M, DelgadoA, Al-Asmar N, Escrich L, Campos-Galindo I, García-Herrero S, Poo ME, Mir P,Simón C. Array-CGH versus FISH for PGS in recurrent miscarriage couples. 29thAnnual Meeting of the European Society of Human Reproduction and Embryology.July 2013; London, UK. Poster Presentation

•••• Rodrigo L, Rubio C, Mateu E, Peinado V, Milán M, Viloria T, Al-Asmar N, MercaderA, Buendía P, Delgado A, Escrich L, Martínez-Jabaloyas JM, Simón C, Gil-Salóm M.FISH on sperm to identify infertile male patients with higher aneuploidy risk. 29thAnnual Meeting of the European Society of Human Reproduction and Embryology.July 2013; London, UK. Poster Presentation

•••• Ferrero H, Gómez R, García-Pascual CM, Simón C, Pellicer A. Dopamine receptorD2 agonist (D2-ag) post-transcripitonally inhibits VEGF production and secretion bylutein granulose cells through non classical D2 transduction pathways. 29th AnnualMeeting of the European Society of Human Reproduction and Embryology. July2013; London, UK. Poster Presentation

•••• Más A, Cervelló I, Gil-Sanchís C, Fau A, Casado M, Simón C. The truncated form ofHMGA2 in myometrial cells induce leiomyoma formation. 69th American Society for

101

Reproductive Medicine Annual Meeting held Conjoint with International Federation ofFertility Societies. October 2013; Boston, Massachusetts, USA. Oral Presentation

•••• Martínez-Arroyo A, Medrano JV, Quiñonero A, Marqués-Marí AI, Simón C. Directreprogramming of human somatic cells to meiotic germ cells. 69th American Societyfor Reproductive Medicine Annual Meeting held Conjoint with InternationalFederation of Fertility Societies. 69th American Society for Reproductive MedicineAnnual Meeting held Conjoint with International Federation of Fertility Societies.October 2013; Boston, Massachusetts, USA. Oral Presentation

•••• Domínguez F, Lozoya T, Moreno-Moya JM, Martínez S, Simón C, Pellicer A.Differential mIRNA profiles of trophoblast tissue obtained in ectopic pregnancies.69th American Society for Reproductive Medicine Annual Meeting held Conjoint withInternational Federation of Fertility Societies. October 2013; Boston, Massachusetts,USA. Oral Presentation

•••• Mateu E, Rodrigo L, Milán M, Mercader A, Simón C, Rubio C. Chromosomalabnormalities and clinical outcome in patients with advanced maternal age (AMA)using comprehensive chromosome screening (CCS). 69th American Society forReproductive Medicine Annual Meeting held Conjoint with International Federation ofFertility Societies. October 2013; Boston, Massachusetts, USA. Oral Presentation

•••• Vilella F, Moreno-Moya JM, Martínez S, Pellicer A, Simón C. MicroRNAs secretedby the human endometrium regulates the transcriptome of the preimplantationembryo. 69th American Society for Reproductive Medicine Annual Meeting heldConjoint with International Federation of Fertility Societies. October 2013; Boston,Massachusetts, USA. Oral Presentation

•••• Al-Asmar N, Rubio C, Peinado V, Campos-Galindo I, García-Herrero S, Simón C.Impact of the number of previous miscarriages on the clinical outcome of recurrentmiscarriage couples undergoing comprehensive chromosome screening (CCS). 69thAmerican Society for Reproductive Medicine Annual Meeting held Conjoint withInternational Federation of Fertility Societies. October 2013; Boston, Massachusetts,USA. Poster Presentation

•••• Sánchez Ribas I, Domínguez F, Ojeda M, León Z, Ballesteros A, Simón C. Liquidchromatography coupled to mass spectrometry (LC-MS) analysis of embryo spentculture media from human t13, m13 and normal embryos do not reveal differences intheir early lipid metabolism. 69th American Society for Reproductive MedicineAnnual Meeting held Conjoint with International Federation of Fertility Societies.October 2013; Boston, Massachusetts, USA. Poster Presentation

•••• Ramirez LB, Vilella F, Calder PC, Ezcurra D, Macklon N, Simón C. Regulation ofprostaglandins E2 and F2α by CBR1 in the human endometrial fluid. 69th AmericanSociety for Reproductive Medicine Annual Meeting held Conjoint with InternationalFederation of Fertility Societies. October 2013; Boston, Massachusetts, USA. PosterPresentation

•••• Vidal C, Martinez-Conejero JA, Giles J, Alama P, Pellicer A, Simón C. Endometrialgene signature in the window of implantation of frozen replacement and ovumdonation cycles using GnRH-agonists or antagonists compared to natural cycles.69th American Society for Reproductive Medicine Annual Meeting held Conjoint withInternational Federation of Fertility Societies. October 2013; Boston, Massachusetts,USA. Poster Presentation

2012•••• Más A, Cervello I, Gil-Sanchís C, Faus A, Ferro J, Pellicer A, Simón C. Identification

of novel genes implicated in leiomyoma formation by wide genomic analysis of sidepopulation cells. 59th Annual Meeting Society for Gynecologic Investigation. March2012; San Diego, California, USA. Poster Presentation

•••• Garrido-Gómez T, Domínguez F, Quiñonero A, Estella C, Vilella F, Simón C.Annexin A2 is critical for endometrial adhesiveness and embryo attachment inhumans by activation of RhoA through F-actin regulation. 59th Annual MeetingSociety for Gynecologic Investigation. March 2012; San Diego, California, USA.Poster Presentation

•••• Tamarit G, Horcajadas JA, Martinez-Conejero JA, Arbones JM, Simón C, Pellicer A.

102

Endometrial apolipoprotein pattern is altered in obese women but not in plasma:implications in endometrial receptivity and embryo implantation. 59th Annual MeetingSociety for Gynecologic Investigation. March 2012; San Diego, California, USA.Poster Presentation

•••• Sánchez-Ribas I, Domínguez F, Puchades L, Riqueros M, Vime P, Ballesteros A,Simón C. Nuclear magnetic resonace analysis of embryo spent culture media formhuman trisomy 21, monosomy 21 and normal day 3 embryos reveal differences intheir early metabolism. 59th Annual Meeting Society for Gynecologic Investigation.March 2012; San Diego, California, USA. Poster Presentation

•••• García-Herrero S, Martínez-Conejero JA, Campos-Galindo I, Ayala-Alvarez G, Ruiz-Alonso M, Simón C, Rubio C. Aneuploidy detection in products of conception(POCS) and prenatal diagnosis by luminex® Technology. The 1st Biomarker Meetingin Reproductive Medicine: Emergence of a New Field. March 2012; Valencia, Spain.Poster Presentation

•••• Gil-Sanchís C, Cervelló I, Santamaría X, Más A, Faus A, Garrido-Gómez T,Quiñonero A, Pellicer A, Simón C. Demostration of Leucine-rich repeat-containingG-protein coupled receptor 5 (Lgr5) as a putative human endometrial stem cellmarker. 28th Annual Meeting of the European Society of Human Reproduction andEmbryology. July 2012; Istanbul, Turkey. Oral Presentation (Basic Science Award forOral Presentation)

•••• Estella C, Herrer I, Moreno-Moya J, Quiñonero A, Pellicer A, Simón C.miRNA signature and dicer requirement during endometrial stromaldecidualization. 28th Annual Meeting of the European Society of HumanReproduction and Embryology. July 2012; Istanbul, Turkey. Oral Presentation

•••• Pellicer A, Gómez R, García-Velasco J, Simón C. The role for dopamine agonists.28th Annual Meeting of the European Society of Human Reproduction andEmbryology. July 2012; Istanbul, Turkey. Oral Presentation

•••• Rodrigo L, Rubio C, Bellver J, Peinado L, Buendía P, Vidal C, Giles J, Domingo J,Remohí J, Pellicer A, Simón C. Improved take-home baby rate with preimplantationgenetic screening in implantation failure couples: a prospective controlled trial in aproperly characterized population28th Annual Meeting of the European Society ofHuman Reproduction and Embryology. July 2012; Istanbul, Turkey. OralPresentation

•••• Mateu E, Rodrigo L, Mir P, Campos I, Escrich L, Vera M, Remohí J, Pellicer A,Simón C. Aneuploidy screening by arrays-CGH in embryos from couples withrecurrent miscarriage: incidence of segmental aneuploidies. 28th Annual Meeting ofthe European Society of Human Reproduction and Embryology. July 2012; Istanbul,Turkey. Oral Presentation

•••• Bermejo A, Cerrillo M, Ortega I, Martínez-Conejero JA, Ruiz-Alonso M, HorcajadasJA, Simón C, García-Velasco JA. Endometrial Receptivity Arrays (ERA) withdifferent luteal support protocols after triggering final oocyte maturation with GnRHagonist. 28th Annual Meeting of the European Society of Human Reproduction andEmbryology. July 2012; Istanbul, Turkey. Oral Presentation

•••• Rubio C, Mateu E, Milán M, Mercader A, Bosch E, Labarta E, Crespo J, Remohí J,Simón C, Pellicer A. Benefits of PGS in advanced maternal age patients: aprospective randomized trial in women between 41-44 years of age. 28th AnnualMeeting of the European Society of Human Reproduction and Embryology. July2012; Istanbul, Turkey. Poster Presentation

•••• Mercader A, Garrido N, Rubio C, Buendía P, Delgado A, Escrich L, Poo ME, SimónC. Cumulative live birth rates per embryo transferred according to the type ofprolonged cultura in a preimplantation genetic screening program. 28th AnnualMeeting of the European Society of Human Reproduction and Embryology. July2012; Istanbul, Turkey. Poster Presentation

•••• Ferrero H, Gómez R, García-Pascual CM, Simón C, Gaytán F, Pellicer A. Dopaminereceptor d2 agonist prevents OHSS modulating VEGF secretion by lutein granulosacells at post-transcriptional level. 28th Annual Meeting of the European Society ofHuman Reproduction and Embryology. July 2012; Istanbul, Turkey. Poster

103

Presentation•••• García-Pascual CM, Zimmermann, Ferrero H, Simón C, Pellicer A, Gómez R.

Inhibition of D114-mediated signaling induces abortion in mice due affection ofdecidual angiogenesis. 28th Annual Meeting of the European Society of HumanReproduction and Embryology. July 2012; Istanbul, Turkey. Poster Presentation

•••• Vilella F, Bradshaw H, Ramirez LB, Stuart JM, Martínez S, Simón C. A non-invasivediagnostic method of human endometrial receptivity based on a specific lipidomicprofile in endometrial fluid. 68th Annual Meeting American Society for ReproductiveMedicine. October 2012; San Diego, California, USA. Oral Presentation

•••• Milán M, Garrido N, Rubio C, Simón C, Remohí J, Pellicer A. Benefits ofpreimplantation genetic screening (PGS) in advanced maternal age (AMA) womendemonstrated by cumulative live-birth rates (CLBR) considering all the embryosreplaced in consecutive cycles. 68th Annual Meeting American Society forReproductive Medicine. October 2012; San Diego, California, USA. OralPresentation

•••• Vera M, Rodrigo L, Mercader A, Peinado V, Simón C, Rubio C. Blastocyst ratesaccording to embryo fragmentation and aneuploidy assessed by array-CGH. 68thAnnual Meeting American Society for Reproductive Medicine. October 2012; SanDiego, California, USA. Poster Presentation

• Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Vilella F, Pellicer A, Simón C.Personalizing embryo transfer (PET) using and endometrial customized array asdiagnostic and therapeutic strategy in patients with implantation failure. 68th AnnualMeeting American Society for Reproductive Medicine. October 2012; San Diego,California, USA. Poster Presentation

• Cervelló I, Gil-Sanchís C, Más A, Faus A, Pellicer A, Simón C. Leucine-rich repeat-containing G-Protein coupled receptor (Lgr5): a putative human endometrial stemcell marker. Copenhagen Bioscience Conferences, a Novo Nordisk FoundationInitiative. 1st Conference The Stem Cell Niche Development and Disease. June2012; Copenhagen, Denmark. Oral Presentation

2011• Delgado A, Mercader A, Escrich L, Buendía P, Rodrigo L, Rubio C, Simón C,

Remohí J, Pellicer A, Meseguer M. Embryo Morphology and development 96 hoursafter fertilization (day 4) strongly correlates with chromosomal aneuploidy. 4thInternational IVI Congress. April 2011; Valencia, Spain. Poster Presentation

•••• Rubio c, Rodrigo L, Mercader A, De los Santos MJ, Mateu E, Bosch E, Simón C,Remohí J, Pellicer A. Randomized controlled trial in patients with repetitiveimplantation failure: day-5 embryo transfer with and without preimplantation geneticscreening (PGS). 4th International IVI Congress. April 2011; Valencia, Spain. PosterPresentation

• Sánchez-Ribas Inma, Riqueros M, Vime P, Jhonsson T, Ballesteros A, Simón C,Domínguez F. Metabolic profliling of human trisomy 21 and normal day 3 IVFembryos reveal diferencies in their early metabolism. 58th Annual Meeting of theSociety for Gynecologic Investigation. March 2011;Miami Beach, USA. PosterPresentation

• Berlanga O, Ramirez L, Martínez S, Quiñonero A, Pellicer A, Simón C. EndometrialPGE2 and PGF2α production in mainly the result of PGH2 metabolism by specificprostaglandin synthases during the window of implantation. 58th Annual Meeting ofthe Society for Gynecologic Investigation. March 2011; Miami Beach, USA. PosterPresentation

• Domínguez F, Yañez-Mo M, Quiñonero A, Martínez S, Palacín M, Cervero A, PellicerA, Sánchez-Madrid F, Simón C. Human endometrial CD98 is essential for blastocystadhesion. 58th Annual Meeting of the Society for Gynecologic Investigation. March2011; Miami Beach, USA. Poster Presentation

•••• Moreno-Moya JM, Martínez-Escribano S, Simón C, Horcajadas JA.Chemoattractant effects of different conditioned media from endometrial epithelialprimary culture in the presence and the absence of glycodelin-A on human

104

trophoblast cell line JEG-3. 58th Annual Meeting of the Society for GynecologicInvestigation. March 2011; Miami Beach, USA. Poster Presentation

• Martínez-Conejero JA, Domínguez F, Simón C, Horcajadas JA. Functionalgenomics differences between adhesive and non-adhesive endometrial epithelialcell lines. 58th Annual Meeting of the Society for Gynecologic Investigation. March2011; Miami Beach, USA. Poster Presentation

•••• Gómez R, Ferrero H, Delgado F, Simón C, Pellicer A, Gaytan F. Differentialexpression of dopamine receptor 2 (drd2) might account for higher risk of OHSSdevelopment. 58th Annual Meeting of the Society for Gynecologic Investigation.March 2011; Miami Beach, USA. Oral Presentation

•••• Ferrero H, Gómez R, Delgado F, Simón C, Gaytan F, Pellicer A. Drd2 agonistsprevents OHSS by reducing VEGF secretion through the activation of Drd2 ingranulosa cells. 58th Annual Meeting of the Society for Gynecologic Investigation.March 2011; Miami Beach, USA. Poster Presentation

•••• Cervelló I, Gil-Sanchís C, Más A, Santamaría X, Moscardó F, Sanz J, Higueras GSanz MA, Pellicer A, Simón C. Endometrial versus bone marrow source of somaticstem cells in human endometrium. 27th Annual Meeting of the European Society ofHuman Reproduction and Embryology. July 2011; Stockholm, Sweden. OralPresentation

•••• García-Pascual CM, Zimmermann RC, Simón C, Sawber C, Pellicer A, Gómez R.The role of angiogenesis specific Notch in corpora lutea formation. 27th AnnualMeeting of the European Society of Human Reproduction and Embryology. July2011; Stockholm, Sweden. Oral Presentation

•••• Mercader A, Buendía P, Delgado A, Escrich L, Amorocho B, Simón C, Remohí J,Pellicer A, Martín J, Rubio C. Novel indications for blastocyst biopsy in apreimplantation genetic diagnosis program. 27th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. July 2011; Stockholm, Sweden.Poster Presentation

•••• Ferrero H, Gómez R, Delgado F, Simón C, Gaytán F, Pellicer A. Drd2 agonistsprevents OHSS by reducing VEGF secretion through the activation of Drd2 ingranulosa cells. 27th Annual Meeting of the European Society of HumanReproduction and Embryology. July 2011; Stockholm, Sweden. Poster Presentation

•••• Mas A, Cervelló I, Gil-Sanchís C, Peris-Pardo L, Faus A, Ferro J, Pellicer A, SimónC. Identification and characterization of putative leiomyoma stem cells. 27th AnnualMeeting of the European Society of Human Reproduction and Embryology. July2011; Stockholm, Sweden. Poster Presentation

•••• Medrano JV, Hguyen HN, Ramathal C, Simón C, Reijo-Pera RA. Overexpression ofconserved RNA-binding proteins induces meiotic progression in germ cellsdifferentiated from pluripotent human stem cells. 27th Annual Meeting of theEuropean Society of Human Reproduction and Embryology. July 2011; Stockholm,Sweden. Poster Presentation

• Vilella F, Ramírez L, Berlanga O, Martínez S, Pellicer A, Simón C. Effects of PGE2and PGF2α on blastocyst adhesion to the human endometrial epithelium. 67thAnnual Meeting American Society for Reproductive Medicine. October 2011;Orlando, Florida, USA. Oral Presentation

• Riboldi M, Gómez E, Aguilar C, Gil-Salom M, Simón C. In vitro differentiation ofhaploid cells after spermatogonial co-culture with sertoli cells from adult humantestes. 67th Annual Meeting American Society for Reproductive Medicine. October2011; Orlando, Florida, USA. Oral Presentation

•••• Estella C, Herrer I, Quiñonero A, Martínez S, Pellicer A, Simón C. Inhibition ofhistone deacetylases in human endometrial stromal cells promotes extracellularmatriz remodelling and inhibits embryo invasion. 67th Annual Meeting AmericanSociety for Reproductive Medicine. October 2011; Orlando, Florida, USA. PosterPresentation

•••• Estella C, Herrer I, Quiñonero A, Martínez S, Pellicer A, Simón C. The endometrialstromal decidualization miRNA signature. 67th Annual Meeting American Society for

105

Reproductive Medicine. October 2011; Orlando, Florida, USA. Poster Presentation2010• Pilla FR, Martínez S, Simón C, Horcajadas JÁ. Is sparc relevant in embryo-

emdometrium dialogue? An in vitro and in vivo analysis. 57th Annual MeetingSociety for Gynecologic Investigation. March 2010. Orlando, Florida, USA. PosterPresentation

• Herraiz S, Pellicer B, Cauli O, Rodrigo R, Felipo V, Simón C, Pellicer A. Pre- andpostnatal brain damage in preeclamptic animal model induced by gestational nitricoxide synthase inhibition. 57th Annual Meeting Society for GynecologicInvestigation. March 2010. Orlando, Florida, USA. Poster Presentation

• Riboldi M, Medrano JV, Marqués-Marí AI, Gómez E, Ruiz V, Poo ME, Gil-Salom M,Simón C. Spermatogonial stem cell lines obtained from testicular biopsies. 57thAnnual Meeting Society for Gynecologic Investigation. March 2010. Orlando, Florida,USA. Poster Presentation

• Garrido-Gómez T, Domínguez F, Quiñonero A, Martínez-Conejero JA, López JA,Camafeita E, Pellicer A, Simón C. Proteomic and secretomic of human endometrialstromal cells in decidualization process. 57th Annual Meeting Society forGynecologic Investigation. March 2010. Orlando, Florida, USA. Poster Presentation

• Más A, Cervelló I, Gil-Sanchís C, Martínez A, Galán A, Ruiz V, Ferro J, O’Connor JE,Pellicer A, Simón C. Somatic stem cell lines from human endometrium. 57th AnnualMeeting Society for Gynecologic Investigation. March 2010. Orlando, Florida, USA.Poster Presentation

• Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Alamá P, Pellicer A, SimónC. Defining the gene expression signature for human endometrial receptivity. 57thAnnual Meeting Society for Gynecologic Investigation. March 2010. Orlando, Florida,USA. Poster Presentation

• Valbuena D, Sánchez E, Aguilar C, Poo Me, Marqués A, Medrano JV, Simón C.Efficiency of a xeno-free HESC cryopreservaton method. The 1st InternationalCongress on Controversies in Cryopreservation of Stem Cells, Reproductive cells,Tissue & Organs. April 2010. Valencia, Spain. Poster Presentation

• Valbuena D, Poo ME, Aguilar C, Martínez S, Quiñonero A, Cobo A, Simón C.Vitrification of isolated mice and human blastómeras. The 1st International Congresson Controversies in Cryopreservation of Stem Cells, Reproductive cells, Tissue &Organs. April 2010. Valencia, Spain. Poster Presentation

• Ruiz-Vela A, Aguilar-Gallardo C, Soriano M, Martínez-Arroyo A, Rincón-Bertolín A,Ruiz V, Gómez E, Medrano J, García-Verdugo J, Simón C. Human Embryonic StemCell microenvironments trigger efficient metaplastic adipogenesis of cancer cells. 8thAnnual Meeting International Society for Stem Cell Research. June 2010; SanFrancisco, USA. Poster Presentation

• Galán A, Póo M, Valbuena D, Montaner D, Ruiz V, Aguilar C, Sánchez E, Gómez E,Dopazo J, Simón C. Comparative genome wide analysis of hESC derived fromsingle blastomeres, morulas and blastocysts. 8th Annual Meeting InternationalSociety for Stem Cell Research. June 2010; San Francisco, USA. PosterPresentation

• Garrido N, Bellver J, Remohí J, Simón C, Pellicer A. Cumulative live-birth ratesconsidering the total number of embryos replaced in consecutive IVF cycles toevaluate IVF success likelihood. 26th Annual Meeting European Society of HumanReproduction & Embryology. June 2010; Rome, Italy. Oral Presentation

• Ferrero H, Gaytán F, Delgado-Rosas F, Gaytán M, Gómez R, Simón C, Pellicer A.Dopamine receptor 2 (drd2) activation inhibits VEGF secretion in granulosaluteinized cells: implications for OHSS treatment in low drd2 milieus. 26th AnnualMeeting European Society of Human Reproduction & Embryology. June 2010;Rome, Italy. Oral Presentation

• Vidal C, Giles J, Remohí J, Simón C, Garrido N, Bellver J, Pellicer A. The use ofGnRH antagonist in endometrial priming improves oocyte donation outcome. Resultsof a prospective-controlled trial. 26th Annual Meeting European Society of HumanReproduction & Embryology. June 2010; Rome, Italy. Oral Presentation

106

• Delgado-Rosas F, Gómez R, Tamarit S, Abad A, Simón C, Pellicer A. Quinagolideinduces regression of human peritoneal endometriotic lesions by enhancingfibrinolisis and decreasing angiogenesis an inflammation. 26th Annual MeetingEuropean Society of Human Reproduction & Embryology. June 2010; Rome, Italy.Poster Presentation

•••• Horcajadas JA, Martinez-Conejero JA, Montesinos M, Morgan M, Fortuño S, SimónC, Pellicer A. Endometrial receptivity is not affected in women with adenomyosis: afunctional genomics analysis. 26th Annual Meeting European Society of HumanReproduction & Embryology. June 2010; Rome, Italy. Poster Presentation

•••• Bosch E, Labarta E, Cruz F, Simón C, Remohí J, Pellicer A. Circulatingprogesterone levels at the end of ovarian stimulation related to ongoing pregnancyrate in different patients subpopulation. 26th Annual Meeting European Society ofHuman Reproduction & Embryology. June 2010; Rome, Italy. Poster Presentation

•••• Rubio C, Domingo J, Rodrigo L, Mercader A, De los Santos MJ, Pehlivan T, BoschE, Fernández M, Simón C, Remohí J, Pellicer A. Potential benefits of PGS inrecurrent implantation failure: a prospective controlled trial in a properlycharacterized population. 26th Annual Meeting European Society of HumanReproduction & Embryology. June 2010; Rome, Italy. Poster Presentation

•••• Gómez E, Riboldi M, Galán A, Medrano JV, Rubio MC, Martinez MC, Martínez-Jabaloyas, Pellicer A, Simón C. Spermatogonial stem cells line from a patient withKlinefelter’s Syndrome. 26th Annual Meeting European Society of HumanReproduction & Embryology. June 2010; Rome, Italy. Poster Presentation

•••• Riboldi M, Medrano JV, Marqués-Marí AI, Gómez E, Poo ME, Aguilar C, Pellicer A,Gil Salom M, Simón C. Spermatogonial stem cell lines form human testicularbiopsies. 26th Annual Meeting European Society of Human Reproduction &Embryology. June 2010; Rome, Italy. Poster Presentation

• Galán A, Montaner D, Poo ME, Ruiz V, Valbuena D, Simón C. Defining cell fate andembryonic genome activation by global single-cel CDNA analysis of blastomeresfrom 5 to 8-cell human embryos. 66th Annual Meeting American Society forReproductive Medicine. October 2010; Denver, USA. Oral Presentation

• Garrido N, Bellver J, Remohí J, Simón C, Pellicer A. Cumulative live-birth rates(CLBR) considering the total number of embryos replaced in 26504 consecutiveovum donation cycles (OD). 66th Annual Meeting American Society for ReproductiveMedicine. October 2010; Denver, USA. Oral Presentation

• Cobo A, Domínguez F, Castelló D, De los Santos JM, Simón C, Remohí J. Effect ofvitrification on human oocytes: a metabolic profiling study. 66th Annual MeetingAmerican Society for Reproductive Medicine. October 2010; Denver, USA. OralPresentation

•••• Berlanga O, Garrido T, Martínez S, Pellicer A, Bradshaw HB, Simón C. Lipidomicprofiling of endometrial fluid as a non-invasive diagnostic tool of human endometrialreceptivity. 66th Annual Meeting American Society for Reproductive Medicine.October 2010; Denver, USA. Poster Presentation

•••• Díaz-Gimeno P, Martínez-Conejero JA, Garrido N, Pellicer A, Simón C, HorcajadasJA. The endometrial receptivity array (ERA) improves the endometrial dating andprovides an objetive method for clinical evaluation. 66th Annual Meeting AmericanSociety for Reproductive Medicine. October 2010; Denver, USA. Poster Presentation

•••• Mercader A, Buendía P, Delgado A, Escrich L, Pellicer A, Simón C. Co-culture withendometrial epithelial cells improves clinical outcome in patients younger than 41years from PGD program. 66th Annual Meeting American Society for ReproductiveMedicine. October 2010; Denver, USA. Poster Presentation

2009• Cervello I, Navarro-Aguilar I, Delgado-Rosas F, Martínez-Conejero JA, Martínez-

Romero, Santonja N, O’Connor JE, Pellicer A, Simón C. Side population is thesomatic stem cell population in human endometrium. 56th Annual Meeting Societyfor Gynecologic Investigation. March 2009; Glasgow Scotland. Oral Presentation

• Altmae S, Martínez-Conejero JA, Salumets A, Simón C, Horcajadas JA, Stavreus-Evers A. Endometrial gene expression analysis during the time of embryo

107

implantation in women with unexplained infertility. 56th Annual Meeting Society forGynecologic Investigation. March 2009; Glasgow Scotland. Oral Presentation

•••• Evans GE, Martínez-Conejero JA, Simón C, Horcajadas JA, Benny PS, PhillipsonGTM, Sin IL. Gene Expression analysis in specific endometrial compartments –epithelial glands and stroma, during the window o implantation in fertile women. 56thAnnual Meeting Society for Gynecologic Investigation. March 2009; GlasgowScotland. Poster Presentation

•••• Domínguez F, Yañez-Mo M, Quiñonero A, Martínez S, Sánchez-Madrid F, Simón C.A system biology approach reveals a relevant functionfor CD147 and CD98 inendometrial receptiveness and trophoblast adhesion. 56th Annual Meeting Societyfor Gynecologic Investigation. March 2009; Glasgow Scotland. Poster Presentation

• Garrido T, Domínguez FD, Quiñonero A, Lopez JA, Camafeita E, Calvo E, Pellicer A,Simón C. Proteomic analysis of the human receptive vs nonreceptive endometriumunveiled a functional relevance of stathmin 1 and annexin a2. ReproductiveMedicine and beyond. The 3rd International IVI Congress. May 2009; Madrid, Spain.Poster Presentation

• Vidal C, Giles J, Simón C, Remohí J, Bellver J, Pellicer A. Use of antagonist GnRHin oocyte recipient endometrium preparation. Reproductive Medicine and beyond.The 3rd International IVI Congress. May 2009; Madrid, Spain. Oral Presentation

• Díaz Gimeno P, Horcajadas JA, Esteban FJ, Martínez-Conejero JA, Simón C. Anew genomics method for human endometrial receptivity diagnosis. ReproductiveMedicine and beyond. The 3rd International IVI Congress. May 2009; Madrid, Spain.Poster Presentation

• Pilla F, Martínez-Escribano S, Simón C, Horcajadas JA. Development of a newthree dimensional (3D) in vitro model for embryonic invasion. Reproductive Medicineand beyond. The 3rd International IVI Congress. May 2009; Madrid, Spain. PosterPresentation

• Mercader A, Rubio C, Buendía P, Delgado A, Escrich L, Remohí J, Pellicer A, SimónC. Improvement of a preimplantation genetic screening program with the co-cultureof embryos with a monolayer of endometrial epithelial cells. 25th Annual Meeting ofEuropean Society of Human Reproduction & Embryology. June – July 2009;Amsterdam, The Netherlands. Poster Presentation

• Delgado A, Mercader A, Buendía P, Escrich L, Simón C, Remohí J, Pellicer A,Meseguer M. Quantification of day-5 embryo morphology effect on implantation ratein a preimplantational genetic diagnosis (PGD) program. 25th Annual Meeting ofEuropean Society of Human Reproduction & Embryology. June – July 2009;Amsterdam, The Netherlands. Poster Presentation

• Buendía P, Rubio C, Martínez M, Rodrigo L, Mateu E, Milán-Sánchez M, MercaderA, Delgado A, Escrich L, Simón C. Clinical outcome in patients with chromosomalrearrangements included in a PGD Program. 7th European CytogeneticsConference. European Cytogeneticists Association (ECA). July 2009; Stockholm,Sweden. Poster Presentation

•••• Cervello I, Mas Aymara, Gil-Sanchis C, Martínez-Romero A, Martínez-Escribano S,Cañete P, Domingo S, Bellver J, Ferro J, Pellicer A, O’Connor JE, Simón C.Adipogenic differentiation of side population cells from human endometrium. 7thAnnual Meeting International Society for Stem Cell Research. July 2009; Barcelona,Spain. Poster Presentation

• Póo ME, Aguilar C, Gómez E, Sánchez E, Medrano JV, Riboldi M, Marqués-Marí A,Galán A, Ruiz V, Enseñat-Waser R, Valbuena D, Simón C. Optimizing the derivationof HESC lines from single blastomere in human feeders. 7th Annual MeetingInternational Society for Stem Cell Research. July 2009; Barcelona, Spain. PosterPresentation

•••• Riboldi M, Enseñat-Waser R, Medrano JV, Póo ME, Gómez E, Marqués-Marí A,Sánchez E, Galan A, Ballesteros A, Castillon G, Ferro J, Simón C. Reprogrammingof human amniotic fluid mesenchymal stem cells by epigenetic mechanisms. 7thAnnual Meeting International Society for Stem Cell Research. July 2009; Barcelona,Spain. Poster Presentation

108

• Galan A, Ruiz V, Póo ME, Esteban FJ, Aguilar C, Enseñat-Waser R, Riboldi M,Sánchez E, Marqués-Marí A, Medrano JV, Valbuena D, Simón C. Are HumanBlastomeres Committed to Trophectoderm or Inner Cell Mass at 6-8 Cell StageEmbryo? 7th Annual Meeting International Society for Stem Cell Research. July2009; Barcelona, Spain. Poster Presentation

•••• Marqués-Marí A, Sánchez E, Póo ME, Galán A, Aguilar C, Gómez E, Ruiz V,Medrano JV, Riboldi M, Enseñat-Waser R, Valbuena D, Simón C. HumanEmbryonic Stem Cell Banking at the Valencia Node of the Spanish Stem Cell Bank.7th Annual Meeting International Society for Stem Cell Research. July 2009;Barcelona, Spain. Poster Presentation

• Evans GE, Martinez-Conejero JA, Benny PS, Phillipson GTM, Simón C, McNoe LA,Pearson JF, Horcajadas JA, Sin IL. Investigating the gene expression of specific cellcompartments in the endometrium. 19th annual Queenstown Molecular BiologyMeetings 2009. September 2009; Queenstown, New Zealand. Oral Presentation

• Novella-Maestre E, Medrano JV, Sánchez-Serrano M, Teruel J, Simón C, Pellicer A.Germ line and pluripotency gene expression markers in adult ovarian cortex. 65thAnnual Meeting of the American Society for Reproductive Medicine. October 2009;Atlanta, USA. Poster Presentation

• Vidal C, Giles J, Simón C, Remohí J, Pellicer A. The use of antonist GnRH inendometrial priming improves oocyte donation outcome. 65th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2009; Atlanta, USA. PosterPresentation

•••• Pellicer A, Sánchez M, Crespo J, Cobo A, Simón C. Dopamine agonists inendometriosis. 16th Annual meeting, The Middle East Fertility Society. November2009; Cairo, Egypt. Oral Presentation

•••• Pellicer A, Sánchez M, Crespo J, Cobo A, Simón C. Fertility preservation in breastcancer patients. 16th Annual meeting, The Middle East Fertility Society. November2009; Cairo, Egypt. Oral Presentation

2008• Cervello I, Martínez-Romero A, Martínez-Conejero JA, Martínez-Escribano JA,

Horcajadas JA, Pellicer A, O’connor JE, Simón C. Is the side population phenotypean essential characteristic for the somatic stem cells in the human endometrium?55th Annual meeting of the Society for Gynecologic Investigation. March 2008; SanDiego, USA. Oral Presentation

• Domínguez F, Quiñonero A, López JA, Camafeita E, Calvo E, Melo M, HorcajadasJA, Pellicer A, Simón C. Proteomic analysis of pre-receptive vs receptive humanendomtrium. 55th Annual meeting of the Society for Gynecologic Investigation.March 2008; San Diego, USA. Poster Presentation

• Rubio C, Rodrigo L, Mercader A, Mateu E, Buendía P, Peinado V, Delgado A, MilánM, Pehlivan T, Viloria T, Mir P, Simón C, Remohí J, Pellicer A. Repeated pregnancyloss. Eighth International Symposium. Preimplantation Genetic Diagnosis. April2008; Barcelona, Spain. Oral Presentation

• Mercader A, Rubio C, Alamá P, Delgado A, Gadea B, Pehlivan T, Bronet F, Simón C,Pellicer A, Remohí J. Incidence of embryo aneuploidies in two hormonal stimulationprotocols. Eighth International Symposium. Preimplantation Genetic Diagnosis. April2008; Barcelona, Spain. Oral Presentation

• Budak TP, Rubio C, Rodrigo L, Mateu E, Mercader A, Buendía P, Viloria T, RemohíJ, Simón C, Pellicer A. Cumulative experience with preimplantation geneticscreening in implantation failure patients. ALPHA 2008, 7th Biennial Conference.May 2008; Istanbul, Turkey. Oral Presentation

• Buendía P, Rubio C, Mercader A, Rodrigo L, Mateu E, Pehlivan T, Viloria T, PeinadoV, Delgado A, Milán M, Gadea B, Simón C, Remohí J, Pellicer A. Identification ofgood prognostic factors for preimplantation genetic diagnosis in unexplainedrecurrent miscarriage couples. ALPHA 2008, 7th Biennial Conference. May 2008;Istanbul, Turkey. Oral Presentation

• Riboldi M, Poo MA, Gómez E, Luengo S, Galán A, Simón C. Isolation andcharacterization of pluripotent cells from amniotic fluid of early miscarriage. 6th

109

International Society for Stem Cell Research Annual Meeting. June 2008;Philadelphia, USA. Poster Presentation

• Portela-Perez S, Muñoz EA, Pabón D, Simón C, Remohí J, Pellicer A. The additionof LH to ovarian stimulation does not produce more premature endometrialmaturation (PEM) than stimulation using FSH alone. 24th Annual Meeting of theEuropean Society of Human Reproduction and Embryology. July 2008; Barcelona,Spain. Poster Presentation

• Garrido T, Domínguez F, Quiñonero A, Martínez JÁ, López E, Camafeita E, Calvo E,Melo M, Pellicer A, Simón C. Endometrial annexin A2 and Stathmin-1 protein profileare modified in the refractory endometrium induced by an IUD. 24th Annual Meetingof the European Society of Human Reproduction and Embryology. July 2008;Barcelona, Spain. Poster Presentation

• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Circulatingprogesterone levels and ongoing pregnancy rate in ovarian stimulation cycles for invitro fertilization. Analysis of 4000 cycles. 24th Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. July 2008; Barcelona, Spain. OralPresentation

• Delgado F, Gómez R, Simón C, Gaytán F, Pellicer A. Expression and localization ofthe dopamine receptor 2 in ovaries of women at different risk of developing ovarianhyperstimulation syndrome. 24th Annual Meeting of the European Society of HumanReproduction and Embryology. July 2008; Barcelona, Spain. Poster Presentation

•••• Sanchez-Ribas I, Dominguez F, Barr J, Castro A, Mato JM, Simón C. Metabolomicprofile as a novel non-invasive tool for human embryo aneuploidy assessment. 64thAnnual Meeting of the American Society for Reproductive Medicine. November2008; San Francisco, USA. Oral Presentation

•••• Gomez R, Gonzalez-Izquierdo M, Delgado F, Remohi J, Simón C, Pellicer A.Squalene epoxidase inhibitors block increased vascular permeability in an ohssmodel without affecting luteal function. 64th Annual Meeting of the American Societyfor Reproductive Medicine. November 2008; San Francisco, USA. Oral Presentation

•••• Martínez-Conejero JA, Bourgain C, Pellicer A, Devroey P, Arce JC, Simón C.Morphological and genomic endometrial development with long-acting degarelixstarting in the mid-luteal or early follicular phase compared to daily ganirelix startingin the mid-follicular phase. 64th Annual Meeting of the American Society forReproductive Medicine. November 2008; San Francisco, USA. Poster Presentation

• Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Medina I, Pellicer A, SimónC. Development of a customized array for the molecular diagnosis of humanendometrial receptivity. 64th Annual Meeting of the American Society forReproductive Medicine. November 2008; San Francisco, USA. Poster Presentation

•••• Peinado V, Rodrigo L, Mir P, Viloria T, Simón C, Pellicer A. chromosomalabnormalities in embryos and spermatozoa from patients with previous abnormalpregnancies. 64th Annual Meeting of the American Society for ReproductiveMedicine. November 2008; San Francisco, USA. Poster Presentation

•••• Labarta E, Bosch E, Alamá P, Simón C, Remohí J, Pellicer A. Incidence of embryoaneuploidies in natural and stimulated cycles in the same oocyte donor. Preliminaryresults. 64th Annual Meeting of the American Society for Reproductive Medicine.November 2008; San Francisco, USA. Oral Presentation

• Vergara V, Garcia G, Meseguer M, Garrido N, Simón C, Pellicer A. The presence ofuterine adenomyosis does not affect implantation in an oocyte donation program.64th Annual Meeting of the American Society for Reproductive Medicine. November2008; San Francisco, USA. Poster Presentation

2007• Domínguez F, Gadea B, Montaner D, Horcajadas JA, Dopazo J, Pellicer A, Simón

C. The Comparison between the human blastocyst secretome of sequential versus coculture IVF systems points to IL-6 as a predictor of implantation. 54th Annual Meeting, Society for Gynecologic Investigation. March 2007; Reno, Nevada. Oral Presentation

• Horcajadas JA, Merelo JJ, Domínguez F, Molina S, Pellicer A, Simón C.

110

Endometrial Database (EDB), a new online tool for endometrial research. 54th Annual Meeting, Society for Gynecologic Investigation. March 2007; Reno, Nevada. Poster Presentation

• Cervelló I, Martínez-Romero A, Martínez-Conejero JA, Martínez-Escribano S, Horcajadas JA, Pellicer A, Oconnor JE, Simón C. The molecular profile of stromal side population in human endometrium has the features of a progenitor stem cell population. 54th Annual Meeting, Society for Gynecologic Investigation. March 2007;Reno, Nevada. Poster Presentation

• Martínez-Conejero JA, Meseguer M, Remohí J, Pellicer A, Simón C, Garrido N. Thesignificance of sperm MUC1 in embryo development and reproductive outcome in anovum donation program. XIX World Congress on Fertility & Sterility. April – May2007; Durban, South Africa. Poster Presentation

• Mercader A, Buendía P, Gadea B, Pehlivan T, Simón C, Remohí J, Pellicer A, RubioC. Elective single embryo transfer vs. double embryo transfer in a PGD programme.Preimplantation Genetic Diagnosis International Society Conference. June 2007;Melbourne, Australia. Poster Presentation

• Novella-Maestre E, Carda C, Noguera I, Ruiz-Sauri A, Simón C, Pellicer A.Antiangiogenic action of dopamine agonists in esperimentally-induced endometrioticlesions. 23rd Annual Meeting of the European Society of Human Reproduction andEmbryology. July 2007; Lyon, France. Oral Presentation

• Loro F, Domínguez F, Quiñonero A, Martínez S, Pellicer A, Simón C. IP-10/CXCR3at the human maternal fetal interface: a “chemoatractive” hypothesis. 23rd AnnualMeeting of the European Society of Human Reproduction and Embryology. July2007; Lyon, France. Oral Presentation

• Domínguez F, Gadea B, Horcajadas JA, Pellicer A, Simón C. Deciphering humansecretome: protein profile of implanting blastocysts. 23rd Annual Meeting of theEuropean Society of Human Reproduction and Embryology. July 2007; Lyon,France. Oral Presentation.

• Busso C, Budak EB, Melo MAB, Simón C, Pellicer A, Remohí J. Oocyte donation inpatients with premature ovarian failure after chemotherapy and pelvic irradiation forHodgkin’s and non Hodgkin’s disease. 23rd Annual Meeting of the European Societyof Human Reproduction and Embryology. July 2007; Lyon, France. PosterPresentation

• Alvarez C, Fernández-Sánchez M, Alonso-Muriel I, Simón C, Pellicer A.Implantation is not affected in women receiving cabergoline (Cb2) to prevent ovarianhyperstimulation syndrome (OHSS) in high-risk ART patients. 23rd Annual Meetingof the European Society of Human Reproduction and Embryology. July 2007; Lyon,France. Poster Presentation

• Horcajadas JA, Requena A, Pacheco A, Mayoral M, Martínez-Conejero JA, PellicerA, Simón C. The effect of menopur vs rfsh in the genomics of human endometrium.23rd Annual Meeting of the European Society of Human Reproduction andEmbryology. July 2007; Lyon, France. Poster Presentation

• Krtolica A, Ilic D, Foulk R, Caceres E, Simón C, Genbacev O. Derivation of the firstcustom-made personal embryonic stem cells. A pilot study. 63rd Annual Meeting,American Society for Reproductive Medicine. October 2007; Washington, USA. OralPresentation

• Ilic D, Genbacev O, Simón C, Foulk R, Krtolica A. Derivation of the humanembryonic stem cells line from the two blastomeres of non-viable embryos. 63rdAnnual Meeting, American Society for Reproductive Medicine. October 2007;Washington, USA. Oral Presentation

• Bosch E, Rubio MC, Mercader A, Simón C, Remohí J, Pellicer A. Embryoaneuploidies in GnRH agosnist vs. GnRH antagonist cycles. Experience of 2000cycles. 63rd Annual Meeting, American Society for Reproductive Medicine. October2007; Washington, USA. Oral Presentation

• Novella-Maestre E, Simón C, Pellicer A. Modulation of angiogenesis by thedopamine agonist cabergoline in experimentally-induced peritoneal endometriclesions. 63rd Annual Meeting, American Society for Reproductive Medicine. October

111

2007; Washington, USA. Oral Presentation• Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Pellicer A, Simón C. Gene

expression analysis of the indometrium reveals that controlled ovarian stimulationinduces a genomic delay with potential clinical implications. 63rd Annual Meeting,American Society for Reproductive Medicine. October 2007; Washington, USA. OralPresentation

• Higón MA, Horcajadas JA, Martínez-Conejero JA, Simón C, Pellicer A. The Impactof single intramural myomas on endometrial receptivity: a histological and genomicanalysis. 63rd Annual Meeting, American Society for Reproductive Medicine.October 2007; Washington, USA. Oral Presentation

• Delgado A, De los Santos MJ, Buendía P, Simón C, Remohí J, Pellicer A. Increasedincidence of mosaic embryos with the microinjection of spermatozoa with abnormalmorphology. 63rd Annual Meeting, American Society for Reproductive Medicine.October 2007; Washington, USA. Poster Presentation

• Labarta E, Bosch E, Simón C, Remohí J, Pellicer A. A prospective, randomizedcontrolled trial comparing highly purified hMG with recombinant FSH + recombinantLH in women undergoing intrauterine insemination: ovarian response and clinicaloutcomes. 63rd Annual Meeting, American Society for Reproductive Medicine.October 2007; Washington, USA. Poster Presentation

• Ilic D, Simón C, Genbacev O, Caceres E, Foulk R, Krtolica A. Embryos from thesame patients yield both normal and aneuploid lines under indentical cultureconditions. 63rd Annual Meeting, American Society for Reproductive Medicine.October 2007; Washington, USA. Poster Presentation

• Loro F, Domínguez F, López JA, Camafeita E, Calvo E, Melo M, Horcajadas JA,Pellicer A, Simón CProteomic analysis of pre-receptive vs receptive human edometrium. 2nd Society forGynecologic Investigation (SGI) International summit on Reproductive Medicine.“From embryo and endometrium to implantation: the translational research.November 2007; Valencia, Spain. Poster Presentation

• Cervelló I, Martínez-Conejero JA, Martínez-Escribano Sebastián Martínez-RomeroA, Delgado-Rosas FM, Riboldi M, Horcajadas JA, Cañete P, O’Connor JE, PellicerA, Simón C. In the human endometrium the percentage of stromal side populationdoes not correlate with the age2nd Society for Gynecologic Investigation (SGI)International summit on Reproductive Medicine. “From embryo and endometrium toimplantation: the translational research. November 2007; Valencia, Spain. PosterPresentation

• Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Pellicer A,Simón C. Development of a customized array for endometrial receptivity (ERA) 2ndSociety for Gynecologic Investigation (SGI) International summit on ReproductiveMedicine. “From embryo and endometrium to implantation: the translationalresearch. November 2007; Valencia, Spain. Poster Presentation

• Herraiz S, Pellicer B, Migue Asensi, Felipo V, Morcillo E, Simón C, Pellicer A.Sildenafil effects in normal pregnancy and preeclampsia employing an animalmodel. 2nd Society for Gynecologic Investigation (SGI) International summit onReproductive Medicine. “From embryo and endometrium to implantation: thetranslational research. November 2007; Valencia, Spain. Poster Presentation

2006• Cervello I, Martínez-Conejero JA, Pellicer A, Simón C. Identification quantification

and co-localization of the BrdU retained cells with Oct3/4 in the murine endometrium. 53rd Annual Meeting of the Society for Gynecologic Investigation. March 2006; Toronto, Canada. Poster Presentation

• Cervero A, Quiñonero A, Domínguez F, Horcajadas JA, Pellicer A, Simón C. Interference of endometrial leptin receptor mRNA expression reduces the adhesion rate of mice embryos to a human endometrial cell line. 53rd Annual Meeting of the Society for Gynecologic Investigation. March 2006; Toronto, Canada. Poster Presentation

• Horcajadas JA, Riesewijk A, Mínguez P, Dopazo J, Polman J, Pellicer A, Simón C.

112

Comparison of the endometrial gene expression profile throughout the window ofimplantation in natural vs. COH cycles. 22nd Annual Meeting, European Society ofHuman Reproduction and Embryology. June 2006; Prague, Czech Republic. OralPresentation

• Meseguer M, De los Santos MJ, Simón C, Remohí J, Pellicer A, Garrido N. Spermglutathione peroxidases-1 and -4 are correlated with embryo asymmetry andblastocyst quality in oocyte donation cycles. 22nd Annual Meeting, EuropeanSociety of Human Reproduction and Embryology. June 2006; Prague, CzechRepublic. Oral Presentation

• Alvarez C, Bosch E, Melo MAB, Fernández-Sánchez M, Muñoz EA, Remohí J,Simón C, Pellicer A. The dopamine agonist Cabergoline prevents moderate-severeearly ovarian hyperstimulation síndrome (OHSS) in high-risk ART patients. 22ndAnnual Meeting, European Society of Human Reproduction and Embryology. June2006; Prague, Czech Republic. Oral Presentation

• Mercader A, Buendía P, Gadea B, Phelivan T, Remohí J, Pellicer A, Rubio C, SimónC. Co-culture improves blastocyst rate from biosied embryos. 22nd Annual Meeting,European Society of Human Reproduction and Embryology. June 2006; Prague,Czech Republic. Poster Presentation

• Rodrigo L, Rubio C, Mateu E, Viloria T, Peinado V, Remohí J, Pellicer A, Simón C, Gil-Salom M. Predictive value of sperm FISH analysis on the incidence of day 3 abnormal embryos in severe male factor couples. 22nd Annual Meeting, European Society of Human Reproduction and Embryology. June 2006; Prague, Czech Republic. Poster Presentation

• Gómez R, González M, Zimmermann R, Remohí J, Simón C, Pellicer A. Seggregation of the antiapermeability and the antiangiogenic effects derived from VEGFR2 blockade by cabergoline. A specific non-toxic approach to treat OHSS. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Oral Presentation

• Horcajadas JA, Mínguez P, Riesewijk A, Dopazo J, Pellicer A, Simón C. Functional genomics of the human endometrial development during the window of implantation.62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Oral Presentation

• Labarta E, Bosch E, Simón C, Remohí J, Pellicer A. The value of estradiol: oocyte ratio as predictor of in vitro fertilization-embryo transfer outcome. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Poster Presentation

• Martínez-Conejero JA, Cervelló I, Garrido N, Meseguer M, Remohí J, Pellicer A, Simón C. Identification of the progenitor stem cell population in the murine testis reveal that slow cycling cells do not correlate with side population. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Poster Presentation

• Labarta E, Bosch E, De los Santos MJ, Simón C, Remohí J, Pellicer A. Premature luteinization in GnRH antagonist cycles: outcome according to day of embryo transfer. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Poster Presentation

• Álvarez C, González S, Crespo J, Simón C, Remohí J, Pellicer A. Cabergoline (CB2) administration to prevent ovarian hiperstimulation síndrome (OHSS) in IVF ICSI does not reduce implantation and pregnancy rates. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Poster Presentation

• Pehlivan TS, Mercader A, De los Santos MJ, Remohí J, Pellicer A, Simón C. Comparison of two different treatment options for implantation failure patients: preimplantation genetic diagnosis versus blastocyst transfer. 62nd Annual Meeting, American Society for Reproductive Medicine. October 2006; Nueva Orleans, USA. Poster Presentation.

2005• Oberyé J, Riesewijk A, Simón C, Pellicer A. Endometrial gene expression after

113

treatment with standard or high dose GnRH antagonist is similar and comparable tonon-stimulated cycles. 8th International Symposium on GnRH Analogues in Cancerand Human Reproduction. February 2005; Salzburg, Austria. Oral Presentation

• Coelingh Bennink H.J.T, Olivennes F, Simón C. An old hormone and a new oralGnRH antagonist for IVF. 8th International Symposium on GnRH Analogues inCancer and Human Reproduction. February 2005; Salzburg, Austria. OralPresentation

• Simón C, Escobedo C, Valbuena D, Genbacev O, Galán A, Krotolica A, Asensi A,Sánchez E, Esplugues J, Fisher S, Pellicer A. First derivation in Spain of humanembryonic stem cell lines: use of long term cryopreserved embryos and animal freeconditions. Stem cell 2005. Progress to therapy? March 2005; Edinburgh, Scotland.Oral and poster Presentation

• Martínez-Conejero JA, Cervello I, Pellicer A, Remohí J, Simón C. Identification,localization and characterization of the progenitor stem cell population in the murinetestis. 52nd Annual Meeting, Society for Gynecologic Investigation. March 2005; LosAngeles, California, USA. Oral Presentation

• Gómez-Gallego R, González M, Alonso-Muriel I, Novella E, Sánchez-Criado J,Remohí J, Simón C, Zimmermann R, Pellicer A. Cabergoline administration is anon-toxic and specific approach to effectively treat OHSS. 52nd Annual Meeting,Society for Gynecologic Investigation. March 2005; Los Angeles, California, USA.Oral Presentation

• Cervello I, Martínez-Conejero JA, Escobedo C, Cervero A, Pellicer A, Simón C.Identification, characterization and colocalization of the progenitor stem cellpopulation in the murine endometrium. 52nd Annual Meeting, Society forGynecologic Investigation. March 2005; Los Angeles, California, USA. OralPresentation

• Horcajadas JA, Domínguez F, Cervero A, Pellicer A, Simón C. Comparison of widegenome analysis in endometrium among natural (fertile), IVF (subfertile) an IUD(non fertile) cycles at the time of implantation. 52nd Annual Meeting, Society forGynecologic Investigation. March 2005; Los Angeles, California, USA. OralPresentation

• Escobedo-Lucea C, Valbuena D, Galán A, Genvaceb O, Sánchez E, Krtolica A,Fisher S, Moreno R, Pellicer A, Simón C. First derivation in Spain of humanembryonic stem cell lines using of long-term cryopreserved embryos and animal-freeconditions. 52nd Annual Meeting, Society for Gynecologic Investigation. March2005; Los Angeles, California, USA. Poster Presentation

• Novella-Maestre E, Gómez-Gallego R, Alonso-Muriel I, González M, Sánchez-Criado JE, Remohí J, Simón C, Pellicer A. Progesterone has no role in theincreased vascular permeability which onsets OHSS. 52nd Annual Meeting, Societyfor Gynecologic Investigation. March 2005; Los Angeles, California, USA. PosterPresentation.

• Alonso-Muriel I, Gómez-Gallego R, Pau E, Novella E, Ruiz A, Remohí J, Simón C,Pellicer A. Free VEGF but not total VEGF is responsible for ovarian hyperstimulationsyndrome (OHSS) onset. 52nd Annual Meeting, Society for GynecologicInvestigation. March 2005; Los Angeles, California, USA. Poster Presentation

• Domínguez F, Yañez-Mo M, Sánchez-Madrid F, Pellicer A, Simón C. Protein profilesof 40 membrane proteins involved in endometrial receptivity in RL-95-2, HEC-1-Aand primary EEC. 52nd Annual Meeting, Society for Gynecologic Investigation.March 2005; Los Angeles, California, USA. Poster Presentation

• Pehlivan T, Rubio C, Rodrigo L, Mercader A, Mateu E, Simón C, Remohí J, PellicerA. The role of preimplantation genetic diagnosis (PGD) in recurrent miscarriagecouples. 13th World Congress on In Vitro Fertilization, Assisted Reproduction &Genetics. May 2005; Istanbul, Turkey. Oral Presentation

• Bosch E, Rubio C, Mercader A, Simón C, Remohí J, Pellicer A. GnRH antagonistsdo not increase embryo aneuploidies incidence. 13th World Congress on In VitroFertilization, Assisted Reproduction & Genetics. May 2005; Istanbul, Turkey. Oral

114

Presentation• Budak E, Fernández M, Reis S, Bosch E, Simón C, Remohí J, Pellicer A. Effect of

duration of estradiol valerate (EV) administration for endometrial preparation indonor oocyte cycles. 13th World Congress on In Vitro Fertilization, AssistedReproduction & Genetics. May 2005; Istanbul, Turkey. Oral Presentation

• Budak E, Bellver J, Simón C, Remohí J, Pellicer A. Reduced multiple pregnancyrates following 2 embryo transfer on day 3. 13th World Congress on In VitroFertilization, Assisted Reproduction & Genetics. May 2005; Istanbul, Turkey. OralPresentation

• Pehlivan T, Calderón G, Prados N, Crespo M, Simón C, Remohí J, Pellicer A. Theeffect of multinucleation in day-2 embryos on IVF outcome. 13th World Congress onIn Vitro Fertilization, Assisted Reproduction & Genetics. May 2005; Istanbul, Turkey.Oral Presentation

• Budak E, Fernández M, Reis S, Bosch E, Simón C, Remohí J, Pellicer A. Effects ofadvanced recipient age on ART success and obstetric outcome. 13th WorldCongress on In Vitro Fertilization, Assisted Reproduction & Genetics. May 2005;Istanbul, Turkey. Oral Presentation

• Bosch E, Vidal C, Crespo J, Simón C, Remohí J, Pellicer A. Highly purified HMGversus rec-FSH in GnRH antagonist cycles. 21st Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. June 2005; Copenhagen,Denmark. Poster Presentation

• Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, Simón C, Pellicer A.Comparison of pregnancies after IVF and oocyte donation shows that the ovary actsas a paracrine organ in cases of LO-OHSS. 21st Annual Meeting of the EuropeanSociety of Human Reproduction and Embryology. June 2005; Copenhagen,Denmark. Poster Presentation

• Rubio C, Rodrigo L, Gil-Salom M, Mateu E, Mercader A, Buendía P, Simón C,Remohí J, Pellicer A. Sperm chromosomal abnormalities and PGD: relationship withsperm parameters. 21st Annual Meeting of the European Society of HumanReproduction and Embryology. June 2005; Copenhagen, Denmark. PosterPresentation

• Galán-Albiñana A, Escobedo-Lucea C, Valbuena D, Sánchez E, Pellicer A, Moreno R, Simón C. Genetic and Immunological profile of two sister HESC lines, VAL-1 andVAL-2, in undifferentiated and differentiated stage. 3rd Annual Meeting International Society for Stem Cell Research. June 2005; San Francisco, USA. Poster Presentation

• Escobedo-Lucea C, Valbuena D, Galán A, Gómez E, Berna A, Genbacev O, Pellicer A, Moreno R, Simón C. Ultrastructure of two sister HESC lines, VAL-1 and VAL-2 in undifferentiated and differentiated stages. 3rd Annual Meeting International Society for Stem Cell Research. 3rd Annual Meeting International Society for Stem Cell Research. June 2005; San Francisco, USA. Poster Presentation

• Genbacev O, Escobedo-Lucea C, Zdravkovic T, Nordstrom A, Valbuena D, Nath A, Galán A, Simón C, Fisher SJ. Maintenance of “stemness” is associated with polarization of blastocyst-derived human embryonic stem cell lines. 3rd Annual Meeting International Society for Stem Cell Research. June 2005; San Francisco, USA. Poster Presentation

• Valbuena D, Galán A, Escobedo-Lucea C, Genbacev O, Krtolica A, Fisher SJ, Sánchez-Luengo S, Gómez AL, Pellicer A, Moreno R, Simón C. An efficient slow freezing HESC cryopreservation method. 3rd Annual Meeting International Society for Stem Cell Research. June 2005; San Francisco, USA. Poster Presentation

• Martínez-Conejero JA, Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J.MUC1 expression in human testis is directly related with fertile status. ConjointAnnual Meeting, American Society for Reproductive Medicine (ASRM) & CanadianFertility and Andrology Society (CFAS). October 2005; Montreal, Canada. OralPresentation

• Horcajadas JA, Catalano R, Gadea B, Sharkey A, Pellicer A, Simón C. The humanembryo-endometrial dialogue: impact of a single blastocyst in the gene expression

115

pattern of endometrial epithelial cells. Conjoint Annual Meeting, American Society forReproductive Medicine (ASRM) & Canadian Fertility and Andrology Society (CFAS).October 2005; Montreal, Canada. Oral Presentation

• Meseguer M, De Los Santos MJ, Simón C, Pellicer A, Remohí J, Garrido N. Spermquality is comparable among those oncological males diagnosed regardless of thecancer types. Conjoint Annual Meeting, American Society for Reproductive Medicine(ASRM) & Canadian Fertility and Andrology Society (CFAS). October 2005;Montreal, Canada. Poster Presentation

• Melo MA, Meseguer M, Simón C, Pellicer A, Remohí J, Garrido N. Stimulationlength, number of high-sized follicules and estradiol on the hCG injection day aremultiple pregnancy risk factors in IUI. Conjoint Annual Meeting, American Society forReproductive Medicine (ASRM) & Canadian Fertility and Andrology Society (CFAS).October 2005; Montreal, Canada. Poster Presentation

• Bosch E, Ruiz A, Crespo J, Simón C, Pellicer A, Remohí J. Coordination and resultsof a global ovum donation program. Conjoint Annual Meeting, American Society forReproductive Medicine (ASRM) & Canadian Fertility and Andrology Society (CFAS).October 2005; Montreal, Canada. Poster Presentation

• Vidal C, Zuzuarregui J, Epifanio R, Simón C, Remohí J, Pellicer A. Urinary humanchorionic gonadotropin (hCG), intramuscular or subcutaneously administered, yieldshigher hCG serum and follicular levels than recombinant hCG in egg donors.Conjoint Annual Meeting, American Society for Reproductive Medicine (ASRM) &Canadian Fertility and Andrology Society (CFAS). October 2005; Montreal, Canada.Poster Presentation

• Mercader A, Rubio C, Rodrigo L, Mateu E, Simón C, Pellicer A. Could donorinsemination failure be and indication for preimplantation genetic diagnosis (PGD)?Conjoint Annual Meeting, American Society for Reproductive Medicine (ASRM) &Canadian Fertility and Andrology Society (CFAS). October 2005; Montreal, Canada.Poster Presentation

• Cervero A, Horcajadas JA, Catalano R, Sharkey A, Pellicer A, Simón C. Gene expression pattern induced by leptin in human endometrial epithelial cells. Conjoint Annual Meeting, American Society for Reproductive Medicine (ASRM) & Canadian Fertility and Andrology Society (CFAS). October 2005; Montreal, Canada. Poster Presentation

2004• Meseguer M, Garrido N, Zuzuarregui JL, Pellicer A, Simón C, Remohí J. Infectious

diseases and genetic disorders found in the routinely screening in an ovum donationprogramme: experience from 10 years follow-up of 1991 candidates. 2nd AnnualInternational Egg Donation Conference. February 2004; Valencia, Spain. OralPresentation

• Bosch E, Troncoso C, Bellver J, Vidal C, Crespo J, Simón C, Pellicer A, Remohí J.Multivariate analysis of factors predicitng success in Egg donation. 2nd AnnualInternational Egg Donation Conference. February 2004; Valencia, Spain. OralPresentation

• Escribá MJ, Ferri MJ, Urios C, Romero JL, Bosch E, Simón C, Pellicer A, Remohí J.Timing for artificial luteal phase set up in EGG donation program. 2nd AnnualInternational Egg Donation Conference. February 2004; Valencia, Spain. OralPresentation

• Soares SR, Rubio C, Rodrigo L, Simón C, Remohí J, Pellicer A. Frecuency ofchromosomal abnormalities in embryos obtained from oocyte donation cycles. 2ndAnnual International Egg Donation Conference. February 2004; Valencia, Spain.Oral Presentation

• Epifanio R, Troncoso C, Bosch E, Rodríguez M, Remohí J, Pellicer A, Simón C.Reproductive outcome and obstetric evolution in women over 50 undergoing ovumdonation. 2nd Annual International Egg Donation Conference. February 2004;Valencia, Spain. Oral Presentation

• Troncoso C, Bosch E, Epifanio R, Aizpurua J, Castillón G, Simón C, Pellicer A.Endometrial thickness and serum oestradiol serum level as predictors of sucess in

116

oocyte donation. 2nd Annual International Egg Donation Conference. February2004; Valencia, Spain. Oral Presentation

• Castillón G, Rabadán S, Reis Soares S, Ramírez A, Bosch E, Simón C, Pellicer A,Remohí J. Advances in recipients endometrial preparation. 2nd Annual InternationalEgg Donation Conference. February 2004; Valencia, Spain. Oral Presentation

• García-Velasco JA, Zúñiga A, Pacheco A, Gómez R, Remohí J, Simón C, Pellicer A.Coasting reduces the incidence of OHSS by inducing apoptosis in small-mediumfollicules. 51st Annual Meeting, Society for Gynecologic Investigation. March 2004;Houston, USA. Poster Presentation

• Domínguez F, Castrillo JL, Avila Silvia, Pellicer A, Simón C. RNA interferencereduces IGFBP-rP1 expression in Rl95-2 cells. 51st Annual Meeting, Society forGynecologic Investigation. March 2004; Houston, USA. Poster Presentation

• Martínez-Conejero JA, Garrido N, Remohí J, Pellicer A, Simón C, Meseguer M. TheMUC1 mucin is present on the human sperm surface. 20th Annual Meeting of theEuropean Society of Human Reproduction and Embryology (ESHRE). June 2004;Berlin, Germany. Poster Presentation

• Boerrigter P, Escudero E, Coelingh Bennink H, Pellicer A, Olivennes F, Simón C.Mifepristone is an affective oral alternative to prevent premature LH surges incontrolled ovarian hyperstimulation. 20th annual Meeting of the European Society ofHuman Reproduction and Embryology (ESHRE). June 2004; Berlin, Germany.Poster Presentation

• Simón C, Bellver J, Vidal C, Bosch E, Martín J, Horcajadas JA, Murphy C, RiesewijkA, Oberyé J, Mannaerts B, Pellicer A. Similar endometrial development in oocytedonors after daily treatment with high- or low-dose GnRH antagonist compared toGnRH agonist and natural cycles. 20th annual Meeting of the European Society ofHuman Reproduction and Embryology (ESHRE). June 2004; Berlin, Germany. OralPresentation

• Garrido, Meseguer M, Simón C, Remohí J, Pellicer A. Report of the results of atwo-year program of sperm wash and intracytoplasmic sperm injection (ICSI) forhuman immunodeficiency virus (HIV) serodiscordant copules. 20th annual Meetingof the European Society of Human Reproduction and Embryology (ESHRE). June2004; Berlin, Germany. Oral Presentation

• Soares SR, Troncoso C, Bosch E, Simón C, Pellicer A. Age and uterinereceptiviness in oocyte donation. 20th annual Meeting of the European Society ofHuman Reproduction and Embryology (ESHRE). June 2004; Berlin, Germany. OralPresentation

• Horcajadas JA, Riesewijk A, Polman J, Mosselman S, Pellicer A, Simón C. Impactof controlled ovarian hyperstimulation on endometrial gene expression profilesduring the window of implantation. 60th Annual Meeting of the American Society forReproductive Medicine. October 2004; Pennsylvania, Philadelphia, USA. OralPresentation

• Horcajadas JA, Catalano R, Burgos A, Sharkey A, Pellicer A, Simón C. Functionalgenomics of endometrial receptivity using an interceptive approach. 60th AnnualMeeting of the American Society for Reproductive Medicine. October 2004;Pennsylvania, Philadelphia, USA. Oral Presentation

• Vidal C, Rubio C, Crespo J, Simón C, Remohí J, Pellicer A. Increased incidence ofchromosomal abnormalities in embryos from polycystic ovarian syndrome patients.60th Annual Meeting of the American Society for Reproductive Medicine. October2004; Pennsylvania, Philadelphia, USA. Oral Presentation

• Meseguer M, Garrido N, Martínez-Conejero JA, Simón C, Pellicer A, Remohí J.Ca+2 and cholesterol and mitochondrial activity in sperm from fertile and infertilemen. 60th Annual Meeting of the American Society for Reproductive Medicine.October 2004; Pennsylvania, Philadelphia, USA. Poster Presentation

• Gómez R, González M, Sánchez-Criado J, Simón C, Remohí J, Pellicer A. Dopamine (D) agonist (A) administration diminishes increased vascular permeability (iVP) in ovarian hyperstimulation sindrome (OHSS) animals by blocking vascular endothelial growth factor receptor 2 (VEGFR2) phosporylation (ph). 60th Annual

117

Meeting of the American Society for Reproductive Medicine. October 2004; Pennsylvania, Philadelphia, USA. Poster Presentation

• Molina NK, Zuzuarregui JL, Simón C, Remohí J, Pellicer A. Early pregnancy loss inpreimplantatory genetic diagnosis. 60th Annual Meeting of the American Society forReproductive Medicine. October 2004; Pennsylvania, Philadelphia, USA. PosterPresentation

• García-Velasco JA, Duque L, Moreno A, Zúñiga A, Requena A, Simón C. Coasting:the experience with the antagonist. 60th Annual Meeting of the American Society forReproductive Medicine. October 2004; Pennsylvania, Philadelphia, USA. PosterPresentation

• Muñoz EA, Garrido N, Melo MA, Simón C, Pellicer A, Remohí J. The importance ofdifficult embryo transfer: A comparison in recipients of shared oocytes. 60th AnnualMeeting of the American Society for Reproductive Medicine. October 2004;Pennsylvania, Philadelphia, USA. Poster Presentation

• Bosch E, Pau E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinizationin GnRH antagonist cycles in oocyte donors and its relationship to recipients cycleoutcome. 60th Annual Meeting of the American Society for Reproductive Medicine.October 2004; Pennsylvania, Philadelphia, USA. Poster Presentation

2003•••• Domínguez F, Luna JJ, Pellicer A, Simón C. Chemokine receptor expression and

localization in human endometrium. 50th Annual Meeting, Society for GynecologicInvestigation. March 2003; Washington. DC., USA. Poster Presentation

• Cervero A, Horcajadas JA, Martín J, De Pablo JL, Escriba MJ, Pellicer A, Simón C.Leptin and leptin receptor in human endometrium and preimplantation embryos.50th Annual Meeting, Society for Gynecologic Investigation. March 2003;Washington. DC., USA. Poster Presentation

•••• Escobedo C, García-Verdugo JM, Escriba MJ, Pellicer A, Simón C. Ultrastructuralstudy of the human blastocyst. 50th Annual Meeting, Society for GynecologicInvestigation. March 2003; Washington. DC., USA. Poster Presentation

• Luna JJ, Horcajadas JA, Domínguez F, Remohí J, Pellicer A, Simón C. Relaxinreceptor LGR-7 mRNA expression and localization in human endometrium throughthe menstrual cycle. 50th Annual Meeting, Society for Gynecologic Investigation.March 2003; Washington. DC., USA. Poster Presentation

• Domínguez F, Cervero A, Avila S, Castrillo JL, Pellicer A, Simón C. IGFBP-rP1expression and localization througout the human menstrual cycle. 50th AnnualMeeting, Society for Gynecologic Investigation. March 2003; Washington. DC., USA.Poster Presentation

• Marí M, Garrido N, Pellicer A, Remohí J, Simón C, Meseguer M. A prospectiverandomized study comparing sperm-grad vs. pure-sperm for density gradientseparation of human spermatozoa in assisted reproduction.15th IFCC- FESCCEuropean Congress of Clinical Cemistry and Laboratory Medicine. 22th NationalCongress of the Spanish Society of Clinical Biochemistry and Molecular Pathology.June 2003; Barcelona, Spain. Poster Presentation

• Marí M, Meseguer M, Pellicer A, Remohí J, Simón C, Garrido N. A prospectiverandomized study comparing sperm-rinse vs. sperm for swim-up capacitation ofhuman spermatozoa in assisted reproduction. 15th IFCC- FESCC EuropeanCongress of Clinical Cemistry and Laboratory Medicine. 22th National Congress ofthe Spanish Society of Clinical Biochemistry and Molecular Pathology. June 2003;Barcelona, Spain. Poster Presentation

• Gómez R, González M, Simón C, Remohí J, Pellicer A. Ovarian hyperstimulationsyndrome (OHSS) is related to the upregulation of rate steps enzymes limitingovarian cholesterol biosynthesis. III International Workshop on Human Implantation:Discovery in the Reproductive Tract in Health and Disease UsingGenomics/Proteomics. June 2003; Madrid, Spain. Poster Presentation

• Martín J, Domínguez F, Ávila S, Pellicer A, Castrillo JL, Simón C. cDNA Microarrayanalysis of human endometrial tissue shows the differential expression of GADD45Aapoptosis-related gene in receptive endometrial. III International Workshop on

118

Human Implantation: Discovery in the Reproductive Tract in Health and DiseaseUsing Genomics/Proteomics. June 2003; Madrid, Spain. Poster Presentation

• Luna JJ, Horcajadas JA, Domínguez F, Remohí J, Pellicer A, Simón C. GeneExpresión pattern and immunoreactive protein localization of LGR7. Receptor inHuman endometrium throughout the menstrual cycle. III International Workshop onHuman Implantation: Discovery in the Reproductive Tract in Health and DiseaseUsing Genomics/Proteomics. June 2003; Madrid, Spain. Poster Presentation

• Reis Soares S, Rubio C, Rodrigo L, Mateu E, Mercader A, Simón C, Remohí J,Pellicer A. Does preimplantation genetic diagnosis improve the outcome of eggdonation cycles?. 19th European Society of Human Reproduction and Embryology(ESHRE) Annual Meeting. June – July 2003; Madrid, Spain. Poster Presentation

• Rodrigo L, Rubio C, Gil-Salom M, Mateu E, Pérez-Cano I, Herrer R, Simón C,Remohí J, Pellicer A. Sperm chromosomal abnormalities: a new indication forpreimplantation genetic diagnosis?. 19th European Society of Human Reproductionand Embryology (ESHRE) Annual Meeting. June – July 2003; Madrid, Spain. PosterPresentation

• Diaz I, Guillén A, Pacheco A, Requena A, Simón C, García-Velasco J. Final oocytematuration with GnRH agonist versus HCG in intrauterine insemination. 19thEuropean Society of Human Reproduction and Embryology (ESHRE) AnnualMeeting. June – July 2003; Madrid, Spain. Poster Presentation

• Bellver J, Muñoz E, Ballesteros A, Reis S, Bosch E, Vidal C, Simón C, Remohí J.Intravenous albumin does not prevent moderate-severe OHSS. 19th EuropeanSociety of Human Reproduction and Embryology (ESHRE) Annual Meeting. June –July 2003; Madrid, Spain. Poster Presentation

• Epifanio RE, Troncoso C, Escudero E, Remohí J, Pellicer A, Simón C. Reproductiveoutcome and obstetric evolution in women >50 undergoing oocyte donation. 19thEuropean Society of Human Reproduction and Embryology (ESHRE) AnnualMeeting. June – July 2003; Madrid, Spain. Poster Presentation

• Bosch E, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Serum LH inovarian stimulation with GnRH antagonists. 19th European Society of HumanReproduction and Embryology (ESHRE) Annual Meeting. June – July 2003; Madrid,Spain. Oral Presentation

• De los Santos MJ, Valencia I, Simón C, Remohí J, Pelllicer A. Prematureluteinization does not affect embryo quality in GnRH antagonists cycles. 19thEuropean Society of Human Reproduction and Embryology (ESHRE) AnnualMeeting. June – July 2003; Madrid, Spain. Oral Presentation

• Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. Glutathione peroxidase 4activity but not expression is lower in infertile males than normal fertile controls. 3rdJoint Meeting of the British Andrology Society, the British Fertility Society and theSociety for Reproduction and Fertility. July 2003; Aberdeen, Scotland. PosterPresentation

• Garrido N, Meseguer M, Simón C, Remohí J, Pellicer A. Seminal glutathione system(glutathione peroxidases 1 and 4, and glutathione reductase) expression and activityis not correlated with classical semen parameters. 3rd Joint Meeting of the BritishAndrology Society, the British Fertility Society and the Society for Reproduction andFertility. July 2003; Aberdeen, Scotland. Poster Presentation

• Domínguez F, Luna Martín JJ, Pellicer A, Simón C. Implantation process of thehuman embryo. TWIN-Meeting Alpha-Andrology 2003, 4th Biennial AlphaConference. 8th Meeting of Andrology in the 2000’s. September 2003; Antwerp,Belgium. Oral Presentation

• Mercader A, Pérez I, Rodrigo L, Gómez E, Mateu E, Amaroroso B, Remohí J,Simón C, Pellicer A, Rubio C. Development of abnormal embryos in sequentialculture versus co-culture systems. TWIN-Meeting Alpha-Andrology 2003, 4thBiennial Alpha Conference. 8th Meeting of Andrology in the 2000’s. September2003; Antwerp, Belgium. Poster Presentation

• Meseguer M, Garrido N, Martínez JA, Simón C, Pellicer A, Remohí J. Intracellularsperm and seminal plasma Ca+2 concentrations affect cryodamage susceptibility

119

after a cycle of freezing and thawing. 59th Annual Meeting of the American Societyfor Reproductive Medicine. October 2003; San Antonio, Texas, USA. PosterPresentatio

• Meseguer M, Garrido N, Rodríguez M, Simón C, Pellicer A, Remohí J. Spermglutathione antioxidant defense system protects from cryodamage after a cycles offreezing and thawing. 59th Annual Meeting of the American Society for ReproductiveMedicine. October 2003; San Antonio, Texas, USA. Poster Presentation

• Rodríguez M, Escudero E, Epifanio R, Garrido N, Meseguer M, Simón C. Amathematical equation to calculate the maximum pregnancy rate with a minimumrisk for multiple pregnancies in patients undergoing IVF. 59th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2003; San Antonio, Texas,USA. Poster Presentation

• Troncoso C, Bosch E, Epifanio R, Simón C, Pellicer A, Remohí J. Endometrialthickness and serum oestradiol serum levels as predictors of success in oocytedonation. 59th Annual Meeting of the American Society for Reproductive Medicine.October 2003; San Antonio, Texas, USA. Poster Presentation

• Pehlivan T.S, Rodrigo L, Simón C, Remohí J, Pellicer A, Rubio C. Chromosomalabnormalities in day 3 embryos from servere oligozoospermic patients. 59th AnnualMeeting of the American Society for Reproductive Medicine. October 2003; SanAntonio, Texas, USA. Poster Presentation

• Garrido N, Meseguer M, Simón C, Pellicer A, Remohí J. Parameters affectingpositive viral load after sperm wash on HIV seropositive patients. 59th AnnualMeeting of the American Society for Reproductive Medicine. October 2003; SanAntonio, Texas, USA. Poster Presentation

• Garrido N, Meseguer M, Rodríguez M, Simón C, Remohí J. PCR detection ofHepatitis C Virus (HCV) in washed sperm. Comparison of two different PCR-dependent methods for determining its presence. 59th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2003; San Antonio, Texas,USA. Poster Presentation

• Lima-Couy I, Cervero A, Bonilla-Musoles F, Remohí J, Pellicer A, Simón C.Endometrial leptin and leptin receptor expression in women with endometriosis. 59thAnnual Meeting of the American Society for Reproductive Medicine. October 2003;San Antonio, Texas, USA. Poster Presentation

• Molina N. M, Bosch E, Troncoso C, Simón C, Pellicer A, Remohí J. Ectopicpregnancy in IVF with own versus donated oocytes. 59th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2003; San Antonio, Texas,USA. Poster Presentation

• Escudero E, Coelingh Bennink H.J.T, Boerrigter P.J, Bunchoten H, Pellicer A, SimónC. High dose of rec-LH overcomes the deleterious effect of high dose GnRHantagonist on embryonic implantation. 59th Annual Meeting of the American Societyfor Reproductive Medicine. October 2003; San Antonio, Texas, USA. OralPresentation

• Gómez R, González M, Simón C, Remohí J, Pellicer A. Tyroxine hydroxylase (TH)downregulation in hyperstimulated ovaries reveals the dopamine agonistbromocriptine (Br2) as an effective and specific method to block increased vascularpermeability (VP) in OHSS. 59th Annual Meeting of the American Society forReproductive Medicine. October 2003; San Antonio, Texas, USA. Oral Presentation

• Gómez R, Lima L, Simón C, Pellicer A. Low-dose LH administration inducesovulation and prevents vascular hyperpermeability and VEGF expression insuperovulated rats. 59th Annual Meeting of the American Society for ReproductiveMedicine. October 2003; San Antonio, Texas, USA. Oral Presentation

2002• Martín J, De Pablo J, Cervero A, Remohí J, Pellicer A, Simón C. Human

endometrial cytoskeleton-associated ezrin family is up-regulated by progesteroneduring the menstrual cycle. In contrast no embryonic regulation was observed. 49thAnnual Meeting of the Society for Gynecologic Investigation. March 2002; Los

120

Angeles, California, USA. Poster Presentation • Martín J, Domínguez F, Avila S, Pellicer A, Castrillo JL, Simón C. cDNA macroarray

analysis of human endometrial tissue shows the differential expresión of GADD45Aapoptosis-related gene in receptive endometria. 49th Annual Meeting of the Societyfor Gynecologic Investigation. March 2002; Los Angeles, California, USA. PosterPresentation

• Riesewijk A, Martín J, Domínguez F, Van Os R, Pellicer A, Mosselman S, Simón C.Genes expressed in receptive versus pre-receptive human endometrium. 49thAnnual Meeting of the Society for Gynecologic Investigation. March 2002; LosAngeles, California, USA. Poster Presentation

• Domínguez F, Avila S, Martín J, Pellicer A, Castrillo J.L, Simón C. Differential geneexpresión of cytokines, chemokines, growth factors and their receptors in RL95-2and HEC-1-A cell lines. 49th Annual Meeting of the Society for GynecologicInvestigation. March 2002; Los Angeles, California, USA. Poster Presentation

• Gomez R, Simón C, Remohí J, Pellicer A. The ovary as a source of gonadotrophindependent vascular endotelial growth factor (VEGF) in an ovarian hyperstimulationsyndrome (OHSS) animal model. 49th Annual Meeting of the Society forGynecologic Investigation. March 2002; Los Angeles, California, USA. PosterPresentation

• Miralles F, Muñoz EA, Scheffer B, Remohí J, Pellicer A, Simón C. Ovarianstimulation in intrauterine insemination with recombinant FSH. 18th Annual MeetingEuropean Society of Human Reproduction and Embryology. July 2002; Vienna,Austria. Oral Presentation

• Troncoso C, Bosch E, Rubio MC, Simón C, Remohí J, Pellicer A. The origin ofbiochemical pregnancies: lessons learned from preimplantation genetic diagnosis.18th Annual Meeting European Society of Human Reproduction and Embryology.July 2002; Vienna, Austria. Oral Presentation

• Muñoz EA, Muñoz M, Navarro J, Simón C, Remohí J, Pellicer A. Reproductiveoutcome of premature ovarian failure. 18th Annual Meeting European Society ofHuman Reproduction and Embryology. July 2002; Vienna, Austria. Oral Presentation

• Garrido N, Meseguer M, Ruiz A, Simón C, Remohí JA, Pellicer A. Success inassisted reproduction cycles is not affected by the time that the sperm has beencryopreserved. 18th Annual Meeting European Society of Human Reproduction andEmbryology. July 2002; Vienna, Austria. Oral Presentation

• Gómez R, Simón C, Remohí JA, Pellicer A. Inhibition of luteal angiogenesis byblocking vascular endothelial growth factor receptor 2 as a specific approach toinhibit vascular permeability in an ovarian hyperstimulation syndrome animal model.18th Annual Meeting European Society of Human Reproduction and Embryology.July 2002; Vienna, Austria. Poster Presentation

• Bosch E, Escudero E, Crespo J, Simón C, Remohí JA, Pellicer A. Follicularasynchrony in ovarian stimulation with GnRH antagonists. 18th Annual MeetingEuropean Society of Human Reproduction and Embryology. July 2002; Vienna,Austria. Poster Presentation

• Escudero E, Rosal LP, Bosch E, Crespo J, Simón C, Remohí JA, Pellicer A. Hasday 4 serum estradiol a predictive value in flare-up? 18th Annual Meeting EuropeanSociety of Human Reproduction and Embryology. July 2002; Vienna, Austria. PosterPresentation

• Scheffer B, García-Velasco JA, Scheffer R, Remohí J, Pellicer A, Simón C.Incidence of monozygotic twuinning is not related to zona pellucidamicromanipulation or blastocyst stage transfer. 18th Annual Meeting EuropeanSociety of Human Reproduction and Embryology. July 2002; Vienna, Austria. PosterPresentation

• ivan T, Rubio C, Rodrigo L, Remohí J, Pellicer A, Simón C. Chromosomalabnormalities in embryos from day 2 ICSI. 18th Annual Meeting European Society ofHuman Reproduction and Embryology. July 2002; Vienna, Austria. PosterPresentation

• Meseguer M, Garrido N, Garcia de Lomas J, Simón C, Remohí J, Pellicer A. HIV

121

and hepatitis C virus presence in washed semen: are they absent or presentalthough non-infective? 18th Annual Meeting European Society of HumanReproduction and Embryology. July 2002; Vienna, Austria. Poster Presentation

• Crespo J, Escudero E, Bosch E, Gaytan J, Simón C, Remohí JA, Pellicer A. Whento start the GnRH antagonist in IVF? Preliminary results. 18th Annual MeetingEuropean Society of Human Reproduction and Embryology. July 2002; Vienna,Austria. Oral Presentation

• Rubio C, Rodrigo L, Phelivan T, Simón C, Remohí JA, Pellicer A. Preimplantationgenetic diagnosis in implantation failure and recurrent pregnancy loss. 18th AnnualMeeting European Society of Human Reproduction and Embryology. July 2002;Vienna, Austria. Oral Presentation

• Simón C. Leptin and leptin receptor in human endometrium and preimplantationembryos. Gordon Research Conference on Reproductive Tract Biology. June – July2002; Connecticut College, New London, USA. Oral Presentation

• Simón C. Ultrastructure of the human blastocyst. Gordon Research Conference onReproductive Tract Biology. June – July 2002; Connecticut College, New London,USA. Oral Presentation

• Bosch E, Valencia I, Crespo J, Simón C, Remohí J, Pellicer A. Relationship betweenserun LH and IVF outcome in cycles with a GnRH Antagonist (Cetrorelix). 58thAnnual Meeting of the American Society for Reproductive Medicine. October 2002;Seattle, Washington, USA. Poster Presentation

• Escudero E, Mercader A, Troncoso C, Remohí J, Pellicer A, Simón C. Perinatologicresults of infants born after an embryo coculture program with human epithelialendomtrial cells. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Poster Presentation

• Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A. Glutathione peroxidaseexpresión and activity correlates with sperm survival after thawing58th AnnualMeeting of the American Society for Reproductive Medicine. October 2002; Seattle,Washington, USA. Poster Presentation

• García-Velasco JA, Corona J, Requena A, Remohí J, Simón C, Pellicer A. Shouldwe operate ovarian endometriomas prior to IVF?. 58th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2002; Seattle, Washington,USA. Poster Presentation

• Garrido N, Messeguer M, Gil-Salom M, Simón C, Remohí J, Pellicer A. Testicularsperm extraction (TESE) an intracytoplasmic sperm injection (ICSI) results insecondary azoospermic patients after chemotherapy. 58th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2002; Seattle, Washington,USA. Poster Presentation

• Pehlivan T, Rubio C, Rodrigo L, Remohí J, Pellicer A, Simón C. Experience inpreimplantation genetic diagnosis for recurrent IVF failure. A Two years follow-upstudy. 58th Annual Meeting of the American Society for Reproductive Medicine.October 2002; Seattle, Washington, USA. Poster Presentation

• Troncoso C, Bosch E, Rubio C, Simón C, Remohí J, Pellicer A. The Origin ofbiochemical pregnancies: lessons learned from preimplantation genetic diagnosis(PGD). 58th Annual Meeting of the American Society for Reproductive Medicine.October 2002; Seattle, Washington, USA. Poster Presentation

• Valencia I, Bosch E, Simón C, Troncoso C, Remohí J, Pellicer A. Progesteroneelevation during GnRH antagonists cycles in IVF adversely affects prefnancy andimplantation rates. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Poster Presentation

• Troncoso C, Escudero E, Gaytan J, Remohí J, Pellicer A, Simón C. Finding theideal number of embryos to transfer on day 3 of development when there is a goodembryo cohort?. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Poster Presentation

• Bosch E, Albert C, Ruiz A, Simón C, Remohí J, Pellicer A. Oocyte and embryoquality in IVF cycles with GnRH antagonist vs GnRH agonist. 58th Annual Meeting of

122

the American Society for Reproductive Medicine. October 2002; Seattle,Washington, USA. Poster Presentation

• Rosal LP, Bosch E, Escudero E, Remohí J, Pellicer A, Simón C. Day 3 embryo-assessment criteria validity for blastocyst transfer in Oocyte donation using a co-culture program. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Poster Presentation

• Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A. Success in assistedreproduction cycles with frozen sperm is not affected by the time that it has beencryopreserved. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Oral Presentation

• Zuzuarregui JL, Meseguer M, Garrido N, Pellicer A, Simón C, Remohí J. Infectiousdiseases and genetic disorders found in the routinely screening in an ovum donationprogramme: experience from 10 years follow-up. 58th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2002; Seattle, Washington,USA. Poster Presentation

• Rodrigo L, Rubio C, Simón C, Remohí J, Pellicer A, Gil-Salom M. Fluorescence “InSitu” hybridization (FISH) análisis of chromosomal abnormalities in testicular andepididymal spermatozoa. 58th Annual Meeting of the American Society forReproductive Medicine. October 2002; Seattle, Washington, USA. Oral Presentation

• Valencia I, Bosch E, Troncoso C, Simón C, Remohí J, Pellicer A. Prematureluteinization during GnRH antagonists cycles in IVF adversely affects pregnancy andimplantation rates. 58th Annual Meeting of the American Society for ReproductiveMedicine. October 2002; Seattle, Washington, USA. Oral Presentation

2001 • Escobedo C, Martín J, Domínguez F, Valbuena D, Mercader A, O’Connor E, Pellicer

A, Simón C. Embryonic regulation of cyclooxigenase-2 in human endometrialepithelial cells. 48th Annual Meeting of the Society for Gynecologic Investigation.March 2001; Toronto, Canada. Poster Presentation

• Martín J, Avila S, Jiménez O, Pellicer A, Castrillo J.L, Simón C. Detection of novelgenes associated to high versus low endometrial receptivity status. 48th AnnualMeeting of the Society for Gynecologic Investigation. March 2001; Toronto, Canada.Poster Presentation

• García-Velasco J.A, Simón C, Mor G, Arici A. Soluble Fas ligan is elevated inperitoneal fluid and serum of women with endometriosis. 48th Annual Meeting of theSociety for Gynecologic Investigation. March 2001; Toronto, Canada. PosterPresentation

• Gaytán J; Bellver J, Camargo F, Remohí J, Pellicer A, Simón C. Endometrial fluidaspiration at different days of the stimulated cycles does not affect IVF/ICSIoutcome. II International Workshop on Human Implantation: Recent Advances &Clinical Aspects. May 2001; Madrid, Spain. Poster Presentation

• Domínguez F, Dasi F, Remohí J, Pellicer A, Simón C. Embryonic regulation ofrantes receptor (CCR5) and MCP-1 receptor (CCR2B) in cultured endometrialepithelial cells (EEC). II International Workshop on Human Implantation: RecentAdvances & Clinical Aspects. May 2001; Madrid, Spain. Poster Presentation

• Valbuena D, Martín J, Remohí J, Pellicer J, Simón C. High estradiol levels aredeleterious to embryonic implantation due to a direct effect on the embryodevelopment. II International Workshop on Human Implantation: Recent Advances &Clinical Aspects. May 2001; Madrid, Spain. Poster Presentation .

• Rubio C, Gil-Salom M, Rodrigo L, Remohí J, Simón C, Pellicer A. Implications ofsperm chromosome abnormalities on ICSI outcome. 17th Annual Meeting EuropeanSociety of Human Reproduction and Embryology. July 2001; Lausanne, Switzerland.Poster Presentation

• Isaza V, García-Velasco JA, Scheffer B, Landazabal A, Martinez-Salazar J,Requena A , Remohí J , Simón C. Does “coasting”affect the outcome in oocytedonation? 17th Annual Meeting European Society of Human Reproduction andEmbryology. July 2001; Lausanne, Switzerland. Poster Presentation

• Requena A, Isaza V, Caligara X, García-Velasco JA, Martinez-Salazar J, Landazabal

123

A, Remohí J, Simón C. Sharing oocytes from a single donor: predictors ofdiscordant outcome. 17th Annual Meeting European Society of Human Reproductionand Embryology. July 2001; Lausanne, Switzerland. Poster Presentation

• Meseguer M, Garrido N, Zuzuarregui JL, Romero JL, Simón C, Remohí J, PellicerA. Is the use of donor spermatozoa a safe option? Infectious diseases and geneticdisorders screening in a sperm donor population and a donor artificial inseminationprogramme: experience from 10 years follow-up. 17th Annual Meeting EuropeanSociety of Human Reproduction and Embryology. July 2001; Lausanne, Switzerland.Poster Presentation

• Rodrigo L, Rubio C, Simón C, Remohí J, Pellicer A, Gil-Salom M. Incidence ofchromosomal abnormalities in testicular and epididymal spermatozoa, analysed byfluorescence in-situ hybridization (FISH). 17th Annual Meeting European Society ofHuman Reproduction and Embryology. July 2001; Lausanne, Switzerland. PosterPresentation

• Bosch E, Ruiz A, De los Santos MJ, Romero JL, Calderón G, Simón C, Remohí J,Pellicer A. Description of a measurable embryo quality index, and its relation toimplantation and pregnancy rates. 17th Annual Meeting European Society of HumanReproduction and Embryology. July 2001; Lausanne, Switzerland. Oral Presentation

• García-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A.Human ovarian steroid secretion in vivo: effects of gonadotrophin-releasing hormoneagonist versus antagonist (cetrorelix). 17th Annual Meeting European Society ofHuman Reproduction and Embryology. July 2001; Lausanne, Switzerland. OralPresentation

• Meseguer M, Garrido N, Romero J, Remohí J, Simón C, Pellicer A. Parametersaffecting sperm survival after thawing in long-term frozen storage. 57th AnnualMeeting of the American Society for Reproductive Medicine. October 2001; Orlando,Florida, USA. Poster Presentation

• Caligara C, Navarro J, Camargo F, Simón C, Pellicer A, Remohí J. Oocyte retrievalrate through repeated identical controlled ovarian stimulation cycles in donors. 57thAnnual Meeting of the American Society for Reproductive Medicine. October 2001;Orlando, Florida, USA. Poster Presentation

• Isaza V, García-Velasco J, Martinez-Salazar J, Requena A, Landazabal A, Simón C.Does measurement of ovarian stromal blood flow by color Doppler predict IVFoutcome?. 57th Annual Meeting of the American Society for Reproductive Medicine.October 2001; Orlando, Florida, USA. Poster Presentation

• Camargo F, Gaytan J, Caligara C, Simón C, Pellicer A, Remohí J. Impact ofultrasound diagnosis of adenomyosis on recipients of sibling oocytes. 57th AnnualMeeting of the American Society for Reproductive Medicine. October 2001; Orlando,Florida, USA. Poster Presentation

• Vargas-Chavarria G, Caligara C, Bosch E, Simón C, Remohí J, Pellicer A. The useof long-acting forms of gonadotropin-releasing hormone analogs (GnRHa Depot)increase miscarriage rates in oocyte donation cycles. 57th Annual Meeting of theAmerican Society for Reproductive Medicine. October 2001; Orlando, Florida, USA.Poster Presentation

• Escriba MJ, Valbuena D, Sánchez E, Remohí J, Pellicer A, Simón C. Diploid rescuefrom tripronucleated human embryos. A new tool for embryo research. 57th AnnualMeeting of the American Society for Reproductive Medicine. October 2001; Orlando,Florida, USA. Poster Presentation

• Vargas-Chavarría G, Meseguer M, Garrigo N, Simón C, Remohí J, Pellicer A.Timing does not influence outcomes in double intrauterine insemination. 57th AnnualMeeting of the American Society for Reproductive Medicine. October 2001; Orlando,Florida, USA. Poster Presentation

• Mercader A, Gamiz P, De los Santos M, Remohí J, Pellicer A, Simón C. Sex ratioafter day 2, day 3 or blastocyst transfer. 57th Annual Meeting of the AmericanSociety for Reproductive Medicine. October 2001; Orlando, Florida, USA. PosterPresentation

• Domínguez F, Avila S, Martin J, Pellicer A, Castrillo J, Simón C. Differential gene

124

expression of cytokines, chemokines, growth factors and their receptors in receptiveversus non-receptive human endometrium. 57th Annual Meeting of the AmericanSociety for Reproductive Medicine. October 2001; Orlando, Florida, USA. OralPresentation

• García-Velasco JA, Martínez-Salazar J, Isaza V, Landazabal A, Requena A, SimónC. Does ultrasound guidance at embryo transfers improve pregnancy rates in oocyterecipients? 57th Annual Meeting of the American Society for Reproductive Medicine.October 2001; Orlando, Florida, USA. Oral Presentation

• Valbuena D, Martín JC, De Pablo JL, Remohí J, Pellicer A, Simón C. Increasinglevels of estradiol are deleterious to embryonic implantation due mainly to a directeffect on the embryo. 57th Annual Meeting of the American Society for ReproductiveMedicine. October 2001; Orlando, Florida, USA. Oral Presentation

• Isaza V, Arbues J, García-Velasco J.A, Requena A, Martínez-Salazar J, LandazábalA, Villasante A, Scheffer B, Remohí J, Pellicer A, Simón C. Nafarelin versustriptorelin for in-vitro fertilization: a randomized study. IV Congress of the EuropeanSociety of Gynaecology. October 2001; Barcelona, Spain. Poster Presentation

• Scheffer B, Isaza V, García-Velasco J.A, Requena A, Martínez-Salazar J,Landazábal A, Villasante A, Remohí J, Pellicer A, Simón C. Monozygotic twinning: aphenomenon independent of assisted reproductive treatment modalities. IVCongress of the European Society of Gynaecology. October 2001; Barcelona, Spain.Poster Presentation.

2000• Garrido N, Krussel J, O’Connor J, Simón C, Pellicer A. Expression, production and

secretion of vascular endothelial growth factor (VEGF) and Interleukin-6 (IL-6) bygranulosa cells in women with endometriosis. 47th Annual Meeting of the Society forGynecologic Investigation. March 2000; Chicago, Illinois, USA. Poster Presentation

• Meseguer M, Simón C, Caballero-Campo P, Martín J, Pellicer A, Aplin J. MUC1 isdown-regulated by TGF-PUC1 is down-regulated by TGF- Pellicer A, Aplin J. fvascular endothelial growth factor (VEGF) aChicago, Illinois, USA. PosterPresentation

• Valbuena K, Jasper M, Galán A, Pellicer A, Simón C. High estradiol levels alterembryonic adhesion on endometrial epithelial cells (EEC). 47th Annual Meeting ofthe Society for Gynecologic Investigation. March 2000; Chicago, Illinois, USA.Poster Presentation

• Meseguer M, Simón C, Wreschner D, Hey N, Aplin J. The alternatively splicedMUC1 isoform SEC is associated with the apical surface of human endometrialepithelial cells. 47th Annual Meeting of the Society for Gynecologic Investigation.March 2000; Chicago, Illinois, USA. Poster Presentation

• Martín J, Jasper M, Valbuena D, Meseguer M, Simón C. Absence of moesinexpression in cultured endometrial-derived cells with more adhesive properties forblastocysts. 47th Annual Meeting of the Society for Gynecologic Investigation. March2000; Chicago, Illinois, USA. Poster Presentation

• Domínguez F, Caballero-Campo P, Meseguer M, Pellicer A, Simón C. Hormonal andembryonic regulation of chemokines IL-8, MCP-1, RANTES and their receptorsCXCR1,CCR2B and CCR5 in human endometrium. 47th Annual Meeting of theSociety for Gynecologic Investigation. March 2000; Chicago, Illinois, USA. PosterPresentation

• De los Santos MJ, Mercader A, Galán A, Prados N, Remohí J, Pellicer A, Simón C.The predictive value of three or more 8-cell embryos on pregnancy rate in co-culturesystem. International Symposium on Art and the Human Blastocyst. March – April2000; Dana Point, California, USA. Oral Presentation

• Rubio C, Vidal F, Mínguez Y, Giménez C, Romero J, Egozcue J, Remohí J, PellicerA, Simón C. Preimplantation Genetics Diagnosis (PGD): a powerful tool in femaleand male carriers of balanced translocations. 10th International Conference onPrenatal Diagnosis And Therapy. June 2000; Barcelona, Spain. Oral Presentation

125

• Garrido N, Krüssel J.S, Remohí J, Simón C, Pellicer A. Progesterone productionand 3P hydroxsteroid dehydrogenase (3P HSD) expression in granulosa cells fromwomen with endometriosis. 16th Annual Meeting European Society of HumanReproduction and Embriology. June 2000; Bologna, Italy. Poster Presentation

• Ibérico G, Serra V, Rodríguez M, Simón C, Pellicer A, Remohí J. Modified earlytransvaginal technique of embryo reduction in multifetal pregnancies resulting fromassisted reproduction techniques. 16th Annual Meeting European Society of HumanReproduction and Embriology. June 2000; Bologna, Italy. Poster Presentation

• Muñoz E, Cuneo S,Ferro J, Vidal C, Pellicer A, Simón C, Remohí J. Intravenousalbumin in the prevention of ovarian hyperstimulation syndrome. 16th AnnualMeeting European Society of Human Reproduction and Embriology. June 2000;Bologna, Italy. Poster Presentation

• García-Velasco J.A, Isaza V, Requena A, Martínez-Salazar J, Landazábal A,Remohí J, Pellicer A, Simón C. Stop protocol versus high doses of gonadotrophinsin low responder IVF patients: a prospective, randomized, controlled trial. 16thAnnual Meeting European Society of Human Reproduction and Embriology. June2000; Bologna, Italy. Poster Presentation

• Camargo F, Crespo J, Cuneo S, Caligara C, Simón C, Pellicer A, Remohí J.Implications of adenomyosis in the infertile patient. 16th Annual Meeting EuropeanSociety of Human Reproduction and Embriology. June 2000; Bologna, Italy. PosterPresentation

• Isaza V, Requena A, García-Velasco J.A, Anarte C, Landazabal A, Martínez-SalazarJ, Remohí J, Pellicer A, Simón C. Urinary-FSH vs recombinant FSH in patientsundergoing intrauterine inseminations: a prospective study. 16th Annual MeetingEuropean Society of Human Reproduction and Embriology. June 2000; Bologna,Italy. Poster Presentation

• Rubio C, Vidal F, Mínguez Y, Romero J, Giménez C, Egozcue J, Remohí J, PellicerA, Simón C. High incidence of chromosomal abnormalities in preimplantationembryos from recurrent spontaneous abortion patients. 16th Annual MeetingEuropean Society of Human Reproduction and Embriology. June 2000; Bologna,Italy. Oral Presentation

• Gil-Salom M, Rubio C, Mínguez Y, Vidal C, Simón C, Remohí J, Pellicer A.Correlation between the severity of oligozoospermia and the incidence of spermchromosomal abnormalities in a risk population. 16th Annual Meeting EuropeanSociety of Human Reproduction and Embriology. June 2000; Bologna, Italy. OralPresentation

• Caligara C, Vargas G, Cuneo S, Rodríguez M, Simón C, Pellicer A, Remohí J. Doesrepeated controlled ovarian hyperstimulation affect oocyte retrieval rate in donors?.16th Annual Meeting European Society of Human Reproduction and Embriology.June 2000; Bologna, Italy. Poster Presentation

• Avila S, Martín J, Simón C, Jiménez O, Mayor P, Martínez-conde A, Castrillo JL.Analisis molecular del mecanismo de implantación de embriones humanos: clonajemediante DDRT-PCR y “cDNA microarrays” de genes especificamente expresadosen células de endometrio receptivo. Genética y Biomedicina molecular 2000.October 2000; Monterrey, Mexico. Poster Presentation

• Domínguez F, Galán A, Mercader A, Garrido N, Pellicer A, Simón C. Identification ofChemokine receptors for IL-8, SDF-1, RANTES and MCP-1 in Human blastocystsand cultured endometrial epithelial cells (EEC). 56th Annual Meeting of the AmericanSociety for Reproductive Medicine. October 2000; San Diego, California, USA.Poster Presentation

• Mercader A, Galán A, De los Santos M.J, Remohí J, Pellicer A, Simón C. Have day3 embryo morphology a predictive value in blastocyst formation. 56th AnnualMeeting of the American Society for Reproductive Medicine. October 2000; SanDiego, California, USA. Oral Presentation

• Martín J, Avila S, Giménez O, Pellicer A, Castrillo J.L, Simón C. Differential geneexpression in high versus low endometrial receptivity status. 56th Annual Meeting of

126

the American Society for Reproductive Medicine. October 2000; San Diego,California, USA. Oral Presentation

• Requena A, García-Velasco J.A, Anarte C, Remohí J, Pellicer A, Simón C. Safety oflong term oral estradiol administration in an oocyte donation program. 56th AnnualMeeting of the American Society for Reproductive Medicine. October 2000; SanDiego, California, USA. Poster Presentation

• González R.R, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Simón C.Expression of leptin and its receptor at protein and mRNA levels in the humanendometrium and endometrial epithelial cells (EEC) co-cultured with humanembryos. Effects of interleukin-1Pxpression of leptin and its receptor at protein andmRNA levels in the human endometrium and endometrial epithelial cells (EEC) co-cultured with human embryos. Effects of interleuk

1999• Simón C, Rubio C, Vidal F, Mínguez Y, Giménez C, Egozcue J, Remohí J, Pellicer

A. In Vitro Fertilization (IVF) and preimplantation genetic diagnosis in patients withrecurrent miscarriage: an analysis of chromosome abnormalities in humanpreimplantation embryos. 46th Annual Meeting of the Society for GynecologicInvestigation. March 1999; Atlanta, Georgia, USA. Oral Presentation

• Albert C, Garrido N, Mercader A, Remohi J, Simón C, Pellicer A. The Endometriumas the origin of ovarian hyperstimulation syndrome (OHSS). 46th Annual Meeting ofthe Society for Gynecologic Investigation. March 1999; Atlanta, Georgia, USA. OralPresentation

• Garrido N, Albert C, O’Connor J.E, Remohí J, Simón C, Pellicer A. The role ofleukocytes in the secretion of interleukin-6 (IL-6) and vascular endothelial growthfactor (VEGF) of women at risk of ovarian hyperstimulation syndrome (OHSS). 46thAnnual Meeting of the Society for Gynecologic Investigation. March 1999; Atlanta,Georgia, USA. Oral Presentation

• Meseguer M, Caballero-Campo P, O’Connor J.E, Galán A, Martín J.C, Remohí J,Pellicer A, Simón C.Embryonic regulation of MUC1 in human uterine epithelial cells.46th Annual Meeting of the Society for Gynecologic Investigation. March 1999;Atlanta, Georgia, USA. Oral Presentation

• Caballero-Campo P, Comoma J, Meseguer M, César J, Mercader A, Remohí J,Pellicer A, Simón C. Chemokines interleukin-8 (IL-8), and monocyte Chemotacticprotein-1 (MCP-1) mRNA regulation in cultured human endometrial epithelial cells(EEC) by the human embryo. 46th Annual Meeting of the Society for GynecologicInvestigation. March 1999; Atlanta, Georgia, USA. Oral Presentation

• Martín J.C, Meseguer M, Caballero-Campo P, Herrer R, Remohí J, Pellicer A,Simón C. Expression of Ezrin, a membrane-cytoskeletal linker, in humanendometrial epithelial cells. 46th Annual Meeting of the Society for GynecologicInvestigation. March 1999; Atlanta, Georgia, USA. Oral Presentation

• Galán A, Herrer R, Mercader A, Meseguer M, Remohí J, Pellicer A and Simón C.Embryonic regulation of endometrial cell apoptosis in the adhesion phase of humanimplantation. International Workshop on Human Implantation: Recent Advances &Clinical Aspects. March 1999; Valencia, Spain. Poster Presentation

• Martín J. C, O´Connor J.E. Mesegure M, Galán A, Caballero-Campo P, Jasper M,Remohí J, Pellicer A, Simón C. Embryonic regulation of ezrin, a membrane-cytoskeletal linker, in human endometrial epithelial cells. International Workshop onHuman Implantation: Recent Advances & Clinical Aspects. March 1999; Valencia,Spain. Poster Presentation

• Moreno C, Mercader A, Ruiz A, Remohí J, Pellicer A, Simón C. Desarrollopreimplantatorio de embriones ICSI. VI Congreso de la Federación Latinoamericanade Sociedades de Esterilidad y fertilidad. I Congreso panameño de infertilidad yendoscopia ginecológica. II Foro Latinoamericano de Reproducción Humana. March1999; Panama. Oral Presentation

• Mercader A, Herrer R, Galán A, Valbuena D, Remohí J, Simón C, Pellicer A.Embryonic development in epithelial endometrial cells co-culture system versussequential culture medium of embryos from patients with repeated failures of

127

implantation. 15th Annual Meeting European Society of Human Reproduction andEmbryology. June 1999; Tours, France. Oral Presentation

• Garrido N, Albert C, Mercader A, O´Connor J.E, Remohí J, Simón C, Pellicer A.Leukocyte subpopulations in ovulatory follicles in patients with endometriosis. 15thAnnual Meeting European Society of Human Reproduction and Embryology. June1999; Tours, France. Poster Presentation

• Mercader A, Galan A, Herrer R, Albert C, Remohí J, Simón C, Pellicer A. Is assistedhatching justified? An analysis of spontaneous hatching in a human epithelialendometrial co-culture system. 15th Annual Meeting European Society of HumanReproduction and Embryology. June 1999; Tours, France. Poster Presentation

• Landazábal A, Díaz I, Valbuen a D, Muñoz E, Remohí J, Simón C, Pellicer A.Endometriosis and in-vitro fertilization: a meta-analysis. 15th Annual MeetingEuropean Society of Human Reproduction and Embryology. June 1999; Tours,France. Poster Presentation

• Díaz I, Navarro J, Vergara F, Alvarez J.C, Simón C, Pellicer A, Remohí J. Effect oflaparoscopic myomectomy in in-vitro fertilization (IVF) outcome in patients with failedcycles prior to surgery. 15th Annual Meeting European Society of HumanReproduction and Embryology. June 1999; Tours, France. Oral Presentation

• Caballero-Campo P, Meseguer M, Martín J.C, Coloma J, O´Connor J.E, Remohi J,Pellicer A and Simón C. Embryonic regulation of MCP-1 in human endometrialepithelial cells. 15th Annual Meeting European Society of Human Reproduction andEmbryology. June 1999; Tours, France. Oral Presentation

• Vergara F, Andreu S, Diaz I, Alvarez J.C, Rodriguez M, Serra V, Simón C, PellicerA, Remohí J. Comparative study of obstetric and perinatal outcome in an oocytedonation programme. 15th Annual Meeting European Society of HumanReproduction and Embryology. June 1999; Tours, France. Oral Presentation

• Diaz I, Navarro J, Simón C, Pellicer A, Remohí J. Impact of stages III-IV ofendometriosis on the outcome in recipients of oocytes from the same donor:matched case-control study. 15th Annual Meeting European Society of HumanReproduction and Embryology. June 1999; Tours, France. Oral Presentation

• Vidal F, Blanco J, Rubio C, Giménez C, Simón C, Martínez M.C, Mínguez Y, SantalóJ, Pellicer A, Remohí J, Egozcue J. Segregation analysis in the spermatozoa andpreimplantation genetic diagnosis in the embryos from a patient 46, XY (7;Y) (p11;q13). Second European Cytogenetics Conference. July 1999; Vienna, Austria.Poster Presentation

• Gonzalez R.R, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Simón C.Dinamics of leptin secretion by human blastocyst and endometrial epithelial.Conjoint Annual Meeting American Society for Reproductive Medicine and CanadianFertility and Andrology Society. September 1999; Toronto Canadá. PosterPresentation

• Meseguer M, Caballero-Campo P, Martin J, Galan A, Remohí J, Pellicer A, Simón C.Hormonal regulation “In vivo” of Muc1 in Human endometrium. Conjoint AnnualMeeting American Society for Reproductive Medicine and Canadian Fertility andAndrology Society. September 1999; Toronto Canadá. Poster Presentation

• Rubio C, Pellicer A, Vidal F, Mínguez Y, Romero J, Giménez C, Remohí J, Simón C.Impact of Chromosome Abnormalities In Human Embryo Development. ConjointAnnual Meeting American Society for Reproductive Medicine and Canadian Fertilityand Andrology Society. September 1999; Toronto Canadá. Oral Presentation

• Albert C, Garrido N, Mercader A, Remohí J, Simón C, Pellicer A. The Role Of TheEndothelium In The Ovarian Hyperestimulation Syndrome (OHSS). Conjoint AnnualMeeting American Society for Reproductive Medicine and Canadian Fertility andAndrology Society. September 1999; Toronto Canadá. Poster Presentation

• Gonzalez R.R, Devoto L, Caballero-Campo P, Mercader A, Campana A, Simón C,Bishof P. Leptina: ¿Un factor regulador de la implantación?. XVI Reunión de laAsociación Latinoamericana de Investigadores en Reproducción Humana.September 1999; Marbella, Chile. Poster Presentation

• Caballero-Campo P,Meseguer M, Martín J.C, Domínguez F, Coloma J, Simón C.

128

Regulación embrionaria del RNAm de la integrina-b3 en cultivos de células delepitelio endometrial (CEE) humano. XVI Reunión de la Asociación Latinoamericanade Investigadores en Reproducción Humana. September 1999; Marbella, Chile.Poster Presentation

• Vidal F, Blanco J, Rubio M.C, Aran B, Egozcue S, Alcolea R, Simón C, Veiga A,Minguez Y, Remohí J, Pellicer A, Barri P, Vendrell J.M, Marina S, Egozcue J.Screening for chromosome abnormalities in spermatozoa from infertile men in aclinical setting. Annual Meeting of the American Society of Human Genetics. October1999; San Francisco, USA. Poster Presentation

1998• Caballero P, Bernal A, Mercader A, O´connor JE Coloma J, Remohi J, Pellicer A,

Simón C. Embryonic regulation of IL-8 production and secretion in humanendometrial epithelial cells. 45th Annual Meeting of the Society for GynecologicInvestigation (SGI). March 1998; Atlanta, USA. Oral Presentation

• Albert C, Mercader A, Herrer R, J, Remohi J, Simón C, Pellicer A. Serum andFollicular Fluid (FF) vascular endothelial growth factor (VEGF) and Interleukin-6levels in women at risk to develop ovarian hyperstimulation syndrome (OHSS). 45thAnnual Meeting of the Society for Gynecologic Investigation (SGI). March 1998;Atlanta, USA. Oral Presentation

• Galán A, O´Connor J.E, Mercader A, Simón C. Embryonic regulation of apoptosis inendometrial epithelium. International Symposium on Reproductive Medicine Co-Sponsored by ASRM ESHRE-IVI. State of the Art of Human implantation.Basic andClinical Aspects. May 1998, Madrid, Spain. Oral Presentation

• Moreno C, Gaitán P, Alvarez J, Molero D, Remohí J, Pellicer A, Simón C.Reproductive outcome of ovum donation recipients acording to the source ofoocytes. International Symposium on Reproductive Medicine Co-Sponsored byASRM ESHRE-IVI. State of the Art of Human implantation.Basic and ClinicalAspects. May 1998, Madrid, Spain. Oral Presentation

• Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J. ICSI as a routine indication in lowresponder patients. 14th Annual Meeting. European Society of Human Reproductionand Embryology. June, 1998; Göteborg, Sweden. Oral Presentation

• Requena A, Neuspiller F, Cobo A.C., Aragonés M, Ruíz A, Remohí J, Simón C,Pellicer A. The potential use of in-vitro maturation of germinal vesicle-stage oocytesin low responders. 14th Annual Meeting. European Society of Human Reproductionand Embryology. June, 1998; Göteborg, Sweden. Oral Presentation

• Rubio C, Blanco J, Mínguez Y, Vidal F, Remohí J, Egozcue J, Simón C. Implicationsof sperm chromosomal abnormalities in habitual abortion. 14th Annual Meeting.European Society of Human Reproduction and Embryology. June, 1998; Göteborg,Sweden. Oral Presentation

• Raga F, Casañ E.M, Ruiz A, Remohí J, Simón C, Polan M.L, Pellicer A.Gonadotrophin-releasing hormone agonist administered throughout the luteal phaseand early pregnancy increases fecundity in IVF-embryo transfer patients. 14thAnnual Meeting. European Society of Human Reproduction and Embryology. June,1998; Göteborg, Sweden. Oral Presentation

• Meseguer M, Gaitán P, Mercader A, Caballero P, Remohí J, Pellicer A, Simón C.Hormonal regulation “in vivo” of MUC1 in mock cycles from patients undergoingoocyte donation. 14th Annual Meeting. European Society of Human Reproductionand Embryology. June, 1998; Göteborg, Sweden. Oral Presentation

• Requena A, Neuspiller F, Cobo A.C, Aragonés M, Rubio C, Remohí J, Simón C,Pellicer A. Endocrine changes in women undergoing follicular aspiration for in-vitroculture of immature oocytes. 14th Annual Meeting. European Society of HumanReproduction and Embryology. June, 1998; Göteborg, Sweden. Poster Presentation

• Cobo A, Aragonés M, Requena A, Neuspiller F, Romero J, Mínguez Y, Simón C,Remohí J, Pellicer A. Analysis of different parameters affecting outcome in in-vitromaturation of human oocytes. 14th Annual Meeting. European Society of HumanReproduction and Embryology. June, 1998; Göteborg, Sweden. Poster Presentation

• Moreno C, Mercader A, Ruiz A, Herrer R, Valbuena D, Remohí J, Pellicer A, Simón

129

C. Preimplantation development outcome of embryos after in-vitro fertilization issuperior to that after intracytoplasmic sperm injection. 14th Annual Meeting.European Society of Human Reproduction and Embryology. June, 1998; Göteborg,Sweden. Poster Presentation

• Vergara F, Andreu S, Díaz I, Neuspiller F, Ardiles G, Simón C, Pellicer A, Remohí J.Obstetric and perinatal outcome in an oocyte donation programe. 14th AnnualMeeting. European Society of Human Reproduction and Embryology. June, 1998;Göteborg, Sweden. Poster Presentation

• Ardiles G, Neuspiller F, Vergara F, Díaz I, Simón C, Pellicer A, Remohí J. Sevenyears of experience in an oocyte donation programme. 14th Annual Meeting.European Society of Human Reproduction and Embryology. June, 1998; Göteborg,Sweden. Poster Presentation

• Gaitán P, Moreno C, Ruiz A, Alvarez J, Remohí J, Simón C, Pellicer A. Predictivevalue of embryonic characteristics before cryopreservation on the outcome afterthawing. 14th Annual Meeting. European Society of Human Reproduction andEmbryology. June, 1998; Göteborg, Sweden. Poster Presentation

• Neuspiller F, Roscizsewski V, Ardiles G, Dolz M, Abad-Velasco L, Pellicer A, SimónC, Remohí J, Bonilla-Musoles F. Three dimensional rendering ultrasound of theendometrium: evaluation with cavity distension medium. 14th Annual Meeting.European Society of Human Reproduction and Embryology. June, 1998; Göteborg,Sweden. Poster Presentation

• Valbuena D, Albert C, Garrido N, Remohí J, Simón C, Pellicer A. Cytokines in olderpatients undergoing IVF: the relationship to the response to controlled ovarianhyperstimulation. 14th Annual Meeting. European Society of Human Reproductionand Embryology. June, 1998; Göteborg, Sweden. Poster Presentation

• Remohí J, Neuspiller F, Ardiles A, Ballesteros A, Landeras J, Requena A, Simón C,Pellicer A. A new technique for submucous myoma resectoscopy. Preliminaryreport. 14th Annual Meeting. European Society of Human Reproduction andEmbryology. June, 1998; Göteborg, Sweden. Poster Presentation

• Kohen P, Caballero P, Castro O, Castro A, Vega M, Simón C, Carvallo P, Devoto L.Análisis de la expresión del receptor tipo I de Interleukina-1 y su antagonista encuerpo lúteo humano. IX Reunión anual de la Sociedad chilena de reproducción ydesarrollo. I Congreso de la Sociedad Chilena de Fertilidad. August 1998; LaSerena, Chile. Oral Presentation

• Caballero-Campo P, Mercader A, Galán A, Meseguer M, Martín JC, Coloma J, O´Connor JE, Pellicer A y Simón C. El co-cultivo con células del epitelio endometrialcomo modelo in vitro para estudios de regulación embrionaria de moléculasendometriales en la especie humana. IX Reunión anual de la Sociedad chilena dereproducción y desarrollo. I Congreso de la Sociedad Chilena de Fertilidad. August1998; La Serena, Chile. Oral Presentation

• Navarro J, Albert C, Mercader A, Remohí J, Simón C, Pellicer A. The follicular andendocrine environment in women with endometriosis: local and systemic cytokineproduction. 54th Annual Meeting of the American Fertility Society for ReproductiveMedicine (ASRM) & 16th World Congress on Fertility and Sterility. October 1998;San Francisco, California, USA. Oral Presentation

• Kohen P, Castro A, Castro O, Carvallo P, Caballero P, Simón C, Devoto L.Interleukin 1b (IL-1b) is a modulator of human luteal steroidogenesis54th AnnualMeeting of the American Fertility Society for Reproductive Medicine (ASRM) & 16thWorld Congress on Fertility and Sterility. October 1998; San Francisco, California,USA. Oral Presentation

• Simón C, Mercader A, Garcia-Velasco J, Valbuena D, Herrer R, Moreno C, PellicerA. Coculture of embryos with autologous human endometrial epithelial cells andtransfer at blastocyst stage increases implantation rates in patients with repeatedfailures of Implantation. 54th Annual Meeting of the American Fertility Society forReproductive Medicine (ASRM) & 16th World Congress on Fertility and Sterility.October 1998; San Francisco, California, USA. Oral Presentation

• Garcia-Velasco J.A., Simón C, Ardiles G, Neuspiller F, Remohí J, Nikas G.

130

Assessment of endometrial response to HRT usig the detection of pinapods inwomen with endometriosis undergoing oocyte donation. 54th Annual Meeting of theAmerican Fertility Society for Reproductive Medicine (ASRM) & 16th WorldCongress on Fertility and Sterility. October 1998; San Francisco, California, USA.Poster Presentation

1997• Simón C, Gimeno M.J, Mercader A, O`Connor E, Polan M.L and Pellicer A.

Embryonic regulation of β3-integrin in human endometrial epithelial cells is mediatedby IL-1. 44th Annual Meeting of the Society for Gynecologic Investigation (SGI).March 1997; San Diego, USA. Oral Presentation

• Pellicer A, Garcia Velasco J.A, Valbuena D, Remohí J, Simón C. Gonadotropinsuppression and oocyte quality. Human Oocytes: from physiology to IVF. April 1997;Bologna, Italy. Oral Presentation

• Asch R.H., Gaytan P, Ruiz A, Simón C, Remohí J and Pellicer A. Young poorresponders do not have a decreased success with ART. 10th World Congress on InVitro Fertilitation & Assisted Reproduction. May 1997; Vancouver, Canada. OralPresentation

• Gaitan P, Simón C, Ruiz A ,Remohí J, Asch R.H. and Pellicer A. The importance ofembryo selection in the success of ICSI. 10th World Congress on In Vitro Fertilitation& Assisted Reproduction. May 1997; Vancouver, Canada. Oral Presentation

• Kruessel JS, Huang HY, Simón C., Behr B., Kloodt A.R. Wen Y., Bielfeld P., PolanM.L. Single blastomeres obtained from human preimplantation embryos expressdifferent amounts of mRNA for various genes: implications for future applications ofthis method for preimplantation diagnosis. 13th Annual Meeting of the ESHRE. June1997; Edinburgh, UK. Oral Presentation

• Nikas G., Garcia Velasco J., Pellicer A. and Simón C. Assessment of uterinereceptivity and timing of embryo transfer using the detection of pinopods. 13thAnnual Meeting of the European Society for Human Reproduction and Embryology(ESHRE). June 1997; Edinburgh, UK. Oral Presentation

• Ardiles G., Levy M., Yalil S., Newspiller F., Remohí J., Simón C. and Pellicer A. Lackof correlation of serum oestradiol concentrations and endometrial thickness withendometrial receptivity in an oocyte donation programme. 13th Annual Meeting ofthe European Society for Human Reproduction and Embryology (ESHRE). June1997; Edinburgh, UK. Oral Presentation

• Simón C., Mercader A., Moreno C., Gaitan P., Grimalt L., Remohí J. and Pellicer A.Instituto Valenciano de Infertilidad. Co-culture of embryos on homologous humanendometrial epithelial cells in patients with repeated implantation failures. 13thAnnual Meeting of the European Society for Human Reproduction and Embryology(ESHRE). June 1997; Edinburgh, UK. Oral Presentation

• Simón C., García Velasco J., Valbuena D., Crespo J., Peinado J.A., Remohí J. andPellicer A. Lower oestradiol concentrations during the preimplantation period in high-responder patients, following and FSH step-down regimen, increase pregnancyrates. 13th Annual Meeting of the European Society for Human Reproduction andEmbryology (ESHRE). June 1997; Edinburgh, UK. Poster Presentation

• Mínguez Y., Rubio C., Romero J.L.L., Gil-Salom M., Simón C., Remohí J. andPellicer A. Effect of endometriosis on ICSI results in couples with male factorinfertility. 13th Annual Meeting of the European Society for Human Reproductionand Embryology (ESHRE). June 1997; Edinburgh, UK. Oral Presentation

• Zuzuarregui J. L., García-Velasco J. A., Landeras J., Simón C., Remohí J. andPellicer A. HIV prevalence in infertile patients. 13th Annual Meeting of the EuropeanSociety for Human Reproduction and Embryology (ESHRE). June 1997; Edinburgh,UK. Oral Presentation

• Albert C, Mercader A, Herrer R, Bernal A, Remohí J, Simón C, Pellicer A. Ovarianhiperstimulation syndrome: the role of hCG in the production of vascular endothelialgrowth factor and interleukin-6. International Workshop on Paracrine Mechanisms inFemale Reproduction. June 1997; Seville, Spain. Oral Presentation

• Bauset C, Valbuena D, Remohí J, Simón C, Pellicer A. Hormone environment in

131

follicles of patients with endometriosis during controlled ovarian stimulation.International Workshop on Paracrine Mechanisms in Female Reproduction. June1997; Seville, Spain. Oral Presentation

• Simón C, Valbuena D. Rol del sistema de la IL-1 en la implantación. VIII Reuniónanual de la Sociedad Chilena de Reproducción y Desarrollo. August 1997; LaSerena, Chile. Oral Presentation

• Vidal F, Rubio C, Simón C, Gimenez C, Pellicer A, Santaló J., Egozcue J.Preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy loss.Second International Symposium on Preimplantation Genetics. September 1997;Chicago, USA. Oral Presentation

• Kruessel J, Simón C, Rubio M. C, Huang H.Y, Wen Y, Kloodt A.R, Bielfeld P, PolanM.L. Expression of Interleukin-1 (IL-1) system messenger ribonucleic acids (mRNAs)in single blastomeres from human preimplantation embryos. 53th Annual Meeting ofthe American Society for Reproductive Medicine. October 1997; Cincinnati, USA.Oral Presentation

• Raga F, Bauset C, Bonilla-Musoles F, Casañ E.M, Remohí J, Simón C, Pellicer A.Reproductive impact of congenital mullerian anomalies on women willing toconceive. 53th Annual Meeting of the American Society for Reproductive Medicine.October 1997; Cincinnati, USA. Oral Presentation

• Simón C, Landeras J, Zuzuarregi J.L, Remohí J, Pellicer A. Early embryonic lossesafter oocyte donation. 53th Annual Meeting of the American Society for ReproductiveMedicine. October 1997; Cincinnati, USA. Poster Presentation

• Simón C, Rubio C, Vidal F, Moreno C, Parrilla J, Pellicer A. Recurrent pregnancyloss. Maternal or/and embryonic fault. Serono Colloquia Australasia “Genes andEnvironment in Human Reproductive Disorders”. November – December 1997;Adelaide, Australia. Oral Presentation

1996• Blanco J, Simón C, Rubio C, Egozcue J, Vidal F. Incidence of disomic sperm nuclei

in a 47, XYY male assessed by fluorescence in situ hybridization (FISH). 28thMeeting of the European Society for Human Genetics (ESHG). April 1996; London,UK. Poster Presentation

• Mercader A, Francés A, Gimeno MJ, Remohí J, Pellicer A, Simón C. Serumconcentrations and endometrial interleukin- 1 system microenvironment of thehuman embryo at the apposition phase under phisiological and supraphisiologicalsteroid levels conditions. 12th Annual Meeting of the European Society for HumanReproduction and Embryology (ESHRE). June – July 1996; Maastricht, TheNetherlands. Oral Presentation

• Guanes P.P, Gallardo E, Levy M, Simón C, Remohí J and Pellicer A. Effect of ageon sperm fertilizing potential: oocyte donation as a model. 12th Annual Meeting ofthe European Society for Human Reproduction and Embryology (ESHRE). June –July 1996; Maastricht, The Netherlands. Oral Presentation

• Blanco J, Rubio C, Simón C, Egozcue J and Vidal F. A fluorescent in-situhybridization study of the spermatogenic process and sperm production in a 47, XYYand a 47,XXY/46, XY infertile male: implications for ICSI. 12th Annual Meeting ofthe European Society for Human Reproduction and Embryology (ESHRE). June –July 1996; Maastricht, The Netherlands. Poster Presentation

• Guanes P.P, Gartner B, Gallardo E, Simón C, Remohí J and Pellicer A. Age doesnot affect uterine resistance to vascular flow in patients undergoing oocyte donation.12th Annual Meeting of the European Society for Human Reproduction andEmbryology (ESHRE). June – July 1996; Maastricht, The Netherlands. PosterPresentation

• Gallardo E, Gutiérrez A, Bauset C, Simón C, Remohí J, Pellicer A. Fertilizaciónespermática. La edad como factor de influencia y la donación de ovocitos comomodelo. XXXIII Reunión anual de la Asociación Mexicana de Medicina de laReproduccion. July 1996; Puerto Vallarta, México. Oral Presentation.

• Gutiérrez GA, Gallardo E, Simón C, Remohí J, Pellicer A. Incidencia del embarazoectópico en reproducción asistida. XXXIII Reunión anual de la Asociación Mexicana

132

de Medicina de la Reproduccion. July 1996; Puerto Vallarta, México. OralPresentation.

• Gutiérrez A, Gallardo E, Simón C, Remohí J, Pellicer A. Niveles séricos de estradiolen receptoras de ovocitos. Su influencia sobre la capacidad de implantación endonación de ovocitos. XXXIII Reunión anual de la Asociación Mexicana de Medicinade la Reproduccion. July 1996; Puerto Vallarta, México. Oral Presentation.

• Gutiérrez A, Simón C, Remohí J, Pellicer A. Inyección intracitoplasmática deespermatozoides (ICSI) con espermatozoides testiculares y epididimarios en frescoy congelados. XXXIII Reunión anual de la Asociación Mexicana de Medicina de laReproduccion. July 1996; Puerto Vallarta, México. Oral Presentation.

• Simón C, Gimeno M.J, Mercader A, O`Connor E, Polan M.L and Pellicer A.Embryonic regulation of integrins P , P and P1 on human endometrial epithelial cells.52th Annual Meeting of the American Society for Reproductive Medicine. November1996; Boston, USA. Oral Presentation

• Kruessel J.S, Simón C, Bielfeld P, Wen Y, Batey D.W, Sha S, Huang H.Y, PolanM.L. Interleukin-1β (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) messengerribonucleic acid (mRNA) expression in different parts of the human fallopian tubethroughout the menstrual cycle: possible implication for early embryonicdevelopment. 52th Annual Meeting of the American Society for ReproductiveMedicine. November 1996; Boston, USA. Oral Presentation

• Castro O, Kohen P, Castro A, Troncoso JL, Simón C, Vega M, Devoto L. Rol deinterleukina-1PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPOral Presentation

1995• De los Santos M.J, Francés A, Mercader A, Ruiz A, Remohí J, Pellicer A, Simón C

Immunohistochemical localization of the interleukin-1 system in the human oocyte andembryo during embryonic development. 11th Annual Meeting of the European Societyfor Human Reproduction and Embryology (ESHRE). June – July 1995; Hamburg,Germany. Oral Presentation

• Cano F, Pellicer A, Gutierrez A, Remohí J, Simón C. Clinical evidence for a detrimentaleffect on uterine receptivity of high serum oestradiol concentrations in high and normal-responder patients. 11th Annual Meeting of the European Society for HumanReproduction and Embryology (ESHRE). June – July 1995; Hamburg, Germany. OralPresentation

• Gallardo E, Guanes PP, Simón C, Gil-Salom M, Rubio C, Mínguez Y, Remohí J andPellicer A. Comparison of fertilization capability of spermatozoa from ejaculate,epididimal biopsy and testicular biopsy using ICSI technique in severe male factorinfertility. 15th World Congress on Fertility and Sterility. September 1995;Montpellier, France. Oral Presentation

• Guanes PP, Mendoza R, Gallardo E, Rodriguez-Escudero F, Remohí J, Neyro JL,Pellicer A, Simón C. Immunosupresion by corticoids does not improve implantationrates in patients with previous IVF failures. 15th World Congress on Fertility andSterility. September 1995; Montpellier, France. Oral Presentation

• Valbuena D., Mercader A, De los Santos MJ, Remohí J, Pellicer A and Simón C.Clinical evidence for a detrimental effect on uterine receptivity of high Serumoestradiol levels troughout the preimplantation period in high versus normalresponder patients. 15th World Congress on Fertility and Sterility. September 1995;Montpellier, France. Oral Presentation

• Gallardo E, Guanes PP, Cano F, Simón C, Remohí J and Pellicer. Effect of aging onthe female reproductive system: evidence for a role of uterine senescence in thedecline in female fecundity. 15th World Congress on Fertility and Sterility. September1995; Montpellier, France. Oral Presentation

• Minguez Y, Rubio C, Simón C, Remohí J, Gil- Salom M, Pellicer A. Efficacy ofintracytoplasmic testicular sperm injection in obstructive azoospermia. 51th AnnualMeeting of the American Society for Reproductive Medicine. October 1995; Seattle,USA. Poster Presentation

133

• Simón C, Mercader A, Francés A, De los Santos M.J, Pellicer A, Remohí J. Effectsof estradiol and progesterone on serum and endometrial IL-1a, IL-1b and IL-1ralevels in patients undergoing oocyte donation. 51th Annual Meeting of the AmericanSociety for Reproductive Medicine. October 1995; Seattle, USA. Poster Presentation

1994• Piquette G.N., Tilly J.L, Prichard L.E, Simón C, Polan M.L. A non-radioactive

method for the detection of apoptosis. 41th Annual Meeting of the Society forGynecologic Investigation (SGI). March 1994; Chicago, USA. Poster Presentation.

• Simón C, Tsafriri A, Dang W, Polan M.L. Interleukin-1 receptor antagonist (IL-1ra)supresses hCG-induced ovulation in the rat. 41th Annual Meeting of the Society forGynecologic Investigation (SGI). March 1994; Chicago, USA. Poster Presentation.

• Piquette GN, Simón C. Detection of apoptosis in human ovarian follicles. AnnualMeeeting of the Endocrine Society. June 1994; Los Angeles, USA. PosterPresentation.

• Gutiérrez A, Cano F, Ruiz A, Simón C, Pellicer A, Remohí J. Does ovarian functioninfluence the outcome of oocyte donation? 10th Annual Meeting of the EuropeanSociety for Human Reproduction and Embryology (ESHRE). June 1994; Brussels,Belgium. Oral presentation

• Cano A, Simón C, Ruiz A, Gutiérrez A, Tarín J, Remohí J, Pellicer A. The use ofgrowth hormone-releasing factor in IVF: possible effects on quality of the humanoocytes. 10th Annual Meeting of the European Society for Human Reproduction andEmbryology (ESHRE). June 1994; Brussels, Belgium. Oral presentation

• Simón C, Francés A, Pellicer A, Polan M.L. Interleukin-1 receptor antagonist (IL-1ra)localization in human endometrium throughout the menstrual cycle. 50th AnnualMeeting of the American Fertility Society (AFS). November 1994; San Antonio,Texas, USA. Oral presentation

• Remohí J, Gutiérrez A, Simón C, Cano F, Tarín J, Pellicer A. Long estradiolreplacement regimen in oocyte donation program. 50th Annual Meeting of theAmerican Fertility Society (AFS). November 1994; San Antonio, Texas, USA. Oralpresentation

1993• Simón C, El-Danasouri I, Piquette G.N, Francés A, Westphal L.M, Polan M.L.

Interleukin-1β increases its own receptor mRNA expression in cultured decidualizedhuman endometrial stromal cells. 40th Annual Meeting of the Society forGynecologic Investigation (SGI). March – April 1993; Toronto, Canada. OralPresentation.

• Piquette G.N, Simón C, Cabtree M.E, Polan M.L. Interleukin-1b (IL-1b) increases IL-1 receptor type I (IL-1R tI) messenger ribonucleic acid levels in cultured humangranulosa-luteal cells. 40th Annual Meeting of the Society for GynecologicInvestigation (SGI). March – April 1993; Toronto, Canada. Poster Presentation.

• Simón C , Francés A, Piquette G.N, Heindrickson M, Polan M.L.Immunohistochemical localization of the Interleukin-1 system in human implantationtrophoblast and decidua. Immunobiology of Reproduction, Serono Symposia. August1993; Boston, USA. Oral Presentation.

• El- Danasouri I, Simón C, Francés A, Piquette G.N, Polan M.L. Platelet-activatingfactor upregulates interleukin-1 receptor type I expression in human endometrialcells in culture. 49th Annual Meeting of the American Fertility Society (AFS). October1993; Montreal, Canada. Oral Presentation.

1992• Simón C, Gómez E, Mir A, De los Santos M.J, Pellicer A. Glucocorticoid treatment

decreases sera embryotoxicity in endometriosis patients. 8th Annual Meeting of theEuropean Society for Human Reproduction and Embryology (ESHRE). July 1992;The Hague, The Netherlands. Oral Presentation.

• Simón C, Piquette G.N, Cabtree M.E, Westphal L.M, Heinrichs W. L, Polan M.L.Interleukin-1 (IL-1) type I receptor expression in human endometrium during themenstrual cycle. 48th Annual Meeting of the American Fertility Society (AFS).November 1992; New Orleans, USA. Poster Presentation.

134

1991• Sampaio M, Calatayud C, Miró F, Tarín JJ, Ruiz A, Simón C, Pellicer A. In Vitro

responses of mouse granulosa and luteal cells to Thyroid Stimulating Hormone(TSH). 7th Annual Meeting of the European Society for Human Reproduction andEmbryology (ESHRE). June 1991; Paris, France. Poster Presentation.

• Bonilla-Musoles F, Simón C, Pellicer A, Remohí J. Vaginal endosonographicmarkers of embryonic malformations. 7th World Congress of IVF and AssistedProcreation. June – July 1991; Paris, France. Poster Presentation.

1990• Miró F, Simón C, Millet A, Pellicer A. Steroidogenesis in vitro of human granulosa

luteal-cells pre-treated in vivo with gonadotropin-releasing hormone analogs. IIInternational Symposium on GnRH Analogues in Cancer and Human Reproduction.November 1990; Geneva, Switzerland. Oral Presentation.

1988• Simón C, Miró F, Ruiz A, Moreno J.L, Tortajada M, Pellicer A. An analysis of pituitary

desensitization with GnRH analogs and in vitro fertilization results starting atdifferent days during the luteal phase. IV Annual Meeting of the European Society forHuman Reproduction and Embryology (ESHRE). July 1988; Barcelona, Spain. OralPresentation.

Nationals 2015• Vera-Rodríguez M, Chavez SL, Rubio C, Reijo-Pera R, Simón C. Alteraciones de

los embriones aneuploides en su morfocinética y perfil transcriptómico. VIII Congreso ASEBIR. November 2015; San Sebastián, Spain. Oral Presentation.

2010• Mercader A, Buendía P, Delgado A, Escrich L, Martín J, Cervero A, Pellicer A,

Simón C. El cocultivo embionario con células del endometrio incrementa losresultados clínicos en pacientes del programa de DGP. XXVIII Congreso NacionalSociedad Española de Fertilidad. May 2010; Valencia, Spain. Oral Presentation

• Mir P, Cervero A, Mutlu A, Simón C, Pellicer A, Martín J. Prevención de poliquistosisrenal autosómica dominante mediante diagnóstico genético preimplantacional.XXVIII Congreso Nacional Sociedad Española de Fertilidad. May 2010; Valencia,Spain. Oral Presentation

2009• Medrano JV, Marqués-Marí AI, Poo ME, Aguilar CE, Valbuena D, Ruiz V, Gómez E,

Riboldi M, Sánchez E, Galan A, Ruiz-Vela A, Simón C. Enrichment of the vasapositive population produced by spontaneous in Vitro germ line differentiation fromHESC by co-localization with CD117 and CD15 membrane cell markers. 5th Bienalcongress of the Spanish Society of Gene Cell Therapy. September – October 2009;Granada, Spain. Oral Presentation

• Mercader A, Buendía P, Delgado A, Gadea B, Escrich L, Rubio C, Simón C. Elcocultivo con células del endometrio favorece el desarrollo embrionario den ciclosde diagnóstico genético preimplantacional por edad materna avanzada. 5ºCongreso ASEBIR. November 2009; Valencia, Spain. Poster Presentation

2007• Cervelló I, Martínez-Romero A, Gil Casanova D, Martínez-Conejero JA, Galán A,

Pellicer A, O’Connor JE, Simón C. Side Population in human endometrium: putativeadult stem cells. X Congreso de la Sociedad Ibérica de Citometría. June 2007;Barcelona, Spain. Oral Presentation

• Galán A, Martínez-Romero A, Herrera G, Sánchez E, Sánchez-Luengo S, Simón C,O’Connor JE. Cuantificación del estado de indiferenciación de las células madreembrionarias humanas mediante inmunofenotipo de superficie. X Congreso de laSociedad Ibérica de Citometría. June 2007; Barcelona, Spain. Oral Presentation

• Medrano JV, Galán A, García A, Valbuena D, Poo ME, Sánchez E, Sánchez-Luengo

135

S, Gómez E, Ruíz V, Simón C. Análisis comparativo de los niveles de expresión demarcadores de indiferenciación en diferentes líneas de células madre embrionariashumanas. IV Congreso de la Sociedad Española de Terapia Génica y Celular.September 2007; Madrid, Spain. Poster Presentation

2006• Labarta E, Bosch E, De los Santos MJ, Simón C, Remohí J, Pellicer A.

Luteinización prematura en ciclos con antagonistas de la GnRH: resultados enfunción del día de la transferencia embrionaria. XXVI Congreso Nacional de la SEF.May – June 2006; Zaragoza, Spain. Oral Presentation

2005• Pellicer A, Domínguez P, Horcajadas J, Simón C. Molecular basis of implantation.

XXXIII Congreso of the Spanish Society of Physiological Sciences. February 2005;Seville, Spain. Oral Presentation

• Berna A, Galán A, Valbuena D, Sánchez S, Melguizo D, Simón C. Células madre. Posibilidades terapêuticas. Simposio Internacional sobre Nuevos Avances en Medicina Reproductiva. October 2005; Valencia, Spain. Oral Presentation

• Galán A, Valbuena D, Escobedo C, Rodríguez C, Simón C. Banco de Líneascelulares de Valencia CIPF. III Curso de Terapia Celular. November 2005; Seville,Spain. Oral Presentation

2004• Garrido N, Meseguer M, Simón C, Remohí J, Pellicer A. Lavado de semen en

varones de parejas serodiscordantes para VIH y VHC. Opciones y resultados. XIIReunión del Grupo Uro-Andrológico de la Asociación Española de Urología. March2004; Valencia, Spain. Oral Presentation

• Fernández M, Castillón G, Remohí J, Pellicer A, Simón C. ¿Debemos tender a latransparencia de un blastocisto único electivo?. XXV Congreso Nacional de la SEF.May 2004; A Coruña, Spain. Oral Presentation

• Meseguer M, Garrido N, Martínez-Conejero JA, Simón C, Pellicer A, Remohí J.Marcadores moleculares de fertilidad espermática y su relación con el análisisbásico del semen. XXV Congreso Nacional de la SEF. May 2004; A Coruña, Spain.Oral Presentation

• Epifanio R, Bosch E, Aizpurua J, Simón C, Remohí J, Pellicer A, Crespo J.Estimulación ovárica en bajas respondedoras: una nueva estrategia. XXV CongresoNacional de la SEF. May 2004; A Coruña, Spain. Oral Presentation

• Fernández M, Castillón G, Remohí J, Pellicer A, Simón C. Resultados comparativosentre la LH recombinante y HMG urinaria en la hiperestimulación ovárica controlada(HOC). XXV Congreso Nacional de la SEF. May 2004; A Coruña, Spain. PosterPresentation

• Martínez F, Valbuena D, Ubeda A, Domínguez F, Sánchez E, Labastida R, Barri PN,Simón C, Pellicer A. Estudio molecular e histeroscópico y su relación con los fallosrepetidos de implantación en FIV. XXV Congreso Nacional de la SEF. May 2004; ACoruña, Spain. Poster Presentation

• Muñoz EA, Garrido N, Tejera A, Aizpurua J, Simón C, Pellicer A, Remohí J. Elhidrosalpinx no afecta la calidad ovocitaria. XXV Congreso Nacional de la SEF. May2004; A Coruña, Spain. Poster Presentation

• Vidal C, Bosch E, Bellver J, Castillón G, Crespo J, Simón C, Remohí J, Pellicer A.Mujeres con síndrome ovario poliquístico tienen mejor pronóstico en reproducciónasistida que mujeres normovuladoras. XXV Congreso Nacional de la SEF. May2004; A Coruña, Spain. Poster Presentation

• Diaz I, Guillén A, Pacheco A, Simón C, Remohí J, Requena A, García Velasco JA.Perfil hormonal en la maduración final ovocitaria con análogos de la GNRHcomparado con HCG en ciclos de inseminación artificial. XXV Congreso Nacional de

136

la SEF. May 2004; A Coruña, Spain. Poster Presentation• Muñoz EA, Garrido N, Tejera A, Soares SR, Simón C, Pellicer A, Remohí J. La

relativa importancia de la transferencia embrionaria difícil. Un estudio en ovocitoscompartidos. XXV Congreso Nacional de la SEF. May 2004; A Coruña, Spain.Poster Presentation

2003• Martínez-Conejero JA, Garrido N, Remohí J, Pellicer A, Simón C, Meseguer M.

Presencia de la mucina MUC1 en el glicocálix del espermatozoide humano. IICongreso de la Asociación para el Estudio de la Biología de la Reproducción(ASEBIR). December 2003; Granada, Spain. Oral Presentation

2002• Giles J, Requena A, Mínguez Y, Herrer R, Villasante A, Simón C. Utilidad del ICSI

en casos de fracaso de IAD. Congreso Nacional de la Sociedad Española deFertilidad. May 2002; Palma de Mallorca, Spain. Oral Presentation

• Aragonés M, Cabañes I, Herrer R, Mínguez I, Garcia-Velasco JA, Simón C. Lamorfología de los pronúcleos no tiene valor predictivo para el desarrollo del embrión.Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palma deMallorca, Spain. Oral Presentation

• Scheffer R, Scheffer B, Garcia-Velasco JA, Remohí J, Pellicer A, Simón C.Relación entre la división embrionaria precoz y la calidad de embriones humanos:estudio preliminar. Congreso Nacional de la Sociedad Española de Fertilidad. May2002; Palma de Mallorca, Spain. Oral Presentation

• Rossal LP, Bosch E, Escudero E, Gaytán J, Remohí J, Pellicer A, Simón C. Validezde los criterios de evaluación embrionaria en el día 3. Congreso Nacional de laSociedad Española de Fertilidad. May 2002; Palma de Mallorca, Spain. OralPresentation

• Romero J. JI, Rubio C, Rodrigo L, Vidal F, Mínguez Y, Pérez-Cano I, Aragonés M,Martínez MC, Simón C, Remohí J, Pellicer A. Diagnóstico genético preimplantatorio(DGP) en parejas portadoras de translocaciones recíprocas y robertsonianas.Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palma deMallorca, Spain. Oral Presentation

• Troncoso C, Bosch E, Escudero E, Bellver J, Valencia I, Simón C, Remohí J,Pellicer A. Estimulación con Citrato de Clomifeno más Gonadotropina MenopáusicaHumana en pacientes con baja respuesta a altas dosis de gonadotropinas.Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palma deMallorca, Spain. Oral Presentation

• Martinez Salazar J, Scheffer B, Corona J, García Velasco JA, Simón C. ¿Predicenlos criterios ecográficos precoces la evolución de las gestaciones obtenidas confecundación in vitro (FIV)?. Congreso Nacional de la Sociedad Española deFertilidad. May 2002; Palma de Mallorca, Spain. Oral Presentation

• Mifsud A, Mínguez Y, García-Velasco JA, Young EL, Pellicer A, Simón C, Remohí J.La longitud de la región de CAG en el receptor de andrógenos y su asociación conel síndrome de ovarios poliquísticos y la infertilidad masculina. Congreso Nacionalde la Sociedad Española de Fertilidad. May 2002; Palma de Mallorca, Spain. OralPresentation

• Scheffer B, García-Velasco JA, Scheffer J, Remohí J, Pellicer A, Simón C. Lafertilidad previa de la donante no es un factor pronóstico en la donación de ovocitos.Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palma deMallorca, Spain. Oral Presentation

• Corona I, Requena A, Viñuela C, Remohí J, Pellicer A, Simón C. Relación de losdías de estimulación ovárica con la calidad de los ovocitos en un programa dedonación de ovocitos. Congreso Nacional de la Sociedad Española de Fertilidad.May 2002; Palma de Mallorca, Spain. Oral Presentation

• Scheffer B, García-Velasco JA, Scheffer R, Remohí J, Pellicer A, Simón C. ¿Afectala duración del coasting los resultados del programa de donación de ovocitos?.Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palma de

137

Mallorca, Spain. Oral Presentation• Escudero E, Mercader A, Rossal L.P, Troncoso C, Gaytan J, Remohí J, Pellicer A,

Simón C. Resultados perinatológicos del programa de cocultivo embrionario concelulas endometriales epiteliales. Congreso Nacional de la Sociedad Española deFertilidad. May 2002; Palma de Mallorca, Spain. Oral Presentation

• Villasante A, Landazabal A, Requena A, Martinez-Salazar J, García-Velasco JA,Simón C. Factores pronósticos de aborto en gestaciones conseguidas trasfecundación in vitro. Congreso Nacional de la Sociedad Española de Fertilidad. May2002; Palma de Mallorca, Spain. Oral Presentation

• Molina N, Crespo J, Bosch E, Escudero E, Simón C, Remohí J, Pellicer A.Resultados de las técnicas de reproducción asistida en pacientes tratados decancer. Congreso Nacional de la Sociedad Española de Fertilidad. May 2002; Palmade Mallorca, Spain. Oral Presentation

• Escobedo MC, Escribá MJ, Remohí J, Pellicer A, Simón C, Verdugo JM. Estudioultraestructural de blastocistos humanos. Congreso Nacional de la SociedadEspañola de Fertilidad. May 2002; Palma de Mallorca, Spain. Poster Presentation

2001• Gil Salom M, Rubio C, Rodrigo L, Mínguez Y, Remohí J, Simón C y Pellicer A. Valor

del FISH de espermatozoides en parejas con fallos repetidos de implantaciónembrionaria tras ICSI. X Congreso Nacional de Andrología. March 2001; Alicante,Spain. Oral Presentation

• Zuzuarregui JL, Marí M, Prados N, Simón C, Remohí J, Pellicer A. Prevalencia de laseropositividad VIH en la población estéril en los años 1991-2000. VI Congresonacional sobre el SIDA. April 2001; Valencia, Spain. Oral Presentation

• Cabañes I, Minguez Y, Aragonés M, Herrer R, García-Velasco J.A, Simón C.¿Predice la selección de embriones el éxito de una transferencia?. XXVI CongresoEspañol de Ginecología y Obstetricia. June 2001; Valencia, Spain. PosterPresentation

• Cabañes I, Isaza V, Grande J, Mínguez Y, Aragonés M, Herrer R, García-VelascoJ.A, Simón C. Valor predictivo de la bhCG precoz en la evolución del embarazo enART. XXVI Congreso Español de Ginecología y Obstetricia. June 2001; Valencia,Spain. Poster Presentation

• Landazabal A, Herrer R, Isaza V, Martínez-Salazar J.F, Requena A, García-VelascoJ.A, Remohí J, Pellicer A, Simón C. Creación del perfil de la paciente con optimaimplantación. XXVI Congreso Español de Ginecología y Obstetricia. June 2001;Valencia, Spain. Poster Presentation

• Isaza V, Requena A, García-Velasco J.A, Martín Salazar J, Landazabal A, Remohí J,Simón C. ¿Compromete el coasting los resultados de donación de ovocitos?. XXVICongreso Español de Ginecología y Obstetricia. June 2001; Valencia, Spain. PosterPresentation

• Isaza V, Scheffer B, García-Velasco J.A, Landazabal A, Simón C, Pellicer A.Resultados de coasting en pacientes de muy alto riesgo de SHO. XXVI CongresoEspañol de Ginecología y Obstetricia. June 2001; Valencia, Spain. PosterPresentation

• Isaza V, Párraga M, Anarte C, García-Velasco J.A, Remohí J, Pellicer A, Simón C.La edad de las pacientes afecta a la tasa de embarazo de inseminacionesartificiales. XXVI Congreso Español de Ginecología y Obstetricia. June 2001;Valencia, Spain. Poster Presentation

• Martínez-Salazar J, Isaza V, Párraga M, Anarte C, Landazabal A, Requena A,Simón C. Influencia del intervalo entre la administración de HCG y la realización deinseminaciones artificiales en la tasa de embarazo. XXVI Congreso Español deGinecología y Obstetricia. June 2001; Valencia, Spain. Poster Presentation

• Pinilla L, Bosch E, Caligara C, Vargas G, Bellver J, Simón C, Pellicer A, Remohí.

138

Incidencia de la cancelación por sangrado en la preparación estrogénica delendometrio para donación de ovocitos. XXVI Congreso Español de Ginecología yObstetricia. June 2001; Valencia, Spain. Oral Presentation

• Caligara C, Camargo F, Pinilla L.F, Escudero E, Navarro J, Bolúmar F, Simón C,Pellicer A, Remohí J. Factores de riesgo para aborto en un programa de donaciónovocitaria. XXVI Congreso Español de Ginecología y Obstetricia. June 2001;Valencia, Spain. Oral Presentation

• Vargas M.G, Camargo F, Caligara C, Escudero E, Pinilla L, Bosch E, Rossal L.P,Simón C, Remohí J, Pellicer A. Análogos GnRH de acción prolongada; Nuevo factorque afecta la tasa de aborto. XXVI Congreso Español de Ginecología y Obstetricia.June 2001; Valencia, Spain. Oral Presentation

• Meseguer M, Garrido N, Zuzuarregui J.L, Romero J.L, Simón C, Remohí J, PellicerA. Análisis multivariante de factores que influyen en las tasas de gestación eimplantación en FIV/ICSI. XXVI Congreso Español de Ginecología y Obstetricia.June 2001; Valencia, Spain. Oral Presentation

• Camargo F, Gaytan J, Vargas G, Ferro J, Bosch E, Simón C, Remohí J, Pellicer A.Las medidas ecográficas de la cavidad endometrial al momento de la transferenciaembrionaria guardan una directa relación con la tasa de implantación y gestación.XXVI Congreso Español de Ginecología y Obstetricia. June 2001; Valencia, Spain.Oral Presentation

• Meseguer M, Garrido N, Zuzuarregui J.L, Romero J.L, Simón C, Remohí J, PellicerA. ¿Es segura la utilización de semen de donante? Estudios de enfermedadesinfecciosas y desórdenes genéticos en una población de donantes de semen: 10años de experiencia. XXVI Congreso Español de Ginecología y Obstetricia. June2001; Valencia, Spain. Oral Presentation

• Escudero E, Rossal L.P, Gaytán P, Simón C, Remohí J, Pellicer A. Sinequiasendouterinas: reconstrucción de la cavidad uterina medante histeroscopia quirúrgicay futuro reproductivo. XXVI Congreso Español de Ginecología y Obstetricia. June2001; Valencia, Spain. Oral Presentation

• Rossal L.P, Escudero E, Bosch E, Simón C, Remohí J, Pellicer A, Ferro J.Evaluación de la necesidad de legrado endometrial aspirativo complementario a lapolipectomia histeroscópica. XXVI Congreso Español de Ginecología y Obstetricia.June 2001; Valencia, Spain. Oral Presentation

• De los Santos MJ, Mercader A, Albert C, Galán A, Zulategui J, Rodrigo L, Remohí J,Pellicer A, Simón C, Rubio C. Influencia del diagnóstico genético preimplantacional(DGP) en la tasa de implantación de los blastocistos humanos. 1er CongresoASEBIR. Asociación para el estudio de la biología de la reproducción. October2001; Murcia, Spain. Oral Presentation

• Gámiz P, Rubio C, Prados N, Romero JLL, Cobo A, Ruiz A, Simón C, Remohí J,Pellicer A, De los Santos MJ. Correlación entre la morfología pronuclear y lapresencia de anomalías cromosómicas embrionarias: estudio preliminar. 1erCongreso ASEBIR. Asociación para el estudio de la biología de la reproducción.October 2001; Murcia, Spain. Oral Presentation

• Garrido N, Meseguer M, Gil-Salom M, Simón C, Pellicer A, Remohí J.Caracterización de las poblaciones celulares del eyaculado y biopsia de testículomediante el análisis del DNA por citometría de flujo. 1er Congreso ASEBIR.Asociación para el estudio de la biología de la reproducción. October 2001; Murcia,Spain. Oral Presentation

• Herrer R, Aragonés M, Scheffer R, Cabañes I, Isaza V, Mínguez Y, Simón C.Relación entre los embarazos múltiples, la calidad embrionaria y la edad de las

139

pacientes. 1er Congreso ASEBIR. Asociación para el estudio de la biología de lareproducción. October 2001; Murcia, Spain. Oral Presentation

• Scheffer R, Cabañes I, Minguez Y, Aragonés M, Herrer R, García-Velasco J.A,Simón C. ¿Predice la selección de embriones el éxito de una transferencia? 1erCongreso ASEBIR. Asociación para el estudio de la biología de la reproducción.October 2001; Murcia, Spain. Oral Presentation

• Aragonés M, Scheffer R, Mercader A, Isaza V, Mínguez Y, García-Velasco JA,Simón C. La transferencia de blastocistos aumenta la tasa de embarazo enreceptoras de ovocitos. 1er Congreso ASEBIR. Asociación para el estudio de labiología de la reproducción. October 2001; Murcia, Spain. Poster Presentation

• Cabañes I, Scheffer R, Isaza V, Grande J, Mínguez Y, Aragonés M, Herrer R,García-Velasco JA, Simón C. Valor predictivo de la PHCG precoz en la evolución delembarazo en ART. 1er Congreso ASEBIR. Asociación para el estudio de la biologíade la reproducción. October 2001; Murcia, Spain. Poster Presentation

2000• Vargas MG, Vidal C, Camargo F, Ibérico G, Cuneo S, Simón C, Remohí J, Pellicer

A. Técnicas de reproducción asistida después de los 40 años. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Cuneo S, Vargas G, Caligara C, Camargo F, Pellicer A, Simón C, Remohí J.Diagnóstico y tratamiento adecuados de la infertilidad por agenesia congenita de losconductos deferentes para evitarla en la descendencia. XXIII Congreso Nacional dela Sociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Camargo F, Crespo J, Navarro J, Simón C, Pellicer A, Remohí J. Adenomiosis einfertilidad: implicaciones clínicas. XXIII Congreso Nacional de la SociedadEspañola de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Camargo F, Crespo J, Remohí J, Simón C, Pellicer A. Patologías asociadas aadenomiosis en la paciente infertil. XXIII Congreso Nacional de la SociedadEspañola de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Camargo F, Navarro J, Vargas G, Ferro J, Pellicer A, Simón C, Remohí J.Pronóstico obstétrico tras las corrección de un útero septo en pacientes coninfertilidad. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Oral Presentation

• Camargo F, Navarro J, Ibérico G, Remohí J, Simón C, Pellicer A, Ferro J.Corrección del útero septo: comparación entre tijera microquirúrgica yresectoscopia. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Oral Presentation

• Muñoz E, Vidal C, Crespo J, Remohí J, Pellicer A, Simón C. Estimulación ováricaen inseminación artificial (IA) con FSH recombinante. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Zuzuarregui J.L, Prados N, Ibérico G, Navarro J, Simón C, Pellicer A, Remohí J.IAD en mujeres sin pareja. XXIII Congreso Nacional de la Sociedad Española deFertilidad. May 2000; Seville, Spain. Oral Presentation

• Zuzuarregui J.L, Prados N, Navarro J, Simón C, Pellicer A, Remohí J. IAD enpacientes con ciclos previos de ICSI. XXIII Congreso Nacional de la SociedadEspañola de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Zuzuarregui J.L, Prados N, Ibérico G, Navarro J, Simón C, Pellicer A, Remohí J.Evolución de la IAD desde 1994. XXIII Congreso Nacional de la Sociedad Españolade Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Isaza V, Requena A, García-Velasco J, Landazábal A, Martínez Salazar J, RemohíJ, Pellicer A, Simón C. FSH-urinaria versus FHS-recombinante en pacientessometidas a inseminación artificial intrauterina: un estudio prospectivo. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Ibérico G, Navarro J, Camargo F, Vidal C, Cúneo S, Simón C, Pellicer A, Remohí J.Tasa de gestación en bajas respondedoras con diferentes protocolos de

140

estimulación ovárica. XXIII Congreso Nacional de la Sociedad Española deFertilidad. May 2000; Seville, Spain. Oral Presentation

• Muñoz E, Bellver J, Navarro J, Camargo F, Vidal C, Simón C, Pellicer A, Remohí J.Nafarelina VS Leuprorelina Acetato en estimulación ovárica para FIV. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Vargas M.G, Vidal C, Ibérico G, Cuneo S, Simón C, Remohí J, Pellicer A.Características y resultados de pacientes que ingresan a primer ciclo de fertilizaciónin vitro tras fallo en IAH. XXIII Congreso Nacional de la Sociedad Española deFertilidad. May 2000; Seville, Spain. Oral Presentation

• Navarro J, Ibérico G, Bosch E, Bellver J, Ferro J, Simón C, Pellicer A, Remohí J.Reducción embrionaria: complicaciones quirúrgicas y pronóstico neonatal según elnúmero de embriones evolutivos. XXIII Congreso Nacional de la Sociedad Españolade Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Navarro J, Bosch E, Díaz I, Ibérico G, Muñoz E, Simón C, Pellicer A, Remohí J.Pronóstico reproductivo en FIV-TE tras miomectomía laparoscópica. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Vargas M.G, Vidal C, Camargo F, Ibérico G, Cuneo S, Simón C, Remohí J, PellicerA. La fecundación in vitro a través de la edad reproductiva de la mujer. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Muñoz E, Bosch E, Mercader A, Pellicer A, Remohí J, Simón C. Relación entre laestimulación ovárica y el desarrollo embrionario. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• De los Santos MJ, Mercader A, Galán A, Romero JL, Ruiz A, Prados N, Cobo A,Remohí J, Pellicer A, Simón C. Valor predictivo de la presencia en cocultivo de treso más embriones de 8 células en el resultado de la gestación. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Aragonés M, Mínguez Y, Zulategui J, Herrer R, García-Velasco J.A, Remohí J,Pellicer A, Simón C. Viabilidad embrionaria tras el proceso decongelación/descongelación en ciclos de ICSI o FIV convencional. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Isaza V, Martinez Salazar J, Requena A, García-Velasco J.A, Remohí J, Pellicer A,Simón C. La administración de agonistas de la hormona liberadora degonadotrofina (A-GnRH) es útil en la transferencia de embriones descongelados enciclos con terapia hormonal sustitutiva. XXIII Congreso Nacional de la SociedadEspañola de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Rodríguez M, Ibérico G, Camargo F, Vargas G, Caligara C, Simón C, Remohí J,Pellicer A. Influencia del efecto “vanishig” en la evolución obstétrica de gestacionesmúltiples obtenidas tras donación ovocitaria. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Ibérico G, Navarro J, Rodríguez M, Camargo F, Vargas G, Simón C, Remohí J,Pellicer A. Cuando proponer la ovodonación en pacientes bajas respondedoras.XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville,Spain. Oral Presentation

• Camargo F, Bellver J, Cuneo S, Ruiz A, Remohí J, Simón C, Pellicer A, Navarro J.Calidad embrionaria en una estimulación con respuesta asincronica. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Camargo F, Ibérico G, Remohí J, Simón C, Pellicer A, Navarro J. Calidad ovocitariaen una estimulación con respuesta asincronica. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Herrer R, Mínguez Y, Aragonés M, Zulategui J, García-Velasco J.A, Remohí J,Pellicer A, Simón C. Correlación de la distribución de los nucleolos con el desarrollo

141

embrionario. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Oral Presentation

• Muñoz J, Aragonés M, Mínguez Y, Herrer R, García-Velasco J.A, Remohí J, PellicerA, Simón C. Microinyección intracitoplasmática (ICSI) en ovocitos metafase I (MI).XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville,Spain. Oral Presentation

• Isaza V, García-Velasco J, Requena A, Martinez-Salazar J, Landazábal A, RemohíJ, Pellicer A, Simón C. Protocolo stop versus altas dosis de gonadotrofinas enpacientes de FIV con baja respuesta: estudio prospectivo, randomizado ycontrolado. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Oral Presentation

• Landazábal A, García-Velasco J, Martinez-Salazar J, Requena A, Isaza V, Grande J,Remohí J, Pellicer A, Simón C. Influencia de diferentes protocolos dehiperestimulación ovárica controlada en el microambiente endocrinológico delfolículo: efectos de la fshr (Gonal F) y del antagonista de la GnRH (Cetrorelix). XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Garrido N, O’Connor JE, Remohí J, Simón C, Pellicer A. Expresión, producción ysecreción del factor vascular de crecimiento endotelial (VEGF) e interleuquina-6 (IL-6) en las células de la granulosa en mujeres con endometriosis. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Ibérico G, Navarro J, Serra V, Rodríguez M, Ferro J, Simón C, Pellicer A, Remohí J.Reducción embrionaria: estudio comparativo con gestaciones simples y múltiples noreducidas. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Ibérico G, Navarro J, Bosch E, Rodríguez M, Ferro J, Simón C, Pellicer A, RemohíJ. Reducción embrionaria: complicaciones quirúrgicas y pronóstico neonatal segúnla edad gestacional a la que se practicó la reducción. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Ibérico G, Navarro J, Bosch E, Vidal C, Bellver J, Simón C, Pellicer A, Remohí J.Reducción embrionaria en gestaciones múltiples de alto riesgo: relación entre elnúmero de embriones reducidos y la morbilidad quirúrgica temprana. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Camargo F, Andreu S, Serra V, Vergara F, Simón C, Pellicer A, Remohí J.Pronóstico obstétrico y perinatal tras técnicas de reproducción asistida. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Vargas M, Ibérico G, Navarro J, Camargo F, Simón C, Pellicer A, Remohí J.Malformaciones fetales asociadas a reducción embrionaria. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Bosch E, Navarro J, Vidal C, Simón C, Remohí J, Pellicer A. Estimulación conCC+hMG en pacientes con baja respuesta a altas dosis de gonadotropinas. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Oral Presentation

• Cabañes I, Mínguez Y, Herrer R, Aragonés M, García-Velasco J.A, Remohí J,Pellicer A, Simón C. Resultados de ICSI en pacientes con eyaculación retrograda.XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville,Spain. Oral Presentation

• Mínguez Y, Rubio C, Vidal F, García-Velasco J, Martinez-Salazar J, Aragonés M,Requena A, Remohí J, Pellicer A, Simón C. Embarazo tras diagnósticopreimplantatorio en una pareja portadora de una translocación cromosómicaequilibrada. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Oral Presentation

142

• Rodrigo L, Rubio C, Vidal F, Blanco J, Remohí J, Pellicer A, Simón C, Gil-Salom M.Hibridación in situ fluorescente (FISH) de espermatozoides obtenidos de biopsia detestículo y de epididimo, en pacientes candidatos para ICSI. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Camargo F, Ibérico G, Cobo A, Remohí J, Simón C, Pellicer A, Navarro J.Pronóstico reproductivo de las pacientes infertiles con adenomiosis tras tres mesesde tratamiento con análogos de la GnRh. XXIII Congreso Nacional de la SociedadEspañola de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Muñoz E, Rodriguez M, Ferro J, Navarro J, Simón C, Pellicer A, Remohí J. Uso dealbúmina en paciente de riesgo para síndrome de hiperestimulación ovárica (SHO).XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville,Spain. Oral Presentation

• Bosch E, Caligara C, Navarro J, Simón C, Pellicer A, Remohí J. La relación grosorendometrial-tasa de implantación varía con la edad. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Camargo, F, Ibérico G, Cobo A, Remohí J, Simón C, Pellicer A, Navarro J.Pronóstico reproductivo de una respuesta ovárica asincrónica a la estimulación.XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville,Spain. Oral Presentation

• Muñoz E, Landeras J, Ballesteros A, Pellicer A, Simón C, Remohí J. Predictores desangrado en ciclo de preparación para donación de ovocitos. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Martínez Salazar J, Isaza V, Anarte C, Requena A, García-Velasco J, Landazabal A,Simón C. Comparación de los resultados del programa de donación de ovocitos,según el número de óvulos maduros obtenidos en cada donante. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. OralPresentation

• Meseguer M, Martín J, Galán A, Remohí J, Pellicer A, Simón C. MUC1 actúa comobarrera selectiva durante la implantación embrionaria y es regulada por el embriónhumano. XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May 2000;Seville, Spain. Oral Presentation

• Santos M.J, Mercader A, Galán A, Romero J.L, Ruiz A, Prados N, Cobo A, RemohíJ, Pellicer A, Simón C. Valor de la presencia en cocultivo de tres o más embrionesde 8 células en el resultado de la gestación. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Oral Presentation

• Bosch E, Caligara C, Navarro J, Simón C, Pellicer A, Remohí J. Valor predictivo delgrosor endometrial en donación de ovocitos. XXIII Congreso Nacional de laSociedad Española de Fertilidad. May 2000; Seville, Spain. Poster Presentation

• Caligara C, Vargas G, Camargo F, Vidal C, Navarro J, Simón C, Pellicer A, RemohíJ. ¿Afecta la hiperestimulación ovárica repetida la recuperación ovocitaria endonantes? XXIII Congreso Nacional de la Sociedad Española de Fertilidad. May2000; Seville, Spain. Poster Presentation

• Anarte C, Requena A, García-Velasco J, Martínez-Salazar J, Isaza V, Landazábal A,Remohí J, Pellicer A, Simón C. Influencia del tabaco en la madurez ovocitaria en unprograma de donación de óvulos. XXIII Congreso Nacional de la Sociedad Españolade Fertilidad. May 2000; Seville, Spain. Poster Presentation

• Anarte C, Grande J, Requena A, García-Velasco J, Martínez-Salazar J, LandazábalA, Remohí J, Pellicer A, Simón C. Estudio del perfil hepático y de coagulación enpacientes incluídas en un programa de donación de óvulos. XXIII CongresoNacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain. PosterPresentation

• Vidal C, Crespo J, Lara C, Ferro J, Serra V, Simón C, Remohí J, Pellicer A. Molaparcial en el primer trimestre en embarazos post-reproducción asistida. XXIIICongreso Nacional de la Sociedad Española de Fertilidad. May 2000; Seville, Spain.Poster Presentation

143

• Ferro J, Vargas G, Camargo F, Cuneo S, Vidal C, Ibérico G, Caligara C, Remohí J,Pellicer A, Simón C. Pseudo linfoma de endometrio. Imagen histeroscópica. Casoclínico. Congreso Nacional de Endoscopia Ginecológica. May – June 2000; Madrid,Spain. Oral Presentation

• Camargo F, Vargas G, Cuneo S, Caligara C, Remohí J, Pellicer A, Simón C, FerroJ. Corrección de un útero septado. Uso de tijera microquirúrgica versusresectoscopia. Congreso Nacional de Endoscopia Ginecológica. May – June 2000;Madrid, Spain. Oral Presentation

1999• Alvarez J.C, Muñoz E, Vergara F, Díaz I, Ibérico G, Simón C, Pellicer A, Remohí J.

Embarazo heterotópico asintomático con gestación múltiple. Revisión de laliteratura. V Reunión de la sección de reproducción de la Sociedad de Obstetricia yGinecologia de la Comunidad Valenciana. January 1999; Requena, Valencia, Spain.Oral Presentation

• Alvarez J.C, Vergara F, Díaz I, Muñoz E, Landazabal A, Simón C, Pellicer A,Remohí J.Transferencia intratubárica de embriones. Resultados preliminares. VReunión de la sección de reproducción de la Sociedad de Obstetricia y Ginecologiade la Comunidad Valenciana. January 1999; Requena, Valencia, Spain. OralPresentation

• Díaz I, Vergara F, Alvarez J.C, Simón C, Pellicer A, Remohí J. Miomectomíalaparoscópica y Reproducción Asistida. V Reunión de la sección de reproducción dela Sociedad de Obstetricia y Ginecologia de la Comunidad Valenciana. January1999; Requena, Valencia, Spain. Oral Presentation

• Herrer R, Domínguez F, Caballero-Campo P, Remohí J, Pellicer A, Simón C. Elsistema de vídeo “time lapse”, una nueva aproximación para el estudio deldesarrollo embrionario. VI Certamen Nacional de Video en Obstetricia yGinecología. April 1999; Lugo, Spain. Oral Presentation

• Alvarez JC, Caballero P, Rodríguez M, Simón C, Pellicer A, Remohí J.Transferencia intratubárica de embriones, una alternativa frente a la estenosiscervical. VI Certamen Nacional de Video en Obstetricia y Ginecología. April 1999;Lugo, Spain. Oral Presentation

• Galán A, OĆonor J.E, Meseguer M, Caballero P, Garrido N, Simón C. Análisis de laproliferación y apoptosis en cultivos de células epiteliales de Endometrio. VICongreso de la Sociedad Ibérica de Citometría. June 1999; Salamanca, Spain. OralPresentation

• Caballero-Campo P, Meseguer M, Garrido N, Galán A, Jasper M, Coloma J, OĆonor J.E, Simón C. Regulación embrionaria sobre células del epitelio endometrialhumano por las quimiocinas interleuquina-8 (IL-8) y proteina quimiotactica demonocitos (MCP-1): Aplicación de la citometria de flujo en la investigación enreproducción asistida. VI Congreso de la Sociedad Ibérica de Citometría. June1999; Salamanca, Spain. Oral Presentation

• Garrido N, O’Connor J.E, Meseguer M, Martín J.C, Galán A, Caballero-Campo P,Simón C, Pellicer A. Análisis de las subpoblaciones leucocitarias del folículo ováricoen pacientes con endometriosis: aplicaciones de la citometria de flujo en lainvestigación en ginecologia. VI Congreso de la Sociedad Ibérica de Citometría.June 1999; Salamanca, Spain. Oral Presentation

• Meseguer M, OĆonor J.E, Caballero-Campo P, Garrido N, Martín J.C, Galán A,Simón C. Regulacion de la mucina MUC1: Aplicaciones de la citometria de flujo a lainvestigación en reproducción asistida. VI Congreso de la Sociedad Ibérica deCitometría. June 1999; Salamanca, Spain. Oral Presentation

• Alvarez J.C, Vergara F, Rodríguez M, Pellicer A, Simón C, Remohí J. Transferenciaintratubárica de embriones en donación de ovocitos. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Andreu S, Vergara F, Muñoz E, Simón C, Pellicer A, Remohí J. Miomas y tasa deaborto en pacientes receptoras de donación de ovocitos. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

144

• Díaz I, Navarro J, Muñoz E, Simón C, Pellicer A, Remohí J. Impacto de los estadiosIII-IV de endometriosis en el resultado de receptoras de ovocitos procedentes de lamisma donante. XXV Congreso Español de Ginecología y Obstetricia. June 1999;Zaragoza, Spain. Oral Presentation

• Díaz I, Vergara F, Álvarez J.C, Simón C, Pellicer A, Remohí J. Miomectomíalaparoscópica y resultados de fecundación in vitro (F.I.V) en pacientes con fallos enciclos previos a la cirugía. XXV Congreso Español de Ginecología y Obstetricia.June 1999; Zaragoza, Spain. Oral Presentation

• Ibérico G, Vergara F, Landazábal A, Simón C, Pellicer A, Remohí J. Tasa degestación y aborto en pacientes con F.I.V. previo o posterior a salpinguectomía porhidrosálpinx. XXV Congreso Español de Ginecología y Obstetricia. June 1999;Zaragoza, Spain. Oral Presentation

• Muñoz E, Díaz i, Vidal C, Simón C, Pellicer A, Remohí J. Donación ovocitaria enpacientes con disgenesia gonadal. XXV Congreso Español de Ginecología yObstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Muñoz E, Vidal C, Muñoz M, Simón C, Pellicer A, Remohí J. La importancia de lospólipos endometriales en la reproducción asistida. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Vergara F, Alvarez J.C, Díaz I, Simón C, Pellicer A, Remohí J. Resultados de unprograma satélite en reproducción asistida. XXV Congreso Español de Ginecologíay Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Zuzuarregui J, Álvarez J.C, Prados N, Simón C, Pellicer A, Remohí J. Influencia dela Edad en la inseminación artificial de donante. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Mínguez Y, Rubio C, Vidal F, Caballero P, Remohí J, Pellicer A, Simón C.Diagnóstico preimplantatorio: indicaciones y resultados. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Poster Presentation

• Requena A, Neuspiller F, Cobo A, Aragonés M, Remohí J, Pellicer A, Simón C.Aplicación de la maduración in vitro de ovocitos en bajas respondedoras a laestimulación ovárica. XXV Congreso Español de Ginecología y Obstetricia. June1999; Zaragoza, Spain. Poster Presentation

• Requena A, García Velasco J.A, Martínez-Salazar F.J, Caballero P, Simón C,Pellicer A. Efectos de la diabetes sobre la maduración del ovocito. XXV CongresoEspañol de Ginecología y Obstetricia. June 1999; Zaragoza, Spain. PosterPresentation

• Landazabal A, Muñoz E, Rodríguez M, Simón C, Remohí J, Pellicer A.Malformación uterina por exposición in útero al dietilestilbestriol (DES) a falloovárico oculto y gestación por reproducción asistida. XXV Congreso Español deGinecología y Obstetricia. June 1999; Zaragoza, Spain. Oral Presentation

• Rubio C, Vidal F, Mínguez Y, Blanco J, Giménez C, Romero J, Remohí J, EgozcueJ, Pellicer A, Simón C. Incidencia de anomalías cromosómicas en embriones yespermatozoides de parejas con aborto de repetición. XX Congreso Nacional deGenética Humana. June 1999; Valencia, Spain. Oral Presentation

• Díaz I, Ferro J, Landazabal A, Muñoz E, Simón C, Pellicer A, Remohí J. Efecto de lamiomectomia laparoscópica en los resultados de fecundación in vitro. 3er congresode la Sociedad Latina de Biología y Medicina de la Reproducción (SO.LA.ME.R).October 1999; Barcelona, Spain. Oral Presentation

• Landazabal A, Ferro J, Muñoz E, Ibérico G,Simón C, Pellicer A, Remohí J.Tratamiento laparoscópico del embarazo ectópico intersticial después de FIV/ET.3er congreso de la Sociedad Latina de Biología y Medicina de la Reproducción(SO.LA.ME.R). October 1999; Barcelona, Spain. Oral Presentation

1998• Muñoz M, Alvarez JC, Ardiles G, Neuspiller F, Pellicer A, Simón C, Remohí J.

Incidencia de cancelación de ciclos en donación de ovocitos: influencia de la edad.V Congreso Nacional de la Asociación Española para el Estudio de la Menopausia.April 1998; Valencia, Spain. Oral Presentation

• Navarro J, Ardiles G, Neuspiller F, Alvarez J.C, Rodríguez M, Pellicer A, Simón C,

145

Remohí J. Donación de ovocitos en mujeres perimenopáusicas. V CongresoNacional de la Asociación Española para el Estudio de la Menopausia. April 1998;Valencia, Spain. Oral Presentation

• Neuspiller F, Navarro J, Ardiles G, Muñoz M, Pellicer A, Simón C, Remohí J.Donación de ovocitos en mujeres con menopausia precoz. V Congreso Nacional dela Asociación Española para el Estudio de la Menopausia. April 1998; Valencia,Spain. Oral Presentation

• Ardiles G, Neuspiller F, Navarro J, Díaz I, Requena A, Pellicer A, Simón C, RemohíJ. Días de estradiol y donación de ovocitos en la perimenopausia. V CongresoNacional de la Asociación Española para el Estudio de la Menopausia. April 1998;Valencia, Spain. Oral Presentation

• Rodríguez M, Muñoz M, Requena A, Navarro J, Vidal C, Simón C, Pellicer A,Remohí J. Transferir 3 ó 4 embriones en FIV ¿Cual es la mejor opción?. XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Albert C, Mercader A, Remohí J, Simón C, Pellicer A. Origen del síndrome dehiperestimulación ovárica (SHO). XXII Congreso Nacional de la Sociedad Españolade Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Gaitán P, Moreno C, Zulategui J, Ruíz A, Simón C, Remohí J, Pellicer A.Transferencias de embriones criopreservados en ciclos natural y sustituido.Resultados. XXII Congreso Nacional de la Sociedad Española de Fertilidad. May1998; Madrid, Spain. Oral Presentation

• Ardiles G, Neuspiller F, Vergara F, Muñoz M, Díaz I, Crespo J, Simón C, Pellicer A,Remohí J. Receptividad endometrial en donación de ovocitos. Factores predictivos.XXII Congreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Vergara F, Andreu S, Diaz I, Alvarez J.C, Requena A, Simón C, Pellicer A, RemohíJ. Resultados perinatales en un programa de donación de ovocitos (DO). XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Alvarez J. C, Neuspiller F, Ardiles G, Vergara F, Requena A, Simón C, Pellicer A,Remohí J. Resultados reproductivos del programa de donación de ovocitos enpacientes con fallo ovárico precoz (FOP) y menopausia quirúrgica. XXII CongresoNacional de la Sociedad Española de Fertilidad. May 1998; Madrid, Spain. OralPresentation

• Díaz I, Rodríguez M, Neuspiller F, Ardiles G, Alvarez J.C, Simón C, Pellicer A,Remohí J. Donación ovocitaria en pacientes mayores de 50 años. Resultados. XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Mercader A, Herrer R, Remohí J, Pellicer A, Simón C. Co-cultivo de embriones concélulas del epitelio endometrial humano hasta el estadio de blastocisto. XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Albert C, Mercader A, Remohí J, Simón C, Pellicer A. Producción sistemática yovárica de vascular endothelial growth factor (VEGF), Interleukina (IL)-1B, e IL-6 enmujeres con síndrome de ovarios poliquísticos (PCO). XXII Congreso Nacional de laSociedad Española de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Neuspiller F, Ardiles G, Vergara F, Alvarez J.C, Muñoz M, Simón C, Pellicer A,Remohí J. Supresión ovárica con diferentes análogos en el programa de donaciónde ovocitos. XXII Congreso Nacional de la Sociedad Española de Fertilidad. May1998; Madrid, Spain. Oral Presentation

• Díaz I, Ardiles G, Neuspiller F, Sánchez R, Moreno C, Simón C, Pellicer A, RemohíJ. Miomectomia laparoscópica y reproducción asistida. XXII Congreso Nacional dela Sociedad Española de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Alvarez J.C, Muñoz M, Neuspiller F, Ardiles G, Díaz I, Simón C, Pellicer A, RemohíJ. Malformaciones müllerianas, tratamiento histeroscópico y fertilidad posterior. XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,

146

Spain. Oral Presentation• Mercader A, Herrer R, Ruíz A, Simón C. Estudio del desarrollo en embriones

cocultivados con células del epitelio endometrial humano. XXII Congreso Nacionalde la Sociedad Española de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Mínguez Y, Vidal F, Rubio C, Giménez C, Remohí J, Egozcue J, Pellicer A, SimónC. Diagnóstico genético preimplantatorio indicaciones y resultados. XXII CongresoNacional de la Sociedad Española de Fertilidad. May 1998; Madrid, Spain. OralPresentation

• Moreno C, Gaitán P, Alvarez J, Zulategui J, Pellicer A, Remohí J, Simón C.Resultados reproductivos en receptoreas de nuestro programa de donación deovocitos de acuerdo al origen de los ovocitos recibidos. XXII Congreso Nacional dela Sociedad Española de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Vergara F, Andreu S, Díaz I, Rodríguez M, Crespo J, Simón C, Pellicer A, Remohí J.Patología obstétrica en gestaciones logradas por donación de ovocitos. XXIICongreso Nacional de la Sociedad Española de Fertilidad. May 1998; Madrid,Spain. Oral Presentation

• Muñoz M, Alvarez J.C, Ardiles G, Neuspiller F, Requena A, Simón C, Pellicer A,Remohí J. Embarazo ectópico y reproducción asistida. XXII Congreso Nacional dela Sociedad Española de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

• Requena A, Neuspiller F, Cobo A, Aragonés M, Rubio C, Simón C, Pellicer A,Remohí J. Estudio endocrinológico del ciclo ovárico tras aspiración folicular en unprograma de maduración ovocitaria in-vitro. XXII Congreso Nacional de la SociedadEspañola de Fertilidad. May 1998; Madrid, Spain. Oral Presentation

1997• Zuzuarregui JL, Gaitán P, García-Velasco JA, Simón C, Pellicer A. Prevalencia de la

seropositividad VIH en la población esteril. IV Congreso nacional sobre el SIDA.April 1997; Valencia, Spain. Oral Presentation

• Mercader A, Simón C, Albert C, Herrer R, Caballero P, Remohí J, Pellicer A.Cocultivo de embriones sobre células epiteliales del endometrio humano enpacientes con repetidos fallos de implantacion. Sociedad Española de Ginecologíay Obstetricia. June 1997; Marbella, Spain. Oral Presentation

• Rubio c, Simón C, Vidal F, Giménez C, Romero JLI, Mercader A, Remohí J, PellicerA. Desarrollo embrionario e incidencia de alteraciones cromosómicas en unprograma de diagnóstico preimplantatorio. Sociedad Española de Ginecología yObstetricia. June 1997; Marbella, Spain. Oral Presentation

• Rubio C, Vidal R, Giménez C, Mínguez Y, Bernal A, Remohí J, Pellicer A, Simón C.Diagnóstico preimplantatorio mediante hibridación "in situ" con fluirescencia (FISH)en una paciente portadora de una translocación Robertsoniana entre loscromosomas 13 y 14 Sociedad Española de Ginecología y Obstetricia. June 1997;Marbella, Spain. Oral Presentation

• Grimalt L, Landores J, Bernal A, Simón C, Remohí J, Pellicer A. Microinyecciónintracitoplasmática y amniocentesis precoz. Sociedad Española de Ginecología yObstetricia. June 1997; Marbella, Spain. Oral Presentation

• Martínez-Salazar FJ, Landeras J, Levy M, Yalil S, Neuspiller F, García Velasco JA,Simón C, Pellicer A, Remohí J. Capacidad Reproductiva femenina tras ligaduratubárica. Sociedad Española de Ginecología y Obstetricia. June 1997; Marbella,Spain. Poster Presentation

• Landeras J, Martínez-Salazar FJ, Levy M, Yalil S, Neuspiller F, García Velasco JA,Simón C, Pellicer A, Remohí J. Capacidad Reproductiva masculina tras vasectomia.Sociedad Española de Ginecología y Obstetricia. June 1997; Marbella, Spain.Poster Presentation

• Vidal F, Giménez C, Rubio C, Calafell JM, Grossman M, Simón C, Cívico S, MarinaF, Egozcue J, Santaló J. Diagnóstico preimplantacional en enfermedades ligadas alsexo. XXIV Symposium Internacional de Fertilidad 97. Institut Universitari Dexeus.November 1997; Barcelona, Spain. Oral Presentation

• Rubio C, Vidal F, Giménez C, Egozcue J, Pellicer A, Simón C. Diagnósticopreimplantatorio de alteraciones cromosómicas embrionarias en pacientes con

147

aborto de repetición XXIV Symposium Internacional de Fertilidad 97. InstitutUniversitari Dexeus. November 1997; Barcelona, Spain. Oral Presentation

1996• Raga F, Bauset C, Simón C, Bonilla-Musoles F. Endometriosis en las pacientes

afectas de anomalías müllerianas. XXI Congreso Nacional de la Sociedad Españolade Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Valbuena D, Guanes PP, Remohí J, Pellicer A, Simón C. Efectos de los analogos dela GnRH sobre la función del cuerpo lúteo humano. XXI Congreso Nacional de laSociedad Española de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Crespo J, Mínguez Y, Amorocho B, Pérez Cano I, Zuzuarregui JL, Romero J, SimónC, Pellicer A, Remohí J. ICSI con semen congelado versus semen fresco en unprograma de donación de ovocitos. XXI Congreso Nacional de la SociedadEspañola de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Gallardo E, Guanes PP, Levy M, Yalil S, Simón C, Pellicer A, Remohí J. Influenciade la edad masculina sobre la capacidad de fertilización espermática: La donaciónde ovocitos como modelo. XXI Congreso Nacional de la Sociedad Española deFertilidad. June 1996; Tenerife, Spain. Oral Presentation

• García-Velasco JA, Guanes PP, Gallardo E, Yalil S, Gartner B, Simón C, Pellicer A,Remohí J. Doppler de arterias uterinas y edad materna en pacientes sometidas adonación de ovocitos. XXI Congreso Nacional de la Sociedad Española deFertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Rodríguez M, Ruiz A, Remohí J, Pellicer A, Simón C. Tras un primer fallo deimplantación, ¿Cuántos embriones deberíamos transferir en el segundo intento?.XXI Congreso Nacional de la Sociedad Española de Fertilidad. June 1996; Tenerife,Spain. Oral Presentation

• Levy M, Gallardo E, Guanes PP, García VJ, Valbuena D, Remohí J, Simón C,Pellicer A. Incidencia del embarazo ectópico en reproducción asistida. XXI CongresoNacional de la Sociedad Española de Fertilidad. June 1996; Tenerife, Spain. OralPresentation

• Romero J, Mercader A, De los Santos MJ, Ruíz A, Mínguez Y, Rubio C, Gimeno MJ,Remohí J, Simón C. Resultados de un programa de cocultivo embrionario conepitelio endometrial humano. XXI Congreso Nacional de la Sociedad Española deFertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Valbuena D, Gimeno MJ, Mercader A, Remohí J, Pellicer A, Devoto L, Simón C.Localización inmunohistoquímica del sistema de la IL-1 en el cuerpo lúteo humano.XXI Congreso Nacional de la Sociedad Española de Fertilidad. June 1996; Tenerife,Spain. Oral Presentation

• Levy M, Gallardo E, Yalil S, Valbuena D, García JA, Cobo AC, Simón C, Pellicer A,Remohí J. Administración prolongada de estrógenos para la preparaciónendometrial en donación de ovocitos. Resultados. XXI Congreso Nacional de laSociedad Española de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Levy M, Gallardo E, Guanes PP, De los Santos MJ, Yalil S, Simón C, Pellicer A,Remohí J. Donación de ovocitos en aborto recurrente. XXI Congreso Nacional de laSociedad Española de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• García-Velasco JA, Gallardo E, Guanes PP, Levy M, Parrilla JJ, Brassesco M,Simón C, Remohí J. Embarazo tras donación de ovocitos en disgenesiasgonadales. XXI Congreso Nacional de la Sociedad Española de Fertilidad. June1996; Tenerife, Spain. Oral Presentation

• Yalil S, Gallardo E, Guanes PP, Gartner B, Valbuena D, Simón C, Pellicer A,Remohí J. Niveles séricos de estradiol en receptoras de ovocitos. Su influenciasobre la capacidad de implantación en donación de ovocitos. XXI CongresoNacional de la Sociedad Española de Fertilidad. June 1996; Tenerife, Spain. OralPresentation

• Yalil S, Guanes PP, Gallardo E, García-Velasco JA, Cobo A, Simón C, Pellicer A,Remohí J. Donación de ovocitos: Resultados de 5 años de experiencia. XXICongreso Nacional de la Sociedad Española de Fertilidad. June 1996; Tenerife,Spain. Oral Presentation

148

• Grimalt L, Jiménez MA, Simón C, Remohí J, Pellicer A, Ruiz A. Primer año deprocedimientos FIV en el IVI Castellón. XXI Congreso Nacional de la SociedadEspañola de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• Valbuena D, Gallardo E, Gartner B, Levy M, Yalil S, Cobo A, Simón C, Pellicer A,Remohí J. Donación de ovocitos de acuerdo a la edad de las receptoras. XXICongreso Nacional de la Sociedad Española de Fertilidad. June 1996; Tenerife,Spain. Oral Presentation

• Rubio C, Francés A, Vidal F, Jiménez C, Remohí J, Pellicer A, Egozcue J, Simón C.Biópsia embrionaria y diagnóstico preimplantatorio para la determinación del sexoen embriones humanos. Resultados preliminares. XXI Congreso Nacional de laSociedad Española de Fertilidad. June 1996; Tenerife, Spain. Oral Presentation

• De los Santos MJ, Romero J, Mercader A, Remohí J, Simón C. Los cocultivos enlos fallos de implantación. XXI Congreso Nacional de la Sociedad Española deFertilidad. June 1996; Tenerife, Spain. Oral Presentation

1994• Romero J, Oliveira N, Simón C, Grimalt L, Remohí J, Pellicer A, Tarín J. Correlación

entre la morfología del acrosoma y la fecundación in vitro. XX Congreso Nacional dela Sociedad Española de Fertilidad. May 1994; Valencia, Spain. Oral Presentation

• De los Santos MJ, Rubio C, Simón C, Remohí J, Pellicer A, Tarín J. Inducción de lareacción acrosómica previa a la microinyección espermática en el espacioperivitelino (SUZI XX Congreso Nacional de la Sociedad Española de Fertilidad.May 1994; Valencia, Spain. Oral Presentation

• Ballesteros A, Molero MD, Rubio MC, Oliveira N, Mercader A, Simón C, Pellicer A,Remohí. Hiperestimulación ovárica severa en ciclos estimulados para FIV. I Reuniónde la Sección de Reproducción de la Sociedad de Obstetricia y Ginecología de laComunidad Valenciana. October 1994; Valencia, Spain. Oral Presentation

• Cano F, Ruiz A, Gallardo E, Grimalt L, Amorocho B, Simón C, Pellicer A, Remohí J.Utilidad del factor liberador de la hormona de crecimiento (GRF) en el FIV. I Reuniónde la Sección de Reproducción de la Sociedad de Obstetricia y Ginecología de laComunidad Valenciana. October 1994; Valencia, Spain. Oral Presentation

• Cano F, Romero J, Gómez PP, Valbuena D, Simón C, Pellicer A, Remohí J.Ventajas de la implementación del desarrollo folicular multiple (DFM) congonadotrofinas en un programa de IAC.I Reunión de la Sección de Reproducción de la Sociedad de Obstetricia yGinecología de la Comunidad Valenciana. October 1994; Valencia, Spain. OralPresentation

• Zuzuarregui JL, Romero JL, Cano F, Mínguez Y, Chamorro MN, Simón C, PellicerA, Remohí J. Estimulación con Gonadotrofinas en IAD. I Reunión de la Sección deReproducción de la Sociedad de Obstetricia y Ginecología de la ComunidadValenciana. October 1994; Valencia, Spain. Oral Presentation

1991• Navarro JE, Simón C, Matallín P, Valero V, Colom E, Bonilla-Musoles F. Test de

Estimulación sónica. Valor predictivo del estado fetal. XXI Congreso Español deGinecología y Obstetricia. May 1991; Alicante, Spain. Oral Presentation

• Simón C, Matallín P, Martorell M, Torres JV. Carcinoma verrucoso vulvar¿Neoplasia o Condiloma?XXI Congreso Español de Ginecología y Obstetricia. May 1991; Alicante, Spain.Oral Presentation

• Simón C, Pellicer A, Matallín P, Bonilla-Musoles F. Reducción embrionaria en uncaso de septuples. XXI Congreso Español de Ginecología y Obstetricia. XXI Congreso Español deGinecología y Obstetricia. May 1991; Alicante, Spain. Oral Presentation

• Matallín P, Simón C, Martorell M, Torres JV. Citometría de flujo en melanomasmalignos vulvares. XXI Congreso Español de Ginecología y Obstetricia. May 1991;Alicante, Spain. Oral Presentation

• Simón C, Pellicer A, Remohí J, Bonilla-Musoles F, Navarro E. Reducción

149

embrionaria. XXI Congreso Español de Ginecología y Obstetricia. May 1991;Alicante, Spain. Oral Presentation

• Raga F, Simón C, Dolz M, Pérez-Gil M, Tortajada M, Bonilla-Musoles.Incompetencia cervical; comparación diagnóstica entre ecografía abdominalperinatal y vaginal. XXI Congreso Español de Ginecología y Obstetricia. May 1991;Alicante, Spain. Oral Presentation

• Simón C, Pardo F, Martínez L, Tortajada M, Pellicer A. Incidencia e impactoreproductivo de las malformaciones uterinas en la población fértil. Reunion Nacionalde la Sociedad Española de Fertilidad. November 1991; Granada, Spain. OralPresentation

• Simón C, Tortajada M, Pellicer A. Influencia del número de gestaciones previassobre la incidencia de abortos en pacientes normales. Reunion Nacional de laSociedad Española de Fertilidad. November 1991; Granada, Spain. OralPresentation

1990• Simón C, Tarín JJ, Matallín P, Sampaio M, Castellvi RM, Pellicer A. Relación entre

anomalías cromosómicas en ovocitos humanos, causa de esterilidad, protocolo deestimulación y dosis de gonadotrofinas. XIX Congreso Nacional de la SociedadEspañola de Fertilidad. October 1990; San Sebastián, Spain. Oral Presentation

• Gómez E, Tarín JJ, Ruiz A, Castellvi RM, Miró F, Simón C, Bonilla-Musoles F.Congelación ultrarápida de embriones humanos. Nuestra experiencia. XIXCongreso Nacional de la Sociedad Española de Fertilidad. October 1990; SanSebastián, Spain. Oral Presentation

• Matallín P, Tarín JJ, Simón C, Castellvi RM, Sampaio M, Bonilla F. Efectos deltabaco en los ovocitos humanos: Analisis citogenético. XIX Congreso Nacional de laSociedad Española de Fertilidad. October 1990; San Sebastián, Spain. OralPresentation

• Gómez E, Tarín J, Simón C, Molero MD, Remohí J. Experiencia programa FIV(1988-1989). Revisión de resultados en 368 casos. XIX Congreso Nacional de laSociedad Española de Fertilidad. October 1990; San Sebastián, Spain. OralPresentation

• Simón C, Tarín J, Gómez E, Molero MD, Remohí J. Estimulación ovárica en unprograma FIV. XIX Congreso Nacional de la Sociedad Española de Fertilidad. XIX CongresoNacional de la Sociedad Española de Fertilidad. October 1990; San Sebastián,Spain. Oral Presentation

1989• Simón C, Sampaio M, Pérez-Gil M, Bonilla-Musoles F. Patología de la vesícula

vitelina y su repercusión sobre el embarazo. XX Congreso Español de Ginecología yObstetricia. May 1989; Palma de Mallorca, Spain. Oral Presentation

• Simón C, Sampaio M, López-Viveros C, Bonilla-Musoles F. Diagnóstico precoz delcarcinoma de ovario con endosonografía vaginal. XX Congreso Español deGinecología y Obstetricia. May 1989; Palma de Mallorca, Spain. Oral Presentation

1988• Alonso MD, Simón C, Marco A, Marcos JM, Seler JM, Gallego J, Lavernia M,

Torres JV, Palanca JM, Chulia V. Estudio de las alteraciones lipídicas tras anestesiageneral con isofluorano en pacientes oncológicas. XIX Congreso Nacional deAnestesiología-Reanimación y Terapia del Dolor. May 1988; Santander, Spain. OralPresentation

1987• Blanes J, Simón C, Matallín P, Bonilla-Musoles F. Parámetros ecográficos en el

control de la ovulación y del cuerpo lúteo normales y patológicos para un programaFIV-TE. XIX Congreso Nacional de la Asociación Ginecológica Española. October,1987; Oviedo, Spain. Oral Presentation

• Simón C, Pérez-Gil M, Tortajada M. Biopsia corial. XIX Congreso Nacional de laAsociación Ginecológica Española. October, 1987; Oviedo, Spain. Oral Presentation

150

1985• Simón C. Cirugía fetal intraútero en la hidrocefalia y patología renal congénita. XVIII

Reunión de Ginecólogos Españoles. April 1985; Granada, Spain. Oral Presentation

151

CV Prof Carlos Simon (1) · 2017-12-29 · 2011 Serono Symposia International Foundation (SSIF)...

Documents

Transcript of CV Prof Carlos Simon (1) · 2017-12-29 · 2011 Serono Symposia International Foundation (SSIF)...